cytokines measurements entityone treatment showed trend decreasing levels entitytwo 4
levels entityone slightly increased following entitytwo treatment
complete response entityone levels entitytwo higher
complete response entityone levels otherprotein higher 24 weeks following entitytwo treatment
complete response entityone levels otherprotein higher 24 weeks following ifnalpha treatment that pretreatment = and levels entitytwo decreased markedly
levels entityone higher 24 weeks following entitytwo treatment
levels entityone higher 24 weeks following otherprotein treatment that pretreatment = and levels entitytwo decreased markedly
weeks following entityone treatment that pretreatment = and levels entitytwo decreased markedly
distributions entityone well mRNAs entitytwo otherprotein collagen
distributions entityone well mRNAs otherprotein entitytwo collagen types
distributions entityone well mRNAs otherprotein otherprotein collagen types entitytwo III
distributions entityone well mRNAs otherprotein otherprotein collagen types otherprotein III entitytwo a
mRNAs entityone entitytwo collagen types
mRNAs entityone otherprotein collagen types entitytwo III
mRNAs entityone otherprotein collagen types otherprotein III entitytwo a
mrnas otherprotein entityone collagen types entitytwo III
mrnas otherprotein entityone collagen types otherprotein III entitytwo a
collagen types entityone III entitytwo a
entityone detected mesenchymal cells the outer fibrous layer chondrocytes the inner cartilaginous matrix positive entitytwo otherprotein
entityone detected mesenchymal cells the outer fibrous layer chondrocytes the inner cartilaginous matrix positive otherprotein entitytwo respectively
matrix positive entityone entitytwo respectively
involvement entityone signaling pathogenesis cartilage cap osteochondroma suggests the role entitytwo the
ratio serum entityone entitytwo otherprotein
ratio serum entityone otherprotein entitytwo otherprotein
ratio serum entityone otherprotein otherprotein entitytwo not
serum otherprotein entityone entitytwo otherprotein
serum otherprotein entityone otherprotein entitytwo not
otherprotein otherprotein entityone entitytwo not
ratio serum entityone entitytwo otherprotein
ratio serum entityone otherprotein entitytwo otherprotein
ratio serum entityone otherprotein otherprotein entitytwo determine
serum otherprotein entityone entitytwo otherprotein
serum otherprotein entityone otherprotein entitytwo determine
otherprotein otherprotein entityone entitytwo determine
analysis the entityone entitytwo ratio
main outcome measures entityone entitytwo molar ratio
days hospitalisation molar entityone entitytwo ratio mean+sd
days hospitalisation molar entityone otherprotein ratio mean+sd infected children creactive proteins>10 mgl 067+031 the highdose group n=81 074+044 the low dose group n=71 073+039 the placebo group n=81 values not differ significantly oneway anova p=0472 patients baseline serum retinol concentrations<070 micromoll changes entitytwo otherprotein ratio
days hospitalisation molar entityone ttr ratio mean+sd infected children creactive proteins>10 mgl 067+031 the highdose group n=81 074+044 the low dose group n=71 073+039 the placebo group n=81 values not differ significantly oneway anova p=0472 patients baseline serum retinol concentrations<070 micromoll changes RBP entitytwo ratio
days hospitalisation molar entityone otherprotein ratio mean+sd infected children creactive proteins>10 mgl 067+031 the highdose group n=81 074+044 the low dose group n=71 073+039 the placebo group n=81 values differ significantly oneway anova p=0472 patients baseline serum retinol concentrations<070 micromoll changes RBP otherprotein ratio admission day were not statistically different the three groups oneway anova p=0548 conclusions this population malnourished hospitalised children molar entitytwo otherprotein ratio
days hospitalisation molar entityone ttr ratio mean+sd infected children creactive proteins>10 mgl 067+031 the highdose group n=81 074+044 the low dose group n=71 073+039 the placebo group n=81 values differ significantly oneway anova p=0472 patients baseline serum retinol concentrations<070 micromoll changes RBPTTR ratio admission day were not statistically different the three groups oneway anova p=0548 conclusions this population malnourished hospitalised children molar rbp entitytwo ratio
hospitalisation molar rbp entityone ratio mean+sd infected children creactive proteins>10 mgl 067+031 the highdose group n=81 074+044 the low dose group n=71 073+039 the placebo group n=81 values not differ significantly oneway anova p=0472 patients baseline serum retinol concentrations<070 micromoll changes entitytwo ttr ratio
hospitalisation molar otherprotein entityone ratio mean+sd infected children creactive proteins>10 mgl 067+031 the highdose group n=81 074+044 the low dose group n=71 073+039 the placebo group n=81 values not differ significantly oneway anova p=0472 patients baseline serum retinol concentrations<070 micromoll changes otherprotein entitytwo ratio
hospitalisation molar rbp entityone ratio mean+sd infected children creactive proteins>10 mgl 067+031 the highdose group n=81 074+044 the low dose group n=71 073+039 the placebo group n=81 values differ significantly oneway anova p=0472 patients baseline serum retinol concentrations<070 micromoll changes RBPTTR ratio admission day were not statistically different the three groups oneway anova p=0548 conclusions this population malnourished hospitalised children molar entitytwo ttr ratio
hospitalisation molar otherprotein entityone ratio mean+sd infected children creactive proteins>10 mgl 067+031 the highdose group n=81 074+044 the low dose group n=71 073+039 the placebo group n=81 values differ significantly oneway anova p=0472 patients baseline serum retinol concentrations<070 micromoll changes otherprotein ttr ratio admission day were not statistically different the three groups oneway anova p=0548 conclusions this population malnourished hospitalised children molar otherprotein entitytwo ratio
micromoll changes entityone entitytwo ratio
micromoll changes entityone otherprotein ratio admission day were statistically different the three groups oneway anova p=0548 conclusions this population malnourished hospitalised children molar entitytwo otherprotein ratio
micromoll changes entityone ttr ratio admission day were statistically different the three groups oneway anova p=0548 conclusions this population malnourished hospitalised children molar rbp entitytwo ratio
changes RBP entityone ratio admission day were statistically different the three groups oneway anova p=0548 conclusions this population malnourished hospitalised children molar entitytwo ttr ratio
changes otherprotein entityone ratio admission day were statistically different the three groups oneway anova p=0548 conclusions this population malnourished hospitalised children molar otherprotein entitytwo ratio
hospitalised children molar entityone entitytwo ratio
express senescenceassociated entityone entitytwo otherprotein
express senescenceassociated entityone entitytwo
morphology express entityone entitytwo
levels entityone entitytwo otherprotein
levels entityone otherprotein entitytwo otherprotein rise
levels entityone otherprotein otherprotein entitytwo rise
levels entityone otherprotein otherprotein otherprotein rise HUCs progressive passages whereas entitytwo increases
levels otherprotein entityone entitytwo otherprotein rise
levels otherprotein entityone otherprotein entitytwo rise
levels p16 entityone otherprotein otherprotein rise HUCs progressive passages whereas entitytwo increases
otherprotein otherprotein entityone entitytwo rise
p16 otherprotein entityone otherprotein rise HUCs progressive passages whereas entitytwo increases
otherprotein otherprotein entityone rise HUCs progressive passages whereas entitytwo increases
induced expression entityone similar entitytwo produces
entityone entitytwo otherprotein otherprotein
entityone otherprotein entitytwo otherprotein
entityone otherprotein otherprotein entitytwo otherprotein
entityone otherprotein otherprotein otherprotein entitytwo otherprotein decrease
entityone otherprotein otherprotein otherprotein otherprotein entitytwo decrease
otherprotein entityone entitytwo otherprotein
otherprotein entityone otherprotein entitytwo otherprotein
otherprotein entityone otherprotein otherprotein entitytwo otherprotein decrease
otherprotein entityone otherprotein otherprotein otherprotein entitytwo decrease
otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein entityone otherprotein entitytwo otherprotein decrease
otherprotein otherprotein entityone otherprotein otherprotein entitytwo decrease
otherprotein otherprotein otherprotein entityone entitytwo otherprotein decrease
otherprotein otherprotein otherprotein entityone otherprotein entitytwo decrease
otherprotein otherprotein entityone entitytwo decrease
find entityone entitytwo otherprotein
find entityone otherprotein entitytwo otherprotein
find entityone otherprotein otherprotein entitytwo otherprotein
find entityone otherprotein otherprotein otherprotein entitytwo transiently
find otherprotein entityone entitytwo otherprotein
find otherprotein entityone otherprotein entitytwo otherprotein
find otherprotein entityone otherprotein otherprotein entitytwo transiently
otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein entityone otherprotein entitytwo transiently
otherprotein otherprotein entityone entitytwo transiently
analysis entityone entitytwo otherprotein otherprotein
analysis entityone otherprotein entitytwo otherprotein otherprotein
analysis entityone otherprotein otherprotein entitytwo otherprotein otherprotein
analysis entityone otherprotein otherprotein otherprotein entitytwo otherprotein otherprotein
analysis entityone otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein
analysis entityone otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein
analysis entityone otherprotein otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein reveals
analysis entityone otherprotein otherprotein otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo reveals altered
analysis otherprotein entityone entitytwo otherprotein otherprotein
analysis otherprotein entityone otherprotein entitytwo otherprotein otherprotein
analysis otherprotein entityone otherprotein otherprotein entitytwo otherprotein otherprotein
analysis otherprotein entityone otherprotein otherprotein otherprotein entitytwo otherprotein
analysis otherprotein entityone otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein
analysis otherprotein entityone otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein reveals
analysis otherprotein entityone otherprotein otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo reveals altered
otherprotein otherprotein entityone entitytwo otherprotein otherprotein
otherprotein otherprotein entityone otherprotein entitytwo otherprotein otherprotein
otherprotein otherprotein entityone otherprotein otherprotein entitytwo otherprotein
otherprotein otherprotein entityone otherprotein otherprotein otherprotein entitytwo otherprotein
otherprotein otherprotein entityone otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein reveals
otherprotein otherprotein entityone otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo reveals altered
otherprotein otherprotein otherprotein entityone entitytwo otherprotein otherprotein
otherprotein otherprotein otherprotein entityone otherprotein entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein otherprotein entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein otherprotein otherprotein entitytwo otherprotein reveals
otherprotein otherprotein otherprotein entityone otherprotein otherprotein otherprotein otherprotein entitytwo reveals altered
otherprotein otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein otherprotein entitytwo otherprotein reveals
otherprotein otherprotein otherprotein entityone otherprotein otherprotein otherprotein entitytwo reveals altered
otherprotein otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein entitytwo otherprotein reveals
otherprotein otherprotein otherprotein entityone otherprotein otherprotein entitytwo reveals altered
otherprotein otherprotein otherprotein entityone entitytwo otherprotein reveals
otherprotein otherprotein otherprotein entityone otherprotein entitytwo reveals altered
otherprotein otherprotein entityone entitytwo reveals altered
mediated endothelin entityone entitytwo receptors
mediated endothelin entityone entitytwo receptors
entityone entitytwo otherprotein
entityone otherprotein entitytwo a
otherprotein entityone entitytwo a
entityone significantly potent entitytwo both
preincubation the entityone antagonist fr139317 microM decreased significantly < the potency entitytwo both
entityone agonist irl had positive inotropic effect in trabeculae the entitytwo antagonist
suggest both entityone entitytwo receptors mediate
apoptotic proteins entityone entitytwo related pathways
entityone entitytwo two
comparative study entityone entitytwo expression
cell adhesion molecule entityone protease entitytwo otherprotein
cell adhesion molecule entityone protease otherprotein entitytwo expression
protease entityone entitytwo expression
rates extensive entityone expression decreased entitytwo expression
lines analysis entityone entitytwo otherprotein
lines analysis entityone otherprotein entitytwo otherprotein
lines analysis entityone otherprotein otherprotein entitytwo otherprotein
lines analysis entityone otherprotein otherprotein otherprotein entitytwo
analysis otherprotein entityone entitytwo otherprotein
analysis otherprotein entityone otherprotein entitytwo otherprotein
analysis otherprotein entityone otherprotein otherprotein entitytwo
otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein entityone otherprotein entitytwo
otherprotein otherprotein entityone entitytwo
entityone entitytwo otherprotein
entityone otherprotein entitytwo otherprotein
entityone otherprotein otherprotein entitytwo genes
otherprotein entityone entitytwo otherprotein
otherprotein entityone otherprotein entitytwo genes
otherprotein otherprotein entityone entitytwo genes
showed mutations entityone entitytwo frequencies
mutational profile involved entityone entitytwo otherprotein
mutational profile involved entityone otherprotein entitytwo concurrently aberrated
profile involved otherprotein entityone entitytwo concurrently aberrated
mechanism calciumstimulated entityone release gastrinoma cells vitro a particular focus the entitytwo otherprotein
mechanism calciumstimulated entityone release gastrinoma cells vitro a particular focus the otherprotein entitytwo
focus the entityone entitytwo
results demonstrated entityone expressed human gastrinoma cells could involved the mechanism calciumevoked entitytwo release
entityone entitytwo involvement
bone morphogenetic proteins entityone entitytwo the
receptor family members entityone neu entitytwo otherprotein
receptor family members entityone neu otherprotein entitytwo otherprotein
receptor family members entityone neu otherprotein otherprotein entitytwo tumor
members otherprotein neu entityone entitytwo otherprotein
members otherprotein neu entityone otherprotein entitytwo tumor
otherprotein neu otherprotein entityone entitytwo tumor
recurrence that entityone entitytwo also
soluble entityone entitytwo otherprotein
soluble entityone receptor entitytwo toxic
soluble entityone entitytwo toxic
measurement soluble entityone entitytwo otherprotein
measurement soluble entityone otherprotein entitytwo serum
soluble otherprotein entityone entitytwo serum
higher levels entityone in patients burns whereas entitytwo levels
burns either entityone entitytwo
higher levels entityone the blister fluid compared serum samples pointing a predominantly local production contrasting the low concentration entitytwo the
bone marrow derived entityone cells using semipurified hhv8 a mature entitytwo dependent
these entityone entitytwo otherprotein tbpassociated
these entityone otherprotein entitytwo tbpassociated factor
these entityone otherprotein otherprotein tbpassociated factor eukaryotic elongation factor entitytwo upregulated
400 otherprotein entityone entitytwo tbpassociated factor
400 otherprotein entityone otherprotein tbpassociated factor eukaryotic elongation factor entitytwo upregulated
otherprotein otherprotein entityone tbpassociated factor eukaryotic elongation factor entitytwo upregulated
concentrations entityone entitytwo otherprotein
concentrations entityone otherprotein entitytwo otherprotein
concentrations entityone otherprotein otherprotein entitytwo cerebrospinal
concentrations otherprotein entityone entitytwo otherprotein
concentrations otherprotein entityone otherprotein entitytwo cerebrospinal
otherprotein otherprotein entityone entitytwo cerebrospinal
correlations entityone entitytwo CSF
abnormal levels entityone entitytwo significantly
prostate namely entityone entitytwo otherprotein
prostate namely entityone otherprotein entitytwo versus otherprotein
prostate namely entityone otherprotein otherprotein versus entitytwo
prostate namely otherprotein entityone entitytwo versus otherprotein
prostate namely otherprotein entityone otherprotein versus entitytwo
otherprotein otherprotein entityone versus entitytwo
measured levels entityone entitytwo otherprotein
measured levels entityone otherprotein entitytwo otherprotein
measured levels entityone otherprotein otherprotein entitytwo the
levels otherprotein entityone entitytwo otherprotein
levels otherprotein entityone otherprotein entitytwo the
otherprotein otherprotein entityone entitytwo the
entityone entitytwo otherprotein
entityone otherprotein entitytwo levels
otherprotein entityone entitytwo levels
dopamine synthetic enzymes entityone entitytwo otherprotein otherprotein
dopamine synthetic enzymes entityone otherprotein entitytwo otherprotein
dopamine synthetic enzymes entityone otherprotein otherprotein entitytwo otherprotein
dopamine synthetic enzymes entityone otherprotein otherprotein otherprotein entitytwo otherprotein
dopamine synthetic enzymes entityone otherprotein otherprotein otherprotein otherprotein entitytwo enzyme
synthetic enzymes otherprotein entityone entitytwo otherprotein
synthetic enzymes otherprotein entityone otherprotein entitytwo otherprotein
synthetic enzymes otherprotein entityone otherprotein otherprotein entitytwo otherprotein
synthetic enzymes otherprotein entityone otherprotein otherprotein otherprotein entitytwo enzyme
enzymes otherprotein otherprotein entityone entitytwo otherprotein
enzymes otherprotein otherprotein entityone otherprotein entitytwo otherprotein
enzymes otherprotein otherprotein entityone otherprotein otherprotein entitytwo enzyme
otherprotein otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein entitytwo enzyme
otherprotein otherprotein entityone entitytwo enzyme
expressions entityone entitytwo otherprotein
expressions entityone otherprotein entitytwo detected
expressions otherprotein entityone entitytwo detected
results entityone entitytwo otherprotein
results entityone otherprotein entitytwo effectively
results entityone otherprotein otherprotein effectively coexpressed transduced cells three separate aav vectors aav entitytwo aav otherprotein
results entityone aadc otherprotein effectively coexpressed transduced cells three separate aav vectors aavth aav entitytwo AAV
results entityone otherprotein GCH effectively coexpressed transduced cells three separate aav vectors aavth aav otherprotein AAV entitytwo
results otherprotein entityone entitytwo effectively
results entityone otherprotein effectively coexpressed transduced cells three separate aav vectors aav entitytwo aavaadc
results otherprotein entityone otherprotein effectively coexpressed transduced cells three separate aav vectors aav otherprotein aav entitytwo AAV
results otherprotein entityone GCH effectively coexpressed transduced cells three separate aav vectors aav otherprotein aavaadc AAV entitytwo
otherprotein entityone effectively coexpressed transduced cells three separate aav vectors aav entitytwo aav otherprotein
otherprotein aadc entityone effectively coexpressed transduced cells three separate aav vectors aav otherprotein aav entitytwo AAVGCH
otherprotein otherprotein entityone effectively coexpressed transduced cells three separate aav vectors aav otherprotein aav otherprotein AAV entitytwo
aav vectors aav entityone aav entitytwo AAV
aav vectors aav entityone aav otherprotein AAV entitytwo
aav otherprotein aav entityone AAV entitytwo
triple transduction entityone entitytwo otherprotein
triple transduction entityone otherprotein entitytwo genes
transduction otherprotein entityone entitytwo genes
current knowledge entityone entitytwo the
possible role entityone product entitytwo atherosclerotic
cytokines entityone entitytwo otherprotein otherprotein
cytokines entityone otherprotein entitytwo otherprotein otherprotein
cytokines entityone otherprotein otherprotein entitytwo otherprotein immunotech
cytokines entityone otherprotein otherprotein otherprotein entitytwo immunotech france
cytokines entityone otherprotein otherprotein otherprotein otherprotein immunotech france entitytwo otherprotein
cytokines entityone otherprotein otherprotein otherprotein otherprotein immunotech france otherprotein entitytwo otherprotein
cytokines entityone otherprotein otherprotein otherprotein otherprotein immunotech france otherprotein otherprotein entitytwo and
cytokines entityone otherprotein otherprotein otherprotein otherprotein immunotech france otherprotein otherprotein otherprotein entitytwo otherprotein and
cytokines entityone otherprotein otherprotein otherprotein otherprotein immunotech france otherprotein otherprotein otherprotein otherprotein entitytwo and otherprotein
cytokines entityone otherprotein otherprotein otherprotein otherprotein immunotech france otherprotein otherprotein otherprotein otherprotein otherprotein and entitytwo UK
cytokines otherprotein entityone entitytwo otherprotein otherprotein
cytokines otherprotein entityone otherprotein entitytwo otherprotein immunotech
cytokines otherprotein entityone otherprotein otherprotein entitytwo immunotech france
cytokines otherprotein entityone otherprotein otherprotein otherprotein immunotech france entitytwo otherprotein
cytokines otherprotein entityone otherprotein otherprotein otherprotein immunotech france otherprotein entitytwo otherprotein
cytokines otherprotein entityone otherprotein otherprotein otherprotein immunotech france otherprotein otherprotein entitytwo and
cytokines otherprotein entityone otherprotein otherprotein otherprotein immunotech france otherprotein otherprotein otherprotein entitytwo otherprotein and
cytokines otherprotein entityone otherprotein otherprotein otherprotein immunotech france otherprotein otherprotein otherprotein otherprotein entitytwo and otherprotein
cytokines otherprotein entityone otherprotein otherprotein otherprotein immunotech france otherprotein otherprotein otherprotein otherprotein otherprotein and entitytwo UK
cytokines otherprotein otherprotein entityone entitytwo otherprotein immunotech
cytokines otherprotein otherprotein entityone otherprotein entitytwo immunotech france
cytokines otherprotein otherprotein entityone otherprotein otherprotein immunotech france entitytwo otherprotein
cytokines otherprotein otherprotein entityone otherprotein otherprotein immunotech france otherprotein entitytwo otherprotein
cytokines otherprotein otherprotein entityone otherprotein otherprotein immunotech france otherprotein otherprotein entitytwo and
cytokines otherprotein otherprotein entityone otherprotein otherprotein immunotech france otherprotein otherprotein otherprotein entitytwo otherprotein and
cytokines otherprotein otherprotein entityone otherprotein otherprotein immunotech france otherprotein otherprotein otherprotein otherprotein entitytwo and otherprotein
cytokines otherprotein otherprotein entityone otherprotein otherprotein immunotech france otherprotein otherprotein otherprotein otherprotein otherprotein and entitytwo UK
otherprotein otherprotein otherprotein entityone entitytwo immunotech france
otherprotein otherprotein otherprotein entityone otherprotein immunotech france entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein immunotech france otherprotein entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein immunotech france otherprotein otherprotein entitytwo and
otherprotein otherprotein otherprotein entityone otherprotein immunotech france otherprotein otherprotein otherprotein entitytwo otherprotein and
otherprotein otherprotein otherprotein entityone otherprotein immunotech france otherprotein otherprotein otherprotein otherprotein entitytwo and otherprotein
otherprotein otherprotein otherprotein entityone otherprotein immunotech france otherprotein otherprotein otherprotein otherprotein otherprotein and entitytwo UK
otherprotein otherprotein otherprotein entityone immunotech france entitytwo otherprotein
otherprotein otherprotein otherprotein entityone immunotech france otherprotein entitytwo otherprotein
otherprotein otherprotein otherprotein entityone immunotech france otherprotein otherprotein entitytwo and
otherprotein otherprotein otherprotein entityone immunotech france otherprotein otherprotein otherprotein entitytwo otherprotein and
otherprotein otherprotein otherprotein entityone immunotech france otherprotein otherprotein otherprotein otherprotein entitytwo and otherprotein
otherprotein otherprotein otherprotein entityone immunotech france otherprotein otherprotein otherprotein otherprotein otherprotein and entitytwo UK
otherprotein immunotech france entityone entitytwo otherprotein
otherprotein immunotech france entityone otherprotein entitytwo and
otherprotein immunotech france entityone otherprotein otherprotein entitytwo otherprotein and
otherprotein immunotech france entityone otherprotein otherprotein otherprotein entitytwo and otherprotein
otherprotein immunotech france entityone otherprotein otherprotein otherprotein otherprotein and entitytwo UK
france otherprotein entityone entitytwo and
france otherprotein entityone otherprotein entitytwo otherprotein and
france otherprotein entityone otherprotein otherprotein entitytwo and otherprotein
france otherprotein entityone otherprotein otherprotein otherprotein and entitytwo UK
otherprotein otherprotein entityone entitytwo otherprotein and
otherprotein otherprotein entityone otherprotein entitytwo and otherprotein
otherprotein otherprotein entityone otherprotein otherprotein and entitytwo UK
otherprotein entityone entitytwo and otherprotein
otherprotein entityone otherprotein and entitytwo UK
otherprotein entityone and entitytwo UK
entityone sP entitytwo levels
serum concentration entityone entitytwo otherprotein
serum concentration entityone otherprotein entitytwo are
concentration otherprotein entityone entitytwo are
recent interest entityone entitytwo gene
recent interest entityone otherprotein gene the genes coding the entitytwo
interest otherprotein entityone gene the genes coding the entitytwo
inflammatory molecules entityone beta entitytwo 2
inflammatory molecules entityone beta otherprotein 2 entitytwo its
inflammatory molecules entityone beta otherprotein 2 otherprotein its receptor antagonist entitytwo otherprotein
inflammatory molecules entityone beta otherprotein 2 otherprotein its receptor antagonist otherprotein entitytwo receptor
inflammatory molecules entityone beta otherprotein 2 otherprotein its receptor antagonist otherprotein otherprotein receptor lipopolysaccharide selectins and entitytwo
otherprotein beta entityone 2 entitytwo its
otherprotein beta entityone 2 otherprotein its receptor antagonist entitytwo otherprotein
otherprotein beta entityone 2 otherprotein its receptor antagonist otherprotein entitytwo receptor
otherprotein beta entityone 2 otherprotein its receptor antagonist otherprotein otherprotein receptor lipopolysaccharide selectins and entitytwo
otherprotein 2 entityone its receptor antagonist entitytwo otherprotein
otherprotein 2 entityone its receptor antagonist otherprotein entitytwo receptor
otherprotein 2 entityone its receptor antagonist otherprotein otherprotein receptor lipopolysaccharide selectins and entitytwo
receptor antagonist entityone entitytwo receptor
receptor antagonist entityone otherprotein receptor lipopolysaccharide selectins and entitytwo
receptor antagonist otherprotein entityone receptor lipopolysaccharide selectins and entitytwo
signaling molecules including entityone entitytwo otherprotein otherprotein
signaling molecules including entityone otherprotein entitytwo otherprotein
signaling molecules including entityone otherprotein otherprotein entitytwo protein
molecules including otherprotein entityone entitytwo otherprotein
molecules including otherprotein entityone otherprotein entitytwo protein
including otherprotein otherprotein entityone entitytwo protein
data concerning entityone entitytwo system
historical incursion regarding entityone renal origin present main extrarenal entitytwo forming enzymes
historical incursion regarding entityone renal origin present main extrarenal otherprotein forming enzymes starting entitytwo otherprotein
historical incursion regarding entityone renal origin present main extrarenal otherprotein forming enzymes starting iso otherprotein entitytwo and
historical incursion regarding entityone renal origin present main extrarenal otherprotein forming enzymes starting iso otherprotein otherprotein entitytwo and ending
historical incursion regarding entityone renal origin present main extrarenal otherprotein forming enzymes starting iso otherprotein otherprotein otherprotein ending the conversion enzyme and entitytwo
main extrarenal entityone forming enzymes starting entitytwo otherprotein
main extrarenal entityone forming enzymes starting iso otherprotein entitytwo and
main extrarenal entityone forming enzymes starting iso otherprotein otherprotein entitytwo and ending
main extrarenal entityone forming enzymes starting iso otherprotein otherprotein otherprotein ending the conversion enzyme and entitytwo
enzymes starting entityone entitytwo and
enzymes starting entityone otherprotein entitytwo and ending
enzymes starting entityone otherprotein otherprotein ending the conversion enzyme and entitytwo
iso otherprotein entityone entitytwo and ending
iso otherprotein entityone otherprotein ending the conversion enzyme and entitytwo
otherprotein entityone ending the conversion enzyme and entitytwo
relations circulating entityone renal origin the extrarenal entitytwo specific
relations circulating entityone renal origin extrarenal ras specific tissue underlying the fact the two entitytwo components cooperate
extrarenal entityone specific tissue underlying the fact the two entitytwo components cooperate
the circulating entityone renal origin acutely activated contribute the accomplishment short term homeostatic reactions tissue entitytwo paracrine
receptors grs entityone entitytwo the
normal nasal tissues entityone labeling only found the vascular wall the expression weakera finding demonstrating entitytwo upregulated
GRs entityone nasal polyps nonallergic patients well upregulation entitytwo expression suggests
extracellular matrix proteins entityone entitytwo otherprotein otherprotein
extracellular matrix proteins entityone otherprotein entitytwo otherprotein otherprotein
extracellular matrix proteins entityone otherprotein otherprotein entitytwo otherprotein otherprotein
extracellular matrix proteins entityone otherprotein otherprotein otherprotein entitytwo otherprotein otherprotein
extracellular matrix proteins entityone otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein otherprotein
extracellular matrix proteins entityone otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein
extracellular matrix proteins entityone otherprotein otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein
extracellular matrix proteins entityone otherprotein otherprotein otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo across cell
matrix proteins otherprotein entityone entitytwo otherprotein otherprotein
matrix proteins otherprotein entityone otherprotein entitytwo otherprotein otherprotein
matrix proteins otherprotein entityone otherprotein otherprotein entitytwo otherprotein otherprotein
matrix proteins otherprotein entityone otherprotein otherprotein otherprotein entitytwo otherprotein otherprotein
matrix proteins otherprotein entityone otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein
matrix proteins otherprotein entityone otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein
matrix proteins otherprotein entityone otherprotein otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo across cell
proteins otherprotein otherprotein entityone entitytwo otherprotein otherprotein
proteins otherprotein otherprotein entityone otherprotein entitytwo otherprotein otherprotein
proteins otherprotein otherprotein entityone otherprotein otherprotein entitytwo otherprotein otherprotein
proteins otherprotein otherprotein entityone otherprotein otherprotein otherprotein entitytwo otherprotein
proteins otherprotein otherprotein entityone otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein
proteins otherprotein otherprotein entityone otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo across cell
otherprotein otherprotein otherprotein entityone entitytwo otherprotein otherprotein
otherprotein otherprotein otherprotein entityone otherprotein entitytwo otherprotein otherprotein
otherprotein otherprotein otherprotein entityone otherprotein otherprotein entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein otherprotein otherprotein entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein otherprotein otherprotein otherprotein entitytwo across cell
otherprotein otherprotein otherprotein entityone entitytwo otherprotein otherprotein
otherprotein otherprotein otherprotein entityone otherprotein entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein otherprotein entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein otherprotein otherprotein entitytwo across cell
otherprotein otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein otherprotein entitytwo across cell
otherprotein otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein entitytwo across cell
otherprotein otherprotein otherprotein entityone entitytwo across cell
assaying entityone complement factors entitytwo the
concentrations entityone entitytwo pleural
concentrations entityone tnfalpha pleural peritoneal effusions different causes to verify whether entitytwo otherprotein otherprotein
concentrations entityone otherprotein pleural peritoneal effusions different causes to verify whether otherprotein entitytwo otherprotein
concentrations entityone otherprotein pleural peritoneal effusions different causes to verify whether otherprotein otherprotein entitytwo complement
concentrations entityone otherprotein pleural peritoneal effusions different causes to verify whether otherprotein otherprotein otherprotein complement factors entitytwo otherprotein
concentrations entityone otherprotein pleural peritoneal effusions different causes to verify whether otherprotein otherprotein otherprotein complement factors otherprotein entitytwo be
concentrations otherprotein entityone pleural peritoneal effusions different causes to verify whether entitytwo otherprotein otherprotein
concentrations otherprotein entityone pleural peritoneal effusions different causes to verify whether tnfalpha entitytwo otherprotein
concentrations otherprotein entityone pleural peritoneal effusions different causes to verify whether tnfalpha otherprotein entitytwo complement
concentrations otherprotein entityone pleural peritoneal effusions different causes to verify whether tnfalpha otherprotein otherprotein complement factors entitytwo otherprotein
concentrations otherprotein entityone pleural peritoneal effusions different causes to verify whether tnfalpha otherprotein otherprotein complement factors otherprotein entitytwo be
verify whether entityone entitytwo otherprotein
verify whether entityone otherprotein entitytwo complement
verify whether entityone otherprotein otherprotein complement factors entitytwo otherprotein
verify whether entityone otherprotein otherprotein complement factors otherprotein entitytwo be
verify whether otherprotein entityone entitytwo complement
verify whether otherprotein entityone otherprotein complement factors entitytwo otherprotein
verify whether otherprotein entityone otherprotein complement factors otherprotein entitytwo be
whether otherprotein otherprotein entityone complement factors entitytwo otherprotein
whether otherprotein otherprotein entityone complement factors otherprotein entitytwo be
complement factors entityone entitytwo be
entityone entitytwo complement
entityone otherprotein complement factors entitytwo otherprotein
entityone otherprotein complement factors otherprotein entitytwo concentrations
otherprotein entityone complement factors entitytwo otherprotein
otherprotein entityone complement factors otherprotein entitytwo concentrations
complement factors entityone entitytwo concentrations
selection entityone effusion entitytwo serum otherprotein
selection entityone effusion otherprotein serum entitytwo effusion
selection entityone effusion otherprotein serum otherprotein effusion entitytwo effusion
otherprotein effusion entityone serum entitytwo effusion
otherprotein effusion entityone serum otherprotein effusion entitytwo effusion
effusion otherprotein serum entityone effusion entitytwo effusion
determination entityone complement factors entitytwo otherprotein
determination entityone complement factors otherprotein entitytwo otherprotein
determination entityone complement factors otherprotein otherprotein entitytwo may
otherprotein complement factors entityone entitytwo otherprotein
otherprotein complement factors entityone otherprotein entitytwo may
factors otherprotein entityone entitytwo may
differential expression entityone entitytwo NK
differential expression entityone otherprotein NK cells cancer patients correlation impaired entitytwo expression withprogression
granulysin entityone NK cells cancer patients correlation impaired entitytwo expression withprogression
entityone been identified an effector molecule colocalized entitytwo the
entityone identified an effector molecule colocalized perforin the cytotoxic granules cytotoxic lymphocytes natural killer cells has been reported kill intracellular pathogens infected cells the presence entitytwo to
molecule colocalized entityone the cytotoxic granules cytotoxic lymphocytes natural killer cells has reported kill intracellular pathogens infected cells the presence entitytwo to
intracellular expression entityone entitytwo NK
high levels entityone entitytwo expression
high levels entityone otherprotein expression entitytwo otherprotein
high levels entityone otherprotein expression otherprotein entitytwo cells
otherprotein entityone expression entitytwo otherprotein
otherprotein entityone expression otherprotein entitytwo cells
otherprotein expression entityone entitytwo cells
decreased levels entityone expression p<0005 despite equally high levels entitytwo expression
tumorfree patients expressed entityone levels similar healthy controls the progressive tumorbearing patients expressed remarkably lower levels entitytwo compared
impaired expression entityone NK cells correlates progression cancer determination entitytwo expression might
entityone member the entitytwo superfamily
inhibitors as entityone entitytwo regulators
inhibitors as entityone otherprotein regulators apoptosis as entitytwo members
inhibitors as entityone otherprotein regulators apoptosis as otherprotein members the entitytwo family
otherprotein entityone regulators apoptosis as entitytwo members
otherprotein entityone regulators apoptosis as otherprotein members the entitytwo family
apoptosis as entityone members the entitytwo family
ligand designated human entityone entitytwo otherprotein
ligand designated human entityone ligand entitytwo its
ligand designated human entityone ligand otherprotein its human receptor entitytwo ortholog
ligand designated human entityone ligand otherprotein its human receptor otherprotein ortholog the recently discovered murine glucocorticoidinduced tnfrrelated entitytwo protein
ligand designated human entityone ligand otherprotein its human receptor otherprotein ortholog the recently discovered murine entitytwo
ligand designated human entityone entitytwo its
ligand designated human entityone otherprotein and human receptor entitytwo ortholog
ligand designated human entityone otherprotein and human receptor otherprotein ortholog the recently discovered murine glucocorticoidinduced tnfrrelated entitytwo protein
ligand designated human entityone otherprotein and human receptor otherprotein ortholog the recently discovered murine entitytwo
human otherprotein ligand entityone its human receptor entitytwo ortholog
human otherprotein ligand entityone its human receptor otherprotein ortholog the recently discovered murine glucocorticoidinduced tnfrrelated entitytwo protein
human otherprotein ligand entityone its human receptor otherprotein ortholog the recently discovered murine entitytwo
human receptor entityone ortholog the recently discovered murine glucocorticoidinduced tnfrrelated entitytwo protein
human receptor entityone ortholog the recently discovered murine entitytwo
murine glucocorticoidinduced tnfrrelated entityone entitytwo
entityone gene mapped chromosome 1q23 near gene the tnf homolog entitytwo otherprotein
entityone gene mapped chromosome 1q23 near gene the tnf homolog otherprotein entitytwo
TNF homolog entityone entitytwo
found entityone mrna several peripheral tissues detected entitytwo protein
levels entityone mrna tissues generally low peripheral blood cells however antigenreceptor stimulation led a substantial induction entitytwo transcripts
cotransfection entityone entitytwo embryonic
cotransfection entityone h otherprotein embryonic kidney cells activated antiapoptotic transcription factor entitytwo via
cotransfection entityone h otherprotein embryonic kidney cells activated antiapoptotic transcription factor otherprotein via pathway appeared involve entitytwo otherprotein
cotransfection entityone h otherprotein embryonic kidney cells activated antiapoptotic transcription factor otherprotein via pathway appeared involve otherprotein entitytwo and
cotransfection entityone h otherprotein embryonic kidney cells activated antiapoptotic transcription factor nfkappab via pathway appeared involve otherprotein otherprotein and entitytwo inducing kinase
cotransfection entityone h otherprotein embryonic kidney cells activated antiapoptotic transcription factor otherprotein via pathway appeared involve otherprotein otherprotein and entitytwo otherprotein
cotransfection entityone h otherprotein embryonic kidney cells activated antiapoptotic transcription factor otherprotein via pathway appeared involve otherprotein otherprotein and otherprotein inducing kinase entitytwo
otherprotein and entityone embryonic kidney cells activated antiapoptotic transcription factor entitytwo via
otherprotein and entityone embryonic kidney cells activated antiapoptotic transcription factor otherprotein via pathway appeared involve entitytwo otherprotein
otherprotein and entityone embryonic kidney cells activated antiapoptotic transcription factor otherprotein via pathway appeared involve otherprotein entitytwo and
otherprotein and entityone embryonic kidney cells activated antiapoptotic transcription factor nfkappab via pathway appeared involve otherprotein otherprotein and entitytwo inducing kinase
otherprotein and entityone embryonic kidney cells activated antiapoptotic transcription factor otherprotein via pathway appeared involve otherprotein otherprotein and entitytwo otherprotein
otherprotein and entityone embryonic kidney cells activated antiapoptotic transcription factor otherprotein via pathway appeared involve otherprotein otherprotein and otherprotein inducing kinase entitytwo
antiapoptotic transcription factor entityone via pathway appeared involve entitytwo otherprotein
antiapoptotic transcription factor entityone via pathway appeared involve otherprotein entitytwo and
antiapoptotic transcription factor entityone via pathway appeared involve otherprotein otherprotein and entitytwo inducing kinase
antiapoptotic transcription factor entityone via pathway appeared involve otherprotein otherprotein and entitytwo otherprotein
antiapoptotic transcription factor entityone via pathway appeared involve otherprotein otherprotein and otherprotein entitytwo
appeared involve entityone entitytwo and
appeared involve entityone otherprotein and entitytwo inducing kinase
appeared involve entityone otherprotein and entitytwo otherprotein
appeared involve entityone otherprotein and otherprotein inducing kinase entitytwo
involve otherprotein entityone and entitytwo inducing kinase
involve otherprotein entityone and entitytwo otherprotein
involve otherprotein entityone and otherprotein inducing kinase entitytwo
otherprotein and entityone entitytwo otherprotein
otherprotein and entityone inducing kinase entitytwo
otherprotein and entityone entitytwo
cotransfection entityone entitytwo Jurkat
thus entityone entitytwo may modulate
sequence his18pro19lys20phe21 entityone entitytwo sitedirected
Phe21 entityone reduced 77fold binding affinity to entitytwo receptor subtypes
Phe21 entityone reduced 77fold binding affinity to entitytwo otherprotein
Phe21 entityone reduced 77fold binding affinity to otherprotein entitytwo B
Phe21 entityone reduced 77fold binding affinity to otherprotein otherprotein B entitytwo to
Phe21 entityone reduced 77fold binding affinity to otherprotein otherprotein B otherprotein to entitytwo
binding affinity entityone entitytwo otherprotein
binding affinity entityone receptor subtypes entitytwo B
binding affinity entityone receptor subtypes otherprotein B entitytwo to
binding affinity entityone receptor subtypes otherprotein B otherprotein to entitytwo
binding affinity entityone entitytwo B
binding affinity entityone otherprotein B entitytwo to
binding affinity entityone otherprotein B otherprotein to entitytwo
receptor subtypes entityone B entitytwo to
receptor subtypes entityone B otherprotein to entitytwo
otherprotein B entityone to entitytwo
responses mediated entityone entitytwo
binding affinity entityone entitytwo the
binding affinity entityone otherprotein the entitytwo
affinity otherprotein entityone the entitytwo
study demonstrates entityone recognizes activates entitytwo otherprotein
study demonstrates entityone recognizes activates otherprotein entitytwo the
study demonstrates entityone recognizes activates otherprotein otherprotein the entitytwo distinct
recognizes activates entityone entitytwo the
recognizes activates entityone otherprotein the entitytwo distinct
activates otherprotein entityone the entitytwo distinct
isolation human entityone its binding specificity entitytwo
interaction entityone cloned fulllength cdna human entitytwo encoded
immunoprecipitation demonstrated entityone interacted a hydrophilic loop region the endoproteolytic cterminal fragment entitytwo not
immunoprecipitation demonstrated entityone interacted a hydrophilic loop region the endoproteolytic cterminal fragment otherprotein not that entitytwo
cterminal fragment entityone not that entitytwo
results suggest entityone entitytwo partly differ
also found another entityone entitytwo interacted
also found another entityone otherprotein interacted entitytwo
found another otherprotein entityone interacted entitytwo
factor receptor superfamily entityone suppresses entitytwo mediated apoptosis
entityone entitytwo otherprotein
entityone otherprotein entitytwo a
otherprotein entityone entitytwo a
demonstrate entityone specifically binds two cellular ligands entitytwo herpes virus
demonstrate entityone specifically binds two cellular ligands otherprotein herpes virus entry mediator entitytwo and
demonstrate entityone specifically binds two cellular ligands otherprotein entitytwo otherprotein
demonstrate entityone specifically binds two cellular ligands otherprotein herpes virus entry mediator otherprotein and entitytwo otherprotein
demonstrate entityone specifically binds two cellular ligands otherprotein herpes virus entry mediator otherprotein and otherprotein ligand entitytwo otherprotein
demonstrate entityone specifically binds two cellular ligands otherprotein herpes virus entry mediator otherprotein and otherprotein ligand otherprotein entitytwo
two cellular ligands entityone herpes virus entry mediator entitytwo and
two cellular ligands entityone entitytwo otherprotein
two cellular ligands entityone herpes virus entry mediator otherprotein and entitytwo otherprotein
two cellular ligands entityone herpes virus entry mediator otherprotein and otherprotein ligand entitytwo otherprotein
two cellular ligands entityone herpes virus entry mediator otherprotein and otherprotein ligand otherprotein entitytwo
virus entry mediator entityone entitytwo otherprotein
virus entry mediator entityone and entitytwo otherprotein
virus entry mediator entityone and otherprotein ligand entitytwo otherprotein
virus entry mediator entityone and otherprotein ligand otherprotein entitytwo
cellular ligands otherprotein entityone entitytwo otherprotein
cellular ligands otherprotein entityone otherprotein ligand entitytwo otherprotein
cellular ligands otherprotein entityone otherprotein ligand otherprotein entitytwo
otherprotein and entityone entitytwo otherprotein
otherprotein and entityone otherprotein entitytwo
otherprotein ligand entityone entitytwo
entityone inhibited entitytwo induced cytotoxicity
shown entityone triggers apoptosis various tumor cells including ht29 cells express entitytwo receptor otherprotein
shown entityone triggers apoptosis various tumor cells including ht29 cells express entitytwo otherprotein
shown entityone triggers apoptosis various tumor cells including ht29 cells express otherprotein receptor entitytwo otherprotein
shown entityone triggers apoptosis various tumor cells including ht29 cells express otherprotein receptor otherprotein entitytwo otherprotein receptors
shown entityone triggers apoptosis various tumor cells including ht29 cells express otherprotein receptor otherprotein otherprotein entitytwo receptors
express entityone entitytwo otherprotein
express entityone receptor entitytwo otherprotein
express entityone receptor otherprotein entitytwo otherprotein receptors
express entityone receptor otherprotein otherprotein entitytwo receptors
express entityone entitytwo otherprotein
express entityone otherprotein entitytwo otherprotein receptors
express entityone otherprotein otherprotein entitytwo receptors
otherprotein receptor entityone entitytwo otherprotein receptors
otherprotein receptor entityone otherprotein entitytwo receptors
receptor otherprotein entityone entitytwo receptors
data suggest entityone inhibits interactions entitytwo otherprotein
data suggest entityone inhibits interactions otherprotein entitytwo otherprotein
data suggest entityone inhibits interactions otherprotein otherprotein entitytwo otherprotein
data suggest entityone inhibits interactions otherprotein otherprotein otherprotein entitytwo thereby suppressing
data suggest entityone inhibits interactions LIGHT otherprotein otherprotein otherprotein thereby suppressing entitytwo mediated ht29
interactions entityone entitytwo otherprotein
interactions entityone otherprotein entitytwo otherprotein
interactions entityone otherprotein otherprotein entitytwo thereby suppressing
interactions entityone otherprotein otherprotein otherprotein thereby suppressing entitytwo mediated ht29
otherprotein entityone entitytwo otherprotein
otherprotein entityone otherprotein entitytwo thereby suppressing
LIGHT entityone otherprotein otherprotein thereby suppressing entitytwo mediated ht29
otherprotein otherprotein entityone entitytwo thereby suppressing
light otherprotein entityone otherprotein thereby suppressing entitytwo mediated ht29
otherprotein otherprotein entityone thereby suppressing entitytwo mediated ht29
thus entityone may play regulatory role suppressing entitytwo otherprotein
thus entityone may play regulatory role suppressing otherprotein and entitytwo mediated cell
suppressing entityone entitytwo mediated cell
determinants the entityone entitytwo receptor
determinants the entityone entitytwo important
determinants the entityone epo receptor important binding entitytwo otherprotein
determinants the entityone epo receptor important binding epo entitytwo mimetic peptide
determinants the entityone otherprotein receptor important binding otherprotein entitytwo
the otherprotein entityone entitytwo important
the otherprotein entityone receptor important binding entitytwo otherprotein
the otherprotein entityone receptor important binding epo entitytwo mimetic peptide
the otherprotein entityone receptor important binding epo entitytwo
determinants the entityone important binding entitytwo otherprotein
determinants the entityone important binding epo entitytwo mimetic peptide
determinants the entityone important binding otherprotein entitytwo
important binding entityone entitytwo mimetic peptide
important binding entityone entitytwo
binding epo entityone entitytwo
domain the entityone entitytwo receptor otherprotein
domain the entityone entitytwo otherprotein
domain the entityone otherprotein receptor entitytwo crucial
domain the entityone epo receptor otherprotein crucial binding entitytwo substitution
domain the entityone epo receptor otherprotein crucial binding eposubstitution Phe93 alanine resulted a dramatic decrease entitytwo binding
domain the entityone otherprotein receptor otherprotein is crucial binding otherprotein substitution Phe93 alanine resulted a dramatic decrease otherprotein binding the escherichia coliexpressed extracellular domain the entitytwo otherprotein binding
domain the entityone epo receptor otherprotein crucial binding eposubstitution Phe93 alanine resulted a dramatic decrease EPO binding the escherichia coliexpressed extracellular domain the otherprotein entitytwo binding protein
domain the entityone otherprotein receptor otherprotein is crucial binding otherprotein substitution Phe93 alanine resulted a dramatic decrease otherprotein binding the escherichia coliexpressed extracellular domain the otherprotein entitytwo otherprotein
domain the entityone otherprotein receptor otherprotein is crucial binding otherprotein substitution Phe93 alanine resulted a dramatic decrease otherprotein binding the escherichia coliexpressed extracellular domain the otherprotein otherprotein binding protein entitytwo no
the otherprotein entityone entitytwo otherprotein
the otherprotein entityone receptor entitytwo crucial
the otherprotein entityone receptor otherprotein crucial binding entitytwo substitution
the otherprotein entityone receptor otherprotein crucial binding eposubstitution Phe93 alanine resulted a dramatic decrease entitytwo binding
the otherprotein entityone receptor epor crucial binding eposubstitution Phe93 alanine resulted a dramatic decrease EPO binding the escherichia coliexpressed extracellular domain the entitytwo otherprotein
the otherprotein entityone receptor otherprotein crucial binding eposubstitution Phe93 alanine resulted a dramatic decrease EPO binding the escherichia coliexpressed extracellular domain the otherprotein entitytwo binding protein
the otherprotein entityone receptor otherprotein crucial binding eposubstitution Phe93 alanine resulted a dramatic decrease EPO binding the escherichia coliexpressed extracellular domain the otherprotein entitytwo otherprotein
the otherprotein entityone receptor otherprotein crucial binding eposubstitution Phe93 alanine resulted a dramatic decrease EPO binding the escherichia coliexpressed extracellular domain the otherprotein otherprotein entitytwo no
domain the entityone entitytwo crucial
domain the entityone otherprotein crucial binding entitytwo substitution
domain the entityone otherprotein crucial binding eposubstitution Phe93 alanine resulted a dramatic decrease entitytwo binding
domain the entityone otherprotein is crucial binding otherprotein substitution Phe93 alanine resulted a dramatic decrease otherprotein binding the escherichia coliexpressed extracellular domain the entitytwo otherprotein binding
domain the entityone otherprotein crucial binding eposubstitution Phe93 alanine resulted a dramatic decrease EPO binding the escherichia coliexpressed extracellular domain the otherprotein entitytwo binding protein
domain the entityone otherprotein is crucial binding otherprotein substitution Phe93 alanine resulted a dramatic decrease otherprotein binding the escherichia coliexpressed extracellular domain the otherprotein entitytwo otherprotein
domain the entityone otherprotein is crucial binding otherprotein substitution Phe93 alanine resulted a dramatic decrease otherprotein binding the escherichia coliexpressed extracellular domain the otherprotein otherprotein binding protein entitytwo no
otherprotein epo receptor entityone crucial binding entitytwo substitution
otherprotein epo receptor entityone crucial binding eposubstitution Phe93 alanine resulted a dramatic decrease entitytwo binding
otherprotein otherprotein receptor entityone crucial binding otherprotein substitution Phe93 alanine resulted a dramatic decrease otherprotein binding the escherichia coliexpressed extracellular domain the entitytwo otherprotein binding
otherprotein epo receptor entityone crucial binding eposubstitution Phe93 alanine resulted a dramatic decrease EPO binding the escherichia coliexpressed extracellular domain the epor entitytwo binding protein
otherprotein otherprotein receptor entityone crucial binding otherprotein substitution Phe93 alanine resulted a dramatic decrease otherprotein binding the escherichia coliexpressed extracellular domain the otherprotein entitytwo otherprotein
otherprotein otherprotein receptor entityone crucial binding otherprotein substitution Phe93 alanine resulted a dramatic decrease otherprotein binding the escherichia coliexpressed extracellular domain the otherprotein otherprotein binding protein entitytwo no
crucial binding entityone substitution Phe93 alanine resulted a dramatic decrease entitytwo binding
crucial binding entityone substitution Phe93 alanine resulted a dramatic decrease EPO binding the escherichia coliexpressed extracellular domain the entitytwo otherprotein
crucial binding entityone substitution Phe93 alanine resulted a dramatic decrease EPO binding the escherichia coliexpressed extracellular domain the otherprotein entitytwo binding protein
crucial binding entityone substitution Phe93 alanine resulted a dramatic decrease EPO binding the escherichia coliexpressed extracellular domain the otherprotein entitytwo otherprotein
crucial binding entityone substitution Phe93 alanine resulted a dramatic decrease EPO binding the escherichia coliexpressed extracellular domain the otherprotein otherprotein entitytwo no
dramatic decrease entityone binding the escherichia coliexpressed extracellular domain the entitytwo otherprotein
dramatic decrease entityone binding the escherichia coliexpressed extracellular domain the otherprotein entitytwo binding protein
dramatic decrease entityone binding the escherichia coliexpressed extracellular domain the otherprotein entitytwo otherprotein
dramatic decrease entityone binding the escherichia coliexpressed extracellular domain the otherprotein otherprotein entitytwo no
domain the entityone entitytwo binding protein
domain the entityone entitytwo otherprotein
domain the entityone otherprotein binding protein entitytwo no
the otherprotein entityone entitytwo otherprotein
the otherprotein entityone binding protein entitytwo no
otherprotein entityone entitytwo no
structure the entityone bound an entitytwo mimetic peptide
structure the entityone bound an entitytwo otherprotein suggesting
structure the entityone bound an otherprotein mimetic peptide entitytwo suggesting
structure the entityone bound an otherprotein mimetic peptide emp1 suggesting Phe93 also important entitytwo binding
bound an entityone entitytwo otherprotein suggesting
bound an entityone mimetic peptide entitytwo suggesting
bound an entityone mimetic peptide emp1 suggesting Phe93 also important entitytwo binding
bound an entityone entitytwo suggesting
bound an entityone emp1 suggesting Phe93 also important entitytwo binding
otherprotein mimetic peptide entityone suggesting Phe93 also important entitytwo binding
alanine substitution entityone residues contact entitytwo the
alanine substitution entityone residues contact emp1 crystal structure investigate the function these residues both entitytwo otherprotein
alanine substitution entityone residues contact otherprotein crystal structure investigate the function these residues both otherprotein entitytwo binding
residues contact entityone crystal structure investigate the function these residues both entitytwo otherprotein
residues contact entityone crystal structure investigate the function these residues both emp1 entitytwo binding
residues both entityone entitytwo binding
important both entityone entitytwo binding met150
important both entityone otherprotein binding met150 not important entitytwo binding
important both entityone EMP1 binding met150 not important EPO binding is critical entitytwo binding
EPO entityone binding met150 not important entitytwo binding
otherprotein entityone binding met150 not important otherprotein binding is critical entitytwo binding
important entityone binding is critical entitytwo binding
determinants both entityone entitytwo even though
determinants both entityone otherprotein even though ligands share sequence structural homology suggesting these residues may represent minimum epitope the entitytwo productive
otherprotein entityone even though ligands share sequence structural homology suggesting these residues may represent minimum epitope the entitytwo productive
native entityone entitytwo formed
interaction entityone entitytwo
native entityone also formed heterodimer entitytwo low
highaffinity trimerization entityone = microM 20 degrees and dimerization entitytwo =
sites each entityone three each entitytwo the
entityone entitytwo mutations account
the human entityone entitytwo hydrophilic loop
the human entityone otherprotein hydrophilic loop entitytwo small
human otherprotein entityone hydrophilic loop entitytwo small
codons for entityone to codons for entitytwo region
mutations the entityone entitytwo gene
predominant localization entityone endoplasmic reticulum Golgi are conflicting reports the localization entitytwo the
cell surface entityone formed complexes vivo actinbinding protein entitytwo otherprotein
cell surface entityone formed complexes vivo actinbinding protein otherprotein entitytwo is
actinbinding protein entityone entitytwo is
domain Alzheimer's entityone entitytwo alphahelices
2942residue fragment entityone entitytwo in
demonstrated entityone E3 not entitytwo decrease
demonstrated entityone E3 not otherprotein can decrease fusogenic activity entitytwo via
but entityone decrease fusogenic activity entitytwo via
neurotoxicity entityone protective effects entitytwo in Alzheimer's
amphipathic helices entityone AI entitytwo simian
entityone binds multiple ccchemokines entitytwo acts
entityone first characterized a receptor entitytwo otherprotein
entityone first characterized a receptor otherprotein entitytwo otherprotein
entityone first characterized a receptor otherprotein otherprotein entitytwo was
receptor entityone entitytwo otherprotein
receptor entityone otherprotein entitytwo was
receptor otherprotein entityone entitytwo was
compete [125I] entityone binding a stable cell line expressing recombinant entitytwo andor
addition entityone entitytwo otherprotein
addition entityone otherprotein entitytwo five
addition entityone otherprotein otherprotein five CCchemokines could compete [125I] entitytwo binding otherprotein
addition entityone otherprotein otherprotein five CCchemokines could compete [125I]MIP1beta binding entitytwo otherprotein otherprotein
addition entityone otherprotein otherprotein five CCchemokines could compete [125I]MIP1beta binding otherprotein entitytwo otherprotein otherprotein
addition entityone otherprotein otherprotein five CCchemokines could compete [125I]MIP1beta binding otherprotein otherprotein entitytwo otherprotein
addition entityone otherprotein otherprotein five CCchemokines could compete [125I]MIP1beta binding otherprotein otherprotein otherprotein entitytwo otherprotein
addition entityone otherprotein otherprotein five CCchemokines could compete [125I]MIP1beta binding otherprotein otherprotein otherprotein otherprotein entitytwo binding
addition otherprotein entityone entitytwo five
addition MIP1beta entityone otherprotein five CCchemokines could compete [125I] entitytwo binding otherprotein
addition otherprotein entityone otherprotein five CCchemokines could compete [125I] otherprotein binding entitytwo otherprotein otherprotein
addition otherprotein entityone otherprotein five CCchemokines could compete [125I] otherprotein binding otherprotein entitytwo otherprotein otherprotein
addition otherprotein entityone otherprotein five CCchemokines could compete [125I] otherprotein binding otherprotein otherprotein entitytwo otherprotein
addition otherprotein entityone otherprotein five CCchemokines could compete [125I] otherprotein binding otherprotein otherprotein otherprotein entitytwo otherprotein
addition otherprotein entityone otherprotein five CCchemokines could compete [125I] otherprotein binding otherprotein otherprotein otherprotein otherprotein entitytwo binding
mip1beta otherprotein entityone five CCchemokines could compete [125I] entitytwo binding otherprotein
otherprotein otherprotein entityone five CCchemokines could compete [125I] otherprotein binding entitytwo otherprotein otherprotein
otherprotein otherprotein entityone five CCchemokines could compete [125I] otherprotein binding otherprotein entitytwo otherprotein otherprotein
otherprotein otherprotein entityone five CCchemokines could compete [125I] otherprotein binding otherprotein otherprotein entitytwo otherprotein
otherprotein otherprotein entityone five CCchemokines could compete [125I] otherprotein binding otherprotein otherprotein otherprotein entitytwo otherprotein
otherprotein otherprotein entityone five CCchemokines could compete [125I] otherprotein binding otherprotein otherprotein otherprotein otherprotein entitytwo binding
compete [125I] entityone binding entitytwo otherprotein otherprotein
compete [125I] entityone binding otherprotein entitytwo otherprotein otherprotein
compete [125I] entityone binding otherprotein otherprotein entitytwo otherprotein
compete [125I] entityone binding otherprotein otherprotein otherprotein entitytwo otherprotein
compete [125I] entityone binding otherprotein otherprotein otherprotein otherprotein entitytwo binding
125i otherprotein binding entityone entitytwo otherprotein otherprotein
125i otherprotein binding entityone otherprotein entitytwo otherprotein
125i otherprotein binding entityone otherprotein otherprotein entitytwo otherprotein
125i otherprotein binding entityone otherprotein otherprotein otherprotein entitytwo binding
otherprotein binding otherprotein entityone entitytwo otherprotein
otherprotein binding otherprotein entityone otherprotein entitytwo otherprotein
otherprotein binding otherprotein entityone otherprotein otherprotein entitytwo binding
binding otherprotein otherprotein entityone entitytwo otherprotein
binding otherprotein otherprotein entityone otherprotein entitytwo binding
otherprotein otherprotein otherprotein entityone entitytwo binding
among ligands entityone the remarkable property binding entitytwo high
among ligands entityone the remarkable property binding otherprotein high affinity without eliciting functional response entitytwo could also
among ligands entityone remarkable property binding ccr5 high affinity without eliciting functional response mcp3 could also inhibit the activation entitytwo otherprotein
among ligands entityone remarkable property binding otherprotein high affinity without eliciting functional response mcp3 could also inhibit the activation otherprotein entitytwo may
among ligands entityone remarkable property binding ccr5 high affinity without eliciting functional response mcp3 could also inhibit the activation CCR5 otherprotein may therefore considered a natural antagonist entitytwo
property binding entityone high affinity without eliciting functional response entitytwo could also
property binding entityone high affinity without eliciting functional response otherprotein could also inhibit activation entitytwo otherprotein
property binding entityone high affinity without eliciting functional response otherprotein could also inhibit activation CCR5 entitytwo may
property binding entityone high affinity without eliciting functional response otherprotein could also inhibit activation CCR5 otherprotein may therefore considered a natural antagonist entitytwo
functional response entityone could also inhibit activation entitytwo otherprotein
functional response entityone could also inhibit activation otherprotein entitytwo may
functional response entityone could also inhibit activation CCR5 otherprotein may therefore considered a natural antagonist entitytwo
activation entityone entitytwo may
activation entityone otherprotein may therefore considered a natural antagonist entitytwo
CCR5 entityone may therefore considered a natural antagonist entitytwo
high affinity entityone binding could also compete monomeric entitytwo binding although
high affinity entityone binding could also compete monomeric gp120 binding although variable potencies maximal entitytwo binding inhibition
high affinity entityone binding could also compete monomeric otherprotein binding although variable potencies maximal otherprotein binding inhibition 80% entitytwo only
high affinity entityone binding could also compete monomeric otherprotein binding although variable potencies maximal otherprotein binding inhibition 80% otherprotein only for entitytwo
compete monomeric entityone binding although variable potencies maximal entitytwo binding inhibition
compete monomeric entityone binding although variable potencies maximal gp120 binding inhibition 80% entitytwo only
compete monomeric entityone binding although variable potencies maximal gp120 binding inhibition 80% otherprotein only for entitytwo
variable potencies maximal entityone binding inhibition 80% entitytwo only
variable potencies maximal entityone binding inhibition 80% otherprotein only for entitytwo
80% entityone only for entitytwo
entityone could compete efficiently entitytwo binding
human chemokine entityone is functional ligand entitytwo
novel chemokine entityone entitytwo otherprotein
novel chemokine entityone otherprotein entitytwo chromosome
chemokine otherprotein entityone entitytwo chromosome
gene entityone entitytwo otherprotein
gene entityone otherprotein entitytwo have
gene entityone otherprotein otherprotein have identified novel chemokine termed entitytwo
gene otherprotein entityone entitytwo have
gene otherprotein entityone otherprotein have identified novel chemokine termed entitytwo
otherprotein otherprotein entityone have identified novel chemokine termed entitytwo
genes entityone entitytwo otherprotein
genes entityone otherprotein entitytwo otherprotein
genes entityone otherprotein otherprotein entitytwo otherprotein
genes entityone otherprotein otherprotein otherprotein entitytwo localized
genes otherprotein entityone entitytwo otherprotein
genes otherprotein entityone otherprotein entitytwo otherprotein
genes otherprotein entityone otherprotein otherprotein entitytwo localized
otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein entityone otherprotein entitytwo localized
otherprotein entityone entitytwo localized
entityone induced transient calcium mobilization specifically entitytwo otherprotein expressing
entityone induced transient calcium mobilization specifically otherprotein entitytwo expressing l12
mobilization specifically entityone entitytwo expressing l12
entityone competed binding 125 entitytwo otherprotein
entityone competed binding 125I otherprotein entitytwo expressing l12
binding 125 entityone entitytwo expressing l12
collectively entityone yet another functional ligand entitytwo
potency entityone a entitytwo ligand seems
potency entityone a otherprotein ligand seems however be approximately 10fold less that entitytwo
otherprotein a entityone ligand seems however be approximately 10fold less that entitytwo
identification entityone further promote understanding the control eosinophil trafficking other entitytwo mediated biological
entityone suppresses function entitytwo homodimers via
entityone suppresses function otherprotein homodimers via interaction entitytwo otherprotein
entityone suppresses function otherprotein homodimers via interaction otherprotein entitytwo
function entityone homodimers via interaction entitytwo otherprotein
function entityone homodimers via interaction otherprotein entitytwo
via interaction entityone entitytwo
entityone entitytwo the
show entityone entitytwo negative
show entityone otherprotein negative regulator entitytwo a
show entityone otherprotein negative regulator otherprotein a candidate mediate function entitytwo the
show otherprotein entityone negative regulator entitytwo a
show otherprotein entityone negative regulator otherprotein a candidate mediate function entitytwo the
negative regulator entityone a candidate mediate function entitytwo the
bind entityone a human embryonic brain cdna library using twohybrid method isolated one clone encoding entitytwo otherprotein gene
bind entityone a human embryonic brain cdna library using twohybrid method isolated one clone encoding otherprotein entitytwo gene
clone encoding entityone entitytwo gene
binding entityone entitytwo fulllength
binding entityone otherprotein fulllength entitytwo confirmed
binding otherprotein entityone fulllength entitytwo confirmed
analysis showed entityone entitytwo otherprotein
analysis showed entityone otherprotein entitytwo colocalized
showed otherprotein entityone entitytwo colocalized
cells showed entityone suppresses transactivation entitytwo cjun
cells showed entityone suppresses transactivation cJun entitytwo not
cells showed entityone suppresses transactivation cJuncJun not entitytwo otherprotein heterodimers
cells showed entityone suppresses transactivation otherprotein otherprotein not otherprotein entitytwo heterodimers consistent
cells showed entityone suppresses transactivation otherprotein otherprotein not otherprotein otherprotein heterodimers consistent the reported function entitytwo otherprotein
cells showed entityone suppresses transactivation otherprotein otherprotein not otherprotein otherprotein heterodimers consistent the reported function otherprotein entitytwo
suppresses transactivation entityone entitytwo not
suppresses transactivation entityone cjun not entitytwo otherprotein heterodimers
suppresses transactivation entityone cjun not cJun entitytwo heterodimers consistent
suppresses transactivation entityone cjun not cJun otherprotein heterodimers consistent the reported function entitytwo otherprotein
suppresses transactivation entityone cjun not cJun otherprotein heterodimers consistent the reported function otherprotein entitytwo
transactivation cJun entityone not entitytwo otherprotein heterodimers
transactivation cJun entityone not cJun entitytwo heterodimers consistent
transactivation cJun entityone not cJun otherprotein heterodimers consistent the reported function entitytwo otherprotein
transactivation cJun entityone not cJun otherprotein heterodimers consistent the reported function otherprotein entitytwo
not entityone entitytwo heterodimers consistent
not entityone otherprotein heterodimers consistent the reported function entitytwo otherprotein
not entityone otherprotein heterodimers consistent the reported function otherprotein entitytwo
by otherprotein entityone heterodimers consistent the reported function entitytwo otherprotein
by otherprotein entityone heterodimers consistent the reported function otherprotein entitytwo
reported function entityone entitytwo
mobility shift assays entityone shown accelerate translocation entitytwo the
mobility shift assays entityone shown accelerate translocation otherprotein cytoplasm the nucleus thereby suppress the binding entitytwo homodimer to
translocation entityone cytoplasm the nucleus thereby suppress the binding entitytwo homodimer to
entityone suppressed entitytwo associated apoptosis
entityone suppressed otherprotein associated apoptosis retinoic acid F9 embryonic carcinoma cells whereas suppression apoptosis attenuated mutation entitytwo
ps1 suppressed entityone associated apoptosis retinoic acid F9 embryonic carcinoma cells whereas suppression apoptosis attenuated mutation entitytwo
novel function entityone via entitytwo otherprotein influences
novel function entityone via otherprotein entitytwo influences otherprotein
novel function entityone via otherprotein otherprotein influences entitytwo mediated transcription
otherprotein via entityone entitytwo influences otherprotein
otherprotein via entityone otherprotein influences entitytwo mediated transcription
otherprotein via otherprotein entityone influences entitytwo mediated transcription
complex human entityone a twodomain extracellular fragment human entitytwo
hereditary haemochromatosis protein entityone complexed entitytwo receptor
hereditary haemochromatosis protein entityone complexed entitytwo
otherprotein complexed entityone entitytwo
entityone binds the entitytwo receptor otherprotein
entityone binds the entitytwo otherprotein
entityone binds the otherprotein receptor entitytwo receptor
entityone binds the otherprotein otherprotein receptor which cells acquire ironloaded entitytwo
binds the entityone entitytwo otherprotein
binds the entityone receptor entitytwo receptor
binds the entityone receptor otherprotein receptor which cells acquire ironloaded entitytwo
binds the entityone entitytwo receptor
binds the entityone otherprotein receptor which cells acquire ironloaded entitytwo
the otherprotein entityone receptor which cells acquire ironloaded entitytwo
extracellular portions entityone entitytwo shows two
extracellular portions entityone otherprotein shows two entitytwo molecules
extracellular portions entityone TfR shows two hfe molecules grasp side a twofold symmetric entitytwo dimer
HFE entityone shows two entitytwo molecules
otherprotein entityone shows two otherprotein molecules grasp side a twofold symmetric entitytwo dimer
tfr shows two entityone molecules grasp side a twofold symmetric entitytwo dimer
containing proteins entityone would 'lie down' parallel membrane the entitytwo helices that
containing proteins entityone would 'lie down' parallel membrane HFE helices that delineate the counterpart the mhc peptidebinding groove make extensive contacts helices the entitytwo dimerization domain
entityone helices that delineate counterpart the mhc peptidebinding groove make extensive contacts helices the entitytwo dimerization domain
structures entityone alone complexed entitytwo differ
structures entityone alone complexed otherprotein differ their domain arrangement dimer interfaces providing mechanism communicating binding events entitytwo chains
complexed entityone differ their domain arrangement dimer interfaces providing mechanism communicating binding events entitytwo chains
entityone entitytwo complex suggests
entityone tfr complex suggests binding site otherprotein entitytwo sheds
entityone otherprotein complex suggests binding site otherprotein otherprotein sheds light upon function entitytwo regulating
otherprotein entityone complex suggests binding site otherprotein entitytwo sheds
HFE entityone complex suggests binding site otherprotein TfR sheds light upon function entitytwo regulating
otherprotein entityone sheds light upon function entitytwo regulating
intensively the entityone entitytwo receptor subfamily
type receptors entityone entitytwo the
type receptors entityone otherprotein the entitytwo otherprotein
type receptors entityone otherprotein the otherprotein entitytwo
receptors otherprotein entityone the entitytwo otherprotein
receptors otherprotein entityone the otherprotein entitytwo
otherprotein the entityone entitytwo
preexisting heteromeric entityone entitytwo BRII
preexisting heteromeric entityone otherprotein entitytwo otherprotein
preexisting heteromeric entityone otherprotein BRII entitytwo homomeric
preexisting heteromeric entityone otherprotein brii otherprotein homomeric entitytwo BRII otherprotein
preexisting heteromeric entityone otherprotein brii otherprotein homomeric BRII entitytwo otherprotein otherprotein
preexisting heteromeric entityone bria BRII otherprotein homomeric briibrii entitytwo bria otherprotein
preexisting heteromeric entityone bria BRII otherprotein homomeric briibrii bria entitytwo otherprotein otherprotein
preexisting heteromeric entityone otherprotein BRIIBRIb homomeric briibrii otherprotein otherprotein entitytwo brib
preexisting heteromeric entityone otherprotein BRIIBRIb homomeric briibrii otherprotein otherprotein brib entitytwo also
preexisting heteromeric entityone bria BRII otherprotein homomeric briibrii bria bria otherprotein otherprotein also entitytwo otherprotein oligomers
preexisting heteromeric entityone otherprotein BRIIBRIb homomeric briibrii otherprotein otherprotein brib brib also otherprotein entitytwo oligomers
preexisting heteromeric brii entityone entitytwo otherprotein
preexisting heteromeric otherprotein entityone otherprotein entitytwo homomeric
preexisting heteromeric brii entityone brii otherprotein homomeric entitytwo BRII bria
preexisting heteromeric brii entityone brii otherprotein homomeric BRII entitytwo bria bria
preexisting heteromeric otherprotein entityone otherprotein otherprotein homomeric otherprotein otherprotein entitytwo bria otherprotein
preexisting heteromeric otherprotein entityone otherprotein otherprotein homomeric otherprotein otherprotein bria entitytwo otherprotein otherprotein
preexisting heteromeric otherprotein entityone otherprotein brib homomeric otherprotein otherprotein bria bria entitytwo brib
preexisting heteromeric otherprotein entityone otherprotein brib homomeric otherprotein otherprotein bria bria brib entitytwo also
preexisting heteromeric otherprotein entityone otherprotein otherprotein homomeric otherprotein otherprotein bria bria otherprotein otherprotein also entitytwo otherprotein oligomers
preexisting heteromeric otherprotein entityone otherprotein brib homomeric otherprotein otherprotein bria bria brib brib also bria entitytwo oligomers
brii otherprotein entityone entitytwo homomeric
brii otherprotein entityone otherprotein homomeric entitytwo brii otherprotein
brii otherprotein entityone otherprotein homomeric brii entitytwo otherprotein otherprotein
heteromeric briibria entityone otherprotein homomeric briibrii entitytwo bria otherprotein
heteromeric briibria entityone otherprotein homomeric briibrii bria entitytwo otherprotein otherprotein
brii otherprotein entityone brib homomeric briibrii otherprotein otherprotein entitytwo brib
brii otherprotein entityone brib homomeric briibrii otherprotein otherprotein brib entitytwo also
heteromeric briibria entityone otherprotein homomeric briibrii bria bria otherprotein otherprotein also entitytwo otherprotein oligomers
brii otherprotein entityone brib homomeric briibrii otherprotein otherprotein brib brib also otherprotein entitytwo oligomers
otherprotein brii entityone homomeric entitytwo BRII otherprotein
otherprotein brii entityone homomeric BRII entitytwo otherprotein otherprotein
bria otherprotein entityone homomeric otherprotein otherprotein entitytwo bria brib
bria otherprotein entityone homomeric otherprotein otherprotein bria entitytwo brib brib
otherprotein otherprotein entityone homomeric otherprotein otherprotein otherprotein otherprotein entitytwo brib
otherprotein otherprotein entityone homomeric otherprotein otherprotein otherprotein otherprotein brib entitytwo also
bria otherprotein entityone homomeric otherprotein otherprotein bria bria brib brib also entitytwo brib oligomers
otherprotein otherprotein entityone homomeric otherprotein otherprotein otherprotein otherprotein brib brib also otherprotein entitytwo oligomers
otherprotein homomeric entityone entitytwo otherprotein otherprotein
otherprotein homomeric entityone brii entitytwo bria otherprotein
otherprotein homomeric entityone brii bria entitytwo otherprotein otherprotein
briibrib homomeric entityone brii otherprotein otherprotein entitytwo brib
briibrib homomeric entityone brii otherprotein otherprotein brib entitytwo also
otherprotein homomeric entityone brii bria bria otherprotein otherprotein also entitytwo otherprotein oligomers
briibrib homomeric entityone brii otherprotein otherprotein brib brib also otherprotein entitytwo oligomers
homomeric brii entityone entitytwo bria otherprotein
homomeric brii entityone bria entitytwo otherprotein otherprotein
homomeric brii entityone otherprotein otherprotein entitytwo brib
homomeric brii entityone otherprotein otherprotein brib entitytwo also
homomeric brii entityone bria bria otherprotein otherprotein also entitytwo otherprotein oligomers
homomeric brii entityone otherprotein otherprotein brib brib also otherprotein entitytwo oligomers
homomeric otherprotein otherprotein entityone entitytwo otherprotein otherprotein
homomeric otherprotein otherprotein entityone bria entitytwo brib
homomeric otherprotein otherprotein entityone bria brib entitytwo also
homomeric otherprotein otherprotein entityone bria otherprotein otherprotein also entitytwo otherprotein oligomers
homomeric otherprotein otherprotein entityone bria brib brib also bria entitytwo oligomers
otherprotein otherprotein bria entityone entitytwo brib
otherprotein otherprotein bria entityone brib entitytwo also
otherprotein otherprotein bria entityone otherprotein otherprotein also entitytwo otherprotein oligomers
otherprotein otherprotein bria entityone brib brib also bria entitytwo oligomers
otherprotein otherprotein otherprotein entityone entitytwo also
otherprotein bria bria entityone brib also entitytwo brib oligomers
otherprotein otherprotein otherprotein entityone brib also otherprotein entitytwo oligomers
bria bria brib entityone also entitytwo brib oligomers
otherprotein otherprotein brib entityone also otherprotein entitytwo oligomers
brib also entityone entitytwo oligomers
entityone binding significantly increased hetero homooligomerization except the entitytwo homooligomer
entityone binding significantly increased hetero homooligomerization except the otherprotein homooligomer binds ligand poorly the absence entitytwo
except the entityone homooligomer binds ligand poorly the absence entitytwo
amino acids entityone involved binding entitytwo otherprotein
amino acids entityone involved binding otherprotein entitytwo those
amino acids entityone involved binding otherprotein otherprotein those entitytwo involved
amino acids entityone involved binding otherprotein otherprotein those otherprotein involved binding entitytwo been
binding entityone entitytwo those
binding entityone otherprotein those entitytwo involved
binding entityone otherprotein those otherprotein involved binding entitytwo been
binding otherprotein entityone those entitytwo involved
binding otherprotein entityone those otherprotein involved binding entitytwo been
those entityone involved binding entitytwo been
the human entityone second immunoglobulinlike domain does bind entitytwo otherprotein
the human entityone second immunoglobulinlike domain does bind otherprotein entitytwo substituted
the human entityone second immunoglobulinlike domain does bind otherprotein otherprotein substituted those human entitytwo
not bind entityone entitytwo substituted
not bind entityone otherprotein substituted those human entitytwo
bind otherprotein entityone substituted those human entitytwo
recruited binding entityone equivalent entitytwo maintained otherprotein
recruited binding entityone equivalent otherprotein maintained entitytwo binding equivalent
recruited binding entityone equivalent otherprotein maintained otherprotein binding equivalent entitytwo also
recruited binding entityone equivalent otherprotein maintained otherprotein binding equivalent otherprotein also bound entitytwo although
recruited binding entityone equivalent otherprotein maintained otherprotein binding equivalent otherprotein also bound otherprotein although lower affinity compared entitytwo
otherprotein equivalent entityone maintained entitytwo binding equivalent
otherprotein equivalent entityone maintained otherprotein binding equivalent entitytwo also
otherprotein equivalent entityone maintained otherprotein binding equivalent otherprotein also bound entitytwo although
otherprotein equivalent entityone maintained otherprotein binding equivalent otherprotein also bound otherprotein although lower affinity compared entitytwo
otherprotein maintained entityone binding equivalent entitytwo also
otherprotein maintained entityone binding equivalent otherprotein also bound entitytwo although
otherprotein maintained entityone binding equivalent otherprotein also bound otherprotein although lower affinity compared entitytwo
binding equivalent entityone also bound entitytwo although
binding equivalent entityone also bound otherprotein although lower affinity compared entitytwo
also bound entityone although lower affinity compared entitytwo
characterization the entityone binding domain the human entitytwo molecule using
characterization the entityone binding domain the human otherprotein molecule using anti entitytwo antibodies
the human entityone molecule using anti entitytwo antibodies
entityone its counterreceptor entitytwo ligand otherprotein
entityone its counterreceptor entitytwo otherprotein
entityone its counterreceptor otherprotein ligand entitytwo members
entityone its counterreceptor otherprotein ligand otherprotein are members the tnfreceptor entitytwo superfamily
its counterreceptor entityone entitytwo otherprotein
its counterreceptor entityone ligand entitytwo members
its counterreceptor entityone ligand otherprotein are members the tnfreceptor entitytwo superfamily
its counterreceptor entityone entitytwo members
its counterreceptor entityone otherprotein are members the tnfreceptor entitytwo superfamily
otherprotein ligand entityone members the tnfreceptor entitytwo superfamily
using soluble entityone entitytwo chimeric protein
using soluble entityone otherprotein alpha chimeric protein assessed ability anti entitytwo mab
using soluble entityone otherprotein alpha chimeric protein assessed ability anti otherprotein MAb inhibit binding entitytwo otherprotein
using soluble entityone otherprotein alpha chimeric protein assessed ability anti otherprotein MAb inhibit binding otherprotein to entitytwo expressed
soluble otherprotein entityone chimeric protein assessed ability anti entitytwo mab
soluble otherprotein entityone chimeric protein assessed ability anti otherprotein MAb inhibit binding entitytwo otherprotein
soluble otherprotein entityone chimeric protein assessed ability anti otherprotein MAb inhibit binding otherprotein to entitytwo expressed
ability anti entityone mab inhibit binding entitytwo otherprotein
ability anti entityone mab inhibit binding otherprotein to entitytwo expressed
binding entityone entitytwo expressed
entityone binding entitytwo blocked
not affect entityone binding entitytwo
pattern entityone binding inhibition shows limited correspondence the functional capacity some anti entitytwo mab
pattern entityone binding inhibition shows limited correspondence the functional capacity some anti otherprotein MAb trigger entitytwo signaling
some anti entityone mab trigger entitytwo signaling
the anti entityone mab m81 also completely inhibits entitytwo otherprotein
the anti entityone mab m81 also completely inhibits otherprotein entitytwo interaction
also completely inhibits entityone entitytwo interaction
investigate entityone entitytwo system
investigate entityone otherprotein system designing assays for soluble entitytwo
otherprotein entityone system designing assays for soluble entitytwo
form human entityone entitytwo sc1
form human entityone entitytwo binds
form human entityone otherprotein binds one entitytwo receptor alpha
form human entityone otherprotein sc1 binds one entitytwo alpha chain
form human entityone otherprotein sc1 binds one entitytwo otherprotein
form human entityone otherprotein binds one otherprotein alpha chain entitytwo alpha
form human entityone otherprotein sc1 binds one otherprotein receptor alpha chain entitytwo been
human otherprotein entityone entitytwo binds
human otherprotein entityone sc1 binds one entitytwo receptor alpha
human otherprotein entityone sc1 binds one entitytwo alpha chain
human otherprotein entityone sc1 binds one entitytwo otherprotein
human otherprotein entityone sc1 binds one otherprotein alpha chain entitytwo alpha
human otherprotein entityone sc1 binds one otherprotein alpha chain entitytwo been
human otherprotein entityone binds one entitytwo receptor alpha
human otherprotein entityone binds one entitytwo alpha chain
human otherprotein entityone binds one entitytwo otherprotein
human otherprotein entityone binds one otherprotein alpha chain entitytwo alpha
human otherprotein entityone binds one otherprotein receptor alpha chain entitytwo been
binds one entityone entitytwo alpha chain
binds one entityone entitytwo otherprotein
binds one entityone receptor alpha chain entitytwo alpha
binds one entityone receptor alpha chain entitytwo been
binds one entityone entitytwo otherprotein
binds one entityone alpha chain entitytwo alpha
binds one entityone alpha chain entitytwo been
binds one entityone entitytwo alpha
binds one entityone entitytwo been
otherprotein alpha chain entityone entitytwo been
entityone entitytwo derived
entityone sc1 derived linking two peptide chains the entitytwo dimer
entityone derived linking two peptide chains the entitytwo dimer
calorimetry shows entityone entitytwo forms
calorimetry shows entityone sc1 forms 11 complex its highaffinity receptor entitytwo alpha
calorimetry shows entityone sc1 forms 11 complex its highaffinity receptor entitytwo an
calorimetry shows entityone forms 11 complex its highaffinity receptor entitytwo alpha
calorimetry shows entityone forms 11 complex its highaffinity receptor entitytwo an
highaffinity receptor entityone entitytwo an
crystal structure entityone entitytwo been
asp111containing domain entityone entitytwo show
loops entityone adopt conformations similar the ordered loops entitytwo observed
loops entityone adopt conformations similar the ordered loops IFNgamma observed the crystal structure the entitytwo otherprotein complex
loops entityone adopt conformations similar the ordered loops ifngamma observed the crystal structure the IFNgamma entitytwo alpha
loops entityone adopt conformations similar the ordered loops otherprotein observed the crystal structure the otherprotein entitytwo complex
ordered loops entityone observed the crystal structure the entitytwo otherprotein complex
ordered loops entityone observed the crystal structure the ifngamma entitytwo alpha
ordered loops entityone observed the crystal structure the ifngamma entitytwo complex
structure the entityone entitytwo alpha
structure the entityone entitytwo complex
the ifngamma entityone entitytwo complex
thus entityone entitytwo binding
acid residues entityone entitytwo residues
acid residues entityone sc1 residues that not observed any reported entitytwo structures
acid residues entityone residues that not observed any reported entitytwo structures
only one entityone entitytwo otherprotein
only one entityone alpha entitytwo biologically
only one entityone entitytwo biologically
one domain entityone sufficient recruit entitytwo alpha
one domain entityone sufficient recruit entitytwo otherprotein
one domain entityone sufficient recruit otherprotein entitytwo beta
one domain entityone sufficient recruit otherprotein entitytwo a
sufficient recruit entityone entitytwo otherprotein
sufficient recruit entityone alpha entitytwo beta
sufficient recruit entityone alpha entitytwo a
sufficient recruit entityone entitytwo beta
sufficient recruit entityone entitytwo a
recruit otherprotein entityone entitytwo a
role entityone dimer to decrease the dissociation constant entitytwo its
entityone antagonists emerge alterations the lowaffinity binding epitope receptor entitytwo
entityone entitytwo induces bone
entityone homodimeric cysteine knot protein as a member the entitytwo otherprotein superfamily
entityone homodimeric cysteine knot protein as a member the otherprotein entitytwo superfamily signals
member the entityone entitytwo superfamily signals
binding epitopes entityone entitytwo type
binding epitopes entityone otherprotein type and entitytwo otherprotein
binding epitopes entityone otherprotein type and otherprotein entitytwo type
binding epitopes entityone otherprotein type and otherprotein otherprotein type were characterized using entitytwo mutant proteins
otherprotein entityone type and entitytwo otherprotein
otherprotein entityone type and otherprotein entitytwo type
BMP2 entityone type and otherprotein otherprotein type were characterized using entitytwo mutant proteins
type and entityone entitytwo type
type and entityone otherprotein type were characterized using entitytwo mutant proteins
otherprotein entityone type were characterized using entitytwo mutant proteins
for highaffinity entityone binding detected spanning interface the entitytwo dimer
structure the entityone entitytwo ectodomain complex
the large entityone entitytwo superfamily
human dimeric entityone complex two high affinity entitytwo extracellular domains
human dimeric entityone complex two high affinity entitytwo otherprotein
human dimeric entityone complex two high affinity otherprotein extracellular domains entitytwo
two high affinity entityone entitytwo otherprotein
two high affinity entityone extracellular domains entitytwo
two high affinity entityone entitytwo
epitopes the entityone dimer contact entitytwo monomers
entityone induces chemotaxis adhesion interacting entitytwo otherprotein
entityone induces chemotaxis adhesion interacting otherprotein entitytwo
interacting entityone entitytwo
entityone entitytwo an
entityone otherprotein an unusually large chemokine is also known entitytwo otherprotein otherprotein
entityone otherprotein an unusually large chemokine is also known otherprotein entitytwo otherprotein
entityone otherprotein an unusually large chemokine is also known otherprotein otherprotein entitytwo otherprotein
entityone otherprotein an unusually large chemokine is also known otherprotein otherprotein otherprotein entitytwo
otherprotein entityone an unusually large chemokine is also known entitytwo otherprotein otherprotein
otherprotein entityone an unusually large chemokine is also known otherprotein entitytwo otherprotein
otherprotein entityone an unusually large chemokine is also known otherprotein otherprotein entitytwo otherprotein
otherprotein entityone an unusually large chemokine is also known otherprotein otherprotein otherprotein entitytwo
also known entityone entitytwo otherprotein
also known entityone otherprotein entitytwo otherprotein
also known entityone otherprotein otherprotein entitytwo
known otherprotein entityone entitytwo otherprotein
known otherprotein entityone otherprotein entitytwo
otherprotein otherprotein entityone entitytwo
studies show entityone binds activates entitytwo and otherprotein
studies show entityone binds activates otherprotein and entitytwo transfected hek293
activates entityone and entitytwo transfected hek293
entityone induced maximal migration entitytwo otherprotein
entityone induced maximal migration otherprotein entitytwo transfected cells
maximal migration entityone entitytwo transfected cells
molar concentration entityone required induce maximum cell migration 20 200fold greater that required entitytwo otherprotein
molar concentration entityone required induce maximum cell migration 20 200fold greater that required otherprotein entitytwo respectively
required entityone entitytwo respectively
polyclonal antibody entityone developed demonstrate the unusually high concentration entitytwo required
polyclonal antibody entityone developed demonstrate the unusually high concentration LEC required induce chemotaxis a property entitytwo not
high concentration entityone required induce chemotaxis a property entitytwo not
entityone recognizes one fgfr isoform known the entitytwo isoform
entityone recognizes one fgfr isoform known the otherprotein iiib isoform entitytwo receptor otherprotein
entityone recognizes one fgfr isoform known the otherprotein iiib isoform entitytwo otherprotein whereas
entityone recognizes one fgfr isoform known the otherprotein iiib isoform otherprotein receptor entitytwo whereas otherprotein
entityone recognizes one fgfr isoform known the otherprotein iiib isoform otherprotein receptor otherprotein whereas entitytwo binds well
entityone recognizes one fgfr isoform known the otherprotein iiib isoform otherprotein receptor otherprotein whereas otherprotein binds well entitytwo otherprotein
entityone recognizes one fgfr isoform known the otherprotein isoform otherprotein receptor otherprotein whereas otherprotein binds well otherprotein entitytwo otherprotein
entityone recognizes one fgfr isoform known the otherprotein iiib isoform otherprotein receptor otherprotein whereas otherprotein binds well otherprotein otherprotein entitytwo interacts
entityone recognizes one fgfr isoform known the otherprotein iiib isoform otherprotein receptor kgfr whereas otherprotein binds well otherprotein otherprotein otherprotein interacts poorly entitytwo
known the entityone isoform entitytwo receptor otherprotein
known the entityone isoform entitytwo otherprotein whereas
known the entityone isoform otherprotein receptor entitytwo whereas otherprotein
known the entityone isoform otherprotein receptor otherprotein whereas entitytwo binds well
known the entityone isoform otherprotein receptor otherprotein whereas otherprotein binds well entitytwo otherprotein
known the entityone isoform otherprotein receptor otherprotein whereas otherprotein binds well otherprotein entitytwo otherprotein
known the entityone isoform otherprotein receptor otherprotein whereas otherprotein binds well otherprotein otherprotein entitytwo interacts
known the entityone isoform otherprotein receptor kgfr whereas otherprotein binds well otherprotein otherprotein otherprotein interacts poorly entitytwo
iiib isoform entityone entitytwo otherprotein whereas
iiib isoform entityone receptor entitytwo whereas otherprotein
iiib isoform entityone receptor otherprotein whereas entitytwo binds well
iiib isoform entityone receptor otherprotein whereas otherprotein binds well entitytwo otherprotein
otherprotein isoform entityone receptor otherprotein whereas otherprotein binds well otherprotein entitytwo otherprotein
iiib isoform entityone receptor otherprotein whereas otherprotein binds well otherprotein otherprotein entitytwo interacts
iiib isoform entityone receptor kgfr whereas otherprotein binds well otherprotein otherprotein otherprotein interacts poorly entitytwo
iiib isoform entityone entitytwo whereas otherprotein
iiib isoform entityone otherprotein whereas entitytwo binds well
iiib isoform entityone otherprotein whereas otherprotein binds well entitytwo otherprotein
otherprotein isoform entityone otherprotein whereas otherprotein binds well otherprotein entitytwo otherprotein
iiib isoform entityone otherprotein whereas otherprotein binds well otherprotein otherprotein entitytwo interacts
iiib isoform entityone kgfr whereas otherprotein binds well otherprotein otherprotein otherprotein interacts poorly entitytwo
otherprotein receptor entityone whereas entitytwo binds well
otherprotein receptor entityone whereas otherprotein binds well entitytwo otherprotein
otherprotein receptor entityone whereas otherprotein binds well otherprotein entitytwo otherprotein
otherprotein receptor entityone whereas otherprotein binds well otherprotein otherprotein entitytwo interacts
otherprotein receptor entityone whereas otherprotein binds well otherprotein otherprotein otherprotein interacts poorly entitytwo
receptor otherprotein whereas entityone binds well entitytwo otherprotein
receptor otherprotein whereas entityone binds well otherprotein entitytwo otherprotein
receptor otherprotein whereas entityone binds well otherprotein otherprotein entitytwo interacts
receptor kgfr whereas entityone binds well otherprotein otherprotein otherprotein interacts poorly entitytwo
binds well entityone entitytwo otherprotein
binds well entityone otherprotein entitytwo interacts
binds well entityone otherprotein otherprotein interacts poorly entitytwo
well otherprotein entityone entitytwo interacts
well otherprotein entityone otherprotein interacts poorly entitytwo
otherprotein otherprotein entityone interacts poorly entitytwo
entityone contains primary site well a region restricts interaction entitytwo
confer entityone specific binding entitytwo not
beta4beta5 strands entityone contributes high affinity receptor binding is critical entitytwo recognition
homologous loop entityone dramatically reduced the affinity entitytwo otherprotein
homologous loop entityone dramatically reduced the affinity otherprotein entitytwo its
homologous loop entityone dramatically reduced the affinity otherprotein otherprotein its biological potency did result the ability bind entitytwo
affinity entityone entitytwo its
affinity entityone otherprotein its biological potency did result the ability bind entitytwo
otherprotein entityone its biological potency did result the ability bind entitytwo
loop replacement mutant entityone l47 retained entitytwo like affinity
loop replacement mutant entityone l47 retained otherprotein like affinity entitytwo for
loop replacement mutant entityone l47 retained otherprotein like affinity otherprotein for entitytwo
otherprotein l47 retained entityone like affinity entitytwo for
otherprotein l47 retained entityone like affinity otherprotein for entitytwo
like affinity entityone for entitytwo
cell surface receptors entityone entitytwo the
binding region entityone entitytwo 35
interestingly entityone binding site overlaps largest continuous hydrophobic patch entitytwo
affinity toward entityone results linear function the whole range affinities investigated suggesting entitytwo binding
structure the entityone ectodomain a dimeric form is induced simultaneous binding entitytwo a
structure the entityone entitytwo heparin ternary
splice form entityone entitytwo bind
splice form entityone otherprotein bind to activated the mesenchymally expressed ligands entitytwo otherprotein
splice form entityone otherprotein bind to activated the mesenchymally expressed ligands otherprotein entitytwo the
splice form entityone otherprotein bind activated mesenchymally expressed ligands otherprotein otherprotein and the epithelial splice form entitytwo otherprotein to
splice form entityone otherprotein bind activated mesenchymally expressed ligands otherprotein otherprotein and the epithelial splice form FGFR2 entitytwo to be
splice form entityone otherprotein bind activated mesenchymally expressed ligands otherprotein otherprotein the epithelial splice form FGFR2 otherprotein to be activated entitytwo otherprotein and
splice form entityone otherprotein bind activated mesenchymally expressed ligands otherprotein otherprotein the epithelial splice form FGFR2 otherprotein to be activated otherprotein entitytwo and otherprotein
splice form entityone otherprotein bind activated mesenchymally expressed ligands otherprotein otherprotein the epithelial splice form FGFR2 otherprotein to be activated otherprotein otherprotein and entitytwo
form otherprotein entityone bind to activated the mesenchymally expressed ligands entitytwo otherprotein
form otherprotein entityone bind to activated the mesenchymally expressed ligands otherprotein entitytwo the
form FGFR2 entityone bind activated mesenchymally expressed ligands otherprotein otherprotein and the epithelial splice form entitytwo otherprotein to
form otherprotein entityone bind activated mesenchymally expressed ligands otherprotein otherprotein and the epithelial splice form otherprotein entitytwo to be
form otherprotein entityone bind to activated mesenchymally expressed ligands otherprotein otherprotein the epithelial splice form otherprotein otherprotein to activated entitytwo otherprotein and
form otherprotein entityone bind to activated mesenchymally expressed ligands otherprotein otherprotein the epithelial splice form otherprotein otherprotein to activated otherprotein entitytwo and otherprotein
form otherprotein entityone bind to activated mesenchymally expressed ligands otherprotein otherprotein the epithelial splice form otherprotein otherprotein to activated otherprotein otherprotein and entitytwo
mesenchymally expressed ligands entityone entitytwo the
mesenchymally expressed ligands entityone otherprotein and epithelial splice form entitytwo otherprotein
mesenchymally expressed ligands entityone otherprotein and epithelial splice form otherprotein entitytwo be
mesenchymally expressed ligands entityone otherprotein epithelial splice form otherprotein otherprotein to activated entitytwo otherprotein and
mesenchymally expressed ligands entityone otherprotein epithelial splice form otherprotein otherprotein to activated otherprotein entitytwo and otherprotein
mesenchymally expressed ligands entityone otherprotein epithelial splice form otherprotein otherprotein to activated otherprotein otherprotein and entitytwo
ligands otherprotein entityone the epithelial splice form entitytwo otherprotein
ligands otherprotein entityone the epithelial splice form otherprotein entitytwo be
ligands otherprotein entityone the epithelial splice form otherprotein otherprotein to activated entitytwo otherprotein
ligands otherprotein entityone the epithelial splice form otherprotein otherprotein to activated otherprotein entitytwo otherprotein
ligands otherprotein entityone the epithelial splice form otherprotein otherprotein to activated otherprotein otherprotein entitytwo
splice form entityone entitytwo be
splice form entityone otherprotein be activated entitytwo otherprotein
splice form entityone otherprotein be activated otherprotein entitytwo otherprotein
splice form entityone otherprotein be activated otherprotein otherprotein entitytwo
form otherprotein entityone be activated entitytwo otherprotein
form otherprotein entityone be activated otherprotein entitytwo otherprotein
form otherprotein entityone be activated otherprotein otherprotein entitytwo
activated entityone entitytwo otherprotein
activated entityone otherprotein entitytwo
activated otherprotein entityone entitytwo
homolog human entityone entitytwo activates
homolog human entityone otherprotein activates human entitytwo
human otherprotein entityone activates human entitytwo
assembly viral entityone human entitytwo two complexes
assembly viral entityone human gp130 two complexes crosslinked a tetramer direct interactions the immunoglobulin domain entitytwo site
assembly viral entityone human otherprotein two complexes crosslinked a tetramer direct interactions the immunoglobulin domain otherprotein site iii viral entitytwo is
otherprotein human entityone two complexes crosslinked a tetramer direct interactions the immunoglobulin domain entitytwo site
il6 human entityone two complexes crosslinked a tetramer direct interactions the immunoglobulin domain gp130 site iii viral entitytwo is
immunoglobulin domain entityone site iii viral entitytwo is
unlike human entityone uses many hydrophilic residues viral cytokine largely uses hydrophobic amino acids contact entitytwo enhances
unlike human entityone uses many hydrophilic residues viral cytokine largely uses hydrophobic amino acids contact otherprotein enhances complementarity the viral entitytwo otherprotein binding
unlike human entityone uses many hydrophilic residues viral cytokine largely uses hydrophobic amino acids contact gp130 enhances complementarity the viral il6 entitytwo binding interfaces
acids contact entityone enhances complementarity the viral entitytwo gp130 binding
acids contact entityone enhances complementarity the viral otherprotein entitytwo binding interfaces
the viral entityone entitytwo binding interfaces
crossreactivity entityone apparently due a chemical plasticity evident the amphipathic entitytwo cytokinebinding sites
entityone entitytwo novel
entityone otherprotein novel growth factor binds entitytwo beta
otherprotein entityone novel growth factor binds entitytwo beta
entityone a multidomain protein the nterminal region homologous the extracellular cub domain entitytwo the
entityone a multidomain protein the nterminal region homologous the extracellular cub domain otherprotein the cterminal region consists a growth factor domain gfd homology vascular entitytwo and
entityone a multidomain protein the nterminal region homologous the extracellular cub domain otherprotein the cterminal region consists a growth factor domain gfd homology vascular otherprotein and entitytwo chain
cub domain entityone the cterminal region consists a growth factor domain gfd homology vascular entitytwo and
cub domain entityone the cterminal region consists a growth factor domain gfd homology vascular otherprotein and entitytwo chain
homology vascular entityone and entitytwo chain
cells bearing entityone beta receptors reveal high affinity binding recombinant gfd entitytwo otherprotein
cells bearing entityone beta receptors reveal high affinity binding recombinant gfd otherprotein to entitytwo homodimers
cells bearing entityone beta receptors reveal high affinity binding recombinant gfd otherprotein to pdgf receptoralpha homodimers entitytwo beta heterodimers
recombinant gfd entityone entitytwo homodimers
recombinant gfd entityone PDGF receptoralpha homodimers entitytwo beta heterodimers
otherprotein to entityone homodimers entitytwo beta heterodimers
entityone exhibits greater mitogenic potency entitytwo comparable
entityone exhibits greater mitogenic potency otherprotein comparable greater mitogenic activity entitytwo otherprotein
entityone exhibits greater mitogenic potency otherprotein comparable greater mitogenic activity otherprotein entitytwo several
mitogenic potency entityone comparable greater mitogenic activity entitytwo otherprotein
mitogenic potency entityone comparable greater mitogenic activity otherprotein entitytwo several
mitogenic activity entityone entitytwo several
analysis entityone vivo a diabetic mouse model delayed wound healing showed entitytwo significantly enhanced
PDGF family entityone a potent mitogen cells mesenchymal origin in vitro in vivo systems a binding pattern similar entitytwo
human entityone entitytwo a
human entityone otherprotein a functional ligand entitytwo otherprotein
human entityone otherprotein a functional ligand otherprotein entitytwo otherprotein
human entityone otherprotein a functional ligand otherprotein otherprotein entitytwo constitutively
human otherprotein entityone a functional ligand entitytwo otherprotein
human otherprotein entityone a functional ligand otherprotein entitytwo otherprotein
human otherprotein entityone a functional ligand otherprotein otherprotein entitytwo constitutively
functional ligand entityone entitytwo otherprotein
functional ligand entityone otherprotein entitytwo constitutively
ligand otherprotein entityone entitytwo constitutively
entityone entitytwo otherprotein
entityone otherprotein entitytwo a
otherprotein entityone entitytwo a
relatively high concentrations entityone induced calcium mobilization chemotaxis via entitytwo otherprotein
relatively high concentrations entityone induced calcium mobilization chemotaxis via otherprotein entitytwo
chemotaxis via entityone entitytwo
entityone also induced calcium mobilization marginal chemotaxis via entitytwo
consistently entityone found bind entitytwo otherprotein
consistently entityone found bind otherprotein entitytwo otherprotein
consistently entityone found bind otherprotein otherprotein entitytwo relatively
bind entityone entitytwo otherprotein
bind entityone otherprotein entitytwo relatively
bind otherprotein entityone entitytwo relatively
binding entityone entitytwo much
binding entityone entitytwo unable
taken together entityone a new lowaffinity functional ligand entitytwo otherprotein
taken together entityone a new lowaffinity functional ligand otherprotein entitytwo otherprotein
taken together entityone a new lowaffinity functional ligand otherprotein otherprotein entitytwo is
functional ligand entityone entitytwo otherprotein
functional ligand entityone otherprotein entitytwo is
ligand otherprotein entityone entitytwo is
cloning entityone ligand entitytwo human
cdna clone designated entityone entitytwo isolated
entityone highly similar an identified murine entitytwo at
entityone highly similar an identified murine otherprotein ligand at cDNA identity the protein identity levels related tumor necrosis factor entitytwo
identified murine entityone at cDNA identity the protein identity levels related tumor necrosis factor entitytwo
murine myeloma entityone identified a ligand entitytwo binding
murine myeloma entityone identified a ligand CD40 binding a soluble entitytwo construct
ligand entityone binding a soluble entitytwo construct
multiprotein complex entityone entitytwo otherprotein
multiprotein complex entityone otherprotein entitytwo a
complex otherprotein entityone entitytwo a
heat shock protein entityone been used to form complexes the entitytwo tyrosine kinase
heat shock protein entityone been used to form complexes the otherprotein tyrosine kinase entitytwo
complexes the entityone tyrosine kinase entitytwo
forms complexes entityone a temperaturesensitive mutant Rous sarcoma virus entitytwo is
addition entityone the lysate complexes wildtype entitytwo which
addition entityone lysate complexes wildtype otherprotein a small portion normally recovered cytosol the native multiprotein complex with the cellular homolog entitytwo which has
addition entityone lysate complexes wildtype otherprotein a small portion normally recovered cytosol the native multiprotein complex the cellular homolog otherprotein which has never recovered cytosol the form a native multiprotein complex with entitytwo
complexes wildtype entityone a small portion normally recovered cytosol native multiprotein complex with the cellular homolog entitytwo which has
complexes wildtype entityone a small portion normally recovered cytosol native multiprotein complex the cellular homolog otherprotein which has never recovered cytosol the form a native multiprotein complex with entitytwo
cellular homolog entityone has never recovered cytosol the form a native multiprotein complex entitytwo
native reconstituted entityone entitytwo complexes
complexes reconstituted entityone multiprotein complex contains entitytwo is
complexes reconstituted entityone multiprotein complex contains otherprotein is major candidate providing protein unfoldase activity required entitytwo association
multiprotein complex contains entityone is major candidate providing protein unfoldase activity required entitytwo association
expressed protein called entityone entitytwo containing one
injection entityone entitytwo proteins alone
injection entityone otherprotein proteins alone quiescent rat fibroblasts not mitogenic effect microinjection entitytwo together
injection entityone Hras proteins alone quiescent rat fibroblasts not mitogenic effect microinjection GRB2 together entitytwo protein stimulated
GRB2 entityone proteins alone quiescent rat fibroblasts not mitogenic effect microinjection entitytwo together
otherprotein entityone proteins alone quiescent rat fibroblasts not mitogenic effect microinjection otherprotein together entitytwo protein stimulated
effect microinjection entityone together entitytwo protein stimulated
results suggest entityone entitytwo plays
oligomerization entityone entitytwo products
entityone a musclespecific hlh protein binds dna vitro a heterodimer several widely expressed hlh proteins as entitytwo gene products
entityone a musclespecific hlh protein binds dna vitro a heterodimer several widely expressed hlh proteins as otherprotein gene products entitytwo otherprotein
entityone a musclespecific hlh protein binds dna vitro a heterodimer several widely expressed hlh proteins as otherprotein gene products otherprotein entitytwo
as entityone gene products entitytwo otherprotein
as entityone gene products otherprotein entitytwo
otherprotein gene products entityone entitytwo
results show entityone heterodimerizes entitytwo otherprotein
results show entityone heterodimerizes otherprotein entitytwo vivo
otherprotein heterodimerizes entityone entitytwo vivo
early gene products entityone entitytwo otherprotein
early gene products entityone otherprotein entitytwo inhibit
early gene products entityone otherprotein otherprotein inhibit activity otherprotein a mechanism independent its association entitytwo products
gene products otherprotein entityone entitytwo inhibit
gene products otherprotein entityone otherprotein inhibit activity otherprotein a mechanism independent its association entitytwo products
otherprotein otherprotein entityone inhibit activity otherprotein a mechanism independent its association entitytwo products
activation entityone entitytwo otherprotein
activation entityone kinase entitytwo NIH
activation entityone entitytwo NIH
entityone the protein kinase activates entitytwo constitutively
entityone the protein kinase activates otherprotein constitutively activated NIH 3t3 cells infected viruses containing either two oncogenic forms p35ec12 p3722w the entitytwo protein kinase
activates entityone constitutively activated NIH 3t3 cells infected viruses containing either two oncogenic forms p35ec12 p3722w the entitytwo protein kinase
entityone proteins purified cells infected EC12 22W viruses activated entitytwo kinase
entityone proteins purified cells infected EC12 22W viruses activated entitytwo skeletal
22w viruses activated entityone entitytwo skeletal
bacterially expressed entityone fusion protein glutathione stransferasep3722w also activated entitytwo kinase
bacterially expressed entityone fusion protein glutathione stransferasep3722w also activated entitytwo vitro
stransferasep3722w also activated entityone entitytwo vitro
one function entityone mitogenic signaling to phosphorylate activate entitytwo kinase
one function entityone mitogenic signaling to phosphorylate activate entitytwo
phosphorylate activate entityone entitytwo
human 75kda entityone entitytwo constructed
human 75kda entityone tnfr2 constructed used generate stable human cell line entitytwo overexpressing tnfr2
human 75kda entityone tnfr2 constructed used generate stable human cell line 293tnfr2 overexpressing entitytwo
human 75kda otherprotein entityone constructed used generate stable human cell line entitytwo overexpressing tnfr2
human 75kda otherprotein entityone constructed used generate stable human cell line 293tnfr2 overexpressing entitytwo
cell line entityone overexpressing entitytwo
sitescell 125I entityone approximately 5fold lower affinity entitytwo =
crosslinking 125I entityone 125I entitytwo 293
crosslinking 125I entityone 125I otherprotein 293 entitytwo cells yielded
crosslinking 125I entityone 125I otherprotein 293 otherprotein cells yielded predominant complexes apparent molecular weights 211000 entitytwo 205000
crosslinking 125I entityone 125ITNFbeta 293 otherprotein cells yielded predominant complexes apparent molecular weights 211000 TNFalpha 205000 244000 entitytwo suggesting
crosslinking 125I entityone 125I otherprotein 293TNFR2 cells yielded predominant complexes apparent molecular weights 211000 TNFalpha 205000 244000 otherprotein suggesting complexes contain two three entitytwo molecules
otherprotein 125I entityone 293 entitytwo cells yielded
125itnfalpha 125I entityone 293 otherprotein cells yielded predominant complexes apparent molecular weights 211000 entitytwo 205000
otherprotein 125I entityone 293 otherprotein cells yielded predominant complexes apparent molecular weights 211000 otherprotein 205000 244000 entitytwo suggesting
otherprotein 125I entityone 293TNFR2 cells yielded predominant complexes apparent molecular weights 211000 otherprotein 205000 244000 TNFbeta suggesting complexes contain two three entitytwo molecules
otherprotein 293 entityone cells yielded predominant complexes apparent molecular weights 211000 entitytwo 205000
125itnfbeta 293 entityone cells yielded predominant complexes apparent molecular weights 211000 otherprotein 205000 244000 entitytwo suggesting
otherprotein 293 entityone cells yielded predominant complexes apparent molecular weights 211000 otherprotein 205000 244000 otherprotein suggesting complexes contain two three entitytwo molecules
211000 entityone 205000 244000 entitytwo suggesting
211000 entityone 205000 244000 otherprotein suggesting complexes contain two three entitytwo molecules
244000 entityone suggesting complexes contain two three entitytwo molecules
immunoprecipitation entityone 32Plabeled entitytwo cells demonstrated
entityone treatment 293 entitytwo cells
extracellular domain entityone induced 4 betaphorbol 12myristate 13acetate not entitytwo otherprotein
extracellular domain entityone induced 4 betaphorbol 12myristate 13acetate not otherprotein entitytwo
not entityone entitytwo
the homodimeric entityone entitytwo been
coassociation entityone entitytwo otherprotein
coassociation entityone otherprotein entitytwo the
coassociation otherprotein entityone entitytwo the
modulation entityone T cell surface induced anti entitytwo 1f7 led
modulation entityone T cell surface induced antiCD26 1f7 led enhanced phosphorylation entitytwo zeta tyrosine
modulation entityone T cell surface induced antiCD26 1f7 led enhanced phosphorylation otherprotein zeta tyrosine residues increased entitytwo associated p56lck
induced anti entityone 1f7 led enhanced phosphorylation entitytwo zeta tyrosine
induced anti entityone 1f7 led enhanced phosphorylation otherprotein zeta tyrosine residues increased entitytwo associated p56lck
enhanced phosphorylation entityone zeta tyrosine residues increased entitytwo associated p56lck
showed entityone comodulated the cell surface entitytwo known
showed entityone comodulated the cell surface otherprotein known membranelinked protein tyrosine phosphatase that anti entitytwo capable
showed entityone comodulated the cell surface otherprotein a known membranelinked protein tyrosine phosphatase that anticd26 capable precipitating entitytwo T
cell surface entityone known membranelinked protein tyrosine phosphatase that anti entitytwo capable
cell surface entityone known membranelinked protein tyrosine phosphatase that anti otherprotein capable precipitating entitytwo T
that anti entityone capable precipitating entitytwo T
strongly suggest entityone may closely associated the entitytwo protein tyrosine
strongly suggest entityone may closely associated otherprotein protein tyrosine phosphatase T cell surface further support the notion the interaction entitytwo otherprotein
strongly suggest entityone may closely associated otherprotein protein tyrosine phosphatase T cell surface further support the notion the interaction CD26 entitytwo results
associated entityone protein tyrosine phosphatase T cell surface further support the notion the interaction entitytwo otherprotein
associated entityone protein tyrosine phosphatase T cell surface further support the notion the interaction otherprotein entitytwo results
interaction entityone entitytwo results
cDNA clone entityone encoding human fibroblast growth factor fgf receptor entitytwo contains
forms the entityone encoded polypeptide was denoted entitytwo
crosslinking iodinated entityone entitytwo otherprotein
crosslinking iodinated entityone otherprotein entitytwo otherprotein
crosslinking iodinated entityone otherprotein otherprotein entitytwo transiently
crosslinking iodinated entityone afgf otherprotein otherprotein transiently expressing cos1 cells revealed major band 95 kda was competed by entitytwo otherprotein
crosslinking iodinated entityone otherprotein otherprotein bfgf transiently expressing cos1 cells revealed major band 95 kda was competed by otherprotein entitytwo
iodinated otherprotein entityone entitytwo otherprotein
iodinated otherprotein entityone otherprotein entitytwo transiently
iodinated otherprotein entityone otherprotein otherprotein transiently expressing cos1 cells revealed major band 95 kda was competed by entitytwo otherprotein
iodinated otherprotein entityone otherprotein bfgf transiently expressing cos1 cells revealed major band 95 kda was competed by aFGF entitytwo
otherprotein otherprotein entityone entitytwo transiently
otherprotein afgf entityone otherprotein transiently expressing cos1 cells revealed major band 95 kda was competed by entitytwo otherprotein
otherprotein otherprotein entityone bfgf transiently expressing cos1 cells revealed major band 95 kda was competed by otherprotein entitytwo
afgf otherprotein entityone transiently expressing cos1 cells revealed major band 95 kda was competed by entitytwo bFGF
otherprotein otherprotein entityone transiently expressing cos1 cells revealed major band 95 kda was competed by otherprotein entitytwo
by entityone entitytwo
binding entityone entitytwo otherprotein
binding entityone otherprotein entitytwo estimated
otherprotein entityone entitytwo estimated
thus entityone encodes human fgf receptor high affinity both entitytwo otherprotein
thus entityone encodes human fgf receptor high affinity both otherprotein entitytwo
affinity both entityone entitytwo
transcription factors entityone entitytwo otherprotein
transcription factors entityone otherprotein entitytwo otherprotein alters
transcription factors entityone otherprotein otherprotein entitytwo alters dna
transcription factors otherprotein entityone entitytwo otherprotein alters
transcription factors otherprotein entityone otherprotein entitytwo alters dna
otherprotein otherprotein entityone entitytwo alters dna
entityone entitytwo otherprotein
entityone otherprotein entitytwo otherprotein families
entityone otherprotein otherprotein entitytwo families
otherprotein entityone entitytwo otherprotein families
otherprotein entityone otherprotein entitytwo families
otherprotein otherprotein entityone entitytwo families
although entityone entitytwo otherprotein
although entityone otherprotein entitytwo otherprotein
although entityone otherprotein otherprotein entitytwo previously
although otherprotein entityone entitytwo otherprotein
although otherprotein entityone otherprotein entitytwo previously
otherprotein otherprotein entityone entitytwo previously
indicate the entityone entitytwo otherprotein
indicate the entityone otherprotein entitytwo otherprotein families
indicate the entityone otherprotein otherprotein entitytwo families
the otherprotein entityone entitytwo otherprotein families
the otherprotein entityone otherprotein entitytwo families
otherprotein otherprotein entityone entitytwo families
human entityone new cyclin interacts two members the entitytwo gene family
entityone showed genetic interactions the entitytwo gene suggesting
entityone showed genetic interactions the otherprotein gene suggesting it functioned START interacting the entitytwo protein
interactions the entityone gene suggesting it functioned START interacting the entitytwo protein
could interact entityone perform start yeast containing entitytwo mutation
one entityone entitytwo the
one entityone and second the human homolog Xenopus entitytwo
one entityone the second the human homolog Xenopus entitytwo
entityone produced E coli bound activated entitytwo protein
entityone produced E coli bound activated otherprotein protein extracts human cells antibodies entitytwo immunoprecipitated
activated entityone protein extracts human cells antibodies entitytwo immunoprecipitated
interactions entityone entitytwo otherprotein
interactions entityone otherprotein entitytwo may
otherprotein entityone entitytwo may
previously unidentified human entityone genes been isolated entitytwo otherprotein
previously unidentified human entityone genes been isolated otherprotein and entitytwo
been isolated entityone entitytwo
microinjection anti entityone antibodies HeLa cells causes arrest mitosis entitytwo otherprotein
microinjection anti entityone antibodies HeLa cells causes arrest mitosis otherprotein and entitytwo display endogenous
microinjection anti entityone antibodies HeLa cells causes arrest mitosis otherprotein and otherprotein display endogenous tyrosine phosphatase activity is stimulated severalfold the absence otherprotein stoichiometric addition either entitytwo B2
arrest mitosis entityone entitytwo display endogenous
arrest mitosis entityone otherprotein display endogenous tyrosine phosphatase activity is stimulated severalfold the absence otherprotein stoichiometric addition either entitytwo B2
otherprotein and entityone display endogenous tyrosine phosphatase activity is stimulated severalfold the absence otherprotein stoichiometric addition either entitytwo B2
association entityone entitytwo otherprotein
association entityone otherprotein entitytwo detected
otherprotein and entityone entitytwo detected
subunits entityone protein kinase also activate the entitytwo tyrosine phosphatase
subunits entityone protein kinase also activate the otherprotein tyrosine phosphatase which entitytwo the
also activate entityone tyrosine phosphatase which entitytwo the
provided entityone intermolecular interaction entitytwo
activation entityone decreases phosphorylation entitytwo sites
fibroblastic cells entityone phosphorylated serine threonine five sites three which phosphorylated vitro entitytwo otherprotein
fibroblastic cells entityone phosphorylated serine threonine five sites three which phosphorylated vitro otherprotein entitytwo
vitro entityone entitytwo
activation entityone results rapid sitespecific dephosphorylation entitytwo one
activation entityone results rapid sitespecific dephosphorylation otherprotein one more these three sites is coincident increased entitytwo binding activity
sitespecific dephosphorylation entityone one more these three sites is coincident increased entitytwo binding activity
recombinant human entityone proteins vitro entitytwo decreases
propose entityone present resting cells a latent phosphorylated form can activated sitespecific dephosphorylation response entitytwo activation
regulatory subunit entityone entitytwo RIIanchoring
regulatory subunit entityone otherprotein entitytwo anchoring proteins
subunit rii entityone entitytwo anchoring proteins
entityone localized specific subcellular environments the binding the regulatory subunit entitytwo dimer
entityone localized specific subcellular environments the binding the regulatory subunit rii dimer entitytwo anchoring proteins
regulatory subunit entityone dimer entitytwo anchoring proteins
performed four entityone anchoring protein sequences entitytwo otherprotein
performed four entityone anchoring protein sequences otherprotein entitytwo two
performed four entityone anchoring protein sequences otherprotein otherprotein two thyroid proteins entitytwo otherprotein
performed four entityone anchoring protein sequences otherprotein otherprotein two thyroid proteins otherprotein entitytwo identified
protein sequences entityone entitytwo two
protein sequences entityone otherprotein two thyroid proteins entitytwo otherprotein
protein sequences entityone otherprotein two thyroid proteins otherprotein entitytwo identified
sequences otherprotein entityone two thyroid proteins entitytwo otherprotein
sequences otherprotein entityone two thyroid proteins otherprotein entitytwo identified
two thyroid proteins entityone entitytwo identified
318amino acid fragment entityone containing amphipathic helix region able bind entitytwo alpha
318amino acid fragment entityone containing amphipathic helix region able bind entitytwo
able bind entityone entitytwo
ala498 significantly diminished entityone entitytwo binding
effect entityone entitytwo binding
proteins interact entityone entitytwo via
protooncogene entityone a component the entitytwo transcription factor
present evidence entityone entitytwo otherprotein
present evidence entityone otherprotein entitytwo specifically
present evidence entityone otherprotein otherprotein specifically phosphorylate sites that phosphorylation positively regulates transacting activity entitytwo
evidence otherprotein entityone entitytwo specifically
evidence otherprotein entityone otherprotein specifically phosphorylate sites that phosphorylation positively regulates transacting activity entitytwo
otherprotein otherprotein entityone specifically phosphorylate sites that phosphorylation positively regulates transacting activity entitytwo
entityone enzymes entitytwo otherprotein
entityone enzymes otherprotein entitytwo are
otherprotein enzymes entityone entitytwo are
entityone activation entitytwo may underlie
competes entityone binding the entitytwo gene product
the human entityone entitytwo widely
entityone acts bring this suppression not clear one clue that entitytwo protein forms
entityone acts bring this suppression not clear one clue that Rb protein forms complexes the transforming oncoproteins several dna tumour viruses that two regions entitytwo essential
that entityone protein forms complexes the transforming oncoproteins several dna tumour viruses that two regions entitytwo essential
human cellular entityone entitytwo relative
human cellular entityone associated protein relative molecular mass 46K entitytwo
human cellular entityone relative molecular mass 46K entitytwo
notion entityone entitytwo homologous
notion entityone otherprotein homologous entitytwo binding properties
notion entityone otherprotein homologous rbbinding properties first several mutated entitytwo proteins
notion entityone otherprotein homologous otherprotein binding properties first several mutated otherprotein proteins failed bind T also not associate entitytwo and
notion entityone otherprotein homologous otherprotein binding properties first several mutated otherprotein proteins failed bind T also not associate otherprotein ap46 second T antigen T peptide amino acids were able compete entitytwo binding
notion entityone otherprotein homologous rbbinding properties first several mutated proteins failed bind T also not associate RbAP46; second T antigen T peptide amino acids were able compete RbAP46 binding entitytwo
otherprotein entityone homologous entitytwo binding properties
otherprotein entityone homologous rbbinding properties first several mutated entitytwo proteins
otherprotein ap46 entityone homologous otherprotein binding properties first several mutated otherprotein proteins failed bind T also not associate entitytwo and
otherprotein ap46 entityone homologous otherprotein binding properties first several mutated otherprotein proteins failed bind T also not associate otherprotein ap46 second T antigen T peptide amino acids were able compete entitytwo binding
otherprotein entityone homologous rbbinding properties first several mutated proteins failed bind T also not associate otherprotein second T antigen and T peptide amino acids were able compete otherprotein binding entitytwo
otherprotein homologous entityone binding properties first several mutated entitytwo proteins
otherprotein homologous entityone binding properties first several mutated proteins failed bind T also not associate entitytwo and
otherprotein homologous entityone binding properties first several mutated proteins failed bind T also not associate RbAP46; second T antigen T peptide amino acids were able compete entitytwo binding
otherprotein homologous entityone binding properties first several mutated proteins failed bind T also not associate otherprotein second T antigen and T peptide amino acids were able compete otherprotein binding entitytwo
first several mutated entityone proteins failed bind T also not associate entitytwo and
first several mutated entityone proteins failed bind T also not associate RbAP46; second T antigen T peptide amino acids were able compete entitytwo binding
first several mutated entityone proteins failed bind T also not associate otherprotein second T antigen and T peptide amino acids were able compete otherprotein binding entitytwo
associate entityone second T antigen and T peptide amino acids were able compete entitytwo binding
associate entityone second T antigen and T peptide amino acids were able compete RbAP46 binding entitytwo
compete entityone binding entitytwo
targeting the entityone entitytwo interaction
receptor the entityone entitytwo
unlabeled entityone entitytwo equally
unlabeled entityone otherprotein equally effective displacing binding labeled entitytwo TNFR
unlabeled tnfalpha entityone equally effective displacing binding labeled entitytwo TNFR
receptor human entityone entitytwo isolated
including for entityone entitytwo otherprotein
including for entityone otherprotein entitytwo betachain
for otherprotein entityone entitytwo betachain
expression entityone showing a single class affinity = nM specificity human entitytwo not
expression entityone showing a single class affinity = nM specificity human otherprotein not entitytwo
specificity human entityone not entitytwo
Tcell antigen entityone acts a receptor substrate the proteintyrosine kinase entitytwo
entityone a tcellspecific antigen binds the bcell antigen entitytwo acts
entityone associates the entitytwo otherprotein otherprotein
entityone associates the otherprotein entitytwo otherprotein complex
entityone associates the otherprotein otherprotein entitytwo complex
entityone associates the entitytwo complex
entityone associates the otherprotein tcr zeta otherprotein complex is rapidly phosphosphorylated tyrosine residues a result entitytwo otherprotein ligation
entityone associates the otherprotein otherprotein cd3 complex is rapidly phosphosphorylated tyrosine residues a result otherprotein entitytwo ligation
associates the entityone entitytwo otherprotein complex
associates the entityone otherprotein entitytwo complex
associates the entityone entitytwo complex
associates the entityone tcr zeta otherprotein complex is rapidly phosphosphorylated tyrosine residues a result entitytwo otherprotein ligation
associates the entityone otherprotein cd3 complex is rapidly phosphosphorylated tyrosine residues a result otherprotein entitytwo ligation
the otherprotein entityone entitytwo complex
the otherprotein entityone entitytwo complex
the otherprotein entityone otherprotein complex is rapidly phosphosphorylated tyrosine residues a result entitytwo otherprotein ligation
the otherprotein entityone cd3 complex is rapidly phosphosphorylated tyrosine residues a result TcR zeta entitytwo ligation
otherprotein otherprotein entityone entitytwo complex
otherprotein tcr zeta entityone complex is rapidly phosphosphorylated tyrosine residues a result entitytwo cd3 ligation
otherprotein otherprotein entityone complex is rapidly phosphosphorylated tyrosine residues a result otherprotein entitytwo ligation
associates the entityone complex is rapidly phosphosphorylated tyrosine residues a result entitytwo otherprotein ligation
associates the entityone complex is rapidly phosphosphorylated tyrosine residues a result otherprotein entitytwo ligation
result entityone entitytwo ligation
demonstrate entityone coupled the proteintyrosine kinase entitytwo can
demonstrate entityone coupled the proteintyrosine kinase p56lck can act a substrate entitytwo
proteintyrosine kinase entityone can act a substrate entitytwo
coexpression entityone entitytwo the
coexpression entityone otherprotein the baculovirus expression system resulted the phosphorylation entitytwo tyrosine
CD5 entityone the baculovirus expression system resulted the phosphorylation entitytwo tyrosine
anti entityone anti entitytwo coprecipitated
anti entityone also precipitated kinase various cells irrespective the expression entitytwo otherprotein
anti entityone also precipitated kinase various cells irrespective the expression otherprotein entitytwo otherprotein
anti entityone also precipitated kinase various cells irrespective the expression otherprotein otherprotein entitytwo
expression entityone entitytwo otherprotein
expression entityone otherprotein entitytwo
expression otherprotein entityone entitytwo
binding entityone and entitytwo detected
binding entityone entitytwo induced
binding entityone otherprotein induced 10 15fold increase entitytwo catalytic activity
p56lck entityone induced 10 15fold increase entitytwo catalytic activity
y394 occupancy entityone associated entitytwo
sh2 domain entityone could recognize entitytwo expressed
entityone interaction entitytwo otherprotein represents
entityone interaction otherprotein entitytwo represents
entityone interaction otherprotein otherprotein represents novel variant a receptorkinas entitytwo in
otherprotein interaction entityone entitytwo represents
otherprotein interaction entityone otherprotein represents novel variant a receptorkinas entitytwo in
interaction otherprotein entityone represents novel variant a receptorkinas entitytwo in
entityone entitytwo desmosomal
terminal "tail" entityone associates directly otherprotein amino terminal "head" type epidermal keratins including entitytwo otherprotein otherprotein
terminal "tail" entityone associates directly otherprotein amino terminal "head" type epidermal keratins including otherprotein entitytwo otherprotein
terminal "tail" entityone associates directly otherprotein amino terminal "head" type epidermal keratins including otherprotein otherprotein entitytwo otherprotein
terminal "tail" entityone associates directly otherprotein amino terminal "head" type epidermal keratins including otherprotein otherprotein otherprotein entitytwo
epidermal keratins including entityone entitytwo otherprotein
epidermal keratins including entityone otherprotein entitytwo otherprotein
epidermal keratins including entityone otherprotein otherprotein entitytwo
keratins including otherprotein entityone entitytwo otherprotein
keratins including otherprotein entityone otherprotein entitytwo
including otherprotein otherprotein entityone entitytwo
purified recombinant entityone head entitytwo tail
stretch the entityone head is conserved among type epidermal keratins that appears play role entitytwo tail binding
factor receptor superfamily entityone suppresses entitytwo mediated apoptosis
entityone entitytwo otherprotein
entityone otherprotein entitytwo a
otherprotein entityone entitytwo a
demonstrate entityone specifically binds two cellular ligands entitytwo herpes virus
demonstrate entityone specifically binds two cellular ligands otherprotein entitytwo otherprotein
demonstrate entityone specifically binds two cellular ligands otherprotein herpes virus entry mediator otherprotein and entitytwo ligand otherprotein
demonstrate entityone specifically binds two cellular ligands otherprotein herpes virus entry mediator otherprotein and entitytwo otherprotein
demonstrate entityone specifically binds two cellular ligands otherprotein herpes virus entry mediator otherprotein and otherprotein ligand entitytwo otherprotein
demonstrate entityone specifically binds two cellular ligands otherprotein herpes virus entry mediator otherprotein and otherprotein ligand otherprotein entitytwo
two cellular ligands entityone entitytwo otherprotein
two cellular ligands entityone herpes virus entry mediator otherprotein and entitytwo ligand otherprotein
two cellular ligands entityone herpes virus entry mediator otherprotein and entitytwo otherprotein
two cellular ligands entityone herpes virus entry mediator otherprotein and otherprotein ligand entitytwo otherprotein
two cellular ligands entityone herpes virus entry mediator otherprotein and otherprotein ligand otherprotein entitytwo
cellular ligands otherprotein entityone entitytwo ligand otherprotein
cellular ligands otherprotein entityone entitytwo otherprotein
cellular ligands otherprotein entityone otherprotein ligand entitytwo otherprotein
cellular ligands otherprotein entityone otherprotein ligand otherprotein entitytwo
otherprotein and entityone entitytwo otherprotein otherprotein
otherprotein and entityone ligand entitytwo otherprotein
otherprotein and entityone ligand otherprotein entitytwo
otherprotein and entityone entitytwo otherprotein
otherprotein and entityone otherprotein entitytwo
otherprotein ligand entityone entitytwo
entityone inhibited entitytwo induced cytotoxicity
shown entityone triggers apoptosis various tumor cells including ht29 cells express entitytwo receptor otherprotein
shown entityone triggers apoptosis various tumor cells including ht29 cells express entitytwo otherprotein
shown entityone triggers apoptosis various tumor cells including ht29 cells express otherprotein receptor entitytwo otherprotein
shown entityone triggers apoptosis various tumor cells including ht29 cells express otherprotein receptor otherprotein entitytwo otherprotein receptors
shown entityone triggers apoptosis various tumor cells including ht29 cells express otherprotein receptor otherprotein otherprotein entitytwo receptors
express entityone entitytwo otherprotein
express entityone receptor entitytwo otherprotein
express entityone receptor otherprotein entitytwo otherprotein receptors
express entityone receptor otherprotein otherprotein entitytwo receptors
express entityone entitytwo otherprotein
express entityone otherprotein entitytwo otherprotein receptors
express entityone otherprotein otherprotein entitytwo receptors
otherprotein receptor entityone entitytwo otherprotein receptors
otherprotein receptor entityone otherprotein entitytwo receptors
receptor otherprotein entityone entitytwo receptors
data suggest entityone inhibits interactions entitytwo otherprotein
data suggest entityone inhibits interactions otherprotein otherprotein entitytwo otherprotein
data suggest entityone inhibits interactions otherprotein otherprotein otherprotein entitytwo otherprotein
data suggest entityone inhibits interactions otherprotein otherprotein otherprotein otherprotein entitytwo thereby suppressing
data suggest entityone inhibits interactions LIGHT otherprotein otherprotein otherprotein otherprotein thereby suppressing entitytwo mediated ht29
interactions entityone otherprotein entitytwo otherprotein
interactions entityone otherprotein otherprotein entitytwo otherprotein
interactions entityone otherprotein otherprotein otherprotein entitytwo thereby suppressing
interactions entityone otherprotein otherprotein otherprotein otherprotein thereby suppressing entitytwo mediated ht29
otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein entityone otherprotein entitytwo thereby suppressing
light otherprotein entityone otherprotein otherprotein thereby suppressing entitytwo mediated ht29
otherprotein otherprotein entityone entitytwo thereby suppressing
otherprotein otherprotein entityone otherprotein thereby suppressing entitytwo mediated ht29
otherprotein otherprotein entityone thereby suppressing entitytwo mediated ht29
thus entityone may play regulatory role suppressing entitytwo otherprotein
thus entityone may play regulatory role suppressing otherprotein and entitytwo mediated cell
suppressing entityone entitytwo mediated cell
entityone protein binds entitytwo zincfinger
entityone protein binds otherprotein zincfinger protein shares epitope otherprotein adenovirus entitytwo protein
protein binds entityone zincfinger protein shares epitope otherprotein adenovirus entitytwo protein
entityone entitytwo a
contains entityone binding motif shares antigenic epitope otherprotein C terminus entitytwo
conserved entityone the entitytwo otherprotein differentiation
conserved entityone the otherprotein entitytwo differentiation factor
otherprotein the entityone entitytwo differentiation factor
function entityone not yet clear structure pattern expression suggest role entitytwo transcriptional
entityone novel death domaincontaining protein interacts otherprotein death domain entitytwo initiates
cytoplasmic domain entityone the yeast twohybrid system have identified novel interacting protein entitytwo binds
cytoplasmic domain entityone the yeast twohybrid system have identified novel interacting protein otherprotein binds entitytwo Fas
cytoplasmic domain entityone the yeast twohybrid system have identified novel interacting protein otherprotein binds fas entitytwo otherprotein
cytoplasmic domain entityone the yeast twohybrid system have identified novel interacting protein otherprotein binds fas Fas entitytwo mutant
cytoplasmic domain entityone the yeast twohybrid system have identified novel interacting protein otherprotein binds fas Fas otherprotein mutant entitytwo possessing enhanced
cytoplasmic domain entityone yeast twohybrid system have identified novel interacting protein otherprotein binds fas Fas otherprotein mutant Fas possessing enhanced killing activity not the functionally inactive mutants entitytwo otherprotein
cytoplasmic domain entityone yeast twohybrid system have identified novel interacting protein otherprotein binds fas fas otherprotein mutant Fas possessing enhanced killing activity not the functionally inactive mutants Fas entitytwo Fas
cytoplasmic domain entityone yeast twohybrid system have identified novel interacting protein otherprotein binds fas fas otherprotein mutant Fas possessing enhanced killing activity not the functionally inactive mutants Fas otherprotein entitytwo otherprotein
cytoplasmic domain entityone yeast twohybrid system have identified novel interacting protein otherprotein binds fas fas otherprotein mutant Fas possessing enhanced killing activity not the functionally inactive mutants Fas otherprotein Fas entitytwo
novel interacting protein entityone binds entitytwo Fas
novel interacting protein entityone binds fas entitytwo otherprotein
novel interacting protein entityone binds otherprotein otherprotein entitytwo mutant
novel interacting protein entityone binds fas Fas otherprotein mutant entitytwo possessing enhanced
novel interacting protein entityone binds fas Fas otherprotein mutant Fas possessing enhanced killing activity not functionally inactive mutants entitytwo otherprotein
novel interacting protein entityone binds otherprotein otherprotein otherprotein mutant otherprotein possessing enhanced killing activity not functionally inactive mutants otherprotein entitytwo otherprotein
novel interacting protein entityone binds fas fas otherprotein mutant Fas possessing enhanced killing activity not functionally inactive mutants Fas otherprotein entitytwo otherprotein
novel interacting protein entityone binds otherprotein otherprotein otherprotein mutant otherprotein possessing enhanced killing activity not functionally inactive mutants otherprotein otherprotein otherprotein entitytwo
otherprotein binds entityone entitytwo otherprotein
otherprotein binds entityone Fas entitytwo mutant
otherprotein binds entityone Fas otherprotein mutant entitytwo possessing enhanced
otherprotein binds entityone Fas otherprotein mutant Fas possessing enhanced killing activity not functionally inactive mutants entitytwo otherprotein
otherprotein binds entityone fas otherprotein mutant Fas possessing enhanced killing activity not functionally inactive mutants Fas entitytwo Fas
otherprotein binds entityone fas otherprotein mutant Fas possessing enhanced killing activity not functionally inactive mutants Fas otherprotein entitytwo otherprotein
otherprotein binds entityone fas otherprotein mutant Fas possessing enhanced killing activity not functionally inactive mutants Fas otherprotein Fas entitytwo
binds fas entityone entitytwo mutant
binds fas entityone otherprotein mutant entitytwo possessing enhanced
binds fas entityone otherprotein mutant Fas possessing enhanced killing activity not functionally inactive mutants entitytwo otherprotein
binds fas entityone otherprotein mutant fas possessing enhanced killing activity not functionally inactive mutants Fas entitytwo Fas
binds fas entityone otherprotein mutant fas possessing enhanced killing activity not functionally inactive mutants Fas otherprotein entitytwo otherprotein
binds fas entityone otherprotein mutant fas possessing enhanced killing activity not functionally inactive mutants Fas otherprotein Fas entitytwo
fas Fas entityone mutant entitytwo possessing enhanced
fas Fas entityone mutant Fas possessing enhanced killing activity not functionally inactive mutants entitytwo otherprotein
otherprotein otherprotein entityone mutant otherprotein possessing enhanced killing activity not functionally inactive mutants otherprotein entitytwo otherprotein
fas fas entityone mutant Fas possessing enhanced killing activity not functionally inactive mutants Fas otherprotein entitytwo otherprotein
otherprotein otherprotein entityone mutant otherprotein possessing enhanced killing activity not functionally inactive mutants otherprotein otherprotein otherprotein entitytwo
mutant entityone possessing enhanced killing activity not functionally inactive mutants entitytwo otherprotein
mutant entityone possessing enhanced killing activity not functionally inactive mutants fas entitytwo Fas
mutant entityone possessing enhanced killing activity not functionally inactive mutants fas otherprotein entitytwo otherprotein
mutant entityone possessing enhanced killing activity not functionally inactive mutants fas otherprotein Fas entitytwo
functionally inactive mutants entityone entitytwo Fas
functionally inactive mutants entityone otherprotein entitytwo otherprotein
functionally inactive mutants entityone otherprotein Fas entitytwo
inactive mutants fas entityone entitytwo otherprotein
inactive mutants otherprotein entityone otherprotein entitytwo
fas otherprotein entityone entitytwo
entityone contains death domain homologous the death domains entitytwo otherprotein
entityone contains death domain homologous the death domains otherprotein entitytwo
death domains entityone entitytwo
point mutation entityone analogous the lpr mutation entitytwo abolishes
point mutation entityone analogous the lpr mutation Fas abolishes ability bind entitytwo suggesting
lpr mutation entityone abolishes ability bind entitytwo suggesting
overexpression entityone MCF7 BJAB cells induces apoptosis like entitytwo induced apoptosis
overexpression entityone MCF7 BJAB cells induces apoptosis like otherprotein induced apoptosis blocked entitytwo specific
overexpression entityone MCF7 BJAB cells induces apoptosis like otherprotein induced apoptosis blocked otherprotein specific inhibitor the entitytwo converting enzyme
overexpression entityone MCF7 BJAB cells induces apoptosis like otherprotein induced apoptosis blocked otherprotein specific inhibitor the entitytwo
apoptosis like entityone induced apoptosis blocked entitytwo specific
apoptosis like entityone induced apoptosis blocked otherprotein specific inhibitor the entitytwo converting enzyme
apoptosis like entityone induced apoptosis blocked otherprotein specific inhibitor the entitytwo
blocked entityone specific inhibitor the entitytwo converting enzyme
blocked entityone specific inhibitor the entitytwo
inhibitor the entityone entitytwo
findings suggest entityone may play important role the proximal signal transduction entitytwo
entityone novel protein containing death domain interacts otherprotein entitytwo otherprotein otherprotein
entityone novel protein containing death domain interacts otherprotein otherprotein entitytwo otherprotein
entityone novel protein containing death domain interacts otherprotein otherprotein otherprotein entitytwo yeast
interacts otherprotein entityone entitytwo otherprotein
interacts otherprotein entityone otherprotein entitytwo yeast
otherprotein otherprotein entityone entitytwo yeast
cell surface receptor entityone entitytwo otherprotein elicits
cell surface receptor entityone otherprotein entitytwo elicits
surface receptor otherprotein entityone entitytwo elicits
intracellular domain entityone entitytwo and
intracellular domain entityone fas and novel kDa protein have named entitytwo otherprotein
intracellular domain entityone fas and novel kDa protein have named otherprotein entitytwo
domain Fas entityone and novel kDa protein have named entitytwo otherprotein
domain Fas entityone and novel kDa protein have named otherprotein entitytwo
have named entityone entitytwo
entityone also interacts weakly otherprotein entitytwo tumor necrosis
entityone also interacts weakly otherprotein otherprotein tumor necrosis factor receptor entitytwo intracellular domain
entityone also interacts weakly otherprotein otherprotein tumor necrosis factor receptor otherprotein intracellular domain not otherprotein mutant version entitytwo corresponding
otherprotein entityone tumor necrosis factor receptor entitytwo intracellular domain
otherprotein entityone tumor necrosis factor receptor otherprotein intracellular domain not otherprotein mutant version entitytwo corresponding
necrosis factor receptor entityone intracellular domain not otherprotein mutant version entitytwo corresponding
entityone contains Nterminal region otherprotein homology protein kinases cterminal region containing a cytoplasmic motif death domain present the entitytwo otherprotein
entityone contains Nterminal region otherprotein homology protein kinases cterminal region containing a cytoplasmic motif death domain present the otherprotein entitytwo intracellular domains
present the entityone entitytwo intracellular domains
an 11kda entityone rapamycinbinding domain otherprotein the 289kda entitytwo characterization
associates otherprotein entityone rapamycin been identified its encoding gene been cloned both human designated entitytwo brown
associates otherprotein entityone rapamycin been identified its encoding gene been cloned both human designated otherprotein brown Albers Shin Ichikawa Ke otherprotein Lane & schreiber 1994 nature london 756758] rat designated entitytwo sabatini
human designated entityone brown Albers Shin Ichikawa Ke otherprotein Lane & schreiber 1994 nature london 756758] rat designated entitytwo sabatini
identified 11kDa entityone rapamycinbinding domain otherprotein entitytwo
interaction entityone entitytwo otherprotein
interaction entityone otherprotein otherprotein entitytwo not
interaction entityone otherprotein otherprotein otherprotein alpha not otherprotein betacomponents entitytwo otherprotein
interaction entityone otherprotein otherprotein otherprotein alpha not otherprotein betacomponents otherprotein entitytwo
interaction otherprotein entityone otherprotein entitytwo not
interaction otherprotein entityone otherprotein otherprotein not otherprotein betacomponents entitytwo otherprotein
interaction otherprotein entityone otherprotein otherprotein not otherprotein betacomponents otherprotein entitytwo
otherprotein otherprotein entityone not otherprotein betacomponents entitytwo otherprotein
otherprotein otherprotein entityone not otherprotein betacomponents otherprotein entitytwo
otherprotein betacomponents entityone entitytwo
superposition the entityone growth hormone structures showed the location these epitopes entitytwo analogous
differential interaction entityone the entitytwo otherprotein
differential interaction entityone the otherprotein entitytwo otherprotein
differential interaction entityone otherprotein otherprotein otherprotein the entitytwo otherprotein receptor
differential interaction entityone otherprotein otherprotein otherprotein the otherprotein entitytwo receptor
differential interaction entityone otherprotein otherprotein otherprotein the entitytwo the
otherprotein the entityone entitytwo otherprotein
otherprotein entityone otherprotein otherprotein the entitytwo otherprotein receptor
otherprotein entityone otherprotein otherprotein the otherprotein entitytwo receptor
otherprotein entityone otherprotein otherprotein the entitytwo the
otherprotein entityone otherprotein the entitytwo otherprotein receptor
otherprotein entityone otherprotein the otherprotein entitytwo receptor
otherprotein entityone otherprotein the entitytwo the
otherprotein entityone entitytwo receptor
otherprotein entityone entitytwo the
otherprotein otherprotein entityone entitytwo the
interaction the entityone entitytwo otherprotein
interaction the entityone receptor entitytwo the
interaction entityone receptor otherprotein and the entitytwo otherprotein
interaction entityone receptor otherprotein and the otherprotein entitytwo otherprotein
interaction entityone receptor otherprotein the otherprotein otherprotein otherprotein two known substrates entitytwo and the
interaction entityone receptor otherprotein the insulin receptor otherprotein otherprotein two known substrates otherprotein and the entitytwo substrate1 otherprotein
interaction entityone receptor otherprotein the otherprotein otherprotein otherprotein two known substrates otherprotein and the entitytwo otherprotein
interaction entityone receptor otherprotein the otherprotein otherprotein otherprotein two known substrates otherprotein and the otherprotein entitytwo
interaction the entityone entitytwo the
interaction entityone otherprotein and the entitytwo otherprotein
interaction entityone otherprotein and the otherprotein entitytwo otherprotein
interaction entityone otherprotein the otherprotein otherprotein otherprotein two known substrates entitytwo and the
interaction entityone otherprotein the insulin receptor otherprotein otherprotein two known substrates otherprotein and the entitytwo substrate1 otherprotein
interaction entityone otherprotein the otherprotein otherprotein otherprotein two known substrates otherprotein and the entitytwo otherprotein
interaction entityone otherprotein the otherprotein otherprotein otherprotein two known substrates otherprotein and the otherprotein entitytwo
otherprotein receptor entityone the entitytwo otherprotein
otherprotein receptor entityone the otherprotein entitytwo otherprotein
otherprotein receptor entityone the otherprotein otherprotein otherprotein two known substrates entitytwo the
otherprotein receptor entityone the insulin receptor otherprotein otherprotein two known substrates otherprotein the entitytwo substrate1 otherprotein
otherprotein receptor entityone the otherprotein otherprotein otherprotein two known substrates otherprotein the entitytwo otherprotein
otherprotein receptor entityone the otherprotein otherprotein otherprotein two known substrates otherprotein the otherprotein entitytwo
and entityone entitytwo otherprotein
entityone otherprotein otherprotein two known substrates entitytwo and the
entityone otherprotein otherprotein two known substrates otherprotein and the entitytwo substrate1 otherprotein
entityone otherprotein otherprotein two known substrates otherprotein and the entitytwo otherprotein
entityone otherprotein otherprotein two known substrates otherprotein and the otherprotein entitytwo
the otherprotein entityone otherprotein two known substrates entitytwo the
insulin receptor entityone otherprotein two known substrates otherprotein the entitytwo substrate1 otherprotein
the otherprotein entityone otherprotein two known substrates otherprotein the entitytwo otherprotein
the otherprotein entityone otherprotein two known substrates otherprotein the otherprotein entitytwo
two known substrates entityone the entitytwo substrate1 otherprotein
two known substrates entityone the entitytwo otherprotein
two known substrates entityone the otherprotein entitytwo
otherprotein the entityone entitytwo otherprotein
otherprotein the entityone substrate1 entitytwo
otherprotein the entityone entitytwo
domains the entityone entitytwo participating
activity the entityone essential the interaction otherprotein entitytwo otherprotein
activity the entityone essential the interaction otherprotein otherprotein entitytwo otherprotein
activity the entityone essential the interaction otherprotein p52shc otherprotein entitytwo otherprotein
activity the entityone essential the interaction otherprotein otherprotein otherprotein ii otherprotein entitytwo bind
activity the entityone essential the interaction otherprotein otherprotein otherprotein otherprotein otherprotein bind the entitytwo the
activity entityone essential the interaction otherprotein p52shc otherprotein p52Shc otherprotein bind the otherprotein in the NPEYjuxtamembrane motif iii contrary entitytwo otherprotein binds
activity entityone essential the interaction otherprotein otherprotein otherprotein ii otherprotein otherprotein bind the otherprotein in the NPEYjuxtamembrane motif iii contrary otherprotein entitytwo binds also
activity entityone essential interaction otherprotein otherprotein otherprotein otherprotein otherprotein bind the otherprotein in the NPEYjuxtamembrane motif iii contrary otherprotein otherprotein binds also the major autophosphorylation sites tyr1131 of the entitytwo and iv
activity entityone essential interaction otherprotein p52shc otherprotein p52Shc otherprotein bind the otherprotein in the NPEYjuxtamembrane motif iii contrary p52Shc otherprotein binds also the major autophosphorylation sites tyr1131 and the otherprotein and the aminoterminal domain of entitytwo required
activity entityone essential interaction otherprotein otherprotein otherprotein otherprotein otherprotein bind otherprotein in the NPEYjuxtamembrane motif iii contrary otherprotein otherprotein binds also the major autophosphorylation sites tyr1131 the otherprotein and the aminoterminal domain of otherprotein required its association otherprotein the entitytwo and the
activity entityone essential interaction otherprotein otherprotein otherprotein otherprotein otherprotein bind otherprotein in the NPEYjuxtamembrane motif iii contrary otherprotein otherprotein binds also the major autophosphorylation sites tyr1131 the otherprotein and the aminoterminal domain of otherprotein required its association otherprotein the otherprotein and the entitytwo
interaction otherprotein entityone entitytwo p52Shc
interaction otherprotein entityone otherprotein entitytwo otherprotein
interaction otherprotein entityone otherprotein ii p52shc entitytwo bind
interaction otherprotein entityone otherprotein p52Shc otherprotein bind the entitytwo the
interaction otherprotein entityone otherprotein p52Shc otherprotein bind otherprotein in the NPEYjuxtamembrane motif iii contrary entitytwo otherprotein binds
interaction otherprotein entityone otherprotein ii p52shc otherprotein bind otherprotein in the NPEYjuxtamembrane motif iii contrary p52Shc entitytwo binds also
interaction otherprotein entityone otherprotein p52Shc otherprotein bind otherprotein in NPEYjuxtamembrane motif iii contrary p52Shc otherprotein binds also the major autophosphorylation sites tyr1131 of the entitytwo and iv
interaction otherprotein entityone otherprotein p52Shc otherprotein bind otherprotein in NPEYjuxtamembrane motif iii contrary p52Shc otherprotein binds also the major autophosphorylation sites tyr1131 and the otherprotein and the aminoterminal domain of entitytwo required
interaction otherprotein entityone otherprotein p52Shc otherprotein bind otherprotein in NPEYjuxtamembrane motif iii contrary p52Shc otherprotein binds also major autophosphorylation sites tyr1131 the otherprotein and the aminoterminal domain of p52Shc required its association otherprotein the entitytwo and the
interaction otherprotein entityone otherprotein p52Shc otherprotein bind otherprotein in NPEYjuxtamembrane motif iii contrary p52Shc otherprotein binds also major autophosphorylation sites tyr1131 the otherprotein and the aminoterminal domain of p52Shc required its association otherprotein the otherprotein and the entitytwo
otherprotein p52shc entityone entitytwo otherprotein
otherprotein otherprotein entityone otherprotein entitytwo bind
otherprotein otherprotein entityone otherprotein otherprotein bind the entitytwo the
otherprotein p52shc entityone p52Shc otherprotein bind otherprotein in the NPEYjuxtamembrane motif iii contrary entitytwo otherprotein
otherprotein otherprotein entityone otherprotein otherprotein bind otherprotein in the NPEYjuxtamembrane motif iii contrary otherprotein entitytwo binds also
otherprotein otherprotein entityone otherprotein otherprotein bind otherprotein in NPEYjuxtamembrane motif iii contrary otherprotein otherprotein binds also the major autophosphorylation sites tyr1131 of the entitytwo and iv
otherprotein p52shc entityone p52Shc otherprotein bind otherprotein in NPEYjuxtamembrane motif iii contrary p52Shc otherprotein binds also the major autophosphorylation sites tyr1131 and the otherprotein and the aminoterminal domain of entitytwo required
otherprotein otherprotein entityone otherprotein irs1 bind otherprotein in NPEYjuxtamembrane motif iii contrary otherprotein IRS1 binds also major autophosphorylation sites tyr1131 the otherprotein and the aminoterminal domain of otherprotein required its association otherprotein the entitytwo and the
otherprotein otherprotein entityone otherprotein otherprotein bind otherprotein in NPEYjuxtamembrane motif iii contrary otherprotein otherprotein binds also major autophosphorylation sites tyr1131 the otherprotein and the aminoterminal domain of otherprotein required its association otherprotein the otherprotein and the entitytwo
otherprotein ii entityone entitytwo bind
otherprotein entityone otherprotein bind the entitytwo the
otherprotein entityone otherprotein bind otherprotein in the NPEYjuxtamembrane motif iii contrary entitytwo otherprotein binds
otherprotein ii entityone otherprotein bind otherprotein in the NPEYjuxtamembrane motif iii contrary p52Shc entitytwo binds also
otherprotein entityone otherprotein bind otherprotein in NPEYjuxtamembrane motif iii contrary p52Shc otherprotein binds also the major autophosphorylation sites tyr1131 of the entitytwo and iv
otherprotein entityone otherprotein bind otherprotein in NPEYjuxtamembrane motif iii contrary p52Shc otherprotein binds also the major autophosphorylation sites tyr1131 and the otherprotein and the aminoterminal domain of entitytwo required
otherprotein entityone otherprotein bind otherprotein in NPEYjuxtamembrane motif iii contrary p52Shc otherprotein binds also major autophosphorylation sites tyr1131 the otherprotein and the aminoterminal domain of p52Shc required its association otherprotein the entitytwo and the
otherprotein entityone otherprotein bind otherprotein in NPEYjuxtamembrane motif iii contrary p52Shc otherprotein binds also major autophosphorylation sites tyr1131 the otherprotein and the aminoterminal domain of p52Shc required its association otherprotein the otherprotein and the entitytwo
otherprotein entityone bind the entitytwo the
p52Shc entityone bind otherprotein in the NPEYjuxtamembrane motif iii contrary entitytwo otherprotein
otherprotein entityone bind otherprotein in the NPEYjuxtamembrane motif iii contrary otherprotein entitytwo binds also
otherprotein entityone bind otherprotein in NPEYjuxtamembrane motif iii contrary otherprotein otherprotein binds also the major autophosphorylation sites tyr1131 of the entitytwo and iv
p52Shc entityone bind otherprotein in NPEYjuxtamembrane motif iii contrary p52Shc otherprotein binds also the major autophosphorylation sites tyr1131 and the otherprotein and the aminoterminal domain of entitytwo required
otherprotein entityone bind otherprotein in NPEYjuxtamembrane motif iii contrary otherprotein irs1 binds also major autophosphorylation sites tyr1131 the otherprotein and the aminoterminal domain of otherprotein required its association otherprotein the entitytwo and the
otherprotein entityone bind otherprotein in NPEYjuxtamembrane motif iii contrary otherprotein otherprotein binds also major autophosphorylation sites tyr1131 the otherprotein and the aminoterminal domain of otherprotein required its association otherprotein the otherprotein and the entitytwo
bind the entityone the npeyjuxtamembrane motif iii contrary entitytwo otherprotein binds
bind the entityone the npeyjuxtamembrane motif iii contrary otherprotein entitytwo binds also
bind entityone the npeyjuxtamembrane motif iii contrary otherprotein otherprotein binds also the major autophosphorylation sites tyr1131 of the entitytwo and iv
bind entityone the npeyjuxtamembrane motif iii contrary p52Shc otherprotein binds also the major autophosphorylation sites tyr1131 and the otherprotein and the aminoterminal domain of entitytwo required
bind entityone npeyjuxtamembrane motif iii contrary otherprotein otherprotein binds also the major autophosphorylation sites tyr1131 the otherprotein and the aminoterminal domain of otherprotein required its association otherprotein the entitytwo and the
bind entityone npeyjuxtamembrane motif iii contrary otherprotein otherprotein binds also the major autophosphorylation sites tyr1131 the otherprotein and the aminoterminal domain of otherprotein required its association otherprotein the otherprotein and the entitytwo
iii contrary entityone entitytwo binds also
iii contrary entityone otherprotein binds also major autophosphorylation sites tyr1131 of the entitytwo and iv
iii contrary entityone otherprotein binds also major autophosphorylation sites tyr1131 and the otherprotein and the aminoterminal domain of entitytwo required
iii contrary entityone otherprotein binds also major autophosphorylation sites tyr1131 otherprotein and the aminoterminal domain of p52Shc required its association otherprotein the entitytwo and the
iii contrary entityone otherprotein binds also major autophosphorylation sites tyr1131 otherprotein and the aminoterminal domain of p52Shc required its association otherprotein the otherprotein and the entitytwo
contrary otherprotein entityone binds also major autophosphorylation sites tyr1131 of the entitytwo and iv
contrary p52Shc entityone binds also major autophosphorylation sites tyr1131 and the otherprotein and the aminoterminal domain of entitytwo required
contrary otherprotein entityone binds also major autophosphorylation sites tyr1131 otherprotein and the aminoterminal domain of otherprotein required its association otherprotein the entitytwo and the
contrary otherprotein entityone binds also major autophosphorylation sites tyr1131 otherprotein and the aminoterminal domain of otherprotein required its association otherprotein the otherprotein and the entitytwo
entityone iv aminoterminal domain of entitytwo required
entityone iv aminoterminal domain of otherprotein required its association otherprotein entitytwo the
entityone iv aminoterminal domain of otherprotein required its association otherprotein otherprotein the entitytwo
aminoterminal domain entityone required its association otherprotein entitytwo the
aminoterminal domain entityone required its association otherprotein otherprotein the entitytwo
otherprotein entityone the entitytwo
i entityone the entitytwo share
i entityone otherprotein share least part the same molecular mechanism underlying interplay otherprotein two substrates entitytwo otherprotein
i entityone otherprotein share least part the same molecular mechanism underlying interplay otherprotein two substrates otherprotein entitytwo ii
i entityone otherprotein share least part the same molecular mechanism underlying interplay otherprotein two substrates otherprotein otherprotein and entitytwo interacts
i entityone otherprotein share least part same molecular mechanism underlying interplay otherprotein two substrates otherprotein otherprotein ii otherprotein interacts otherprotein the entitytwo a
i entityone otherprotein share least part same molecular mechanism underlying interplay otherprotein two substrates p52shc otherprotein ii otherprotein interacts otherprotein the otherprotein in fashion is different that used entitytwo
entityone share least part same molecular mechanism underlying interplay otherprotein two substrates entitytwo and otherprotein
entityone share least part same molecular mechanism underlying interplay otherprotein two substrates otherprotein entitytwo and ii
entityone share least part same molecular mechanism underlying interplay otherprotein two substrates otherprotein IRS1 and ii entitytwo interacts
entityone share least part same molecular mechanism underlying interplay otherprotein two substrates otherprotein otherprotein and ii otherprotein interacts otherprotein entitytwo a
entityone share least part same molecular mechanism underlying interplay otherprotein two substrates p52shc otherprotein and ii otherprotein interacts otherprotein otherprotein in fashion is different that used entitytwo
two substrates entityone entitytwo ii
two substrates entityone otherprotein and entitytwo interacts
two substrates entityone otherprotein ii otherprotein interacts otherprotein entitytwo a
two substrates entityone otherprotein ii otherprotein interacts otherprotein otherprotein in fashion is different that used entitytwo
substrates otherprotein entityone ii entitytwo interacts
substrates otherprotein entityone ii otherprotein interacts otherprotein entitytwo a
substrates p52shc entityone ii otherprotein interacts otherprotein otherprotein in fashion is different that used entitytwo
and entityone interacts otherprotein entitytwo a
and entityone interacts otherprotein otherprotein in fashion is different that used entitytwo
otherprotein entityone a fashion is different that used entitytwo
both entityone the entitytwo
entityone physically associates otherprotein entitytwo Src
designed identify entityone src homology SH3binding molecules report cloning entitytwo src
designed identify entityone src homology SH3binding molecules report cloning otherprotein entitytwo an
cloning entityone entitytwo an
sh3 domains entityone entitytwo
protein product entityone subcellular fractionation experiments showed entitytwo mainly
main entityone region implicated the association otherprotein entitytwo found
proteins entityone entitytwo otherprotein helixloophelix
proteins entityone otherprotein entitytwo helixloophelix proteins
proteins otherprotein entityone entitytwo helixloophelix proteins
interaction entityone subunit entitytwo otherprotein
interaction entityone subunit otherprotein otherprotein entitytwo otherprotein
interaction entityone subunit otherprotein otherprotein otherprotein entitytwo receptors analysed
otherprotein subunit entityone otherprotein entitytwo otherprotein
otherprotein subunit entityone otherprotein otherprotein entitytwo receptors analysed
otherprotein otherprotein entityone entitytwo receptors analysed
interaction the entityone subunit entitytwo otherprotein
interaction entityone subunit otherprotein otherprotein the entitytwo receptor otherprotein
interaction entityone subunit otherprotein otherprotein the entitytwo otherprotein
interaction entityone subunit otherprotein otherprotein the otherprotein entitytwo the
interaction entityone subunit otherprotein otherprotein the otherprotein otherprotein the entitytwo receptor otherprotein
interaction entityone subunit otherprotein otherprotein the otherprotein otherprotein the entitytwo otherprotein
interaction entityone subunit otherprotein otherprotein the otherprotein otherprotein the otherprotein receptor entitytwo investigated
otherprotein subunit entityone otherprotein entitytwo receptor otherprotein
otherprotein subunit entityone otherprotein entitytwo otherprotein
otherprotein subunit entityone otherprotein otherprotein entitytwo the
otherprotein subunit entityone otherprotein otherprotein otherprotein the entitytwo receptor otherprotein
otherprotein subunit entityone otherprotein otherprotein otherprotein the entitytwo otherprotein
otherprotein subunit entityone otherprotein otherprotein otherprotein the otherprotein receptor entitytwo investigated
otherprotein entityone entitytwo otherprotein
otherprotein entityone receptor entitytwo the
otherprotein entityone receptor otherprotein the entitytwo receptor otherprotein
otherprotein entityone receptor otherprotein the entitytwo otherprotein
otherprotein entityone receptor otherprotein the otherprotein receptor entitytwo investigated
otherprotein entityone entitytwo the
otherprotein entityone otherprotein the entitytwo receptor otherprotein
otherprotein entityone otherprotein the entitytwo otherprotein
otherprotein entityone otherprotein the otherprotein receptor entitytwo investigated
otherprotein otherprotein entityone the entitytwo receptor otherprotein
otherprotein otherprotein entityone the entitytwo otherprotein
otherprotein otherprotein entityone the otherprotein receptor entitytwo investigated
otherprotein the entityone entitytwo otherprotein
otherprotein the entityone receptor entitytwo investigated
otherprotein the entityone entitytwo investigated
mutated entityone entitytwo otherprotein
mutated entityone otherprotein and entitytwo its
otherprotein entityone entitytwo its
activation indicated entityone + csh2 CSH2 interact otherprotein entitytwo beta
activation indicated entityone + csh2 CSH2 interact otherprotein entitytwo otherprotein
activation indicated entityone + csh2 CSH2 interact otherprotein otherprotein beta entitytwo beta whereas
activation indicated entityone + csh2 CSH2 interact otherprotein otherprotein beta entitytwo whereas nsh2
activation indicated entityone csh2 CSH2 interact otherprotein otherprotein otherprotein beta whereas nsh2 SH3 + NSH2 interact w otherprotein entitytwo beta
activation indicated entityone csh2 CSH2 interact otherprotein otherprotein beta otherprotein beta whereas nsh2 SH3 + NSH2 interact w otherprotein entitytwo
otherprotein entityone entitytwo otherprotein
otherprotein entityone beta entitytwo beta whereas
otherprotein entityone beta entitytwo whereas nsh2
otherprotein entityone beta otherprotein beta whereas nsh2 SH3 NSH2 interact w otherprotein entitytwo beta
otherprotein entityone beta otherprotein beta whereas nsh2 SH3 NSH2 interact w otherprotein entitytwo
otherprotein entityone entitytwo beta whereas
otherprotein entityone entitytwo whereas nsh2
otherprotein entityone otherprotein beta whereas nsh2 SH3 NSH2 interact w otherprotein entitytwo beta
otherprotein entityone otherprotein beta whereas nsh2 SH3 NSH2 interact w otherprotein entitytwo
otherprotein beta entityone entitytwo whereas nsh2
otherprotein entityone beta whereas nsh2 SH3 NSH2 interact w otherprotein entitytwo beta
otherprotein beta entityone beta whereas nsh2 SH3 NSH2 interact w otherprotein entitytwo
otherprotein entityone whereas nsh2 SH3 NSH2 interact w otherprotein entitytwo beta
otherprotein beta entityone whereas nsh2 SH3 NSH2 interact w otherprotein entitytwo
w otherprotein entityone entitytwo
interaction entityone N+CSH2 otherprotein entitytwo otherprotein
interaction entityone N+CSH2 otherprotein otherprotein beta entitytwo otherprotein
interaction entityone N+CSH2 otherprotein otherprotein beta otherprotein entitytwo beta otherprotein
interaction entityone N+CSH2 otherprotein otherprotein beta otherprotein entitytwo otherprotein
interaction entityone N+CSH2 otherprotein otherprotein beta delta c43 otherprotein beta entitytwo which
n+csh2 otherprotein entityone entitytwo otherprotein
n+csh2 otherprotein entityone otherprotein entitytwo beta otherprotein
n+csh2 otherprotein entityone otherprotein entitytwo otherprotein
n+csh2 otherprotein entityone delta c43 otherprotein beta entitytwo which
otherprotein otherprotein beta entityone entitytwo betadelta c43
otherprotein otherprotein beta entityone entitytwo delta c43
otherprotein otherprotein beta entityone otherprotein beta entitytwo which
beta otherprotein entityone entitytwo otherprotein
delta c43 entityone beta entitytwo which
delta c43 entityone entitytwo which
mutating y960f entityone Y950F entitytwo
upon interaction entityone otherprotein entitytwo otherprotein
upon interaction entityone otherprotein otherprotein beta entitytwo 4fold
upon interaction entityone otherprotein otherprotein beta otherprotein 4fold less compared entitytwo
otherprotein otherprotein entityone entitytwo 4fold
otherprotein otherprotein entityone otherprotein 4fold less compared entitytwo
otherprotein otherprotein beta entityone 4fold less compared entitytwo
activation otherprotein entityone entitytwo beta
activation otherprotein entityone entitytwo 4fold
activation otherprotein entityone otherprotein beta 4fold less compared entitytwo was
activation otherprotein entityone otherprotein beta 4fold less compared otherprotein beta was somewhat increased 2fold entitytwo beta otherprotein
activation otherprotein entityone otherprotein beta 4fold less compared otherprotein beta was somewhat increased 2fold entitytwo otherprotein
activation otherprotein entityone otherprotein beta 4fold less compared otherprotein beta was somewhat increased 2fold otherprotein beta entitytwo
otherprotein otherprotein entityone entitytwo 4fold
otherprotein otherprotein entityone beta 4fold less compared entitytwo was
otherprotein otherprotein entityone beta 4fold less compared otherprotein beta was somewhat increased 2fold entitytwo beta otherprotein
otherprotein otherprotein entityone beta 4fold less compared otherprotein beta was somewhat increased 2fold entitytwo otherprotein
otherprotein otherprotein entityone beta 4fold less compared otherprotein beta was somewhat increased 2fold otherprotein beta entitytwo
otherprotein otherprotein entityone 4fold less compared entitytwo was
otherprotein otherprotein entityone 4fold less compared otherprotein beta was somewhat increased 2fold entitytwo beta otherprotein
otherprotein otherprotein entityone 4fold less compared otherprotein beta was somewhat increased 2fold entitytwo otherprotein
otherprotein otherprotein entityone 4fold less compared otherprotein beta was somewhat increased 2fold otherprotein beta entitytwo
compared entityone was somewhat increased 2fold entitytwo beta otherprotein
compared entityone was somewhat increased 2fold entitytwo otherprotein
compared entityone was somewhat increased 2fold otherprotein beta entitytwo
increased 2fold entityone entitytwo otherprotein
increased 2fold entityone beta entitytwo
increased 2fold entityone entitytwo
cterminal domain entityone appears exert negative control binding entitytwo thereby providing
cterminal domain entityone appears exert negative control binding otherprotein thereby providing possible regulatory mechanism direct activation the entitytwo pathway
binding entityone thereby providing possible regulatory mechanism direct activation the entitytwo pathway
the protein entityone otherprotein entitytwo revealed
intehraction entityone entitytwo confirmed
transfection entityone entitytwo COS
transfection entityone otherprotein COS cells increased entitytwo expression relative
transfection entityone otherprotein COS cells increased alpha expression relative cells transfected otherprotein entitytwo mock
alpha and entityone COS cells increased entitytwo expression relative
alpha entityone COS cells increased alpha expression relative cells transfected otherprotein entitytwo and mock
cos cells increased entityone expression relative cells transfected otherprotein entitytwo mock
effects the entityone mediated cell surface entitytwo
polyclonal anti entityone antibody provided evidence the 60kda protein isolated this study entitytwo
antibodies human entityone significantly inhibited mitogenic activity entitytwo human
cell surface entityone binds the entitytwo mediating
interact otherprotein entityone transcriptional synergy otherprotein entitytwo otherprotein
interact otherprotein entityone transcriptional synergy otherprotein otherprotein entitytwo otherprotein
interact otherprotein entityone transcriptional synergy otherprotein otherprotein otherprotein delta entitytwo
synergy otherprotein entityone entitytwo otherprotein
synergy otherprotein entityone otherprotein delta entitytwo
otherprotein otherprotein entityone entitytwo
using radiolabeled entityone protein probe screened B cell cdna expression library isolated a number clones encoding entitytwo interacting proteins
dna binding proteins entityone entitytwo otherprotein
dna binding proteins entityone otherprotein entitytwo one clone
binding proteins otherprotein entityone entitytwo one clone
functional interactions entityone entitytwo leucine
amino acids entityone disrupted entitytwo otherprotein physical
amino acids entityone disrupted pu1 entitytwo physical interaction
PU1 disrupted entityone entitytwo physical interaction
found entityone entitytwo functionally
assays showed entityone entitytwo simultaneously
subunit human entityone reveals interactions otherprotein entitytwo otherprotein
subunit human entityone reveals interactions otherprotein otherprotein entitytwo mediate
interactions otherprotein entityone entitytwo mediate
transcription factor entityone consists entitytwo otherprotein
transcription factor entityone consists otherprotein entitytwo at
transcription factor entityone consists otherprotein tbp at least eight entitytwo associated factors
otherprotein consists entityone entitytwo at
otherprotein consists entityone tbp at least eight entitytwo associated factors
consists otherprotein entityone at least eight entitytwo associated factors
human entityone termed entitytwo
find entityone the human homologue Drosophila entitytwo
otherprotein drosophila entityone entitytwo interacts
otherprotein drosophila entityone otherprotein ii32 interacts otherprotein Cterminal 39amino acid activation domain the acidic transactivator entitytwo otherprotein
otherprotein drosophila entityone otherprotein ii32 interacts otherprotein Cterminal 39amino acid activation domain the acidic transactivator otherprotein entitytwo well
otherprotein drosophila entityone otherprotein ii32 interacts otherprotein Cterminal 39amino acid activation domain acidic transactivator otherprotein otherprotein well w otherprotein the general transcription factor entitytwo
drosophila otherprotein ii40 entityone interacts otherprotein Cterminal 39amino acid activation domain the acidic transactivator entitytwo otherprotein
drosophila otherprotein ii40 entityone interacts otherprotein Cterminal 39amino acid activation domain the acidic transactivator otherprotein entitytwo well
drosophila otherprotein ii40 entityone interacts otherprotein Cterminal 39amino acid activation domain acidic transactivator otherprotein otherprotein well w otherprotein the general transcription factor entitytwo
acidic transactivator entityone entitytwo well
acidic transactivator entityone otherprotein well w otherprotein general transcription factor entitytwo
acidic transactivator otherprotein entityone well w otherprotein general transcription factor entitytwo
partial recombinant entityone complex containing entitytwo capable
partial recombinant entityone complex containing otherprotein ii32 capable mediating vitro transcriptional activation the entitytwo activation domain
otherprotein complex containing entityone capable mediating vitro transcriptional activation the entitytwo activation domain
potential interaction entityone entitytwo otherprotein receptors
potential interaction entityone otherprotein entitytwo receptors revealed
otherprotein entityone entitytwo receptors revealed
entityone binds independently two transmembrane receptors entitytwo neurotrophin receptor
entityone binds independently two transmembrane receptors entitytwo the
entityone binds independently two transmembrane receptors otherprotein neurotrophin receptor the entitytwo otherprotein tyrosine
entityone binds independently two transmembrane receptors otherprotein neurotrophin receptor the otherprotein entitytwo tyrosine kinase
entityone binds independently two transmembrane receptors otherprotein neurotrophin receptor the entitytwo are
entityone binds independently two transmembrane receptors otherprotein neurotrophin receptor the otherprotein otherprotein tyrosine kinase receptor are coexpressed the majority neuronal cells respond entitytwo
transmembrane receptors entityone entitytwo the
transmembrane receptors entityone neurotrophin receptor the entitytwo otherprotein tyrosine
transmembrane receptors entityone neurotrophin receptor the otherprotein entitytwo tyrosine kinase
transmembrane receptors entityone neurotrophin receptor the entitytwo are
transmembrane receptors entityone neurotrophin receptor the otherprotein otherprotein tyrosine kinase receptor are coexpressed the majority neuronal cells respond entitytwo
transmembrane receptors entityone the entitytwo otherprotein tyrosine
transmembrane receptors entityone the otherprotein entitytwo tyrosine kinase
transmembrane receptors entityone the entitytwo are
transmembrane receptors entityone the otherprotein otherprotein tyrosine kinase receptor are coexpressed the majority neuronal cells respond entitytwo
receptor the entityone entitytwo tyrosine kinase
receptor the entityone entitytwo are
receptor the entityone otherprotein tyrosine kinase receptor are coexpressed the majority neuronal cells respond entitytwo
the otherprotein entityone entitytwo are
the otherprotein entityone tyrosine kinase receptor are coexpressed the majority neuronal cells respond entitytwo
receptor the entityone are coexpressed the majority neuronal cells respond entitytwo
association entityone entitytwo receptors
multimeric complexes entityone entitytwo not
multimeric complexes entityone otherprotein not detected affinity crosslinking immunoprecipitation crosslinked entitytwo receptor complexes
multimeric complexes entityone otherprotein not detected affinity crosslinking immunoprecipitation crosslinked entitytwo complexes
multimeric complexes entityone otherprotein not detected affinity crosslinking immunoprecipitation crosslinked otherprotein receptor complexes otherprotein entitytwo specific antibodies
multimeric complexes entityone p75 not detected affinity crosslinking immunoprecipitation crosslinked otherprotein receptor complexes otherprotein otherprotein specific antibodies resulted selective immunoprecipitation crosslinked entitytwo
otherprotein entityone not detected affinity crosslinking immunoprecipitation crosslinked entitytwo receptor complexes
otherprotein entityone not detected affinity crosslinking immunoprecipitation crosslinked entitytwo complexes
otherprotein entityone not detected affinity crosslinking immunoprecipitation crosslinked otherprotein receptor complexes otherprotein entitytwo specific antibodies
otherprotein entityone not detected affinity crosslinking immunoprecipitation crosslinked otherprotein receptor complexes otherprotein otherprotein specific antibodies resulted selective immunoprecipitation crosslinked entitytwo
immunoprecipitation crosslinked entityone entitytwo complexes
immunoprecipitation crosslinked entityone receptor complexes otherprotein entitytwo specific antibodies
immunoprecipitation crosslinked entityone receptor complexes otherprotein otherprotein specific antibodies resulted selective immunoprecipitation crosslinked entitytwo
immunoprecipitation crosslinked entityone complexes otherprotein entitytwo specific antibodies
immunoprecipitation crosslinked entityone complexes otherprotein otherprotein specific antibodies resulted selective immunoprecipitation crosslinked entitytwo
complexes otherprotein entityone specific antibodies resulted selective immunoprecipitation crosslinked entitytwo
indicate the entityone entitytwo receptors
indicate the entityone otherprotein receptors potentially interact that an association may responsible the generation high affinity entitytwo binding sites
otherprotein entityone receptors potentially interact that an association may responsible the generation high affinity entitytwo binding sites
macrophage inflammatory protein entityone regulated activation normal expressed secreted entitytwo otherprotein
macrophage inflammatory protein entityone regulated activation normal expressed secreted otherprotein entitytwo otherprotein
macrophage inflammatory protein entityone regulated activation normal expressed secreted otherprotein otherprotein entitytwo the
expressed secreted entityone entitytwo otherprotein
expressed secreted entityone otherprotein entitytwo the
secreted otherprotein entityone entitytwo the
chemokine receptor designated entityone entitytwo
entityone a seventransmembrane domain proteincoupled receptor closely related the previously reported monocyte neutrophilselective receptor entitytwo also known
entityone a seventransmembrane domain proteincoupled receptor closely related the previously reported monocyte neutrophilselective receptor otherprotein also known the entitytwo otherprotein receptor
entityone a seventransmembrane domain proteincoupled receptor closely related the previously reported monocyte neutrophilselective receptor otherprotein also known the otherprotein entitytwo receptor
neutrophilselective receptor entityone also known the entitytwo otherprotein receptor
neutrophilselective receptor entityone also known the otherprotein entitytwo receptor
known the entityone entitytwo receptor
kidney cells entityone entitytwo otherprotein
kidney cells entityone otherprotein entitytwo both
kidney cells entityone otherprotein otherprotein both potent agonists entitytwo otherprotein
kidney cells entityone otherprotein otherprotein both potent agonists otherprotein entitytwo
cells otherprotein entityone entitytwo both
cells otherprotein entityone otherprotein both potent agonists entitytwo otherprotein
cells otherprotein entityone otherprotein both potent agonists otherprotein entitytwo
otherprotein otherprotein entityone both potent agonists entitytwo otherprotein
otherprotein otherprotein entityone both potent agonists otherprotein entitytwo
potent agonists entityone entitytwo
however entityone also agonist entitytwo not
however entityone also agonist otherprotein not entitytwo otherprotein
however entityone also agonist otherprotein not otherprotein entitytwo an
however entityone also agonist otherprotein not CKR1; otherprotein an agonist entitytwo not
however entityone also agonist CC ckr3 not otherprotein otherprotein an agonist otherprotein not entitytwo
agonist entityone not entitytwo otherprotein
agonist entityone not otherprotein entitytwo an
agonist entityone not CKR1; otherprotein an agonist entitytwo not
agonist entityone not otherprotein otherprotein an agonist otherprotein not entitytwo
otherprotein not entityone entitytwo an
otherprotein not entityone otherprotein an agonist entitytwo not
ckr3 not entityone otherprotein an agonist CC ckr1 not entitytwo
CC ckr1 entityone an agonist entitytwo not
otherprotein entityone an agonist otherprotein not entitytwo
agonist entityone not entitytwo
structure a entityone entitytwo complex
the human entityone entitytwo otherprotein atp
the human entityone otherprotein entitytwo atp complex
human otherprotein entityone entitytwo atp complex
binds homophilically entityone the surface one cell binds entitytwo an
demonstrate entityone associates otherprotein complex containing entitytwo otherprotein
demonstrate entityone associates otherprotein complex containing otherprotein entitytwo mink
complex containing entityone entitytwo mink
intracellular segment entityone binds directly the intracellular domain entitytwo not
intracellular segment entityone binds directly the intracellular domain otherprotein not alpha entitytwo
intracellular domain entityone not alpha entitytwo
phosphatase activity including entityone cadherins associated otherprotein entitytwo now
phosphatase activity including entityone cadherins associated otherprotein ptpmu now found a tyrosinephosphorylated form indicating the cadherins may an endogenous substrate entitytwo
associated otherprotein entityone now found a tyrosinephosphorylated form indicating the cadherins may an endogenous substrate entitytwo
receptor BMPs entityone is distantly related entitytwo otherprotein
receptor BMPs entityone is distantly related otherprotein entitytwo Caenorhabditis
distantly related entityone entitytwo Caenorhabditis
transfected cos1 cells entityone entitytwo less
transfected cos1 cells entityone otherprotein less efficiently entitytwo bound
transfected cos1 cells entityone otherprotein less efficiently otherprotein bound entitytwo
cos1 cells otherprotein entityone less efficiently entitytwo bound
cos1 cells otherprotein entityone less efficiently otherprotein bound entitytwo
less efficiently entityone bound entitytwo
binding entityone entitytwo otherprotein
binding entityone otherprotein entitytwo also
binding otherprotein entityone entitytwo also
transduced entityone the presence type receptors stimulation entitytwo otherprotein
transduced entityone the presence type receptors stimulation otherprotein entitytwo
stimulation entityone entitytwo
entityone is known bind proteins recently shown associate otherprotein entitytwo to
effect the entityone kinase activity entitytwo
association entityone otherprotein entitytwo vivo
cloned entityone gene encodes member protein family includes yeast entitytwo protein a
cloned entityone gene encodes member protein family includes yeast otherprotein protein a component the transcriptional regulator entitytwo otherprotein
cloned entityone gene encodes member protein family includes yeast otherprotein protein a component the transcriptional regulator otherprotein entitytwo
includes yeast entityone protein component the transcriptional regulator entitytwo otherprotein
includes yeast entityone protein component the transcriptional regulator otherprotein entitytwo
transcriptional regulator entityone entitytwo
entityone protein interacts otherprotein entitytwo protein
entityone protein interacts otherprotein otherprotein w otherprotein entitytwo protein
interacts otherprotein entityone protein w otherprotein entitytwo protein
products the entityone entitytwo genes
otherprotein entityone entitytwo form
otherprotein entityone otherprotein form entitytwo complex
otherprotein otherprotein entityone form entitytwo complex
entityone gene identical a gene entitytwo ref
recombinant entityone binds directly entitytwo in
recombinant entityone binds directly otherprotein vitro in yeast participates in the formation the entitytwo complex
binds directly entityone vitro in yeast participates in the formation the entitytwo complex
central role entityone assembly interacting otherprotein entitytwo other
bzip domains entityone entitytwo mediate
bzip domains entityone otherprotein mediate physical association otherprotein entitytwo
otherprotein entityone mediate physical association otherprotein entitytwo
entityone entitytwo oncoproteins form
ability entityone entitytwo proteins
ability entityone otherprotein proteins interact directly otherprotein entitytwo otherprotein
ability entityone otherprotein proteins interact directly otherprotein otherprotein entitytwo general
otherprotein entityone proteins interact directly otherprotein entitytwo otherprotein
otherprotein entityone proteins interact directly otherprotein otherprotein entitytwo general
otherprotein entityone entitytwo general
show both entityone entitytwo bind specifically
show both entityone otherprotein bind specifically stably entitytwo mutational analysis
show both entityone otherprotein bind specifically stably otherprotein mutational analysis demonstrates both basic region leucine zipper domains entitytwo otherprotein
show both entityone c otherprotein bind specifically stably otherprotein mutational analysis demonstrates both basic region leucine zipper domains c otherprotein entitytwo necessary
show both entityone otherprotein bind specifically stably TBPMutational analysis demonstrates both basic region leucine zipper domains c otherprotein otherprotein necessary sufficient stable association otherprotein entitytwo
otherprotein entityone bind specifically stably entitytwo mutational analysis
otherprotein entityone bind specifically stably otherprotein mutational analysis demonstrates both basic region leucine zipper domains entitytwo c
otherprotein entityone bind specifically stably otherprotein mutational analysis demonstrates both basic region leucine zipper domains otherprotein entitytwo necessary
otherprotein entityone bind specifically stably TBPMutational analysis demonstrates both basic region leucine zipper domains otherprotein c otherprotein necessary sufficient stable association otherprotein entitytwo
stably entityone mutational analysis demonstrates both basic region leucine zipper domains entitytwo otherprotein
stably entityone mutational analysis demonstrates both basic region leucine zipper domains otherprotein entitytwo necessary
stably entityone mutational analysis demonstrates both basic region leucine zipper domains otherprotein otherprotein necessary sufficient stable association otherprotein entitytwo
zipper domains entityone entitytwo necessary
zipper domains entityone otherprotein necessary sufficient stable association otherprotein entitytwo
otherprotein entityone necessary sufficient stable association otherprotein entitytwo
cterminal region entityone previously shown be binding site the viral activator protein entitytwo interacts
cterminal region entityone previously shown be binding site the viral activator protein otherprotein interacts otherprotein entitytwo otherprotein
cterminal region entityone previously shown be binding site the viral activator protein otherprotein interacts otherprotein otherprotein entitytwo proteins
viral activator protein entityone interacts otherprotein entitytwo otherprotein
viral activator protein entityone interacts otherprotein otherprotein entitytwo proteins
interacts otherprotein entityone entitytwo proteins
propose entityone entitytwo proteins function
propose entityone otherprotein proteins function transcriptional activators part recruiting entitytwo form
otherprotein entityone proteins function transcriptional activators part recruiting entitytwo form
entityone susceptibility gene product binds directly the human entitytwo associated factor
entityone susceptibility gene product binds directly the human entitytwo otherprotein ii250
entityone susceptibility gene product binds directly the human otherprotein associated factor entitytwo
the human entityone entitytwo otherprotein ii250
the human entityone associated factor entitytwo
the human entityone entitytwo
entityone protein product the entitytwo tumorsuppressor gene
stimulation entityone mediated transcription entitytwo partially
mutation the entityone entitytwo otherprotein ii250
mutation the entityone associated factor entitytwo first identified
mutation the entityone associated factor otherprotein ii250 first identified the cell cycle regulatory protein entitytwo
mutation the entityone entitytwo first identified
mutation the entityone otherprotein ii250 first identified the cell cycle regulatory protein entitytwo
otherprotein associated factor entityone first identified the cell cycle regulatory protein entitytwo
stimulation entityone mediated transcription entitytwo ts13
stimulation entityone mediated transcription otherprotein ts13 cells the nonpermissive temperature could restored the introduction wildtype human entitytwo
mediated transcription entityone ts13 cells the nonpermissive temperature could restored the introduction wildtype human entitytwo
demonstrate entityone binds directly entitytwo vitro
results suggest entityone confer transcriptional regulation possibly cell cycle control tumor suppression an interaction otherprotein entitytwo particular
results suggest entityone confer transcriptional regulation possibly cell cycle control tumor suppression an interaction otherprotein otherprotein particular otherprotein entitytwo
interaction otherprotein entityone particular otherprotein entitytwo
characterization entityone entitytwo h
characterization entityone otherprotein ii20 entitytwo three subunits
characterization entityone otherprotein ii20 h otherprotein ii28 three subunits the human transcription factor entitytwo
otherprotein ii18 entityone entitytwo three subunits
otherprotein ii18 entityone h otherprotein ii28 three subunits the human transcription factor entitytwo
otherprotein ii20 entityone three subunits the human transcription factor entitytwo
otherprotein iis entityone entitytwo associated factors
otherprotein iis entityone otherprotein associated factors the human HeLa cell entitytwo complexes
otherprotein iis entityone otherprotein associated factors the human HeLa cell otherprotein complexes entitytwo otherprotein
otherprotein iis entityone otherprotein associated factors the human HeLa cell otherprotein complexes otherprotein ii28 entitytwo h
otherprotein iis entityone otherprotein associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 entitytwo otherprotein
otherprotein iis entityone otherprotein associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 h otherprotein ii18 entitytwo a
otherprotein iis entityone otherprotein associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 h otherprotein ii28 a core entitytwo present
otherprotein iis entityone otherprotein associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core h otherprotein present both the previously described entitytwo species
otherprotein iis entityone otherprotein associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain entitytwo h otherprotein
otherprotein iis entityone otherprotein associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain h otherprotein ii30 entitytwo alpha
otherprotein iis entityone otherprotein associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain h otherprotein ii30 entitytwo h
otherprotein iis entityone otherprotein associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 h otherprotein alpha entitytwo beta respectively
otherprotein iis entityone otherprotein associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 h otherprotein alpha entitytwo respectively
otherprotein iis entityone otherprotein associated factors human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha h otherprotein beta respectively is the homologue Drosophila entitytwo h otherprotein
otherprotein iis entityone otherprotein associated factors human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 h otherprotein alpha h otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta entitytwo is a
otherprotein iis entityone otherprotein associated factors human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha h otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel entitytwo shows
otherprotein iis entityone otherprotein associated factors human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel h otherprotein which shows homology the nterminal region the yeast entitytwo has
iis otherprotein entityone associated factors the human HeLa cell entitytwo complexes
iis otherprotein entityone associated factors the human HeLa cell otherprotein complexes entitytwo otherprotein
iis otherprotein entityone associated factors the human HeLa cell otherprotein complexes otherprotein ii28 entitytwo h
iis otherprotein entityone associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 entitytwo otherprotein
iis otherprotein entityone associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 h otherprotein ii18 entitytwo a
iis otherprotein entityone associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 h otherprotein ii28 a core entitytwo present
iis otherprotein entityone associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core h otherprotein present both the previously described entitytwo species
iis otherprotein entityone associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain entitytwo h otherprotein
iis otherprotein entityone associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain h otherprotein ii30 entitytwo alpha
iis otherprotein entityone associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain h otherprotein ii30 entitytwo h
iis otherprotein entityone associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 h otherprotein alpha entitytwo beta respectively
iis otherprotein entityone associated factors the human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 h otherprotein alpha entitytwo respectively
iis otherprotein entityone associated factors human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha h otherprotein beta respectively is the homologue Drosophila entitytwo h otherprotein
iis otherprotein entityone associated factors human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 h otherprotein alpha h otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta entitytwo is a
iis otherprotein entityone associated factors human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha h otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel entitytwo shows
iis otherprotein entityone associated factors human HeLa cell otherprotein complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel h otherprotein which shows homology the nterminal region the yeast entitytwo has
HeLa cell entityone complexes entitytwo otherprotein
HeLa cell entityone complexes otherprotein ii28 entitytwo h
HeLa cell entityone complexes otherprotein ii28 otherprotein ii20 entitytwo otherprotein
HeLa cell entityone complexes otherprotein ii28 otherprotein ii20 h otherprotein ii18 entitytwo a
HeLa cell entityone complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 h otherprotein ii28 a core entitytwo present
HeLa cell entityone complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core h otherprotein present both the previously described entitytwo species
HeLa cell entityone complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core h otherprotein present both the previously described otherprotein species e otherprotein lack contain entitytwo otherprotein alpha
HeLa cell entityone complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described htfiid species e otherprotein lack contain h otherprotein ii30 entitytwo alpha
HeLa cell entityone complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain h otherprotein ii30 entitytwo otherprotein
HeLa cell entityone complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described htfiid species e otherprotein lack contain h otherprotein ii30 otherprotein entitytwo beta respectively
HeLa cell entityone complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain h otherprotein ii30 otherprotein alpha entitytwo respectively
HeLa cell entityone complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively is the homologue Drosophila entitytwo h otherprotein
HeLa cell entityone complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain h otherprotein ii30 otherprotein alpha otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta entitytwo is a
HeLa cell entityone complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel entitytwo shows
HeLa cell entityone complexes otherprotein ii28 otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta otherprotein ii18 is a novel h otherprotein which shows homology the nterminal region the yeast entitytwo has
cell otherprotein complexes entityone entitytwo h
cell otherprotein complexes entityone otherprotein ii20 entitytwo otherprotein
cell otherprotein complexes entityone otherprotein ii20 h otherprotein ii18 entitytwo a
cell otherprotein complexes entityone otherprotein ii20 otherprotein ii18 h otherprotein ii28 a core entitytwo present
cell otherprotein complexes entityone otherprotein ii20 otherprotein ii18 otherprotein ii28 a core h otherprotein present both the previously described entitytwo species
cell otherprotein complexes entityone otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain entitytwo h otherprotein
cell otherprotein complexes entityone otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain h otherprotein ii30 entitytwo alpha
cell otherprotein complexes entityone otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain h otherprotein ii30 entitytwo h
cell otherprotein complexes entityone otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 h otherprotein alpha entitytwo beta respectively
cell otherprotein complexes entityone otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 h otherprotein alpha entitytwo respectively
cell otherprotein complexes entityone otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha h otherprotein beta respectively is the homologue Drosophila entitytwo h otherprotein
cell otherprotein complexes entityone otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 h otherprotein alpha h otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta entitytwo is a
cell otherprotein complexes entityone otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha h otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel entitytwo shows
cell otherprotein complexes entityone otherprotein ii20 otherprotein ii18 otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel h otherprotein which shows homology the nterminal region the yeast entitytwo has
otherprotein ii28 entityone entitytwo otherprotein
otherprotein ii28 entityone h otherprotein ii18 entitytwo a
otherprotein ii28 entityone otherprotein ii18 h otherprotein ii28 a core entitytwo present
otherprotein ii28 entityone otherprotein ii18 otherprotein ii28 a core h otherprotein present both the previously described entitytwo species
otherprotein ii28 entityone otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain entitytwo h otherprotein
otherprotein ii28 entityone otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain h otherprotein ii30 entitytwo alpha
otherprotein ii28 entityone otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain h otherprotein ii30 entitytwo h
otherprotein ii28 entityone otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 h otherprotein alpha entitytwo beta respectively
otherprotein ii28 entityone otherprotein ii18 otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 h otherprotein alpha entitytwo respectively
otherprotein ii28 entityone otherprotein ii18 otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha h otherprotein beta respectively is the homologue Drosophila entitytwo h otherprotein
otherprotein ii28 entityone otherprotein ii18 otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 h otherprotein alpha h otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta entitytwo is a
otherprotein ii28 entityone otherprotein ii18 otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha h otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel entitytwo shows
otherprotein ii28 entityone otherprotein ii18 otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel h otherprotein which shows homology the nterminal region the yeast entitytwo has
otherprotein ii20 entityone entitytwo a
otherprotein ii20 entityone otherprotein ii28 a core entitytwo present
otherprotein ii20 entityone otherprotein ii28 a core otherprotein present both the previously described entitytwo species
otherprotein ii20 entityone otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain entitytwo otherprotein
otherprotein ii20 entityone otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 entitytwo alpha
otherprotein ii20 entityone otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 entitytwo h
otherprotein ii20 entityone otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha entitytwo beta respectively
otherprotein ii20 entityone otherprotein ii28 a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha entitytwo respectively
otherprotein ii20 entityone otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively is the homologue Drosophila entitytwo h otherprotein
otherprotein ii20 entityone otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha h otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta entitytwo is a
otherprotein ii20 entityone otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel entitytwo shows
otherprotein ii20 entityone otherprotein ii28 a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta otherprotein ii18 is a novel h otherprotein which shows homology the nterminal region the yeast entitytwo has
otherprotein ii18 entityone a core entitytwo present
otherprotein ii18 entityone a core otherprotein present both the previously described entitytwo species
otherprotein ii18 entityone a core otherprotein present both the previously described otherprotein species e otherprotein lack contain entitytwo otherprotein
otherprotein ii18 entityone a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 entitytwo alpha
otherprotein ii18 entityone a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 entitytwo h
otherprotein ii18 entityone a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha entitytwo beta respectively
otherprotein ii18 entityone a core otherprotein present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha entitytwo respectively
otherprotein ii18 entityone a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively is the homologue Drosophila entitytwo h otherprotein
otherprotein ii18 entityone a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha h otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta entitytwo is a
otherprotein ii18 entityone a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel entitytwo shows
otherprotein ii18 entityone a core otherprotein present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta otherprotein ii18 is a novel h otherprotein which shows homology the nterminal region the yeast entitytwo has
a core entityone present both the previously described entitytwo species
a core entityone present both the previously described otherprotein species e otherprotein lack contain entitytwo otherprotein
a core entityone present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 entitytwo alpha
a core entityone present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 entitytwo h
a core entityone present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha entitytwo beta respectively
a core entityone present both the previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha entitytwo respectively
a core entityone present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively is the homologue Drosophila entitytwo h otherprotein
a core entityone present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha h otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta entitytwo is a
a core entityone present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel entitytwo shows
a core entityone present both previously described otherprotein species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively the homologue Drosophila otherprotein ii30 beta otherprotein ii18 is a novel h otherprotein which shows homology the nterminal region the yeast entitytwo has
previously described entityone species e otherprotein lack contain entitytwo otherprotein
previously described entityone species e otherprotein lack contain otherprotein ii30 entitytwo alpha
previously described entityone species e otherprotein lack contain otherprotein ii30 entitytwo h
previously described entityone species e otherprotein lack contain otherprotein ii30 otherprotein alpha entitytwo beta respectively
previously described entityone species e otherprotein lack contain otherprotein ii30 otherprotein alpha entitytwo respectively
previously described entityone species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively is homologue Drosophila entitytwo h otherprotein
previously described entityone species e otherprotein lack contain otherprotein ii30 otherprotein alpha h otherprotein beta respectively homologue Drosophila otherprotein ii30 beta entitytwo is a
previously described entityone species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel entitytwo shows
previously described entityone species e otherprotein lack contain otherprotein ii30 otherprotein alpha otherprotein beta respectively homologue Drosophila otherprotein ii30 beta otherprotein ii18 is a novel h otherprotein which shows homology the nterminal region the yeast entitytwo has
lack contain entityone entitytwo alpha
lack contain entityone entitytwo h
lack contain entityone otherprotein alpha entitytwo beta respectively
lack contain entityone otherprotein alpha entitytwo respectively
lack contain entityone otherprotein alpha otherprotein beta respectively is homologue Drosophila entitytwo h otherprotein
lack contain entityone otherprotein alpha h otherprotein beta respectively homologue Drosophila otherprotein ii30 beta entitytwo is a
lack contain entityone otherprotein alpha otherprotein beta respectively homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel entitytwo shows
lack contain entityone otherprotein alpha otherprotein beta respectively homologue Drosophila otherprotein ii30 beta otherprotein ii18 is a novel h otherprotein which shows homology the nterminal region the yeast entitytwo has
otherprotein ii30 entityone entitytwo h
otherprotein ii30 entityone alpha entitytwo beta respectively
otherprotein ii30 entityone alpha entitytwo respectively
otherprotein ii30 entityone alpha otherprotein beta respectively is homologue Drosophila entitytwo h otherprotein
otherprotein ii30 entityone alpha h otherprotein beta respectively homologue Drosophila otherprotein ii30 beta entitytwo is a
otherprotein ii30 entityone alpha otherprotein beta respectively homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel entitytwo shows
otherprotein ii30 entityone alpha otherprotein beta respectively homologue Drosophila otherprotein ii30 beta otherprotein ii18 is a novel h otherprotein which shows homology the nterminal region the yeast entitytwo has
otherprotein ii30 entityone entitytwo beta respectively
otherprotein ii30 entityone entitytwo respectively
otherprotein ii30 entityone otherprotein beta respectively is homologue Drosophila entitytwo h otherprotein
otherprotein ii30 entityone h otherprotein beta respectively homologue Drosophila otherprotein ii30 beta entitytwo is a
otherprotein ii30 entityone otherprotein beta respectively homologue Drosophila otherprotein ii30 beta h otherprotein ii18 is a novel entitytwo shows
otherprotein ii30 entityone otherprotein beta respectively homologue Drosophila otherprotein ii30 beta otherprotein ii18 is a novel h otherprotein which shows homology the nterminal region the yeast entitytwo has
otherprotein alpha entityone entitytwo respectively
otherprotein alpha entityone beta respectively is homologue Drosophila entitytwo otherprotein
otherprotein alpha entityone beta respectively homologue Drosophila otherprotein ii30 beta entitytwo is a
otherprotein alpha entityone beta respectively homologue Drosophila otherprotein ii30 beta otherprotein ii18 is a novel entitytwo shows
otherprotein alpha entityone beta respectively homologue Drosophila otherprotein ii30 beta otherprotein ii18 is a novel otherprotein which shows homology the nterminal region the yeast entitytwo has
otherprotein alpha entityone respectively is homologue Drosophila entitytwo otherprotein
otherprotein alpha entityone respectively homologue Drosophila otherprotein ii30 beta entitytwo is a
otherprotein alpha entityone respectively homologue Drosophila otherprotein ii30 beta otherprotein ii18 is a novel entitytwo shows
otherprotein alpha entityone respectively homologue Drosophila otherprotein ii30 beta otherprotein ii18 is a novel otherprotein which shows homology the nterminal region the yeast entitytwo has
Drosophila entityone entitytwo a
Drosophila entityone otherprotein ii18 a novel entitytwo shows
Drosophila entityone otherprotein ii18 a novel otherprotein which shows homology the nterminal region the yeast entitytwo has
otherprotein ii30 beta entityone a novel entitytwo shows
otherprotein ii30 beta entityone a novel otherprotein which shows homology the nterminal region the yeast entitytwo has
a novel entityone shows homology the nterminal region the yeast entitytwo has
otherprotein to entityone entitytwo a
otherprotein to entityone otherprotein ii18 a entitytwo betaspecific
otherprotein to entityone otherprotein ii18 a entitytwo specific
otherprotein to entityone otherprotein ii18 a otherprotein betaspecific entitytwo otherprotein
otherprotein to entityone otherprotein ii18 a otherprotein betaspecific otherprotein entitytwo the
otherprotein to entityone otherprotein ii18 a otherprotein betaspecific otherprotein h otherprotein ii20 the homologue entitytwo alternatively
otherprotein to entityone otherprotein ii18 a otherprotein betaspecific otherprotein h otherprotein ii20 the homologue otherprotein alternatively spliced form d entitytwo otherprotein
otherprotein to entityone otherprotein ii18 a otherprotein betaspecific otherprotein h otherprotein ii20 the homologue otherprotein alternatively spliced form d otherprotein ii30 alpha entitytwo
otherprotein ii28 entityone a entitytwo betaspecific
otherprotein ii28 entityone a entitytwo specific
otherprotein ii28 entityone a otherprotein betaspecific entitytwo otherprotein
otherprotein ii28 entityone a otherprotein betaspecific otherprotein entitytwo the
otherprotein ii28 entityone a otherprotein betaspecific otherprotein h otherprotein ii20 the homologue entitytwo alternatively
otherprotein ii28 entityone a otherprotein betaspecific otherprotein h otherprotein ii20 the homologue otherprotein alternatively spliced form d entitytwo otherprotein
otherprotein ii28 entityone a otherprotein betaspecific otherprotein h otherprotein ii20 the homologue otherprotein alternatively spliced form d otherprotein ii30 alpha entitytwo
ii18 a entityone entitytwo specific
ii18 a entityone betaspecific entitytwo otherprotein
ii18 a entityone betaspecific otherprotein entitytwo the
ii18 a entityone betaspecific otherprotein h otherprotein ii20 the homologue entitytwo alternatively
ii18 a entityone betaspecific otherprotein h otherprotein ii20 the homologue otherprotein alternatively spliced form d entitytwo otherprotein
ii18 a entityone betaspecific otherprotein h otherprotein ii20 the homologue otherprotein alternatively spliced form d otherprotein ii30 alpha entitytwo
ii18 a entityone specific entitytwo otherprotein
ii18 a entityone specific otherprotein entitytwo the
ii18 a entityone specific otherprotein h otherprotein ii20 the homologue entitytwo alternatively
ii18 a entityone specific otherprotein h otherprotein ii20 the homologue otherprotein alternatively spliced form d entitytwo otherprotein
ii18 a entityone specific otherprotein h otherprotein ii20 the homologue otherprotein alternatively spliced form d otherprotein ii30 alpha entitytwo
otherprotein betaspecific entityone entitytwo the
otherprotein betaspecific entityone otherprotein ii20 the homologue entitytwo alternatively
otherprotein betaspecific entityone otherprotein ii20 the homologue otherprotein alternatively spliced form d entitytwo otherprotein
otherprotein betaspecific entityone otherprotein ii20 the homologue otherprotein alternatively spliced form d otherprotein ii30 alpha entitytwo
otherprotein entityone the homologue entitytwo alternatively
otherprotein entityone the homologue otherprotein alternatively spliced form d entitytwo otherprotein
otherprotein entityone the homologue otherprotein alternatively spliced form d otherprotein ii30 alpha entitytwo
homologue entityone alternatively spliced form d entitytwo otherprotein
homologue entityone alternatively spliced form d otherprotein ii30 alpha entitytwo
form d entityone entitytwo
show entityone interacts otherprotein entitytwo in
show entityone interacts otherprotein otherprotein ii18 vitro intracellularly; in cont otherprotein to Drosophila homologue entitytwo also interacts
show entityone interacts otherprotein otherprotein ii18 vitro intracellularly; in cont otherprotein to Drosophila homologue otherprotein ii28 also interacts directly otherprotein entitytwo
interacts otherprotein entityone vitro intracellularly; in cont otherprotein to Drosophila homologue entitytwo also interacts
interacts otherprotein entityone vitro intracellularly; in cont otherprotein to Drosophila homologue otherprotein ii28 also interacts directly otherprotein entitytwo
Drosophila homologue entityone also interacts directly otherprotein entitytwo
analysis indicates entityone entitytwo bind
analysis indicates entityone otherprotein ii18 bind distinct domains entitytwo h otherprotein
analysis indicates entityone h otherprotein ii18 bind distinct domains h otherprotein ii28 entitytwo also interacts
analysis indicates entityone otherprotein ii18 bind distinct domains h otherprotein ii28 h otherprotein ii18 also interacts otherprotein entitytwo it
analysis indicates entityone otherprotein ii18 bind distinct domains h otherprotein ii28 h otherprotein ii18 also interacts otherprotein tbp it interacts strongly otherprotein entitytwo h
analysis indicates entityone otherprotein ii18 bind distinct domains otherprotein ii28 h otherprotein ii18 also interacts otherprotein tbp it interacts strongly otherprotein h otherprotein ii28 entitytwo
otherprotein entityone bind distinct domains entitytwo otherprotein
otherprotein entityone bind distinct domains h otherprotein ii28 entitytwo also interacts
TBP entityone bind distinct domains otherprotein ii28 h otherprotein ii18 also interacts otherprotein entitytwo it
otherprotein entityone bind distinct domains otherprotein ii28 h otherprotein ii18 also interacts otherprotein otherprotein it interacts strongly otherprotein entitytwo h
otherprotein entityone bind distinct domains otherprotein ii28 otherprotein ii18 also interacts otherprotein otherprotein it interacts strongly otherprotein h otherprotein ii28 entitytwo
distinct domains entityone entitytwo also interacts
distinct domains entityone otherprotein ii18 also interacts otherprotein entitytwo it
distinct domains entityone otherprotein ii18 also interacts otherprotein otherprotein it interacts strongly otherprotein entitytwo h
distinct domains entityone otherprotein ii18 also interacts otherprotein otherprotein it interacts strongly otherprotein otherprotein ii28 entitytwo
otherprotein ii28 entityone also interacts otherprotein entitytwo it
otherprotein ii28 entityone also interacts otherprotein otherprotein it interacts strongly otherprotein entitytwo h
otherprotein ii28 entityone also interacts otherprotein otherprotein it interacts strongly otherprotein otherprotein ii28 entitytwo
interacts otherprotein entityone it interacts strongly otherprotein entitytwo h
interacts otherprotein entityone it interacts strongly otherprotein otherprotein ii28 entitytwo
strongly otherprotein entityone entitytwo
binding entityone entitytwo requires distinct
binding entityone h otherprotein ii30 requires distinct domains entitytwo
otherprotein ii28 entityone requires distinct domains entitytwo
homologous drosophila proteins entityone interacts directly otherprotein entitytwo however
homologous drosophila proteins entityone interacts directly otherprotein otherprotein however additional interactions entitytwo h
homologous drosophila proteins entityone interacts directly otherprotein otherprotein however additional interactions h otherprotein ii20 entitytwo h
homologous drosophila proteins entityone interacts directly otherprotein otherprotein however additional interactions h otherprotein ii20 h otherprotein ii28 entitytwo detected
directly otherprotein entityone however additional interactions entitytwo h
directly otherprotein entityone however additional interactions h otherprotein ii20 entitytwo h
directly otherprotein entityone however additional interactions h otherprotein ii20 h otherprotein ii28 entitytwo detected
additional interactions entityone entitytwo h
additional interactions entityone h otherprotein ii28 entitytwo detected
otherprotein ii20 entityone entitytwo detected
organization entityone entitytwo complexes
otherprotein entityone entitytwo its
otherprotein entityone otherprotein its relatives entitytwo otherprotein
otherprotein entityone otherprotein its relatives otherprotein entitytwo
tumor suppressor protein entityone its relatives entitytwo otherprotein
tumor suppressor protein entityone its relatives otherprotein entitytwo
its relatives entityone entitytwo
cdna the entityone family be cloned designated entitytwo multiple
cdna the entityone family be cloned designated otherprotein multiple entitytwo family members
cloned designated entityone multiple entitytwo family members
least two members entityone entitytwo
entityone entitytwo bind
entityone otherprotein bind all entitytwo family members
otherprotein entityone bind all entitytwo family members
however various entityone complexes display strong differences the ability bind e otherprotein entitytwo otherprotein
however various entityone complexes display strong differences the ability bind e otherprotein otherprotein entitytwo vivo
however various entityone complexes display strong differences the ability bind e otherprotein p otherprotein otherprotein vivo the specificity entitytwo otherprotein
however various entityone complexes display strong differences the ability bind e otherprotein otherprotein p107 vivo the specificity otherprotein entitytwo binding
however various entityone complexes display strong differences the ability bind e otherprotein otherprotein otherprotein vivo the specificity otherprotein otherprotein binding mediated the entitytwo subunit
otherprotein entityone entitytwo vivo
otherprotein entityone otherprotein vivo the specificity entitytwo otherprotein
otherprotein entityone p107 vivo the specificity p otherprotein entitytwo binding
otherprotein entityone otherprotein vivo the specificity p otherprotein otherprotein binding mediated the entitytwo subunit
otherprotein entityone vivo the specificity entitytwo p107
otherprotein entityone vivo the specificity otherprotein entitytwo binding
otherprotein entityone vivo the specificity otherprotein p107 binding mediated the entitytwo subunit
specificity entityone entitytwo binding
specificity entityone otherprotein binding mediated the entitytwo subunit
otherprotein entityone binding mediated the entitytwo subunit
independent sites entityone trigger entitytwo dimer formation
helical cytokine entityone its specific binding subunit entitytwo form
helical cytokine entityone its specific binding subunit otherprotein alpha form 11 complex by promoting homodimerization the signalling subunit entitytwo the
specific binding subunit entityone form 11 complex by promoting homodimerization the signalling subunit entitytwo the
tagged forms entityone used in solutionphase binding assays show the soluble extracellular domains entitytwo undergo dimerization
site entityone variants complexed otherprotein entitytwo bind
site entityone variants complexed otherprotein otherprotein bind single entitytwo molecule
site entityone variants complexed otherprotein otherprotein bind single gp130 molecule are unable dimerize whereas combined site variants lose ability interact otherprotein entitytwo
complexed otherprotein entityone bind single entitytwo molecule
complexed otherprotein entityone bind single gp130 molecule are unable dimerize whereas combined site variants lose ability interact otherprotein entitytwo
bind single entityone molecule are unable dimerize whereas combined site variants lose ability interact otherprotein entitytwo
conclusion entityone dimer formed direct binding two independent differently oriented sites entitytwo
composed two entityone two entitytwo two
composed two entityone two otherprotein two entitytwo molecules
two otherprotein two entityone two entitytwo molecules
entityone interaction otherprotein entitytwo ties mitogenic
entityone entitytwo protooncogenes transduce
show that entityone associates otherprotein entitytwo somatic
furthermore entityone be activated vitro a entitytwo dependent manner
cycle the entityone entitytwo pathways might
cycle the entityone otherprotein pathways might mediated part entitytwo
the otherprotein entityone pathways might mediated part entitytwo
direct interaction entityone subunits the entitytwo
entityone a serinethreonine protein kinase positioned downstream entitytwo the
entityone a serinethreonine protein kinase positioned downstream otherprotein the entitytwo cascade
positioned downstream entityone the entitytwo cascade
potentially regulate entityone isolated clone encoding carboxylterminal half the entitytwo heterotrimeric
vitro purified entityone subunits specifically bound a gst fusion protein encoding amino acids of entitytwo otherprotein
vitro purified entityone subunits specifically bound a gst fusion protein encoding amino acids of otherprotein entitytwo
acids of entityone entitytwo
mutants GST entityone indicate the region located amino acids and is primary determinant interaction otherprotein entitytwo
carboxyl terminus entityone entitytwo blocked
carboxyl terminus entityone otherprotein blocked binding entitytwo otherprotein
carboxyl terminus entityone otherprotein blocked binding otherprotein entitytwo however
carboxyl terminus entityone otherprotein blocked binding otherprotein otherprotein however entitytwo binding proteins
carboxyl terminus entityone otherprotein blocked binding otherprotein otherprotein however otherprotein binding proteins entitytwo 1433
terminus otherprotein entityone blocked binding entitytwo otherprotein
terminus otherprotein entityone blocked binding otherprotein entitytwo however
terminus otherprotein entityone blocked binding otherprotein otherprotein however entitytwo binding proteins
terminus otherprotein entityone blocked binding otherprotein otherprotein however otherprotein binding proteins entitytwo 1433
binding entityone entitytwo however
binding entityone otherprotein however entitytwo binding proteins
binding entityone otherprotein however otherprotein binding proteins entitytwo 1433
otherprotein entityone however entitytwo binding proteins
otherprotein entityone however otherprotein binding proteins entitytwo 1433
however entityone binding proteins entitytwo 1433
vitro binding entityone entitytwo revealed
vitro binding entityone G beta gamma revealed affinity interaction = + nM similar that seen entitytwo otherprotein
vitro binding entityone otherprotein revealed affinity interaction = + nM similar that seen otherprotein entitytwo =
otherprotein entityone revealed affinity interaction = + nM similar that seen entitytwo otherprotein
otherprotein entityone revealed affinity interaction = + nM similar that seen G beta gamma entitytwo =
seen entityone entitytwo =
native heterotrimeric entityone complexes measured pertussis toxin adpribosylation G alpha could disrupted increasing amounts entitytwo otherprotein
vivo complexes entityone entitytwo isolated
vivo complexes entityone otherprotein isolated human embryonic kidney 293t cells transfected otherprotein epitopetagged entitytwo
otherprotein entityone isolated human embryonic kidney 293t cells transfected otherprotein epitopetagged entitytwo
entityone transcriptional activation mediated coactivators entitytwo otherprotein
entityone transcriptional activation mediated coactivators otherprotein ii40 entitytwo
mediated coactivators entityone entitytwo
multisubunit entityone entitytwo thought
activation domain entityone two subunits the entitytwo complex otherprotein
activation domain entityone two subunits the otherprotein complex entitytwo otherprotein
activation domain entityone two subunits the otherprotein complex otherprotein ii40 entitytwo reported
subunits the entityone complex entitytwo otherprotein
subunits the entityone complex otherprotein ii40 entitytwo reported
otherprotein complex entityone entitytwo reported
activation domain entityone impaired ability this domain activate transcription simultaneously ability interact otherprotein entitytwo otherprotein
activation domain entityone impaired ability this domain activate transcription simultaneously ability interact otherprotein otherprotein ii40 entitytwo
otherprotein entityone entitytwo
furthermore partial entityone complex containing drosophila entitytwo otherprotein
furthermore partial entityone complex containing drosophila otherprotein entitytwo human otherprotein
furthermore partial entityone complex containing drosophila otherprotein otherprotein human entitytwo otherprotein
furthermore partial entityone complex containing drosophila otherprotein otherprotein human otherprotein ii250 entitytwo d
furthermore partial entityone complex containing drosophila otherprotein otherprotein human otherprotein ii250 otherprotein ii60 entitytwo supported activation
furthermore partial entityone complex containing drosophila otherprotein otherprotein human otherprotein ii250 otherprotein ii60 d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas entitytwo a
furthermore partial entityone complex containing drosophila otherprotein otherprotein human otherprotein ii250 otherprotein ii60 d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas otherprotein a subcomplex lacking entitytwo otherprotein
furthermore partial entityone complex containing drosophila otherprotein otherprotein human otherprotein ii250 otherprotein ii60 d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas otherprotein a subcomplex lacking otherprotein ii40 entitytwo not
complex containing drosophila entityone entitytwo human otherprotein
complex containing drosophila entityone otherprotein human entitytwo otherprotein
complex containing drosophila entityone otherprotein human otherprotein ii250 entitytwo d
complex containing drosophila entityone otherprotein human otherprotein ii250 otherprotein ii60 entitytwo supported activation
complex containing drosophila entityone otherprotein human otherprotein ii250 otherprotein ii60 d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas entitytwo a
complex containing drosophila entityone otherprotein human otherprotein ii250 otherprotein ii60 d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas otherprotein a subcomplex lacking entitytwo otherprotein
complex containing drosophila entityone otherprotein human otherprotein ii250 otherprotein ii60 d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas otherprotein a subcomplex lacking otherprotein ii40 entitytwo not
containing drosophila otherprotein entityone human entitytwo otherprotein
containing drosophila otherprotein entityone human otherprotein ii250 entitytwo d
containing drosophila otherprotein entityone human otherprotein ii250 otherprotein ii60 entitytwo supported activation
containing drosophila otherprotein entityone human otherprotein ii250 otherprotein ii60 d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas entitytwo a
containing drosophila otherprotein entityone human otherprotein ii250 otherprotein ii60 d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas otherprotein a subcomplex lacking entitytwo otherprotein
containing drosophila otherprotein entityone human otherprotein ii250 otherprotein ii60 d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas otherprotein a subcomplex lacking otherprotein ii40 entitytwo not
otherprotein human entityone entitytwo d
otherprotein human entityone otherprotein ii60 entitytwo supported activation
otherprotein otherprotein human entityone otherprotein ii60 d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas entitytwo a
otherprotein human entityone otherprotein ii60 d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas otherprotein a subcomplex lacking entitytwo otherprotein
otherprotein human entityone otherprotein ii60 d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas otherprotein a subcomplex lacking otherprotein ii40 entitytwo not
human otherprotein ii250 entityone entitytwo supported activation
human otherprotein ii250 entityone d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas entitytwo a
human otherprotein ii250 entityone d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas otherprotein a subcomplex lacking entitytwo otherprotein
human otherprotein ii250 entityone d otherprotein ii40 supported activation a gal4 otherprotein fusion protein vitro whereas otherprotein a subcomplex lacking otherprotein ii40 entitytwo not
otherprotein ii60 entityone supported activation a gal4 otherprotein fusion protein vitro whereas entitytwo a
otherprotein ii60 entityone supported activation a gal4 otherprotein fusion protein vitro whereas otherprotein a subcomplex lacking entitytwo otherprotein
otherprotein ii60 entityone supported activation a gal4 otherprotein fusion protein vitro whereas otherprotein a subcomplex lacking otherprotein ii40 entitytwo not
vitro whereas entityone a subcomplex lacking entitytwo otherprotein
vitro whereas entityone a subcomplex lacking otherprotein ii40 entitytwo not
subcomplex lacking entityone entitytwo not
results suggest entityone entitytwo important
results suggest entityone otherprotein ii60 important targets transmitting activation signals entitytwo the
otherprotein ii40 entityone important targets transmitting activation signals entitytwo the
bzip transcription factor entityone entitytwo bound
entityone entitytwo families
bzip regions entityone entitytwo bound
that entityone entitytwo heterodimer
entityone a multisubunit protein complex comprised the entitytwo otherprotein
entityone a multisubunit protein complex comprised the otherprotein entitytwo multiple
comprised the entityone entitytwo multiple
encoding human entityone otherprotein entitytwo has
encoding human entityone otherprotein otherprotein ii55 has known homolog Drosophila entitytwo now
human tfiid otherprotein entityone has known homolog Drosophila entitytwo now
entityone shown interact otherprotein largest subunit entitytwo human
entityone shown interact otherprotein largest subunit otherprotein ii230 human entitytwo its
entityone shown interact otherprotein largest subunit otherprotein ii230 human otherprotein its central region w otherprotein multiple activatorsincluding entitytwo otherprotein otherprotein
entityone shown interact otherprotein largest subunit otherprotein ii230 human otherprotein its central region w otherprotein multiple activatorsincluding otherprotein entitytwo otherprotein otherprotein
entityone shown interact otherprotein largest subunit otherprotein ii230 human otherprotein its central region w otherprotein multiple activatorsincluding otherprotein otherprotein entitytwo otherprotein adenoviral
entityone shown interact otherprotein largest subunit otherprotein ii230 human otherprotein its central region w otherprotein multiple activatorsincluding otherprotein otherprotein otherprotein entitytwo adenoviral otherprotein
entityone shown interact otherprotein largest subunit otherprotein ii230 human otherprotein its central region w otherprotein multiple activatorsincluding otherprotein otherprotein otherprotein otherprotein adenoviral entitytwo human
entityone shown interact otherprotein largest subunit otherprotein ii230 human otherprotein its central region w otherprotein multiple activatorsincluding otherprotein otherprotein otherprotein otherprotein adenoviral otherprotein human immunodeficiency virustype entitytwo proteinsthrough
largest subunit entityone human entitytwo its
largest subunit entityone human otherprotein its central region w otherprotein multiple activatorsincluding entitytwo otherprotein otherprotein
largest subunit entityone human otherprotein its central region w otherprotein multiple activatorsincluding otherprotein entitytwo otherprotein otherprotein
largest subunit entityone human otherprotein its central region w otherprotein multiple activatorsincluding otherprotein otherprotein entitytwo otherprotein adenoviral
largest subunit entityone human otherprotein its central region w otherprotein multiple activatorsincluding otherprotein otherprotein otherprotein entitytwo adenoviral otherprotein
largest subunit entityone human otherprotein its central region w otherprotein multiple activatorsincluding otherprotein otherprotein otherprotein otherprotein adenoviral entitytwo human
largest subunit entityone human otherprotein its central region w otherprotein multiple activatorsincluding otherprotein otherprotein otherprotein otherprotein adenoviral otherprotein human immunodeficiency virustype entitytwo proteinsthrough
ii230 human entityone its central region w otherprotein multiple activatorsincluding entitytwo otherprotein otherprotein
ii230 human entityone its central region w otherprotein multiple activatorsincluding otherprotein entitytwo otherprotein otherprotein
ii230 human entityone its central region w otherprotein multiple activatorsincluding otherprotein otherprotein entitytwo otherprotein adenoviral
ii230 human entityone its central region w otherprotein multiple activatorsincluding otherprotein otherprotein otherprotein entitytwo adenoviral otherprotein
ii230 human entityone its central region w otherprotein multiple activatorsincluding otherprotein otherprotein otherprotein otherprotein adenoviral entitytwo human
ii230 human entityone its central region w otherprotein multiple activatorsincluding otherprotein otherprotein otherprotein otherprotein adenoviral otherprotein human immunodeficiency virustype entitytwo proteinsthrough
otherprotein multiple activatorsincluding entityone entitytwo otherprotein otherprotein
otherprotein multiple activatorsincluding entityone otherprotein entitytwo otherprotein adenoviral
otherprotein multiple activatorsincluding entityone otherprotein otherprotein entitytwo adenoviral otherprotein
otherprotein multiple activatorsincluding entityone otherprotein otherprotein otherprotein adenoviral entitytwo human
otherprotein multiple activatorsincluding entityone otherprotein otherprotein otherprotein adenoviral otherprotein human immunodeficiency virustype entitytwo proteinsthrough
multiple activatorsincluding otherprotein entityone entitytwo otherprotein adenoviral
multiple activatorsincluding otherprotein entityone otherprotein entitytwo adenoviral otherprotein
multiple activatorsincluding otherprotein entityone otherprotein otherprotein adenoviral entitytwo human
multiple activatorsincluding otherprotein entityone otherprotein otherprotein adenoviral otherprotein human immunodeficiency virustype entitytwo proteinsthrough
activatorsincluding otherprotein otherprotein entityone entitytwo adenoviral otherprotein
activatorsincluding otherprotein otherprotein entityone otherprotein adenoviral entitytwo human
activatorsincluding otherprotein otherprotein entityone otherprotein adenoviral otherprotein human immunodeficiency virustype entitytwo proteinsthrough
otherprotein otherprotein otherprotein entityone adenoviral entitytwo human
otherprotein otherprotein otherprotein entityone adenoviral otherprotein human immunodeficiency virustype entitytwo proteinsthrough
otherprotein otherprotein adenoviral entityone human immunodeficiency virustype entitytwo proteinsthrough
entityone interacting region entitytwo localized
entityone interacting region otherprotein localized its dnabinding domain is distinct the glutaminerich activation domains previously shown interact otherprotein drosophila entitytwo
ii55interacting region entityone localized its dnabinding domain is distinct the glutaminerich activation domains previously shown interact otherprotein drosophila entitytwo
regulatory subunit entityone entitytwo reveals hydrophobic
regulatory subunit entityone otherprotein beta reveals hydrophobic amino acids are essential entitytwo dimerization andor
regulatory subunit entityone otherprotein beta reveals hydrophobic amino acids are essential otherprotein beta dimerization andor anchoring entitytwo the
otherprotein beta entityone reveals hydrophobic amino acids are essential entitytwo dimerization andor
otherprotein beta entityone reveals hydrophobic amino acids are essential otherprotein beta dimerization andor anchoring entitytwo the
essential entityone dimerization andor anchoring entitytwo the
neurons entityone entitytwo sequestered
neurons entityone otherprotein sequestered the dendritic cytoskeleton the regulatory subunit entitytwo the
otherprotein beta entityone sequestered the dendritic cytoskeleton the regulatory subunit entitytwo the
neuronal anchor protein entityone a coohterminal 22residue entitytwo binding tethering
homodimerization entityone binding activities entitytwo
phe36 generates monomeric entityone subunits cannot bind entitytwo
misfolding since mutant entityone monomers bind camp inhibit catalytic subunit entitytwo otherprotein
misfolding since mutant entityone monomers bind camp inhibit catalytic subunit otherprotein otherprotein same affinity efficacy wildtype entitytwo dimers
catalytic subunit entityone otherprotein same affinity efficacy wildtype entitytwo dimers
roles stabilizing entityone entitytwo interactions
consequence destabilizing entityone dimers the loss intracellular targetinganchoring capacity monomers fail bind entitytwo
affinity entityone dimers the entitytwo tethering site
produced dimeric entityone protein binds entitytwo approximately
produced dimeric entityone protein binds otherprotein approximately avidly as wildtype entitytwo
protein binds entityone approximately avidly as wildtype entitytwo
spleen tyrosine kinase entityone associates otherprotein Srcfamily kinase entitytwo otherprotein
spleen tyrosine kinase entityone associates otherprotein Srcfamily kinase otherprotein entitytwo a
spleen tyrosine kinase entityone associates otherprotein Srcfamily kinase otherprotein otherprotein a entitytwo
Srcfamily kinase entityone entitytwo a
Srcfamily kinase entityone otherprotein a entitytwo
srcfamily kinase otherprotein entityone a entitytwo
spleen tyrosine kinase entityone Srcfamily kinase entitytwo otherprotein otherprotein
spleen tyrosine kinase entityone Srcfamily kinase otherprotein entitytwo otherprotein contribute
spleen tyrosine kinase entityone Srcfamily kinase otherprotein otherprotein entitytwo contribute
Srcfamily kinase entityone entitytwo otherprotein contribute
Srcfamily kinase entityone otherprotein entitytwo contribute
srcfamily kinase otherprotein entityone entitytwo contribute
show entityone entitytwo human
entityone entitytwo coimmunoprecipitated
entityone otherprotein coimmunoprecipitated mature activated bcell lines gelpurified entitytwo otherprotein
entityone Lyn coimmunoprecipitated mature activated bcell lines gelpurified syk entitytwo reassociated
syk entityone coimmunoprecipitated mature activated bcell lines gelpurified entitytwo Lyn
otherprotein entityone coimmunoprecipitated mature activated bcell lines gelpurified otherprotein entitytwo reassociated
lines gelpurified entityone entitytwo reassociated
entityone entitytwo interaction may
entityone otherprotein interaction may dependent the stage Bcell differentiation since entitytwo otherprotein associations
entityone lyn interaction may dependent the stage Bcell differentiation since syk entitytwo associations
entityone otherprotein interaction may dependent the stage Bcell differentiation since syk otherprotein associations not detected preB myeloma cell lines entitytwo an
entityone lyn interaction may dependent the stage bcell differentiation since syklyn associations not detected preB myeloma cell lines Syk an immature Bcell line not reassociate otherprotein entitytwo vitro
Syk entityone interaction may dependent the stage Bcell differentiation since entitytwo lyn associations
otherprotein entityone interaction may dependent the stage Bcell differentiation since otherprotein entitytwo associations
Syk entityone interaction may dependent the stage Bcell differentiation since syklyn associations not detected preB myeloma cell lines entitytwo an
otherprotein entityone interaction may dependent the stage bcell differentiation since otherprotein lyn associations not detected preB myeloma cell lines otherprotein an immature Bcell line not reassociate otherprotein entitytwo vitro
bcell differentiation since entityone entitytwo associations
bcell differentiation since entityone otherprotein associations not detected preB myeloma cell lines entitytwo an
bcell differentiation since entityone lyn associations not detected preB myeloma cell lines Syk an immature bcell line not reassociate otherprotein entitytwo vitro
differentiation since syk entityone associations not detected preB myeloma cell lines entitytwo an
differentiation since otherprotein entityone associations not detected preB myeloma cell lines otherprotein an immature bcell line not reassociate otherprotein entitytwo vitro
cell lines entityone an immature bcell line not reassociate otherprotein entitytwo vitro
coprecipitating otherprotein entityone particular serinethreonine phosphorylated protein kDa size entitytwo
coprecipitated otherprotein entityone entitytwo
associated otherprotein entityone entitytwo
coprecipitated otherprotein entityone resembled entitytwo associated otherprotein
coprecipitated otherprotein entityone resembled otherprotein associated entitytwo several
otherprotein resembled entityone associated entitytwo several
thus entityone may serve a link entitytwo otherprotein
thus entityone may serve a link otherprotein entitytwo coupling
link entityone entitytwo coupling
functional analysis entityone novel entitytwo binding protein
functional analysis entityone novel entitytwo otherprotein
otherprotein novel entityone entitytwo otherprotein
encode novel entityone entitytwo termed otherprotein
encode novel entityone binding protein termed entitytwo
encode novel entityone termed entitytwo
entityone protein shares significant homology otherprotein entitytwo other
entityone protein shares significant homology otherprotein bcl2 other entitytwo family proteins
homology otherprotein entityone other entitytwo family proteins
jurkat coexpression entityone entitytwo provided markedly
jurkat coexpression entityone otherprotein provided markedly increased protection cell death induced several stimuli including staurosporine anti otherprotein antibody cytolytic cells relative cells contained gene transfermediated elevations e otherprotein entitytwo otherprotein
jurkat coexpression entityone Bcl2 provided markedly increased protection cell death induced several stimuli including staurosporine anti otherprotein antibody cytolytic cells relative cells contained gene transfermediated elevations e otherprotein BAG1 entitytwo protein alone
BAG1 entityone provided markedly increased protection cell death induced several stimuli including staurosporine anti otherprotein antibody cytolytic cells relative cells contained gene transfermediated elevations e otherprotein entitytwo Bcl2
otherprotein entityone provided markedly increased protection cell death induced several stimuli including staurosporine anti otherprotein antibody cytolytic cells relative cells contained gene transfermediated elevations e otherprotein otherprotein entitytwo protein alone
otherprotein entityone entitytwo protein alone
previously ascribed entityone independent pathways may instead reflect need the combination entitytwo otherprotein
previously ascribed entityone independent pathways may instead reflect need the combination Bcl2 entitytwo
combination entityone entitytwo
entityone binds an alternatively spliced exon entitytwo
cdna human entityone the cooh terminus human entitytwo reticulocyte
exon of entityone alternatively spliced exon necessary sufficient interaction otherprotein translated entitytwo our
expression system entityone relatives human entitytwo related protein
expression system entityone relatives human entitytwo otherprotein
expression system entityone relatives human otherprotein entitytwo otherprotein
expression system entityone relatives human otherprotein otherprotein entitytwo the
expression system entityone relatives human otherprotein otherprotein otherprotein the entitytwo Torpedo
expression system entityone relatives human otherprotein otherprotein otherprotein the otherprotein Torpedo electric organ also bind translated entitytwo
dystrophin relatives human entityone entitytwo otherprotein
dystrophin relatives human entityone related protein entitytwo otherprotein
dystrophin relatives human entityone related protein otherprotein entitytwo the
dystrophin relatives human entityone related protein otherprotein otherprotein the entitytwo Torpedo
dystrophin relatives human entityone related protein otherprotein otherprotein the otherprotein Torpedo electric organ also bind translated entitytwo
otherprotein relatives human entityone entitytwo otherprotein
otherprotein relatives human entityone otherprotein entitytwo the
otherprotein relatives human entityone otherprotein otherprotein the entitytwo Torpedo
otherprotein relatives human entityone otherprotein otherprotein the otherprotein Torpedo electric organ also bind translated entitytwo
otherprotein related protein entityone entitytwo the
otherprotein related protein entityone otherprotein the entitytwo Torpedo
otherprotein related protein entityone otherprotein the otherprotein Torpedo electric organ also bind translated entitytwo
protein otherprotein entityone the entitytwo Torpedo
protein otherprotein entityone the otherprotein Torpedo electric organ also bind translated entitytwo
otherprotein the entityone Torpedo electric organ also bind translated entitytwo
37kd fragment entityone sufficient interact otherprotein translated entitytwo its
37kd fragment entityone sufficient interact otherprotein translated dystrophin its homologues suggesting the entitytwo binding site
37kd fragment entityone sufficient interact otherprotein translated otherprotein its homologues suggesting the otherprotein binding site entitytwo occurs
otherprotein translated entityone its homologues suggesting the entitytwo binding site
otherprotein translated entityone its homologues suggesting the dystrophin binding site entitytwo occurs
suggesting the entityone binding site entitytwo occurs
interaction otherprotein entityone subunit entitytwo required
interaction otherprotein entityone subunit otherprotein required transcriptional activation entitytwo
otherprotein subunit entityone required transcriptional activation entitytwo
factors particular entityone entitytwo been
general transcription factor entityone also target a transcriptional activator namely entitytwo otherprotein
general transcription factor entityone also target a transcriptional activator namely otherprotein entitytwo binds
general transcription factor entityone also target a transcriptional activator namely otherprotein otherprotein binds the entitytwo promoter
transcriptional activator namely entityone entitytwo binds
transcriptional activator namely entityone otherprotein binds the entitytwo promoter
activator namely otherprotein entityone binds the entitytwo promoter
find entityone binds entitytwo subunit
find entityone binds otherprotein subunit entitytwo that
find entityone binds otherprotein subunit otherprotein that entitytwo transcriptional
otherprotein binds entityone subunit entitytwo that
srf binds entityone subunit otherprotein that entitytwo transcriptional
otherprotein subunit entityone that entitytwo transcriptional
entityone central charged cluster domain required binding entitytwo activation
domain impairs entityone ability support entitytwo activated transcription
domain impairs entityone ability support otherprotein activated transcription vitro has little effect the protein's basal transcription activity its ability support entitytwo activated transcription
ability support entityone activated transcription vitro has little effect the protein's basal transcription activity its ability support entitytwo activated transcription
correlation entityone entitytwo binding
correlation entityone rap74 binding otherprotein transcriptional activation suggests entitytwo a
correlation entityone otherprotein binding otherprotein transcriptional activation suggests otherprotein a critical target entitytwo activated transcription
correlation otherprotein entityone binding otherprotein transcriptional activation suggests entitytwo a
correlation SRF entityone binding otherprotein transcriptional activation suggests RAP74 a critical target entitytwo activated transcription
activation suggests entityone a critical target entitytwo activated transcription
transcription factor entityone blocked entitytwo gene product
encoded the entityone entitytwo functions
accumulation entityone protein the nucleoli differentiated u937 cells correlates otherprotein inhibition rDNA transcription addition entitytwo an
accumulation entityone protein the nucleoli differentiated u937 cells correlates otherprotein inhibition rDNA transcription addition Rb an vitro transcription system inhibits transcription RNA polyme otherprotein I; this inhibition requires functional entitytwo pocket
accumulation entityone protein the nucleoli differentiated u937 cells correlates otherprotein inhibition rDNA transcription addition an vitro transcription system inhibits transcription RNA polyme otherprotein I; this inhibition requires functional Rb pocket; 4 entitytwo specifically inhibits
accumulation entityone protein nucleoli differentiated u937 cells correlates otherprotein inhibition rDNA transcription addition an vitro transcription system inhibits transcription rna polyme otherprotein I; this inhibition requires functional pocket; 4 Rb specifically inhibits the activity the RNA polyme otherprotein I transcription factor entitytwo otherprotein
accumulation entityone protein nucleoli differentiated u937 cells correlates otherprotein inhibition rDNA transcription addition an vitro transcription system inhibits transcription rna polyme otherprotein I; this inhibition requires functional pocket; 4 Rb specifically inhibits the activity the RNA polyme otherprotein I transcription factor otherprotein entitytwo vitro
addition entityone an vitro transcription system inhibits transcription RNA polyme otherprotein I; this inhibition requires functional entitytwo pocket
addition entityone an vitro transcription system inhibits transcription RNA polyme otherprotein I; this inhibition requires functional pocket; 4 entitytwo specifically inhibits
addition entityone an vitro transcription system inhibits transcription rna polyme otherprotein I; this inhibition requires functional pocket; 4 specifically inhibits activity the RNA polyme otherprotein I transcription factor entitytwo otherprotein
addition entityone an vitro transcription system inhibits transcription rna polyme otherprotein I; this inhibition requires functional pocket; 4 specifically inhibits activity the RNA polyme otherprotein I transcription factor otherprotein entitytwo vitro
requires functional entityone pocket 4 entitytwo specifically inhibits
requires functional entityone pocket 4 specifically inhibits activity the rna polyme otherprotein I transcription factor entitytwo otherprotein
requires functional entityone pocket 4 specifically inhibits activity the rna polyme otherprotein I transcription factor otherprotein entitytwo vitro
pocket 4 entityone specifically inhibits activity the rna polyme otherprotein I transcription factor entitytwo otherprotein
pocket 4 entityone specifically inhibits activity the rna polyme otherprotein I transcription factor otherprotein entitytwo vitro
transcription factor entityone entitytwo vitro
interaction entityone entitytwo
mechanism which entityone suppresses cell growth namely entitytwo directly represses
beta entityone homodimer alpha entitytwo heterodimer
type receptors entityone entitytwo first
show beta entityone binds the entitytwo act otherprotein
show beta entityone binds the otherprotein entitytwo induces
show beta entityone binds the otherprotein act otherprotein induces activin binding the type receptor kinase entitytwo form
show beta entityone binds the otherprotein act otherprotein induces activin binding the type receptor kinase otherprotein form entitytwo betabeta
binds the entityone entitytwo induces
binds the entityone act otherprotein induces activin binding the type receptor kinase entitytwo form
binds the entityone act otherprotein induces activin binding the type receptor kinase otherprotein form entitytwo betabeta
the otherprotein entityone induces activin binding the type receptor kinase entitytwo form
the otherprotein entityone induces activin binding the type receptor kinase otherprotein form entitytwo betabeta
receptor kinase entityone form entitytwo betabeta
entityone complexes which entitytwo chain occupies
entityone also binds entitytwo its
entityone also binds Act otherprotein its beta subunit competes otherprotein binding activin entitytwo fails
entityone also binds Act otherprotein its beta subunit competes otherprotein binding activin Act otherprotein fails form entitytwo
also binds entityone its beta subunit competes otherprotein binding activin entitytwo fails
also binds entityone its beta subunit competes otherprotein binding activin Act otherprotein fails form entitytwo
activin entityone fails form entitytwo
entityone inhibitor cyclindependent kinases controls dna replication interaction otherprotein entitytwo
entityone tumoursuppressor protein controls expression a gene encoding entitytwo cyclindependent protein
levels entityone protein increased senescent cells entitytwo overexpression blocks
many tumour cells entityone exists quaternary complex otherprotein cyclin a CDK the entitytwo otherprotein
many tumour cells entityone exists quaternary complex otherprotein cyclin a CDK the otherprotein entitytwo
cdk the entityone entitytwo
entityone controls cdk activity thereby affecting cellcycle control whereas entitytwo functions
show entityone directly inhibits entitytwo dependent dna
furthermore entityone blocks ability entitytwo activate
furthermore entityone blocks ability otherprotein activate entitytwo principal
ability entityone activate entitytwo principal
direct interaction entityone entitytwo
thus entityone mediated suppression cell proliferation entitytwo otherprotein
thus entityone mediated suppression cell proliferation otherprotein entitytwo may
cell proliferation entityone entitytwo may
nuclear protein entityone a coactivator the transcription factor entitytwo
entityone activated phosphorylation entitytwo otherprotein
entityone activated phosphorylation otherprotein entitytwo precisely
entityone activated phosphorylation otherprotein otherprotein precisely phosphorylation stimulates entitytwo function
phosphorylation entityone entitytwo precisely
phosphorylation entityone otherprotein precisely phosphorylation stimulates entitytwo function
phosphorylation otherprotein entityone precisely phosphorylation stimulates entitytwo function
protein Mr265K entityone binds specifically the entitytwo phosphorylated form
protein Mr265K entityone binds specifically the otherprotein phosphorylated form entitytwo
specifically the entityone phosphorylated form entitytwo
parameters the entityone entitytwo interaction
parameters the entityone cbp interaction report that entitytwo activate
phospho otherprotein entityone interaction report that entitytwo activate
activation domain entityone interacts otherprotein basal transcription factor entitytwo a
activation domain entityone interacts otherprotein basal transcription factor otherprotein a domain is conserved the yeast coactivator entitytwo ref
basal transcription factor entityone a domain is conserved the yeast coactivator entitytwo ref
a coactivator entityone augments activity phosphorylated entitytwo activate
the transglutaminase entityone entitytwo
function entityone the identity proteins interact otherprotein entitytwo remain unknown
identify specific entityone protein interactions recombinant fusion protein affinity reagent constructed used identify proteins associating otherprotein entitytwo human
binding entityone fresh platelet lysates the entitytwo fusion protein
entityone also shown coprecipitate otherprotein entitytwo immunoprecipitation
entityone also shown coprecipitate otherprotein hsp27 immunoprecipitation studies to colocalize otherprotein entitytwo immunofluorescence
coprecipitate otherprotein entityone immunoprecipitation studies to colocalize otherprotein entitytwo immunofluorescence
binding platelet entityone entitytwo suggest
binding platelet entityone HSP27 suggest entitytwo may participate
binding platelet entityone otherprotein suggest otherprotein may participate the cellular localization andor enzymatic regulation platelet entitytwo
platelet otherprotein entityone suggest entitytwo may participate
platelet fxiii entityone suggest HSP27 may participate the cellular localization andor enzymatic regulation platelet entitytwo
suggest entityone may participate the cellular localization andor enzymatic regulation platelet entitytwo
acids the entityone aminoterminal domain required transcriptional activation binding entitytwo the
acids the entityone aminoterminal domain required transcriptional activation binding otherprotein the adenovirus entitytwo 55kd protein
acids the entityone aminoterminal domain required transcriptional activation binding otherprotein the adenovirus entitytwo 55kd protein
activation binding entityone the adenovirus entitytwo 55kd protein
activation binding entityone the adenovirus entitytwo 55kd protein
adenovirus entityone entitytwo 55kd protein
terminus the entityone protein been shown contain transactivation activity well the domains entitytwo adenovirus
terminus the entityone protein been shown contain transactivation activity well the domains otherprotein adenovirus entitytwo 55kd protein
terminus the entityone protein been shown contain transactivation activity well the domains otherprotein adenovirus entitytwo 55kd protein
domains entityone adenovirus entitytwo 55kd protein
domains entityone adenovirus entitytwo 55kd protein
adenovirus entityone entitytwo 55kd protein
trp23 human entityone both required transactivation activity binding the adenovirus entitytwo 55kd protein
trp23 human entityone both required transactivation activity binding the adenovirus otherprotein 55kd protein the human entitytwo p53 protein
trp23 human entityone both required transactivation activity binding the adenovirus otherprotein 55kd protein the human otherprotein entitytwo protein
the adenovirus entityone 55kd protein the human entitytwo otherprotein protein
the adenovirus entityone 55kd protein the human otherprotein entitytwo protein
the human entityone entitytwo protein
interactions entityone human entitytwo otherprotein
interactions entityone human otherprotein entitytwo
otherprotein human entityone entitytwo
ability the entityone protein bind a entitytwo specific dna
residues contact entityone Ad5 entitytwo 55kd oncogene
dimerization entityone required interaction otherprotein cytoskeletal component entitytwo
measurement entityone i3ai5a interaction otherprotein human entitytwo otherprotein
measurement entityone i3ai5a interaction otherprotein human otherprotein entitytwo two
otherprotein human entityone entitytwo two
interaction entityone the entitytwo using
entityone entitytwo a
entityone otherprotein a major substrate the entitytwo has
entityone otherprotein a major substrate the otherprotein has implicated entitytwo signaling
otherprotein entityone a major substrate the entitytwo has
otherprotein entityone a major substrate the otherprotein has implicated entitytwo signaling
substrate the entityone has implicated entitytwo signaling
although entityone thought interact otherprotein entitytwo receptor
although entityone thought interact otherprotein entitytwo nature
otherprotein entityone entitytwo nature
interaction human entityone the entitytwo receptor
interaction human entityone the entitytwo
otherprotein the entityone entitytwo
demonstrate entityone forms specific complex otherprotein cytoplasmic domain the entitytwo both
show the entityone unable phosphorylate entitytwo protein containing
protein entityone key mediator mitogenesis differentiation associates otherprotein entitytwo refs
proteins entityone entitytwo otherprotein
proteins entityone otherprotein entitytwo otherprotein
proteins entityone otherprotein otherprotein entitytwo members
proteins otherprotein entityone entitytwo otherprotein
proteins otherprotein entityone otherprotein entitytwo members
otherprotein otherprotein entityone entitytwo members
xenopus oocytes enhanced entityone activity promoted entitytwo dependent oocyte
interactions the entityone protein otherprotein and members the entitytwo family including
interactions the entityone protein otherprotein and members the bcl2 family including entitytwo otherprotein otherprotein
interactions the entityone protein otherprotein members the bcl2 family including otherprotein entitytwo otherprotein and
interactions the entityone protein otherprotein members the bcl2 family including otherprotein otherprotein entitytwo and otherprotein
interactions the entityone protein otherprotein members the bcl2 family including otherprotein otherprotein otherprotein and entitytwo explored
members the entityone family including entitytwo otherprotein otherprotein
members the entityone family including otherprotein entitytwo otherprotein
members the entityone family including otherprotein otherprotein entitytwo otherprotein
members the entityone family including otherprotein otherprotein otherprotein entitytwo explored
otherprotein family including entityone entitytwo otherprotein
otherprotein family including entityone otherprotein entitytwo otherprotein
otherprotein family including entityone otherprotein otherprotein entitytwo explored
family including otherprotein entityone entitytwo otherprotein
family including otherprotein entityone otherprotein entitytwo explored
including otherprotein otherprotein entityone entitytwo explored
entityone also interacted otherprotein entitytwo otherprotein
entityone also interacted otherprotein otherprotein entitytwo w
entityone also interacted otherprotein otherprotein otherprotein w otherprotein dominant inhibitors entitytwo otherprotein
entityone also interacted otherprotein otherprotein otherprotein w otherprotein dominant inhibitors otherprotein entitytwo
interacted otherprotein entityone entitytwo w
interacted otherprotein entityone otherprotein w otherprotein dominant inhibitors entitytwo otherprotein
interacted otherprotein entityone otherprotein w otherprotein dominant inhibitors otherprotein entitytwo
otherprotein otherprotein entityone w otherprotein dominant inhibitors entitytwo otherprotein
otherprotein otherprotein entityone w otherprotein dominant inhibitors otherprotein entitytwo
dominant inhibitors entityone entitytwo
entityone displayed same pattern combinatorial interactions otherprotein entitytwo family proteins
entityone displayed same pattern combinatorial interactions otherprotein bcl2 family proteins entitytwo
interactions otherprotein entityone family proteins entitytwo
deletion mutants entityone suggested entitytwo homodimerization involves
deletion mutants entityone suggested Bcl2 homodimerization involves interactions two distinct regions otherprotein the entitytwo protein since
deletion mutants entityone suggested bcl2 homodimerization involves interactions two distinct regions otherprotein the Bcl2 protein since LexA protein containing entitytwo amino acids
deletion mutants entityone suggested bcl2 homodimerization involves interactions two distinct regions otherprotein the bcl2 protein since LexA protein containing Bcl2 amino acids mediated functional interactions otherprotein B42 fusion protein containing entitytwo amino acids
deletion mutants entityone suggested bcl2 homodimerization involves interactions two distinct regions otherprotein the bcl2 protein since LexA protein containing bcl2 amino acids mediated functional interactions otherprotein B42 fusion protein containing Bcl2 amino acids but not complement B42 fusion protein containing entitytwo amino acids
bcl2 suggested entityone homodimerization involves interactions two distinct regions otherprotein the entitytwo protein since
bcl2 suggested entityone homodimerization involves interactions two distinct regions otherprotein the bcl2 protein since LexA protein containing entitytwo amino acids
bcl2 suggested entityone homodimerization involves interactions two distinct regions otherprotein the bcl2 protein since LexA protein containing bcl2 amino acids mediated functional interactions otherprotein B42 fusion protein containing entitytwo amino acids
bcl2 suggested entityone homodimerization involves interactions two distinct regions otherprotein the bcl2 protein since LexA protein containing bcl2 amino acids mediated functional interactions otherprotein B42 fusion protein containing bcl2 amino acids but not complement B42 fusion protein containing entitytwo amino acids
otherprotein the entityone protein since LexA protein containing entitytwo amino acids
otherprotein the entityone protein since LexA protein containing bcl2 amino acids mediated functional interactions otherprotein B42 fusion protein containing entitytwo amino acids
otherprotein the entityone protein since LexA protein containing bcl2 amino acids mediated functional interactions otherprotein B42 fusion protein containing bcl2 amino acids but not complement B42 fusion protein containing entitytwo amino acids
lexa protein containing entityone amino acids mediated functional interactions otherprotein B42 fusion protein containing entitytwo amino acids
lexa protein containing entityone amino acids mediated functional interactions otherprotein B42 fusion protein containing bcl2 amino acids but not complement B42 fusion protein containing entitytwo amino acids
fusion protein containing entityone amino acids but not complement B42 fusion protein containing entitytwo amino acids
to lexa entityone fusion proteins expression a lexa entitytwo protein
fusion proteins containing entityone entitytwo otherprotein
fusion proteins containing entityone otherprotein entitytwo not
fusion proteins containing entityone otherprotein otherprotein not containing entitytwo alternatively
fusion proteins containing entityone otherprotein otherprotein not containing otherprotein alternatively spliced form entitytwo lacks
proteins containing otherprotein entityone entitytwo not
proteins containing otherprotein entityone otherprotein not containing entitytwo alternatively
proteins containing otherprotein entityone otherprotein not containing otherprotein alternatively spliced form entitytwo lacks
otherprotein otherprotein entityone not containing entitytwo alternatively
otherprotein otherprotein entityone not containing otherprotein alternatively spliced form entitytwo lacks
those containing entityone alternatively spliced form entitytwo lacks
model whereby entityone entitytwo differentially regulate
model whereby entityone otherprotein differentially regulate entitytwo function
model whereby entityone otherprotein differentially regulate bcl2 function indicate requirements entitytwo bax heterodimerization
model whereby entityone otherprotein differentially regulate otherprotein function indicate requirements otherprotein entitytwo heterodimerization may
model whereby entityone otherprotein differentially regulate bcl2 function indicate requirements Bcl2Bax heterodimerization may different those entitytwo bcl2 homodimerization
model whereby entityone otherprotein differentially regulate bcl2 function indicate requirements Bcl2Bax heterodimerization may different those Bcl2 entitytwo homodimerization
whereby otherprotein entityone differentially regulate entitytwo function
whereby otherprotein entityone differentially regulate bcl2 function indicate requirements entitytwo otherprotein heterodimerization
whereby bax entityone differentially regulate otherprotein function indicate requirements otherprotein entitytwo heterodimerization may
whereby otherprotein entityone differentially regulate bcl2 function indicate requirements bcl2 otherprotein heterodimerization may different those entitytwo Bcl2 homodimerization
whereby otherprotein entityone differentially regulate bcl2 function indicate requirements Bcl2 otherprotein heterodimerization may different those Bcl2 entitytwo homodimerization
otherprotein differentially regulate entityone function indicate requirements entitytwo otherprotein heterodimerization
otherprotein differentially regulate entityone function indicate requirements Bcl2 entitytwo heterodimerization may
otherprotein differentially regulate entityone function indicate requirements bcl2 otherprotein heterodimerization may different those entitytwo Bcl2 homodimerization
otherprotein differentially regulate entityone function indicate requirements Bcl2 otherprotein heterodimerization may different those Bcl2 entitytwo homodimerization
requirements entityone entitytwo heterodimerization may
requirements entityone otherprotein heterodimerization may different those entitytwo bcl2 homodimerization
requirements entityone otherprotein heterodimerization may different those Bcl2 entitytwo homodimerization
requirements bcl2 entityone heterodimerization may different those entitytwo Bcl2 homodimerization
requirements Bcl2 entityone heterodimerization may different those Bcl2 entitytwo homodimerization
those entityone entitytwo homodimerization
renaturation entityone entitytwo the
rates which entityone entitytwo otherprotein
rates which entityone otherprotein entitytwo released
rates which entityone otherprotein otherprotein released entitytwo a
otherprotein entityone entitytwo released
otherprotein entityone otherprotein released entitytwo a
otherprotein otherprotein entityone released entitytwo a
entityone entitytwo chosen
entityone otherprotein chosen substrates they exhibit different solution requirements the chaperonin system they form stable "folding arrested" complexes otherprotein entitytwo
otherprotein entityone chosen substrates they exhibit different solution requirements the chaperonin system they form stable "folding arrested" complexes otherprotein entitytwo
folding entityone its native state occurs far earlier t12 1 min for entitytwo t12
renaturation rate entityone otherprotein groE chaperonins mirrored committed renaturation rates following entitytwo depletion
suggests entityone must interact otherprotein entitytwo throughout
mechanism correct entityone undergoes rebinding release cycles does entitytwo
interaction entityone gamma chains otherprotein entitytwo otherprotein
interaction entityone gamma chains otherprotein otherprotein entitytwo implications
chains otherprotein entityone entitytwo implications
entityone entitytwo signaling requires
entityone il2 signaling requires dimerization the entitytwo receptor beta
entityone otherprotein signaling requires dimerization the entitytwo otherprotein
entityone otherprotein signaling requires dimerization the otherprotein receptor beta entitytwo common
otherprotein entityone signaling requires dimerization the entitytwo receptor beta
otherprotein entityone signaling requires dimerization the entitytwo otherprotein
otherprotein entityone signaling requires dimerization the otherprotein entitytwo common
dimerization the entityone entitytwo otherprotein
dimerization the entityone receptor beta entitytwo common
dimerization the entityone entitytwo common
entityone entitytwo otherprotein whose
entityone otherprotein entitytwo whose receptors
entityone otherprotein otherprotein whose receptors known contain gamma and entitytwo whose receptor
entityone otherprotein otherprotein whose receptors known contain gamma otherprotein whose receptor shown to contain gamma induced tyrosine phosphorylation activation the janus family tyrosine kinases entitytwo and otherprotein
entityone otherprotein otherprotein whose receptors known contain gamma otherprotein whose receptor shown to contain gamma induced tyrosine phosphorylation activation the janus family tyrosine kinases otherprotein and entitytwo
otherprotein entityone entitytwo whose receptors
otherprotein entityone otherprotein whose receptors known contain gamma and entitytwo whose receptor
otherprotein entityone otherprotein whose receptors known contain gamma otherprotein whose receptor shown to contain gamma induced tyrosine phosphorylation activation the janus family tyrosine kinases entitytwo and otherprotein
otherprotein entityone otherprotein whose receptors known contain gamma otherprotein whose receptor shown to contain gamma induced tyrosine phosphorylation activation the janus family tyrosine kinases otherprotein and entitytwo
otherprotein otherprotein entityone whose receptors known contain gamma and entitytwo whose receptor
otherprotein otherprotein entityone whose receptors known contain gamma otherprotein whose receptor shown to contain gamma induced tyrosine phosphorylation activation the janus family tyrosine kinases entitytwo and otherprotein
otherprotein otherprotein entityone whose receptors known contain gamma otherprotein whose receptor shown to contain gamma induced tyrosine phosphorylation activation the janus family tyrosine kinases otherprotein and entitytwo
gamma entityone whose receptor shown to contain gamma induced tyrosine phosphorylation activation the janus family tyrosine kinases entitytwo and otherprotein
gamma entityone whose receptor shown to contain gamma induced tyrosine phosphorylation activation the janus family tyrosine kinases otherprotein and entitytwo
family tyrosine kinases entityone entitytwo
entityone entitytwo associated
entityone otherprotein associated otherprotein entitytwo gamma
entityone otherprotein associated otherprotein otherprotein gamma respectively; entitytwo induced otherprotein
entityone Jak3 associated otherprotein otherprotein beta gamma respectively; otherprotein induced entitytwo otherprotein
entityone otherprotein associated otherprotein otherprotein beta gamma respectively; otherprotein induced otherprotein entitytwo increased
entityone jak3 associated otherprotein otherprotein beta gamma respectively; otherprotein induced Jak3 otherprotein beta increased entitytwo gamma
otherprotein entityone associated otherprotein entitytwo gamma
otherprotein entityone associated otherprotein otherprotein gamma respectively; entitytwo induced jak3
otherprotein entityone associated otherprotein otherprotein beta gamma respectively; otherprotein induced entitytwo otherprotein
otherprotein entityone associated otherprotein otherprotein beta gamma respectively; otherprotein induced jak3 entitytwo increased
otherprotein entityone associated otherprotein otherprotein beta gamma respectively; otherprotein induced jak3 otherprotein beta increased entitytwo gamma
associated otherprotein entityone gamma respectively; entitytwo induced otherprotein
associated otherprotein entityone gamma respectively; otherprotein induced entitytwo otherprotein
associated otherprotein entityone gamma respectively; otherprotein induced otherprotein entitytwo increased
associated otherprotein entityone gamma respectively; otherprotein induced jak3 otherprotein beta increased entitytwo gamma
gamma respectively; entityone induced entitytwo otherprotein
gamma respectively; entityone induced otherprotein entitytwo increased
gamma respectively; entityone induced jak3 otherprotein increased entitytwo gamma
respectively otherprotein induced entityone entitytwo increased
respectively otherprotein induced entityone otherprotein beta increased entitytwo gamma
otherprotein induced jak3 entityone increased entitytwo gamma
patients prevent normal entityone activation suggesting mutations entitytwo may result
structure a entityone entitytwo receptor complex
human pituitary hormones entityone entitytwo otherprotein
human pituitary hormones entityone otherprotein entitytwo otherprotein regulate
human pituitary hormones entityone otherprotein otherprotein entitytwo regulate
pituitary hormones otherprotein entityone entitytwo otherprotein regulate
pituitary hormones otherprotein entityone otherprotein entitytwo regulate
otherprotein otherprotein entityone entitytwo regulate
entityone entitytwo receptors otherprotein
entityone otherprotein receptors entitytwo otherprotein
entityone otherprotein receptors otherprotein entitytwo respectively
otherprotein entityone receptors entitytwo otherprotein
otherprotein entityone receptors otherprotein and entitytwo respectively
otherprotein receptors entityone entitytwo respectively
case entityone activation involves receptor homodimerization a sequential process active ternary complex containing one ligand two receptor molecules formed association a receptor molecule an intermediate complex entitytwo not
case entityone activation involves receptor homodimerization a sequential process active ternary complex containing one ligand two receptor molecules formed association a receptor molecule an intermediate complex otherprotein not bind the entitytwo receptor
case entityone activation involves receptor homodimerization a sequential process active ternary complex containing one ligand two receptor molecules formed association a receptor molecule an intermediate complex otherprotein not bind the hgh receptor entitytwo binds
case entityone activation involves receptor homodimerization a sequential process active ternary complex containing one ligand two receptor molecules formed association a receptor molecule an intermediate complex otherprotein not bind hgh receptor hGH binds both the entitytwo otherprotein
case entityone activation involves receptor homodimerization a sequential process active ternary complex containing one ligand two receptor molecules formed association a receptor molecule an intermediate complex otherprotein not bind hgh receptor hGH binds both the otherprotein entitytwo mutagenesis
case entityone activation involves receptor homodimerization a sequential process active ternary complex containing one ligand two receptor molecules formed association a receptor molecule an intermediate complex otherprotein not bind hgh receptor hGH binds both the otherprotein otherprotein and mutagenesis studies shown the receptorbinding sites entitytwo overlap
intermediate complex entityone not bind the entitytwo receptor
intermediate complex entityone not bind the hgh receptor entitytwo binds
intermediate complex entityone not bind otherprotein receptor otherprotein binds both the entitytwo otherprotein
intermediate complex entityone not bind otherprotein receptor otherprotein binds both the otherprotein entitytwo and mutagenesis
intermediate complex entityone not bind hgh receptor hGH binds both the otherprotein otherprotein mutagenesis studies shown the receptorbinding sites entitytwo overlap
bind the entityone receptor entitytwo binds
bind entityone receptor hGH binds both the entitytwo otherprotein
bind entityone receptor hGH binds both the otherprotein entitytwo mutagenesis
bind entityone receptor hGH binds both the otherprotein otherprotein and mutagenesis studies shown the receptorbinding sites entitytwo overlap
hgh receptor entityone binds both entitytwo otherprotein
hgh receptor entityone binds both otherprotein entitytwo mutagenesis
hgh receptor entityone binds both otherprotein otherprotein and mutagenesis studies shown the receptorbinding sites entitytwo overlap
both entityone entitytwo mutagenesis
both entityone otherprotein and mutagenesis studies shown the receptorbinding sites entitytwo overlap
otherprotein entityone mutagenesis studies shown the receptorbinding sites entitytwo overlap
complex entityone bound the extracellular domain the entitytwo
otherprotein entityone entitytwo complex reveal
otherprotein entityone otherprotein complex reveal entitytwo bind
otherprotein hGH entityone complex reveal entitytwo bind
copurification entityone entitytwo three
copurification entityone otherprotein three additional proteins entitytwo otherprotein
copurification entityone otherprotein three additional proteins otherprotein entitytwo otherprotein
copurification entityone otherprotein three additional proteins otherprotein otherprotein entitytwo
copurification otherprotein entityone three additional proteins entitytwo otherprotein
copurification otherprotein entityone three additional proteins otherprotein entitytwo otherprotein
copurification otherprotein entityone three additional proteins otherprotein otherprotein entitytwo
three additional proteins entityone entitytwo otherprotein
three additional proteins entityone otherprotein entitytwo
additional proteins otherprotein entityone entitytwo
entityone also present immunoaffinitypurified entitytwo complexes along
entityone also present immunoaffinitypurified otherprotein complexes along otherprotein entitytwo another
entityone also present immunoaffinitypurified otherprotein complexes along otherprotein otherprotein another protein entitytwo
present immunoaffinitypurified entityone complexes along otherprotein entitytwo another
present immunoaffinitypurified entityone complexes along otherprotein otherprotein another protein entitytwo
along otherprotein entityone another protein entitytwo
antibodies entityone detect similar levels entitytwo all
antibodies entityone detect similar levels p23 all tissues tested crossreact otherprotein protein the size mice rabbits guinea pigs humans Saccharomyces cerevisiae indicating entitytwo a
similar levels entityone all tissues tested crossreact otherprotein protein the size mice rabbits guinea pigs humans Saccharomyces cerevisiae indicating entitytwo a
bacterially overexpressed human entityone used raise several monoclonal antibodies entitytwo
antibodies specifically immunoprecipitate entityone complex otherprotein entitytwo all
region human entityone using two hybrid system expression entitytwo E
a human entityone entitytwo
encoding human entityone entitytwo a
encoding human entityone otherprotein from Burkitt lymphoma cell line bjab express 90 110 kda polypeptide COS7 cells binds entitytwo specifically
human otherprotein entityone burkitt lymphoma cell line bjab express a 90 110 kda polypeptide COS7 cells binds entitytwo specifically
acid sequence entityone 60% identical 73% similar mouse entitytwo otherprotein
acid sequence entityone 60% identical 73% similar mouse otherprotein entitytwo otherprotein
acid sequence entityone 60% identical 73% similar mouse otherprotein m otherprotein entitytwo expressed
acid sequence entityone 60% identical 73% similar mouse otherprotein m otherprotein r otherprotein expressed an entitytwo dependent mouse
acid sequence entityone 60% identical 73% similar mouse otherprotein m otherprotein r otherprotein expressed an otherprotein dependent mouse prob cell line baf3 binds entitytwo otherprotein
acid sequence entityone 60% identical 73% similar mouse otherprotein m otherprotein r otherprotein expressed an otherprotein dependent mouse prob cell line baf3 binds otherprotein otherprotein high affinity pM the transfected cells exhibit proliferative response to entitytwo
similar mouse entityone entitytwo otherprotein
similar mouse entityone otherprotein entitytwo expressed
similar mouse entityone otherprotein r otherprotein expressed an entitytwo dependent mouse
similar mouse entityone otherprotein r otherprotein expressed an otherprotein dependent mouse prob cell line baf3 binds entitytwo otherprotein
similar mouse entityone otherprotein r otherprotein expressed an otherprotein dependent mouse prob cell line baf3 binds otherprotein otherprotein high affinity pM the transfected cells exhibit proliferative response to entitytwo
mouse otherprotein entityone entitytwo expressed
mouse otherprotein entityone otherprotein expressed an entitytwo dependent mouse
mouse otherprotein entityone otherprotein expressed an otherprotein dependent mouse prob cell line baf3 binds entitytwo otherprotein
mouse otherprotein entityone otherprotein expressed an otherprotein dependent mouse prob cell line baf3 binds otherprotein otherprotein high affinity pM the transfected cells exhibit proliferative response to entitytwo
otherprotein entityone expressed an entitytwo dependent mouse
otherprotein entityone expressed an otherprotein dependent mouse prob cell line baf3 binds entitytwo otherprotein
otherprotein entityone expressed an otherprotein dependent mouse prob cell line baf3 binds otherprotein otherprotein high affinity pM the transfected cells exhibit proliferative response to entitytwo
expressed an entityone dependent mouse prob cell line baf3 binds entitytwo otherprotein
expressed an entityone dependent mouse prob cell line baf3 binds otherprotein otherprotein high affinity pM the transfected cells exhibit proliferative response to entitytwo
line baf3 binds entityone otherprotein high affinity pM the transfected cells exhibit proliferative response to entitytwo
mouse entityone not bind entitytwo h
mouse entityone not bind h otherprotein entitytwo expressing baf3
mouse entityone not bind h otherprotein h otherprotein expressing baf3 cells not respond mouse cytokine observations consistent otherprotein the known species specificity entitytwo
bind entityone entitytwo expressing baf3
bind entityone h otherprotein expressing baf3 cells not respond mouse cytokine observations consistent otherprotein the known species specificity entitytwo
otherprotein entityone expressing baf3 cells not respond mouse cytokine observations consistent otherprotein the known species specificity entitytwo
clones expression entityone mrna downregulated activation the cells otherprotein anti entitytwo and
like entityone entitytwo structurally
like entityone otherprotein is structurally related entitytwo
otherprotein entityone structurally related entitytwo
entityone inhibits macrophage activation entitytwo relationship
participation the entityone entitytwo chain
participation the entityone receptor gamma chain entitytwo receptor complexes
participation the entityone receptor gamma chain entitytwo complexes
participation the entityone chain entitytwo receptor complexes
participation the entityone chain entitytwo complexes
gamma chain entityone entitytwo complexes
chain the entityone entitytwo receptor
chain the entityone entitytwo shared
chain entityone otherprotein receptor shared otherprotein the functional entitytwo receptor
chain entityone otherprotein receptor shared otherprotein the functional entitytwo is
the otherprotein entityone entitytwo shared
otherprotein entityone receptor shared otherprotein the functional entitytwo receptor
otherprotein entityone receptor shared otherprotein the functional entitytwo is
chain entityone shared otherprotein the functional entitytwo receptor
chain entityone shared otherprotein the functional entitytwo is
otherprotein functional entityone entitytwo is
specific the entityone receptor gamma chain showed the gamma chain participates the functional highaffinity receptor complexes entitytwo are
entityone protein kinase stimulated UV light entitytwo binds
entityone protein kinase stimulated UV light Ha otherprotein binds phosphorylates entitytwo activation domain
light entityone binds phosphorylates entitytwo activation domain
expression mediated entityone entitytwo
effect entityone transcriptional activity results part enhanced phosphorylation the entitytwo nh2terminal activation
characterization entityone distant relative the entitytwo group
significantly entityone partially activates entitytwo potentiates
entityone binds the entitytwo transactivation domain
entityone a ligand the entitytwo receptor proteintyrosine
entityone a ligand the entitytwo
ligand the entityone entitytwo
ligand the entityone entitytwo been
ligand entityone receptor proteintyrosine kinase been isolated using the extracellular domain entitytwo of
ligand entityone been isolated using the extracellular domain entitytwo of
singlestep purification entityone protein previously identified the product an early response gene induced entitytwo
that recombinant entityone induces autophosphorylation entitytwo intact
that recombinant entityone induces autophosphorylation otherprotein intact cells consistent otherprotein entitytwo an
that recombinant entityone induces autophosphorylation ECK intact cells consistent otherprotein b61 an authentic ligand entitytwo
induces autophosphorylation entityone intact cells consistent otherprotein entitytwo an
induces autophosphorylation entityone intact cells consistent otherprotein otherprotein an authentic ligand entitytwo
consistent otherprotein entityone an authentic ligand entitytwo
entityone a member a large orphan receptor proteintyrosine kinase family headed EPH we suggest ligands other members this family be related entitytwo can
factor tnf entityone entitytwo members
surface form entityone assembled biosynthesis heteromeric complex otherprotein entitytwo otherprotein a
surface form entityone assembled biosynthesis heteromeric complex otherprotein otherprotein beta entitytwo a type
complex otherprotein entityone entitytwo type
secreted entityone a homotrimer binds distinct tnf receptors 60 80 kilodaltons however receptors not recognize major cell surface entitytwo otherprotein complex
secreted entityone a homotrimer binds distinct tnf receptors 60 80 kilodaltons however receptors not recognize major cell surface ltalpha entitytwo complex
major cell surface entityone entitytwo complex
specific human entityone identified suggests cell surface may functions are distinct those secreted entitytwo
cytokine designated entityone entitytwo produced
cytokine designated entityone otherprotein produced a wide variety cells tissues shares many biological properties otherprotein entitytwo
cytokine designated otherprotein entityone produced a wide variety cells tissues shares many biological properties otherprotein entitytwo
chain entityone receptor inhibited the biological activity entitytwo IL15
chain entityone receptor inhibited the biological activity IL15 entitytwo competed
chain entityone receptor inhibited the biological activity otherprotein otherprotein competed binding otherprotein entitytwo indicating
chain entityone receptor inhibited the biological activity IL15 IL15 competed binding otherprotein il2 indicating entitytwo uses components
chain entityone receptor inhibited the biological activity otherprotein otherprotein competed binding otherprotein il2 indicating otherprotein uses components the entitytwo receptor
chain entityone receptor inhibited the biological activity otherprotein otherprotein competed binding otherprotein il2 indicating otherprotein uses components the entitytwo
biological activity entityone entitytwo competed
biological activity entityone IL15 competed binding otherprotein entitytwo indicating
biological activity entityone IL15 competed binding otherprotein otherprotein indicating entitytwo uses components
biological activity entityone IL15 competed binding otherprotein il2 indicating IL15 uses components the entitytwo receptor
biological activity entityone IL15 competed binding otherprotein otherprotein indicating IL15 uses components the entitytwo
IL15 entityone competed binding otherprotein entitytwo indicating
IL15 entityone competed binding otherprotein otherprotein indicating entitytwo uses components
IL15 entityone competed binding otherprotein il2 indicating IL15 uses components the entitytwo receptor
IL15 entityone competed binding otherprotein otherprotein indicating IL15 uses components the entitytwo
binding otherprotein entityone indicating entitytwo uses components
binding otherprotein entityone indicating otherprotein uses components the entitytwo receptor
binding otherprotein entityone indicating otherprotein uses components the entitytwo
il2 indicating entityone uses components the entitytwo receptor
otherprotein indicating entityone uses components the entitytwo
components the entityone entitytwo
domains the entityone entitytwo transcription factors
domains the entityone otherprotein transcription factors mediate specific interaction otherprotein entitytwo
otherprotein entityone transcription factors mediate specific interaction otherprotein entitytwo
the ubiquitous entityone the lymphoidspecific entitytwo transcription factors
interact otherprotein entityone entitytwo component
interact otherprotein entityone otherprotein component the entitytwo factor
otherprotein otherprotein entityone component the entitytwo factor
show entityone efficiently associates otherprotein entitytwo otherprotein
show entityone efficiently associates otherprotein otherprotein entitytwo
associates otherprotein entityone entitytwo
pou homeodomain entityone the evolutionarily conserved cterminal core domain entitytwo both
entityone pou domain is highly homologous the entitytwo pou domain
entityone pou domain is highly homologous the otherprotein pou domain likewise mediates interaction otherprotein entitytwo
homologous the entityone pou domain likewise mediates interaction otherprotein entitytwo
vivo entityone be coprecipitated otherprotein entitytwo cotransfected
vivo entityone be coprecipitated otherprotein otherprotein cotransfected cos1 cells entitytwo coimmunoprecipitates
vivo entityone be coprecipitated otherprotein otherprotein cotransfected cos1 cells TBP coimmunoprecipitates otherprotein endogenous entitytwo HeLa
coprecipitated otherprotein entityone cotransfected cos1 cells entitytwo coimmunoprecipitates
coprecipitated otherprotein entityone cotransfected cos1 cells otherprotein coimmunoprecipitates otherprotein endogenous entitytwo HeLa
cos1 cells entityone coimmunoprecipitates otherprotein endogenous entitytwo HeLa
cotransfection human entityone entitytwo expression vectors
mammalian splicing factor entityone otherprotein entitytwo relation
mammalian splicing factor entityone otherprotein otherprotein relation its 60kd subunit yeast entitytwo
otherprotein otherprotein entityone relation its 60kd subunit yeast entitytwo
a prespliceosome entityone snrnp functions premessenger rna mrna splicing together otherprotein splicing factors sfs entitytwo several
shown the entityone subunits correspond three the 17s entitytwo specific polypeptides
entityone interacts otherprotein entitytwo the
entityone interacts otherprotein otherprotein the presence entitytwo generate
entityone interacts otherprotein snRNP the presence otherprotein generate structure similar 17S entitytwo suggests
entityone interacts otherprotein otherprotein the presence otherprotein generate structure similar 17S otherprotein suggests function entitytwo otherprotein
entityone interacts otherprotein otherprotein the presence SF3b generate structure similar 17S otherprotein suggests function SF3a entitytwo the
entityone interacts otherprotein snRNP the presence otherprotein generate structure similar 17S snRNP suggests function SF3a otherprotein the incorporation entitytwo the
interacts otherprotein entityone the presence entitytwo generate
interacts otherprotein entityone the presence otherprotein generate structure similar 17S entitytwo suggests
interacts otherprotein entityone the presence otherprotein generate structure similar 17S snRNP suggests function entitytwo otherprotein
interacts otherprotein entityone the presence SF3b generate structure similar 17S snRNP suggests function otherprotein entitytwo the
interacts otherprotein entityone the presence otherprotein generate structure similar 17S snRNP suggests function otherprotein otherprotein the incorporation entitytwo the
presence entityone generate structure similar 17S entitytwo suggests
presence entityone generate structure similar 17S otherprotein suggests function entitytwo SF3b
presence entityone generate structure similar 17S otherprotein suggests function otherprotein entitytwo the
presence entityone generate structure similar 17S snRNP suggests function otherprotein SF3b the incorporation entitytwo the
similar 17S entityone suggests function entitytwo otherprotein
similar 17S entityone suggests function otherprotein entitytwo the
similar 17S entityone suggests function otherprotein otherprotein the incorporation entitytwo the
function entityone entitytwo the
function entityone otherprotein the incorporation entitytwo the
otherprotein entityone the incorporation entitytwo the
60kilodalton subunit entityone related the yeast splicing protein entitytwo
entityone Ala>Gly substitution helix of entitytwo repeat
2 entityone repeat of one dimer otherprotein helix of entitytwo repeat
otherprotein entityone gene mutation nucleotide change identified codon resulting an ala>gly substitution the first helical domain entitytwo repeat
entityone human and phase protein phosphatase associates otherprotein entitytwo
isolate human entityone entitytwo
yeast entityone interacts otherprotein cyclindependent kinases including human entitytwo otherprotein
yeast entityone interacts otherprotein cyclindependent kinases including human otherprotein entitytwo otherprotein
yeast entityone interacts otherprotein cyclindependent kinases including human otherprotein otherprotein entitytwo not
yeast entityone interacts otherprotein cyclindependent kinases including human otherprotein otherprotein otherprotein not otherprotein entitytwo
kinases including human entityone entitytwo otherprotein
kinases including human entityone otherprotein entitytwo not
kinases including human entityone otherprotein otherprotein not otherprotein entitytwo
including human otherprotein entityone entitytwo not
including human otherprotein entityone otherprotein not otherprotein entitytwo
otherprotein otherprotein entityone not otherprotein entitytwo
HeLa cells entityone expressed the to transition the protein forms stabl otherprotein exes otherprotein entitytwo
overexpression wildtype entityone delays progression the cell cycle yeast HeLa cells delay dependent entitytwo phosphatase activity
entityone cdkinteracting protein entitytwo a
cyclindependent kinase entityone associates otherprotein entitytwo and
entityone encodes novel kd protein is found entitytwo otherprotein
entityone encodes novel kd protein is found otherprotein entitytwo otherprotein
entityone encodes novel kd protein is found otherprotein otherprotein entitytwo otherprotein
entityone encodes novel kd protein is found otherprotein otherprotein otherprotein entitytwo immunoprecipitates
found entityone entitytwo otherprotein
found entityone otherprotein entitytwo otherprotein
found entityone otherprotein otherprotein entitytwo immunoprecipitates
found otherprotein entityone entitytwo otherprotein
found otherprotein entityone otherprotein entitytwo immunoprecipitates
otherprotein otherprotein entityone entitytwo immunoprecipitates
entityone a potent tightbinding inhibitor Cdks can inhibit phosphorylation entitytwo otherprotein
entityone a potent tightbinding inhibitor Cdks can inhibit phosphorylation otherprotein entitytwo otherprotein otherprotein
entityone a potent tightbinding inhibitor Cdks can inhibit phosphorylation otherprotein otherprotein entitytwo otherprotein cdk2
entityone a potent tightbinding inhibitor Cdks can inhibit phosphorylation otherprotein otherprotein otherprotein entitytwo otherprotein otherprotein
entityone a potent tightbinding inhibitor Cdks can inhibit phosphorylation otherprotein otherprotein cdk2 otherprotein entitytwo otherprotein
entityone a potent tightbinding inhibitor Cdks can inhibit phosphorylation otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein
entityone a potent tightbinding inhibitor Cdks can inhibit phosphorylation otherprotein otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein
entityone a potent tightbinding inhibitor Cdks can inhibit phosphorylation otherprotein otherprotein otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein complexes
entityone a potent tightbinding inhibitor Cdks can inhibit phosphorylation otherprotein otherprotein otherprotein otherprotein otherprotein otherprotein 1cdk4 otherprotein entitytwo complexes
phosphorylation entityone entitytwo otherprotein otherprotein
phosphorylation entityone otherprotein entitytwo otherprotein cdk2
phosphorylation entityone otherprotein otherprotein entitytwo otherprotein otherprotein
phosphorylation entityone otherprotein cdk2 otherprotein entitytwo otherprotein
phosphorylation entityone otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein
phosphorylation entityone otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein
phosphorylation entityone otherprotein otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein complexes
phosphorylation entityone otherprotein otherprotein otherprotein otherprotein otherprotein 1cdk4 otherprotein entitytwo complexes
otherprotein entityone entitytwo otherprotein cdk2
otherprotein entityone otherprotein entitytwo otherprotein otherprotein
otherprotein entityone cdk2 otherprotein entitytwo otherprotein
otherprotein entityone otherprotein otherprotein otherprotein entitytwo otherprotein
otherprotein entityone otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein
otherprotein entityone otherprotein otherprotein otherprotein otherprotein otherprotein entitytwo otherprotein complexes
otherprotein entityone otherprotein otherprotein otherprotein otherprotein 1cdk4 otherprotein entitytwo complexes
otherprotein otherprotein entityone entitytwo cdk2 otherprotein
otherprotein otherprotein entityone otherprotein entitytwo otherprotein
otherprotein otherprotein entityone otherprotein cdk2 entitytwo otherprotein
otherprotein otherprotein entityone otherprotein cdk2 otherprotein entitytwo otherprotein
otherprotein otherprotein entityone otherprotein cdk2 otherprotein otherprotein entitytwo otherprotein complexes
otherprotein otherprotein entityone otherprotein cdk2 otherprotein 1cdk4 otherprotein entitytwo complexes
otherprotein cdk2 entityone entitytwo otherprotein
otherprotein otherprotein entityone otherprotein entitytwo otherprotein
otherprotein otherprotein entityone otherprotein otherprotein entitytwo otherprotein
otherprotein otherprotein entityone otherprotein otherprotein otherprotein entitytwo otherprotein complexes
otherprotein otherprotein entityone otherprotein otherprotein 1cdk4 otherprotein entitytwo complexes
otherprotein cdk2 otherprotein entityone entitytwo otherprotein
otherprotein cdk2 otherprotein entityone otherprotein entitytwo otherprotein
otherprotein cdk2 otherprotein entityone otherprotein otherprotein entitytwo otherprotein complexes
otherprotein cdk2 otherprotein entityone otherprotein 1cdk4 otherprotein entitytwo complexes
otherprotein otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein entitytwo otherprotein complexes
otherprotein otherprotein otherprotein entityone cdk4 otherprotein entitytwo complexes
otherprotein otherprotein entityone entitytwo cdk4 complexes
otherprotein otherprotein entityone otherprotein entitytwo complexes
otherprotein 1cdk4 entityone entitytwo complexes
experiments indicate entityone entitytwo function
zincfinger transcription factors entityone entitytwo
recently cloned entityone such entitytwo
ability entityone initiate transcription augmented the presence a tata motif binding sites transcription factor entitytwo
functional cooperation entityone entitytwo explored
found entityone entitytwo form
otherprotein entityone entitytwo mediate
physical interaction entityone entitytwo may thus
involvement entityone signal transducer entitytwo otherprotein
involvement entityone signal transducer otherprotein entitytwo mediated signal
otherprotein signal transducer entityone entitytwo mediated signal
entityone novel cytokine otherprotein a variety biofunctions overlap otherprotein of entitytwo
previously identified entityone specific binding protein is distinct that entitytwo a
binding proteins entityone entitytwo prompted
binding proteins entityone otherprotein prompted to investigate whether entitytwo shares common
binding proteins entityone IL6 prompted to investigate whether il11 shares common signal transduction mechanisms otherprotein entitytwo
IL11 entityone prompted to investigate whether entitytwo shares common
otherprotein entityone prompted to investigate whether otherprotein shares common signal transduction mechanisms otherprotein entitytwo
investigate whether entityone shares common signal transduction mechanisms otherprotein entitytwo
signals triggered entityone entitytwo a
results showed entityone entitytwo both
results showed entityone otherprotein both stimulate cell proliferation induce similar pattern protein tyrosine phosphorylation activate same protooncogene entitytwo expression
otherprotein entityone both stimulate cell proliferation induce similar pattern protein tyrosine phosphorylation activate same protooncogene entitytwo expression
findings imply entityone entitytwo share similar
findings imply entityone otherprotein share similar early signaling events otherprotein possibility using same signal transducer entitytwo
otherprotein entityone share similar early signaling events otherprotein possibility using same signal transducer entitytwo
next tested whether entityone induced signaling be inhibited anti entitytwo antibodies
next tested whether entityone induced signaling be inhibited anti otherprotein antibodies blocked entitytwo mediated functions
inhibited anti entityone antibodies blocked entitytwo mediated functions
observed anti entityone antibodies abolished cell proliferation protein tyrosine phosphorylation entitytwo gene expression
observed anti entityone antibodies abolished cell proliferation protein tyrosine phosphorylation otherprotein gene expression elicited entitytwo otherprotein
observed anti entityone antibodies abolished cell proliferation protein tyrosine phosphorylation otherprotein gene expression elicited otherprotein entitytwo TF1
tyrosine phosphorylation entityone gene expression elicited entitytwo otherprotein
tyrosine phosphorylation entityone gene expression elicited otherprotein entitytwo TF1
expression elicited entityone entitytwo TF1
finally anti entityone antibody inhibited ability entitytwo not
finally anti entityone antibody inhibited ability otherprotein not entitytwo transduce
ability entityone not entitytwo transduce
results demonstrate entityone entitytwo utilize different
results demonstrate entityone otherprotein utilize different ligand binding proteins share common signal transducer entitytwo TF1
otherprotein entityone utilize different ligand binding proteins share common signal transducer entitytwo TF1
entityone associates otherprotein entitytwo catalytic subunit
entityone entitytwo interacts
encodes novel entityone catalytic subunit entitytwo differs
encodes novel entityone catalytic subunit otherprotein differs the originally defined entitytwo an
otherprotein catalytic subunit entityone differs the originally defined entitytwo an
assays demonstrated entityone isoforms preferentially bind hypophosphorylated form entitytwo
moreover similar entityone sequences required binding entitytwo otherprotein
moreover similar entityone sequences required binding otherprotein entitytwo
required binding entityone entitytwo
representative the entityone entitytwo tnf receptor
high affinity human entityone entitytwo expression
high affinity human entityone receptor expression T cells association otherprotein entitytwo driven proliferation
high affinity human entityone expression T cells association otherprotein entitytwo driven proliferation
express single entityone 90 kda whereas activated cells express additional 76kda entitytwo binding protein
function the entityone entitytwo molecules
receptors entityone driven proliferation entitytwo expression
proliferate entityone correlated otherprotein expression the entitytwo otherprotein
proliferate entityone correlated otherprotein expression the otherprotein entitytwo not
proliferate entityone correlated otherprotein expression the otherprotein otherprotein not otherprotein expression the entitytwo otherprotein
proliferate entityone correlated otherprotein expression the otherprotein il7r not otherprotein expression the otherprotein entitytwo
expression the entityone entitytwo not
expression the entityone otherprotein and w otherprotein expression the entitytwo otherprotein
expression the entityone otherprotein and w otherprotein expression the otherprotein entitytwo
the otherprotein entityone not otherprotein expression the entitytwo otherprotein
the otherprotein entityone not otherprotein expression the otherprotein entitytwo
expression the entityone entitytwo
entityone driven proliferation mediated via high affinity entitytwo accordingly
entityone driven proliferation mediated via high affinity otherprotein accordingly scatchard analysis revealed like entitytwo otherprotein
entityone driven proliferation mediated via high affinity il7r accordingly scatchard analysis revealed like otherprotein entitytwo otherprotein
entityone driven proliferation mediated via high affinity otherprotein accordingly scatchard analysis revealed like otherprotein otherprotein entitytwo otherprotein bound
entityone driven proliferation mediated via high affinity il7r accordingly scatchard analysis revealed like otherprotein il7r otherprotein entitytwo bound il7
entityone driven proliferation mediated via high affinity otherprotein accordingly scatchard analysis revealed like otherprotein otherprotein otherprotein otherprotein bound entitytwo otherprotein
via high affinity entityone accordingly scatchard analysis revealed like entitytwo otherprotein
via high affinity entityone accordingly scatchard analysis revealed like otherprotein entitytwo otherprotein
via high affinity entityone accordingly scatchard analysis revealed like otherprotein otherprotein the entitytwo otherprotein
via high affinity entityone accordingly scatchard analysis revealed like otherprotein otherprotein the otherprotein entitytwo bound otherprotein
via high affinity entityone accordingly scatchard analysis revealed like otherprotein il7r otherprotein il7r bound entitytwo otherprotein
like entityone entitytwo otherprotein
like entityone otherprotein the entitytwo otherprotein
like entityone otherprotein the otherprotein entitytwo bound otherprotein
like entityone otherprotein otherprotein otherprotein bound entitytwo otherprotein
like otherprotein entityone entitytwo otherprotein
like otherprotein entityone otherprotein entitytwo bound otherprotein
like otherprotein entityone otherprotein il7r bound entitytwo otherprotein
otherprotein the entityone entitytwo bound otherprotein
otherprotein otherprotein entityone otherprotein bound entitytwo otherprotein
il7r otherprotein entityone bound entitytwo otherprotein
showed the entityone entitytwo otherprotein
showed the entityone otherprotein entitytwo not
otherprotein entityone entitytwo not
previously cloned entityone found stain unstimulated cells express the entitytwo otherprotein
previously cloned entityone found stain unstimulated cells express the otherprotein entitytwo not
previously cloned entityone found stain unstimulated cells express otherprotein otherprotein but Tcell clones express predominantly the entitytwo otherprotein
previously cloned entityone found stain unstimulated cells express otherprotein otherprotein but Tcell clones express predominantly the otherprotein entitytwo
express the entityone entitytwo not
express entityone otherprotein but Tcell clones express predominantly the entitytwo otherprotein
express entityone otherprotein but Tcell clones express predominantly the otherprotein entitytwo
otherprotein entityone not tcell clones express predominantly the entitytwo otherprotein
otherprotein entityone not tcell clones express predominantly the otherprotein entitytwo
express predominantly entityone entitytwo
immunoprecipitated cloned entityone a 90kda species both 125isurfacelabeled resting activated cells were unable precipitate 76kDa entitytwo
pcr analysis entityone expressing cells could detect splicing the extracellular domain the cloned entitytwo thereby excluding
pcr analysis entityone expressing cells could detect splicing extracellular domain the cloned otherprotein thereby excluding the possibility the entitytwo otherprotein
pcr analysis entityone expressing cells could detect splicing extracellular domain the cloned otherprotein thereby excluding the possibility the p76 entitytwo a
pcr analysis entityone expressing cells could detect splicing extracellular domain the cloned otherprotein thereby excluding the possibility the p76 otherprotein is previously undescribed splice variant the cloned entitytwo
cloned entityone thereby excluding the possibility the entitytwo otherprotein
cloned entityone thereby excluding the possibility the otherprotein entitytwo a
cloned entityone thereby excluding the possibility the otherprotein otherprotein is previously undescribed splice variant the cloned entitytwo
possibility the entityone entitytwo a
possibility the entityone otherprotein is previously undescribed splice variant the cloned entitytwo
the otherprotein entityone a previously undescribed splice variant the cloned entitytwo
demonstrate the entityone entitytwo the
demonstrate entityone otherprotein is the Tcell homologue the cloned entitytwo imply
demonstrate entityone otherprotein is the Tcell homologue the cloned otherprotein imply the entitytwo and otherprotein
demonstrate entityone otherprotein is the Tcell homologue the cloned otherprotein imply the p90 and entitytwo otherprotein
demonstrate entityone otherprotein is the Tcell homologue the cloned otherprotein imply the p90 and otherprotein entitytwo different
the otherprotein entityone the tcell homologue the cloned entitytwo imply
the p90 entityone the tcell homologue the cloned otherprotein imply the entitytwo and otherprotein
the otherprotein entityone the tcell homologue the cloned otherprotein imply the otherprotein and entitytwo otherprotein
the otherprotein entityone the tcell homologue the cloned otherprotein imply the otherprotein and otherprotein entitytwo different
the cloned entityone imply the entitytwo otherprotein
the cloned entityone imply the otherprotein entitytwo otherprotein
the cloned entityone imply the otherprotein otherprotein entitytwo different
imply the entityone entitytwo otherprotein
imply the entityone otherprotein entitytwo different
otherprotein entityone entitytwo different
novel high affinity entityone may necessary entitytwo driven proliferation
characterization the entityone binding proteins entitytwo otherprotein
characterization the entityone binding proteins otherprotein and entitytwo
otherprotein binding proteins entityone entitytwo
entityone gene product entitytwo regulates cell
two proteins entityone entitytwo cloned originally
two proteins entityone otherprotein cloned originally their interaction otherprotein entitytwo
otherprotein and entityone cloned originally their interaction otherprotein entitytwo
products the entityone entitytwo genes
products the entityone otherprotein genes ubiquitously expressed large kDa entitytwo 195
products the entityone otherprotein genes ubiquitously expressed large kDa otherprotein and kDa entitytwo nuclear phosphoproteins
otherprotein entityone genes ubiquitously expressed large kDa entitytwo and 195
otherprotein and entityone genes ubiquitously expressed large kDa otherprotein and kDa entitytwo nuclear phosphoproteins
kda entityone 195 kDa entitytwo nuclear phosphoproteins
identify complexes entityone entitytwo vivo
identify complexes entityone otherprotein vivo are dissociated in the presence purified human papillomavirus entitytwo protein
otherprotein entityone vivo are dissociated the presence purified human papillomavirus entitytwo protein
potentially oncogenic cyclins entityone entitytwo share common
potentially oncogenic cyclins entityone otherprotein share common properties subunit configuration tyrosine phosphorylation physical association otherprotein entitytwo protein
cyclins otherprotein entityone share common properties subunit configuration tyrosine phosphorylation physical association otherprotein entitytwo protein
'mitotic cyclin' entityone exhibits properties growth factor sensitivity susceptibility viral subversion association otherprotein tumorsuppressor protein properties are indicative an entitytwo otherprotein
'mitotic cyclin' entityone exhibits properties growth factor sensitivity susceptibility viral subversion association otherprotein tumorsuppressor protein properties are indicative an otherprotein entitytwo well
indicative an entityone entitytwo well
identified human entityone entitytwo a
moreover entityone found be phosphorylated tyrosine residues vivo like entitytwo readily
moreover entityone found be phosphorylated tyrosine residues vivo like otherprotein readily phosphorylated entitytwo vitro
vivo like entityone readily phosphorylated entitytwo vitro
human osteosarcoma cells entityone induced early and becomes associated otherprotein entitytwo Cdkbinding
cells demonstrated entityone associated otherprotein entitytwo otherprotein
cells demonstrated entityone associated otherprotein p34 otherprotein entitytwo that
cells demonstrated entityone associated otherprotein p34 otherprotein otherprotein that entitytwo immun otherprotein
otherprotein entityone entitytwo that
otherprotein entityone otherprotein that entitytwo immun otherprotein
p34 otherprotein entityone that entitytwo immun otherprotein
sh2sh3 domaincontaining protein entityone interacts otherprotein tyrosinephosphorylated entitytwo otherprotein
sh2sh3 domaincontaining protein entityone interacts otherprotein tyrosinephosphorylated otherprotein and entitytwo implications
sh2sh3 domaincontaining protein entityone interacts otherprotein tyrosinephosphorylated otherprotein and otherprotein implications otherprotein control entitytwo signalling
otherprotein tyrosinephosphorylated entityone entitytwo implications
otherprotein tyrosinephosphorylated entityone otherprotein implications otherprotein control entitytwo signalling
otherprotein and entityone implications otherprotein control entitytwo signalling
entityone small protein comprising one sh2 domain two sh3 domains represents human homologue the caenorhabditis elegans protein entitytwo
entityone entitytwo been
entityone otherprotein been implicated a highly conserved mechanism regulates entitytwo signalling
otherprotein entityone been implicated a highly conserved mechanism regulates entitytwo signalling
response entityone entitytwo forms
major otherprotein substrate entityone the second the sh2 domaincontaining oncogenic protein entitytwo
interactions entityone these two proteins require ligand activation the entitytwo are
interactions entityone these two proteins require ligand activation the otherprotein are mediated the binding the sh2 domain entitytwo phosphotyrosines
interactions entityone these two proteins require ligand activation the otherprotein are mediated the binding the sh2 domain G otherprotein to phosphotyrosines both entitytwo otherprotein
interactions entityone these two proteins require ligand activation the otherprotein are mediated the binding the sh2 domain G otherprotein to phosphotyrosines both otherprotein entitytwo
activation the entityone are mediated the binding the sh2 domain entitytwo phosphotyrosines
activation the entityone are mediated the binding the sh2 domain otherprotein phosphotyrosines both entitytwo otherprotein
activation the entityone are mediated the binding the sh2 domain otherprotein phosphotyrosines both otherprotein entitytwo
sh2 domain entityone phosphotyrosines both entitytwo otherprotein
sh2 domain entityone phosphotyrosines both otherprotein entitytwo
phosphotyrosines both entityone entitytwo
although entityone associates otherprotein entitytwo otherprotein
although entityone associates otherprotein otherprotein entitytwo is
although entityone associates otherprotein otherprotein otherprotein is tyrosinephosphorylated entitytwo stimulation implying
although entityone associates otherprotein otherprotein otherprotein tyrosinephosphorylated otherprotein stimulation implying entitytwo is not
associates otherprotein entityone entitytwo is
associates otherprotein entityone otherprotein is tyrosinephosphorylated entitytwo stimulation implying
associates otherprotein entityone otherprotein tyrosinephosphorylated otherprotein stimulation implying entitytwo is not
otherprotein otherprotein entityone is tyrosinephosphorylated entitytwo stimulation implying
otherprotein otherprotein entityone tyrosinephosphorylated otherprotein stimulation implying entitytwo is not
tyrosinephosphorylated entityone stimulation implying entitytwo not
yvin present entityone entitytwo otherprotein
yvin present entityone otherprotein entitytwo specifically
yvin present entityone otherprotein otherprotein specifically binds SH2 domain entitytwo otherprotein
present otherprotein entityone entitytwo specifically
present otherprotein entityone otherprotein specifically binds SH2 domain entitytwo otherprotein
otherprotein otherprotein entityone specifically binds SH2 domain entitytwo otherprotein
interestingly entityone entitytwo simultaneously
interestingly entityone otherprotein simultaneously bind distinct tyrosine phosphorylated regions the entitytwo molecule suggesting
interestingly entityone otherprotein simultaneously bind distinct tyrosine phosphorylated regions the otherprotein molecule suggesting mechanism whereby entitytwo could provide
otherprotein entityone simultaneously bind distinct tyrosine phosphorylated regions the entitytwo molecule suggesting
otherprotein entityone simultaneously bind distinct tyrosine phosphorylated regions the otherprotein molecule suggesting mechanism whereby entitytwo could provide
the entityone molecule suggesting mechanism whereby entitytwo could provide
proteinprotein interactions entityone the two targets entitytwo otherprotein
proteinprotein interactions entityone the two targets otherprotein entitytwo
two targets entityone entitytwo
regulation the entityone related transcription factor entitytwo binding
regulation the entityone related transcription factor otherprotein binding the entitytwo protein
related transcription factor entityone binding the entitytwo protein
entityone gene product entitytwo a
entityone a lymphoidspecific entitytwo transcription factor
demonstrated entityone contains sequence motif is highly related the entitytwo binding sites
demonstrated entityone contains sequence motif is highly related the binding sites several viral oncoproteins binds the pocket region entitytwo in
related the entityone binding sites several viral oncoproteins binds the pocket region entitytwo in
entityone binds exclusively the underphosphorylated form entitytwo fails
entityone binds exclusively the underphosphorylated form Rb fails bind entitytwo mutants derived
underphosphorylated form entityone fails bind entitytwo mutants derived
association entityone entitytwo resting
phosphorylation entityone results the release entitytwo is
phosphorylation entityone results release Elf1 is correlated temporally otherprotein the activation entitytwo mediated transcription
release entityone is correlated temporally otherprotein activation entitytwo mediated transcription
phosphorylationdefective form entityone inhibited entitytwo dependent transcription
results demonstrate entityone interacts specifically otherprotein lineagerestricted entitytwo transcription factor
entityone entitytwo specifically recognizes
shown entityone purified human hela cells a multisubunit complex four polypeptides designated entitytwo alpha beta
shown entityone purified human hela cells a multisubunit complex four polypeptides designated entitytwo beta gamma
four polypeptides designated entityone entitytwo beta gamma
cDNAs encoding entityone gamma entitytwo delta
cDNAs encoding entityone gamma PTF delta well functional studies otherprotein cognate antibodies recognize native entitytwo complex
ptf gamma entityone delta well functional studies otherprotein cognate antibodies recognize native entitytwo complex
the four entityone subunits originally found copurify conventional chromatography indeed form tightly associated complex further show the entitytwo defined
association the entityone entitytwo otherprotein
association the entityone otherprotein otherprotein entitytwo consistent
association entityone otherprotein otherprotein ptf consistent otherprotein the previous report a entitytwo related complex
association entityone otherprotein otherprotein otherprotein consistent otherprotein the previous report a otherprotein related complex entitytwo containing substoichiometric
association entityone tbp otherprotein otherprotein consistent otherprotein the previous report a otherprotein related complex otherprotein containing substoichiometric levels entitytwo a
association entityone otherprotein otherprotein otherprotein consistent otherprotein the previous report a otherprotein related complex otherprotein containing substoichiometric levels otherprotein a component entitytwo identical
association entityone otherprotein otherprotein ptf consistent otherprotein the previous report a ptfrelated complex otherprotein containing substoichiometric levels otherprotein a component otherprotein identical sequence the entitytwo gamma reported
the otherprotein entityone otherprotein entitytwo consistent
otherprotein entityone otherprotein ptf consistent otherprotein the previous report a entitytwo related complex
otherprotein entityone otherprotein otherprotein consistent otherprotein the previous report a otherprotein related complex entitytwo containing substoichiometric
otherprotein entityone otherprotein otherprotein consistent otherprotein the previous report a otherprotein related complex otherprotein containing substoichiometric levels entitytwo a
otherprotein entityone otherprotein otherprotein consistent otherprotein the previous report a otherprotein related complex otherprotein containing substoichiometric levels TBP a component entitytwo identical
otherprotein entityone otherprotein ptf consistent otherprotein the previous report a ptfrelated complex otherprotein containing substoichiometric levels TBP a component otherprotein identical sequence the entitytwo gamma reported
otherprotein otherprotein entityone consistent otherprotein previous report a entitytwo related complex
otherprotein otherprotein entityone consistent otherprotein previous report a ptfrelated complex entitytwo containing substoichiometric
tbp otherprotein entityone consistent otherprotein previous report a ptfrelated complex otherprotein containing substoichiometric levels entitytwo a
otherprotein otherprotein entityone consistent otherprotein previous report a ptfrelated complex otherprotein containing substoichiometric levels otherprotein a component entitytwo identical
otherprotein otherprotein entityone consistent otherprotein previous report a ptfrelated complex otherprotein containing substoichiometric levels otherprotein a component otherprotein identical sequence the entitytwo gamma reported
report a entityone related complex entitytwo containing substoichiometric
report a entityone related complex otherprotein containing substoichiometric levels entitytwo a
report a entityone related complex otherprotein containing substoichiometric levels otherprotein a component entitytwo identical
report a entityone related complex otherprotein containing substoichiometric levels otherprotein a component otherprotein identical sequence the entitytwo gamma reported
otherprotein related complex entityone containing substoichiometric levels entitytwo a
otherprotein related complex entityone containing substoichiometric levels otherprotein a component entitytwo identical
PTFrelated complex entityone containing substoichiometric levels otherprotein a component otherprotein identical sequence the entitytwo gamma reported
substoichiometric levels entityone a component entitytwo identical
substoichiometric levels entityone a component otherprotein identical sequence the entitytwo gamma reported
a component entityone identical sequence the entitytwo gamma reported
both recombinant entityone gamma entitytwo delta
both recombinant entityone gamma PTF delta otherprotein entitytwo consistent
both recombinant entityone gamma PTF delta otherprotein tbp consistent otherprotein otherprotein natural association entitytwo w otherprotein
both recombinant entityone gamma PTF delta otherprotein otherprotein consistent otherprotein otherprotein natural association otherprotein w otherprotein entitytwo a
both recombinant entityone gamma ptf delta otherprotein tbp consistent otherprotein otherprotein natural association TBP w otherprotein PTF a semistable entitytwo tbpassociated factor
both recombinant entityone gamma ptf delta otherprotein tbp consistent otherprotein otherprotein natural association tbp w otherprotein PTF a semistable TBP entitytwo associated factor
both recombinant entityone gamma ptf delta otherprotein otherprotein consistent otherprotein otherprotein natural association otherprotein w otherprotein PTF a semistable otherprotein otherprotein associated factor complex w otherprotein possible functional interactions PSEbound entitytwo TATAbound
both recombinant entityone gamma ptf delta otherprotein tbp consistent otherprotein otherprotein natural association TBP w otherprotein ptf a semistable tbptbpassociated factor complex w otherprotein possible functional interactions PSEbound PTF TATAbound entitytwo promoter
ptf gamma entityone delta otherprotein entitytwo consistent
ptf gamma entityone delta otherprotein tbp consistent otherprotein otherprotein natural association entitytwo w otherprotein
ptf gamma entityone delta otherprotein otherprotein consistent otherprotein otherprotein natural association otherprotein w otherprotein entitytwo a
ptf gamma entityone delta otherprotein tbp consistent otherprotein otherprotein natural association TBP w otherprotein ptf a semistable entitytwo tbpassociated factor
ptf gamma entityone delta otherprotein tbp consistent otherprotein otherprotein natural association tbp w otherprotein ptf a semistable TBP entitytwo associated factor
ptf gamma entityone delta otherprotein otherprotein consistent otherprotein otherprotein natural association otherprotein w otherprotein ptf a semistable otherprotein otherprotein associated factor complex w otherprotein possible functional interactions PSEbound entitytwo TATAbound
ptf gamma entityone delta otherprotein tbp consistent otherprotein otherprotein natural association TBP w otherprotein ptf a semistable tbptbpassociated factor complex w otherprotein possible functional interactions PSEbound ptf TATAbound entitytwo promoter
delta otherprotein entityone consistent otherprotein otherprotein natural association entitytwo w otherprotein
delta otherprotein entityone consistent otherprotein otherprotein natural association TBP w otherprotein entitytwo a
delta otherprotein entityone consistent otherprotein otherprotein natural association TBP w otherprotein otherprotein a semistable entitytwo tbpassociated factor
delta otherprotein entityone consistent otherprotein otherprotein natural association tbp w otherprotein otherprotein a semistable TBP entitytwo associated factor
delta otherprotein entityone consistent otherprotein otherprotein natural association TBP w otherprotein ptf a semistable tbptbpassociated factor complex w otherprotein possible functional interactions PSEbound entitytwo TATAbound
delta otherprotein entityone consistent otherprotein otherprotein natural association TBP w otherprotein otherprotein a semistable tbptbpassociated factor complex w otherprotein possible functional interactions PSEbound otherprotein TATAbound entitytwo promoter
natural association entityone otherprotein entitytwo a
natural association entityone otherprotein otherprotein a semistable entitytwo tbpassociated factor
natural association entityone otherprotein otherprotein a semistable tbp entitytwo associated factor
natural association entityone otherprotein ptf a semistable tbptbpassociated factor complex w otherprotein possible functional interactions PSEbound entitytwo TATAbound
natural association entityone otherprotein otherprotein a semistable tbptbpassociated factor complex w otherprotein possible functional interactions PSEbound otherprotein TATAbound entitytwo promoter
tbp otherprotein entityone a semistable entitytwo tbpassociated factor
tbp otherprotein entityone a semistable tbp entitytwo associated factor
otherprotein otherprotein entityone a semistable otherprotein otherprotein associated factor complex w otherprotein possible functional interactions PSEbound entitytwo TATAbound
tbp otherprotein entityone a semistable tbptbpassociated factor complex w otherprotein possible functional interactions PSEbound ptf TATAbound entitytwo promoter
a semistable entityone entitytwo associated factor
a semistable entityone tbpassociated factor complex w otherprotein possible functional interactions PSEbound entitytwo TATAbound
a semistable entityone tbpassociated factor complex w otherprotein possible functional interactions PSEbound otherprotein TATAbound entitytwo promoter
semistable tbp entityone associated factor complex w otherprotein possible functional interactions PSEbound entitytwo TATAbound
semistable tbp entityone associated factor complex w otherprotein possible functional interactions PSEbound otherprotein TATAbound entitytwo promoter
interactions PSEbound entityone TATAbound entitytwo promoter
extracts depleted entityone entitytwo associated factors
extracts depleted entityone TBPassociated factors transcription the promoter restored recombinant entitytwo not
extracts depleted entityone TBPassociated factors transcription the promoter restored recombinant tbp not entitytwo otherprotein
extracts depleted entityone TBPassociated factors transcription the promoter restored recombinant tbp not otherprotein entitytwo indicating
extracts depleted entityone TBPassociated factors transcription the promoter restored recombinant tbp not otherprotein otherprotein indicating transcription class snRNA genes requires entitytwo complex different
TBP entityone associated factors transcription the promoter restored recombinant entitytwo not
tbp entityone associated factors transcription the promoter restored recombinant TBP not entitytwo otherprotein
tbp entityone associated factors transcription the promoter restored recombinant TBP not otherprotein entitytwo indicating
tbp entityone associated factors transcription the promoter restored recombinant TBP not otherprotein otherprotein indicating transcription class snRNA genes requires entitytwo complex different
restored recombinant entityone not entitytwo otherprotein
restored recombinant entityone not otherprotein entitytwo indicating
restored recombinant entityone not otherprotein otherprotein indicating transcription class snRNA genes requires entitytwo complex different
not entityone entitytwo indicating
not entityone otherprotein indicating transcription class snRNA genes requires entitytwo complex different
otherprotein entityone indicating transcription class snRNA genes requires entitytwo complex different
entityone entitytwo TRADD
entityone otherprotein entitytwo otherprotein interactions
entityone otherprotein TRADD entitytwo interactions define
entityone otherprotein TRADD otherprotein interactions define two distinct entitytwo signal transduction
tradd entityone entitytwo otherprotein interactions
otherprotein entityone otherprotein entitytwo interactions define
otherprotein entityone otherprotein otherprotein interactions define two distinct entitytwo signal transduction
tradd otherprotein entityone entitytwo interactions define
tradd otherprotein entityone otherprotein interactions define two distinct entitytwo signal transduction
otherprotein otherprotein entityone interactions define two distinct entitytwo signal transduction
apoptosis activate entityone signaling cascades emanating entitytwo otherprotein
apoptosis activate entityone signaling cascades emanating otherprotein entitytwo
cascades emanating entityone entitytwo
entityone a entitytwo associated signal
show entityone directly interacts otherprotein entitytwo otherprotein
show entityone directly interacts otherprotein otherprotein entitytwo signal transducers
show entityone directly interacts otherprotein otherprotein otherprotein signal transducers activate entitytwo induce
interacts otherprotein entityone entitytwo signal transducers
interacts otherprotein entityone otherprotein signal transducers activate entitytwo induce
otherprotein otherprotein entityone signal transducers activate entitytwo induce
entityone mutant lacking Nterminal ring finger domain a dominantnegative inhibitor TNFmediated entitytwo activation
conversely entityone mutant lacking Nterminal amino acids a dominantnegative inhibitor TNFinduced apoptosis does inhibit entitytwo activation
thus two entityone entitytwo signaling cascades
thus two entityone tradd signaling cascades appear bifurcate entitytwo
two otherprotein entityone signaling cascades appear bifurcate entitytwo
characterization entityone binding human entitytwo T
entityone T cell activation also known entitytwo directly
entityone T cell activation also known otherprotein directly associated otherprotein entitytwo otherprotein
entityone T cell activation also known otherprotein directly associated otherprotein otherprotein entitytwo the
also known entityone directly associated otherprotein entitytwo otherprotein
also known entityone directly associated otherprotein otherprotein entitytwo the
associated otherprotein entityone entitytwo the
binding entityone entitytwo the
found entityone associated otherprotein entitytwo T
found entityone associated otherprotein otherprotein T cell lines lacking otherprotein entitytwo otherprotein
found entityone associated otherprotein otherprotein T cell lines lacking otherprotein ADA entitytwo enzymatic activity
found entityone associated otherprotein otherprotein T cell lines lacking otherprotein ADA dipeptidyl peptidase enzymatic activity indicating the association entitytwo ADA
found entityone associated otherprotein otherprotein T cell lines lacking otherprotein ADA otherprotein enzymatic activity indicating the association otherprotein entitytwo not
associated otherprotein entityone T cell lines lacking otherprotein entitytwo otherprotein
associated otherprotein entityone T cell lines lacking otherprotein otherprotein entitytwo enzymatic activity
associated otherprotein entityone T cell lines lacking otherprotein otherprotein dipeptidyl peptidase enzymatic activity indicating the association entitytwo otherprotein
associated otherprotein entityone T cell lines lacking otherprotein ADA otherprotein enzymatic activity indicating the association otherprotein entitytwo not
otherprotein entityone entitytwo enzymatic activity
otherprotein entityone dipeptidyl peptidase enzymatic activity indicating the association entitytwo ADA
otherprotein entityone otherprotein enzymatic activity indicating the association otherprotein entitytwo not
otherprotein entityone enzymatic activity indicating the association entitytwo otherprotein
ADA entityone enzymatic activity indicating the association dipeptidyl peptidase and entitytwo not
association entityone entitytwo not
demonstrated entityone entitytwo colocalized
demonstrated entityone otherprotein colocalized the cell surface not inside cells suggesting entitytwo not
demonstrated entityone ADA colocalized the cell surface not inside cells suggesting CD26 not transport entitytwo the
CD26 entityone colocalized the cell surface not inside cells suggesting entitytwo not
otherprotein entityone colocalized the cell surface not inside cells suggesting otherprotein not transport entitytwo the
cells suggesting entityone not transport entitytwo the
showed human entityone transfected murine preb cell lines lacking human entitytwo acquired ada
showed human entityone transfected murine preb cell lines lacking human ada acquired entitytwo an
lines lacking human entityone acquired entitytwo an
cell surface entityone inhibited cell proliferation entitytwo production induced
hand cells expressing entityone entitytwo the
data suggest entityone the cell surface involved an important immunoregulatory mechanism which released entitytwo binds
data suggest entityone the cell surface involved an important immunoregulatory mechanism which released ada binds cell surface entitytwo this
which released entityone binds cell surface entitytwo this
characterized human entityone a second isoform human entitytwo
alpha and entityone nearly identical their homologues mouse suggesting strong functional conservation among individual isoforms much like entitytwo human beta
alpha and entityone nearly identical their homologues mouse suggesting strong functional conservation among individual isoforms much like otherprotein human entitytwo multiple
isoforms much like entityone human entitytwo multiple
chromosomal locations entityone chromosome 16q2223 entitytwo chromosome
show like entityone beta and entitytwo interact
show like entityone beta and otherprotein interact otherprotein peptides encoding syntrophinbinding region entitytwo otherprotein otherprotein
show like entityone beta and otherprotein interact otherprotein peptides encoding syntrophinbinding region otherprotein entitytwo otherprotein related
show like entityone beta and otherprotein interact otherprotein peptides encoding syntrophinbinding region dystrophin otherprotein entitytwo related protein
show like entityone beta otherprotein interact otherprotein peptides encoding syntrophinbinding region otherprotein otherprotein entitytwo and the
show like entityone beta otherprotein interact otherprotein peptides encoding syntrophinbinding region otherprotein otherprotein otherprotein related protein and the entitytwo
beta and entityone interact otherprotein peptides encoding syntrophinbinding region entitytwo otherprotein otherprotein
beta and entityone interact otherprotein peptides encoding syntrophinbinding region otherprotein entitytwo otherprotein related
beta and entityone interact otherprotein peptides encoding syntrophinbinding region dystrophin otherprotein entitytwo related protein
beta entityone interact otherprotein peptides encoding syntrophinbinding region otherprotein otherprotein entitytwo and the
beta entityone interact otherprotein peptides encoding syntrophinbinding region otherprotein otherprotein otherprotein related protein and the entitytwo
syntrophinbinding region entityone entitytwo otherprotein
syntrophinbinding region entityone otherprotein entitytwo related protein
syntrophinbinding region entityone otherprotein entitytwo the
syntrophinbinding region entityone otherprotein otherprotein the entitytwo
region dystrophin entityone entitytwo related protein
region otherprotein entityone entitytwo the
region otherprotein entityone otherprotein related protein the entitytwo
dystrophin otherprotein entityone entitytwo the
dystrophin otherprotein entityone related protein the entitytwo
otherprotein otherprotein entityone the entitytwo
general transcription factor entityone nucleates initiation complex formation direct core promoter binding commits promoters otherprotein chromatin transcription mediates action transcriptional activators phenomenon may correlate otherprotein enhanced entitytwo recruitment
general transcription factor entityone nucleates initiation complex formation direct core promoter binding commits promoters otherprotein chromatin transcription mediates action transcriptional activators phenomenon may correlate otherprotein enhanced tfiid recruitment conformational changes entitytwo promoter complexes
otherprotein enhanced entityone recruitment conformational changes entitytwo promoter complexes
the multiprotein entityone complex identified primary entitytwo otherprotein otherprotein
the multiprotein entityone complex identified primary otherprotein entitytwo tbpassociated factors
identified primary entityone entitytwo tbpassociated factors
the human entityone subunits entitytwo otherprotein
the human entityone subunits otherprotein entitytwo h
the human entityone subunits otherprotein h otherprotein and entitytwo
human otherprotein subunits entityone entitytwo h
human otherprotein subunits entityone otherprotein and entitytwo
otherprotein entityone entitytwo
analyses native entityone complexes accompanying crystallographic studies results suggest there a histone octamerlike otherprotein complex otherprotein entitytwo
entityone kinase associated otherprotein entitytwo
biological activities entityone entitytwo mediated
biological activities entityone otherprotein mediated its type receptor entitytwo
activities otherprotein entityone mediated its type receptor entitytwo
ligand binds entityone initiates signaling cascade results the activation the transcription regulator entitytwo otherprotein
ligand binds entityone initiates signaling cascade results the activation the transcription regulator otherprotein entitytwo
transcription regulator entityone entitytwo
protein kinase designated entityone entitytwo receptorassociated kinase
protein kinase designated entityone entitytwo purified
designated otherprotein entityone entitytwo purified
line overexpressing entityone HeLa cells exposed entitytwo otherprotein
line overexpressing entityone HeLa cells exposed otherprotein entitytwo rapidly associated
line overexpressing entityone HeLa cells exposed otherprotein otherprotein rapidly associated otherprotein entitytwo complex
exposed entityone entitytwo rapidly associated
exposed entityone otherprotein rapidly associated otherprotein entitytwo complex
exposed otherprotein entityone rapidly associated otherprotein entitytwo complex
acid sequence entityone shares similarity otherprotein pellea protein kinase is essential the activation of a entitytwo homolog
3'5'monophosphatedependent protein kinase entityone entitytwo otherprotein
3'5'monophosphatedependent protein kinase entityone otherprotein entitytwo otherprotein
3'5'monophosphatedependent protein kinase entityone otherprotein otherprotein entitytwo ar
3'5'monophosphatedependent protein kinase entityone otherprotein otherprotein otherprotein ar otherprotein exed an entitytwo otherprotein
3'5'monophosphatedependent protein kinase entityone otherprotein otherprotein otherprotein ar otherprotein exed an otherprotein entitytwo
kinase otherprotein entityone entitytwo otherprotein
kinase otherprotein entityone otherprotein entitytwo ar
kinase otherprotein entityone otherprotein otherprotein ar otherprotein exed an entitytwo otherprotein
kinase otherprotein entityone otherprotein otherprotein ar otherprotein exed an otherprotein entitytwo
otherprotein entityone entitytwo ar
otherprotein entityone otherprotein ar otherprotein exed an entitytwo otherprotein
otherprotein entityone otherprotein ar otherprotein exed an otherprotein entitytwo
otherprotein otherprotein entityone ar otherprotein exed an entitytwo otherprotein
otherprotein otherprotein entityone ar otherprotein exed an otherprotein entitytwo
exed an entityone entitytwo
third enzyme entityone entitytwo binds otherprotein
third enzyme entityone otherprotein binds entitytwo a
third enzyme entityone otherprotein binds otherprotein a site distinct those bound entitytwo otherprotein
third enzyme entityone otherprotein binds otherprotein a site distinct those bound otherprotein entitytwo
third enzyme otherprotein entityone binds entitytwo a
third enzyme otherprotein entityone binds otherprotein a site distinct those bound entitytwo otherprotein
third enzyme otherprotein entityone binds otherprotein a site distinct those bound otherprotein entitytwo
otherprotein otherprotein binds entityone a site distinct those bound entitytwo otherprotein
otherprotein otherprotein binds entityone a site distinct those bound otherprotein entitytwo
bound entityone entitytwo
subcellular distributions entityone entitytwo similar
protein kinase entityone the entitytwo signaling complex
death domain entityone entitytwo triggers distinct
death domain entityone otherprotein triggers distinct signaling pathways leading apoptosis entitytwo activation
death domain entityone otherprotein triggers distinct signaling pathways leading apoptosis otherprotein activation its interaction otherprotein death domain protein entitytwo
domain otherprotein entityone triggers distinct signaling pathways leading apoptosis entitytwo activation
domain otherprotein entityone triggers distinct signaling pathways leading apoptosis otherprotein activation its interaction otherprotein death domain protein entitytwo
apoptosis entityone activation its interaction otherprotein death domain protein entitytwo
show entityone interacts strongly otherprotein entitytwo another death
show entityone interacts strongly otherprotein otherprotein another death domain protein was shown previously associate otherprotein entitytwo antigen
strongly otherprotein entityone another death domain protein was shown previously associate otherprotein entitytwo antigen
also show entityone a serinethreonine kinase is recruited entitytwo otherprotein
also show entityone a serinethreonine kinase is recruited otherprotein entitytwo a
recruited entityone entitytwo a
the intact entityone protein induces entitytwo activation
death domain entityone induces apoptosis potently inhibits entitytwo activation
distinct domains entityone participate the tnf signaling cascades leading apoptosis entitytwo activation
carboxyterminal region entityone previously shown interact directly otherprotein entitytwo cytoplasmic
carboxyterminal region entityone previously shown interact directly otherprotein otherprotein cytoplasmic component the entitytwo glycoprotein complex
directly otherprotein entityone cytoplasmic component the entitytwo glycoprotein complex
determinants binding entityone entitytwo receptors generation
determinants binding entityone otherprotein receptors generation receptorselective entitytwo variants
binding otherprotein entityone receptors generation receptorselective entitytwo variants
entityone entitytwo expression
entityone mediates endothelial cell proliferation angiogenesis vascular growth vascular permeability via endothelial cell receptors entitytwo otherprotein otherprotein
entityone mediates endothelial cell proliferation angiogenesis vascular growth vascular permeability via endothelial cell receptors otherprotein entitytwo otherprotein otherprotein
entityone mediates endothelial cell proliferation angiogenesis vascular growth vascular permeability via endothelial cell receptors otherprotein otherprotein entitytwo otherprotein
entityone mediates endothelial cell proliferation angiogenesis vascular growth vascular permeability via endothelial cell receptors otherprotein otherprotein otherprotein entitytwo otherprotein
entityone mediates endothelial cell proliferation angiogenesis vascular growth vascular permeability via endothelial cell receptors otherprotein otherprotein otherprotein otherprotein entitytwo
endothelial cell receptors entityone entitytwo otherprotein otherprotein
endothelial cell receptors entityone otherprotein entitytwo otherprotein
endothelial cell receptors entityone otherprotein otherprotein entitytwo otherprotein
endothelial cell receptors entityone otherprotein otherprotein otherprotein entitytwo
cell receptors otherprotein entityone entitytwo otherprotein
cell receptors otherprotein entityone otherprotein entitytwo otherprotein
cell receptors otherprotein entityone otherprotein otherprotein entitytwo
receptors otherprotein otherprotein entityone entitytwo otherprotein
receptors otherprotein otherprotein entityone otherprotein entitytwo
otherprotein otherprotein otherprotein entityone entitytwo
charged surface entityone mediates binding entitytwo otherprotein
charged surface entityone mediates binding otherprotein entitytwo
mediates binding entityone entitytwo
critical binding entityone entitytwo negatively
critical binding entityone otherprotein negatively charged residues asp63 glu64 Glu67 associated otherprotein entitytwo binding
binding otherprotein entityone negatively charged residues asp63 glu64 Glu67 associated otherprotein entitytwo binding
entityone model based entitytwo indicated
otherprotein the entityone site minimal effect entitytwo binding
otherprotein the entityone site minimal effect FLT1 binding mutants deficient entitytwo binding
otherprotein the entityone site minimal effect otherprotein binding mutants deficient otherprotein binding not affect entitytwo binding
minimal effect entityone binding mutants deficient entitytwo binding
minimal effect entityone binding mutants deficient FLT1 binding not affect entitytwo binding
mutants deficient entityone binding not affect entitytwo binding
mutants lacking entityone affinity however entitytwo deficient mutants
mutational analysis implicates entityone not entitytwo otherprotein
mutational analysis implicates entityone not otherprotein entitytwo induction
otherprotein not entityone entitytwo induction
the proteintyrosinephosphatase entityone otherprotein another sh2containing protein entitytwo
entityone associates otherprotein entitytwo otherprotein receptor
entityone associates otherprotein otherprotein entitytwo receptor
entityone associates otherprotein entitytwo ligand
entityone associates otherprotein otherprotein otherprotein receptor ligand stimulation binding entitytwo this
entityone associates otherprotein otherprotein otherprotein receptor ligand stimulation binding SHPTP2 this receptor promotes tyrosine phosphorylation entitytwo
otherprotein entityone entitytwo receptor
otherprotein entityone entitytwo ligand
otherprotein entityone otherprotein receptor ligand stimulation binding entitytwo this
otherprotein entityone otherprotein receptor ligand stimulation binding SHPTP2 this receptor promotes tyrosine phosphorylation entitytwo
otherprotein otherprotein entityone entitytwo ligand
otherprotein otherprotein entityone receptor ligand stimulation binding entitytwo this
otherprotein otherprotein entityone receptor ligand stimulation binding SHPTP2 this receptor promotes tyrosine phosphorylation entitytwo
otherprotein entityone ligand stimulation binding entitytwo this
otherprotein entityone ligand stimulation binding SHPTP2 this receptor promotes tyrosine phosphorylation entitytwo
binding entityone this receptor promotes tyrosine phosphorylation entitytwo
using entityone bait supplying exogenous tyrosine kinase gene the yeast cells have found entitytwo interacts
using entityone bait supplying exogenous tyrosine kinase gene the yeast cells have found SHPTP2 interacts otherprotein another signaling protein entitytwo
found entityone interacts otherprotein another signaling protein entitytwo
carboxyl end entityone to SH2 domain the carboxyterminus entitytwo
demonstrate entityone binds entitytwo vitro
the human entityone entitytwo physically interacted
the human entityone otherprotein physically interacted otherprotein entitytwo via
human otherprotein entityone physically interacted otherprotein entitytwo via
interaction binding entityone its hormone response elements otherprotein as homodimer as heterodimer otherprotein entitytwo inhibited
interaction binding entityone its hormone response elements otherprotein as homodimer as heterodimer otherprotein otherprotein inhibited entitytwo a
otherprotein entityone inhibited entitytwo a
transfected cells wildtype entityone repressed hormonedependent transcriptional activation entitytwo
otherprotein mutant entityone otherprotein had effect activated transcriptional activity entitytwo depending
enhanced degradation entityone receptors a sorting entitytwo otherprotein
enhanced degradation entityone receptors a sorting otherprotein entitytwo
a sorting entityone entitytwo
protein entityone entitytwo identified
protein entityone otherprotein identified a human cell line bound a region the entitytwo otherprotein containing
protein entityone otherprotein identified a human cell line bound a region otherprotein entitytwo containing the
sorting otherprotein entityone identified a human cell line bound a region the entitytwo otherprotein containing
sorting otherprotein entityone identified a human cell line bound a region otherprotein entitytwo containing the
region entityone entitytwo containing the
entityone contains region homology a yeast vacuolar sorting protein overexpression entitytwo decreased
entityone contains region homology a yeast vacuolar sorting protein overexpression SNX1 decreased amount entitytwo the
overexpression entityone decreased amount entitytwo the
thus entityone likely play role sorting entitytwo lysosomes
35 entityone entitytwo
entityone binds specifically 3' splice sites previous studies failed demonstrate function entitytwo
extracts deficient entityone inactive; however constitutive enhancerdependent splicing could restored the addition purified recombinant entitytwo
enhancer revealed entityone directly mediates interactions entitytwo proteins
thus entityone functions a bridge entitytwo the
thus entityone functions a bridge U2AF65 the enhancer complex recruit entitytwo the
bridge entityone the enhancer complex recruit entitytwo the
excision repair complex entityone nucleotide excision repair protein entitytwo Cockayne
excision repair complex entityone nucleotide excision repair protein otherprotein Cockayne syndrome group entitytwo protein
excision repair complex entityone nucleotide excision repair protein otherprotein entitytwo
excision repair protein entityone Cockayne syndrome group entitytwo protein
excision repair protein entityone entitytwo
syndrome group entityone entitytwo
subunits entityone entitytwo otherprotein
subunits entityone otherprotein entitytwo proteins
subunits otherprotein entityone entitytwo proteins
the cloned entityone entitytwo otherprotein otherprotein
the cloned entityone otherprotein entitytwo otherprotein
the cloned entityone otherprotein otherprotein entitytwo otherprotein
the cloned entityone otherprotein otherprotein otherprotein entitytwo genes
the cloned entityone otherprotein otherprotein otherprotein otherprotein genes encode polypeptide subunits of entitytwo examine
cloned otherprotein entityone entitytwo otherprotein
cloned otherprotein entityone otherprotein entitytwo otherprotein
cloned otherprotein entityone otherprotein otherprotein entitytwo genes
cloned otherprotein entityone otherprotein otherprotein otherprotein genes encode polypeptide subunits of entitytwo examine
cloned otherprotein otherprotein entityone entitytwo otherprotein
cloned otherprotein otherprotein entityone otherprotein entitytwo genes
cloned otherprotein otherprotein entityone otherprotein otherprotein genes encode polypeptide subunits of entitytwo examine
otherprotein otherprotein otherprotein entityone entitytwo genes
otherprotein otherprotein otherprotein entityone otherprotein genes encode polypeptide subunits of entitytwo examine
otherprotein otherprotein entityone genes encode polypeptide subunits of entitytwo examine
examined interactions entityone components human ner protein entitytwo the
examined interactions entityone components human ner protein otherprotein the entitytwo protein
human ner protein entityone the entitytwo protein
demonstrate the entityone entitytwo otherprotein
demonstrate the entityone otherprotein entitytwo otherprotein
demonstrate the entityone otherprotein otherprotein entitytwo proteins interact
the otherprotein entityone entitytwo otherprotein
the otherprotein entityone otherprotein entitytwo proteins interact
otherprotein otherprotein entityone entitytwo proteins interact
entityone protein interacts otherprotein multiple subunits entitytwo w
entityone protein interacts otherprotein multiple subunits otherprotein w otherprotein entitytwo protein
multiple subunits entityone w otherprotein entitytwo protein
residues human entityone entitytwo crucial
residues human entityone otherprotein crucial binding both human entitytwo and
residues human entityone otherprotein crucial binding both human otherprotein and entitytwo identified
residues human entityone hlif crucial binding both human otherprotein and otherprotein identified analysis alanine scanning mutants entitytwo assays
human otherprotein entityone crucial binding both human entitytwo and
human otherprotein entityone crucial binding both human otherprotein and entitytwo identified
human otherprotein entityone crucial binding both human otherprotein and otherprotein identified analysis alanine scanning mutants entitytwo assays
the human entityone and entitytwo identified
the human entityone and otherprotein identified analysis alanine scanning mutants entitytwo assays
otherprotein and entityone identified analysis alanine scanning mutants entitytwo assays
region entityone important binding the entitytwo composed
two residues entityone contribute majority free energy entitytwo binding phe156
second region entityone includes residues the carboxyl terminus the dhelix AB loop also a weak influence entitytwo binding
residues entityone both A Chelices involved binding entitytwo coreceptor
abolition the entityone binding site entitytwo created antagonists
abolition the entityone binding site otherprotein created antagonists entitytwo action
binding site entityone created antagonists entitytwo action
entityone glucose transporter interacts otherprotein entitytwo otherprotein
entityone glucose transporter interacts otherprotein cal otherprotein entitytwo
interacts otherprotein entityone entitytwo
integral membrane glycoprotein entityone entitytwo synthesized
observed entityone entitytwo
product consisting entityone a protein approximately kDa designated entitytwo cal otherprotein
product consisting entityone a protein approximately kDa designated otherprotein entitytwo 60
kDa designated entityone entitytwo 60
the entityone entitytwo the
the entityone cal otherprotein the entitytwo otherprotein interactions
the entityone cal otherprotein the gt155 entitytwo interactions
the entityone cal otherprotein the gt155 otherprotein interactions dependent the presence correctly modified oligosaccharide group entitytwo a characteristic
the entityone cal otherprotein the gt155 otherprotein interactions dependent the presence correctly modified oligosaccharide group GT155 a characteristic many entitytwo interactions
the gt155 entityone the entitytwo otherprotein interactions
the otherprotein entityone the otherprotein entitytwo interactions
the gt155 entityone the gt155 otherprotein interactions dependent the presence correctly modified oligosaccharide group entitytwo a characteristic
the otherprotein entityone the otherprotein otherprotein interactions dependent the presence correctly modified oligosaccharide group otherprotein a characteristic many entitytwo interactions
otherprotein the entityone entitytwo interactions
otherprotein the entityone otherprotein interactions dependent the presence correctly modified oligosaccharide group entitytwo a characteristic
otherprotein the entityone otherprotein interactions dependent the presence correctly modified oligosaccharide group GT155 a characteristic many entitytwo interactions
the gt155 entityone interactions dependent the presence correctly modified oligosaccharide group entitytwo a characteristic
the otherprotein entityone interactions dependent the presence correctly modified oligosaccharide group otherprotein a characteristic many entitytwo interactions
oligosaccharide group entityone characteristic many entitytwo interactions
entityone mutant was glycosylated aggt155 not associate otherprotein entitytwo otherprotein
entityone mutant was glycosylated aggt155 not associate otherprotein cal otherprotein entitytwo
associate otherprotein entityone entitytwo
entityone soluble homologue entitytwo also
entityone soluble homologue cal otherprotein also shown interact otherprotein entitytwo when
soluble homologue entityone also shown interact otherprotein entitytwo when
show both entityone entitytwo interact
show both entityone otherprotein interact otherprotein entitytwo a
cal otherprotein entityone interact otherprotein entitytwo a
the human entityone entitytwo evidence
entityone entitytwo otherprotein
entityone receptor entitytwo a
entityone entitytwo a
domain the entityone search amino acid residues involved entitytwo otherprotein binding
domain the entityone search amino acid residues involved otherprotein entitytwo binding
residues involved entityone entitytwo binding
bacteria soluble entityone binding proteins entitytwo characterized
bacteria soluble entityone binding proteins otherprotein characterized entitytwo binding activity
epo binding proteins entityone characterized entitytwo binding activity
tic reduction entityone binding the entitytwo
mutation fulllength entityone expressed COS cells abolished detectable entitytwo binding
a critical entityone binding determinant the entitytwo
a specific entityone binding protein structurally related the entitytwo receptor alpha
a specific entityone binding protein structurally related the entitytwo alpha chain
related the entityone entitytwo alpha chain
entityone entitytwo a
entityone otherprotein is cytokine secreted activated lymphocytes shares many not biological activities otherprotein entitytwo
otherprotein entityone a cytokine secreted activated lymphocytes shares many not biological activities otherprotein entitytwo
constituents the entityone receptor approximately 140kda glycoprotein entitytwo the
constituents the entityone receptor approximately 140kda glycoprotein otherprotein the gamma chain gammac the entitytwo receptor
constituents the entityone receptor approximately 140kda glycoprotein otherprotein the gamma chain gammac the entitytwo ne
constituents the entityone receptor approximately 140kda glycoprotein otherprotein the gamma chain gammac the otherprotein receptor ne otherprotein of proteins binds entitytwo
approximately 140kda glycoprotein entityone the gamma chain gammac the entitytwo receptor
approximately 140kda glycoprotein entityone the gamma chain gammac the entitytwo ne
approximately 140kda glycoprotein entityone the gamma chain gammac the otherprotein receptor ne otherprotein of proteins binds entitytwo
gammac the entityone entitytwo ne
gammac the entityone receptor ne otherprotein of proteins binds entitytwo
gammac the entityone ne otherprotein of proteins binds entitytwo
cdna encoding entityone binding protein entitytwo the
entityone shows homology otherprotein entitytwo receptor
otherprotein entityone cdna bind entitytwo otherprotein
otherprotein entityone cdna bind otherprotein w otherprotein high affinity do bind entitytwo
cDNA bind entityone otherprotein high affinity do bind entitytwo
otherprotein cloned entityone cdna entitytwo cdna resulted
otherprotein cloned entityone cdna otherprotein cdna resulted the reconstitution a small number receptors recognized entitytwo otherprotein
otherprotein cloned entityone cdna otherprotein cDNA resulted the reconstitution a small number receptors recognized otherprotein entitytwo
cdna entityone cDNA resulted the reconstitution a small number receptors recognized entitytwo otherprotein
cdna entityone cDNA resulted the reconstitution a small number receptors recognized otherprotein entitytwo
recognized entityone entitytwo
phagocyte entityone a complex membrane entitytwo comprised
phagocyte entityone a complex membrane otherprotein comprised subunits entitytwo otherprotein
phagocyte entityone a complex membrane otherprotein comprised subunits otherprotein phox entitytwo three
phagocyte entityone a complex membrane otherprotein comprised subunits otherprotein phox otherprotein three cytosol proteins entitytwo otherprotein
phagocyte entityone a complex membrane otherprotein comprised subunits otherprotein phox otherprotein three cytosol proteins otherprotein entitytwo otherprotein
phagocyte entityone a complex membrane otherprotein comprised subunits otherprotein phox otherprotein three cytosol proteins otherprotein otherprotein entitytwo translocate
phagocyte entityone a complex membrane cytochrome b558 comprised subunits otherprotein phox otherprotein three cytosol proteins otherprotein otherprotein otherprotein rac translocate membrane bind entitytwo
complex membrane entityone comprised subunits entitytwo otherprotein
complex membrane entityone comprised subunits otherprotein phox entitytwo three
complex membrane entityone comprised subunits otherprotein phox otherprotein three cytosol proteins entitytwo otherprotein
complex membrane entityone comprised subunits otherprotein phox otherprotein three cytosol proteins otherprotein entitytwo otherprotein
complex membrane entityone comprised subunits otherprotein phox otherprotein three cytosol proteins otherprotein otherprotein entitytwo translocate
complex membrane entityone comprised subunits otherprotein phox otherprotein three cytosol proteins otherprotein otherprotein otherprotein rac translocate membrane bind entitytwo
comprised subunits entityone entitytwo three
comprised subunits entityone otherprotein three cytosol proteins entitytwo otherprotein
comprised subunits entityone otherprotein three cytosol proteins otherprotein entitytwo otherprotein
comprised subunits entityone otherprotein three cytosol proteins otherprotein otherprotein entitytwo translocate
comprised subunits entityone otherprotein three cytosol proteins otherprotein otherprotein otherprotein rac translocate membrane bind entitytwo
otherprotein phox entityone three cytosol proteins entitytwo otherprotein
otherprotein phox entityone three cytosol proteins otherprotein entitytwo otherprotein
otherprotein phox entityone three cytosol proteins otherprotein otherprotein entitytwo translocate
otherprotein phox entityone three cytosol proteins otherprotein otherprotein otherprotein rac translocate membrane bind entitytwo
three cytosol proteins entityone entitytwo otherprotein
three cytosol proteins entityone otherprotein entitytwo translocate
three cytosol proteins entityone otherprotein otherprotein rac translocate membrane bind entitytwo
cytosol proteins otherprotein entityone entitytwo translocate
cytosol proteins otherprotein entityone otherprotein rac translocate membrane bind entitytwo
otherprotein otherprotein entityone translocate membrane bind entitytwo
cytosolic components entityone entitytwo binding
cytosolic components entityone otherprotein binding entitytwo other
components otherprotein entityone binding entitytwo other
structure the entityone cyclindependentkinase inhibitor bound the entitytwo otherprotein complex
structure the entityone cyclindependentkinase inhibitor bound the otherprotein entitytwo complex
bound the entityone entitytwo complex
the human entityone inhibitory domain bound the phosphorylated entitytwo otherprotein otherprotein
the human entityone inhibitory domain bound the phosphorylated otherprotein entitytwo otherprotein complex
the human entityone inhibitory domain bound the phosphorylated otherprotein otherprotein entitytwo complex
the phosphorylated entityone entitytwo otherprotein complex
the phosphorylated entityone otherprotein entitytwo complex
phosphorylated otherprotein entityone entitytwo complex
entityone binds otherprotein as extended structure interacting otherprotein entitytwo otherprotein
entityone binds otherprotein as extended structure interacting otherprotein otherprotein entitytwo
otherprotein entityone entitytwo
entityone entitytwo ligand
entityone related protein ligand specific activator the tyrosine kinase receptor entitytwo
entityone ligand specific activator the tyrosine kinase receptor entitytwo
tyrosine kinases entityone entitytwo otherprotein
tyrosine kinases entityone otherprotein entitytwo otherprotein
tyrosine kinases entityone otherprotein otherprotein entitytwo constitute
tyrosine kinases otherprotein entityone entitytwo otherprotein
tyrosine kinases otherprotein entityone otherprotein entitytwo constitute
otherprotein otherprotein entityone entitytwo constitute
entityone entitytwo been
entityone otherprotein been shown play key roles vascular development two receptors bind are activated entitytwo otherprotein
entityone otherprotein been shown play key roles vascular development two receptors bind are activated vascular otherprotein entitytwo
otherprotein entityone been shown play key roles vascular development two receptors bind are activated entitytwo otherprotein
otherprotein entityone been shown play key roles vascular development two receptors bind are activated vascular otherprotein entitytwo
activated entityone entitytwo
protein designated entityone entitytwo otherprotein specifically
protein designated entityone related protein entitytwo specifically binds
protein designated entityone related protein otherprotein specifically binds extracellular domain entitytwo stimulates the
protein designated entityone related protein otherprotein specifically binds extracellular domain Flt4 stimulates the tyrosine phosphorylation entitytwo expressed
protein designated entityone entitytwo specifically binds
protein designated entityone otherprotein specifically binds extracellular domain entitytwo stimulates the
protein designated entityone otherprotein specifically binds extracellular domain Flt4 stimulates the tyrosine phosphorylation entitytwo expressed
otherprotein related protein entityone specifically binds extracellular domain entitytwo stimulates the
otherprotein related protein entityone specifically binds extracellular domain Flt4 stimulates the tyrosine phosphorylation entitytwo expressed
extracellular domain entityone stimulates tyrosine phosphorylation entitytwo expressed
entityone fails bind appreciably the extracellular domain entitytwo otherprotein
entityone fails bind appreciably the extracellular domain otherprotein entitytwo
extracellular domain entityone entitytwo
fibril formation entityone entitytwo typical
linking entityone fragment a entitytwo dnabinding domain
linking entityone fragment a otherprotein dnabinding domain bait also a entitytwo transactivation domain
fragment a entityone dnabinding domain bait also a entitytwo transactivation domain
saccharomyces cerevisiae harboring entityone entitytwo otherprotein
saccharomyces cerevisiae harboring entityone otherprotein entitytwo otherprotein genes
saccharomyces cerevisiae harboring entityone otherprotein otherprotein entitytwo genes
cerevisiae harboring otherprotein entityone entitytwo otherprotein genes
cerevisiae harboring otherprotein entityone otherprotein entitytwo genes
otherprotein otherprotein entityone entitytwo genes
entityone protein fused the drosophila protein entitytwo lexabicoid failed
entityone protein fused the drosophila protein otherprotein entitytwo otherprotein failed
entityone protein fused the drosophila protein bicoid lexa entitytwo failed
entityone protein fused drosophila protein otherprotein lexa otherprotein failed interact otherprotein the entitytwo fragment fused
entityone protein fused drosophila protein otherprotein lexa otherprotein failed interact otherprotein the otherprotein fragment fused entitytwo indicating
entityone protein fused drosophila protein otherprotein lexa otherprotein failed interact otherprotein the otherprotein fragment fused abeta indicating the observed entitytwo Abeta interaction
entityone protein fused drosophila protein otherprotein lexa otherprotein failed interact otherprotein the otherprotein fragment fused abeta indicating the observed Abeta entitytwo interaction
Drosophila protein entityone entitytwo bicoid failed
Drosophila protein entityone otherprotein entitytwo failed
Drosophila protein entityone otherprotein bicoid failed interact otherprotein entitytwo fragment fused
Drosophila protein entityone otherprotein bicoid failed interact otherprotein otherprotein fragment fused entitytwo indicating
Drosophila protein entityone otherprotein bicoid failed interact otherprotein otherprotein fragment fused abeta indicating the observed entitytwo Abeta interaction
Drosophila protein entityone otherprotein bicoid failed interact otherprotein otherprotein fragment fused abeta indicating the observed Abeta entitytwo interaction
drosophila protein bicoid entityone entitytwo failed
drosophila protein otherprotein entityone otherprotein failed interact otherprotein entitytwo fragment fused
drosophila protein otherprotein entityone otherprotein failed interact otherprotein otherprotein fragment fused entitytwo indicating
drosophila protein otherprotein entityone otherprotein failed interact otherprotein otherprotein fragment fused abeta indicating the observed entitytwo Abeta interaction
drosophila protein otherprotein entityone otherprotein failed interact otherprotein otherprotein fragment fused abeta indicating the observed Abeta entitytwo interaction
protein bicoid otherprotein entityone failed interact otherprotein entitytwo fragment fused
protein bicoid otherprotein entityone failed interact otherprotein otherprotein fragment fused entitytwo indicating
protein bicoid otherprotein entityone failed interact otherprotein otherprotein fragment fused abeta indicating the observed entitytwo Abeta interaction
protein bicoid otherprotein entityone failed interact otherprotein otherprotein fragment fused abeta indicating the observed Abeta entitytwo interaction
otherprotein entityone fragment fused entitytwo indicating
otherprotein entityone fragment fused abeta indicating the observed entitytwo Abeta interaction
otherprotein entityone fragment fused abeta indicating the observed Abeta entitytwo interaction
fragment fused entityone indicating the observed entitytwo abeta interaction
fragment fused entityone indicating the observed abeta entitytwo interaction
the observed entityone entitytwo interaction
yeast expressing entityone entitytwo bait
yeast expressing entityone otherprotein bait the entitytwo transactivation domain
yeast expressing entityone abeta bait the otherprotein transactivation domain fused an entitytwo fragment
yeast expressing otherprotein entityone bait the entitytwo transactivation domain
yeast expressing otherprotein entityone bait the otherprotein transactivation domain fused an entitytwo fragment
bait the entityone transactivation domain fused an entitytwo fragment
influence entityone entitytwo dimerization
influence entityone il6 dimerization formation the high affinity hexameric entitytwo receptor complex
influence entityone otherprotein dimerization formation the high affinity hexameric entitytwo complex
influence otherprotein entityone dimerization formation the high affinity hexameric entitytwo receptor complex
influence otherprotein entityone dimerization formation the high affinity hexameric entitytwo complex
high affinity hexameric entityone entitytwo complex
high affinity entityone entitytwo signaling complex
high affinity entityone il6 signaling complex consists entitytwo two
high affinity entityone il6 signaling complex consists IL6 two membraneassociated receptor components low affinity specific entitytwo receptor
high affinity entityone otherprotein signaling complex consists otherprotein two membraneassociated receptor components low affinity specific entitytwo the
high affinity entityone otherprotein signaling complex consists otherprotein two membraneassociated receptor components low affinity specific otherprotein receptor the affinity convertersignal transducing protein entitytwo
high affinity otherprotein entityone signaling complex consists entitytwo two
high affinity otherprotein entityone signaling complex consists IL6 two membraneassociated receptor components low affinity specific entitytwo receptor
high affinity otherprotein entityone signaling complex consists IL6 two membraneassociated receptor components low affinity specific entitytwo the
high affinity otherprotein entityone signaling complex consists IL6 two membraneassociated receptor components low affinity specific otherprotein the affinity convertersignal transducing protein entitytwo
complex consists entityone two membraneassociated receptor components low affinity specific entitytwo receptor
complex consists entityone two membraneassociated receptor components low affinity specific entitytwo the
complex consists entityone two membraneassociated receptor components low affinity specific otherprotein the affinity convertersignal transducing protein entitytwo
affinity specific entityone entitytwo the
affinity specific entityone receptor the affinity convertersignal transducing protein entitytwo
affinity specific entityone the affinity convertersignal transducing protein entitytwo
monomeric entityone dimeric entitytwo forms
monomeric entityone dimeric otherprotein forms Escherichia coliderived human entitytwo the
monomeric entityone dimeric otherprotein forms Escherichia coliderived human il6 the extracellular "soluble" portions the entitytwo receptor
monomeric entityone dimeric otherprotein forms Escherichia coliderived human otherprotein the extracellular "soluble" portions the entitytwo otherprotein
monomeric entityone dimeric otherprotein forms Escherichia coliderived human otherprotein the extracellular "soluble" portions the otherprotein receptor entitytwo otherprotein
monomeric entityone dimeric otherprotein forms Escherichia coliderived human otherprotein the extracellular "soluble" portions the otherprotein receptor otherprotein and entitytwo been
monomeric entityone dimeric otherprotein forms Escherichia coliderived human il6 extracellular "soluble" portions the otherprotein otherprotein otherprotein been purified order investigate the effect entitytwo dimerization
otherprotein dimeric entityone forms Escherichia coliderived human entitytwo the
otherprotein dimeric entityone forms Escherichia coliderived human il6 the extracellular "soluble" portions the entitytwo receptor
dimeric entityone forms Escherichia coliderived human otherprotein and the extracellular "soluble" portions the entitytwo otherprotein
dimeric entityone forms Escherichia coliderived human otherprotein the extracellular "soluble" portions the otherprotein receptor entitytwo and otherprotein
dimeric entityone forms Escherichia coliderived human otherprotein and the extracellular "soluble" portions the otherprotein receptor otherprotein and entitytwo been
otherprotein dimeric entityone forms Escherichia coliderived human il6 extracellular "soluble" portions the otherprotein otherprotein otherprotein been purified order investigate the effect entitytwo dimerization
escherichia coliderived human entityone the extracellular "soluble" portions the entitytwo receptor
escherichia coliderived human entityone the extracellular "soluble" portions the entitytwo otherprotein
escherichia coliderived human entityone the extracellular "soluble" portions the otherprotein entitytwo otherprotein
escherichia coliderived human entityone the extracellular "soluble" portions the otherprotein otherprotein entitytwo been
escherichia coliderived human entityone extracellular "soluble" portions the otherprotein otherprotein otherprotein been purified order investigate the effect entitytwo dimerization
portions the entityone entitytwo otherprotein
portions the entityone receptor entitytwo otherprotein
portions the entityone receptor otherprotein entitytwo been
portions entityone receptor otherprotein otherprotein been purified order investigate the effect entitytwo dimerization
portions the entityone entitytwo otherprotein
portions the entityone otherprotein and entitytwo been
portions entityone otherprotein otherprotein been purified order investigate the effect entitytwo dimerization
otherprotein receptor entityone entitytwo been
otherprotein entityone otherprotein been purified order investigate the effect entitytwo dimerization
otherprotein entityone been purified order investigate effect entitytwo dimerization
although entityone a higher binding affinity immobilized entitytwo determined
although entityone a higher binding affinity immobilized otherprotein as determined biosensor analysis employing surface plasmon resonance detection entitytwo more
although entityone a higher binding affinity immobilized otherprotein as determined biosensor analysis employing surface plasmon resonance detection otherprotein is potent entitytwo a
affinity immobilized entityone determined biosensor analysis employing surface plasmon resonance detection entitytwo more
affinity immobilized entityone determined biosensor analysis employing surface plasmon resonance detection otherprotein is potent entitytwo a
plasmon resonance detection entityone more potent entitytwo a
binding affinity entityone appears be due its ability crosslink two entitytwo molecules
studies the entityone ternary complex formation demonstrated the reduced biological potency entitytwo resulted
studies the entityone ternary complex formation demonstrated the reduced biological potency IL6D resulted a decreased ability the entitytwo otherprotein
studies the entityone ternary complex formation demonstrated the reduced biological potency otherprotein resulted a decreased ability the otherprotein entitytwo complex
studies entityone ternary complex formation demonstrated the reduced biological potency otherprotein resulted a decreased ability the otherprotein otherprotein complex couple otherprotein the soluble portion entitytwo
biological potency entityone resulted a decreased ability the entitytwo otherprotein
biological potency entityone resulted a decreased ability the otherprotein entitytwo complex
biological potency entityone resulted a decreased ability otherprotein s otherprotein complex couple otherprotein the soluble portion entitytwo
ability the entityone entitytwo complex
ability entityone otherprotein complex couple otherprotein the soluble portion entitytwo
otherprotein entityone complex couple otherprotein soluble portion entitytwo
data imply entityone induced dimerization entitytwo not
data imply entityone induced dimerization s otherprotein not driving force promoting formation the hexameric entitytwo otherprotein otherprotein
data imply entityone induced dimerization otherprotein not driving force promoting formation the hexameric il6 entitytwo otherprotein
data imply entityone induced dimerization s otherprotein not driving force promoting formation the hexameric il6 otherprotein entitytwo complex
il6induced dimerization entityone not driving force promoting formation the hexameric entitytwo otherprotein otherprotein
induced dimerization entityone not driving force promoting formation the hexameric otherprotein entitytwo otherprotein
induced dimerization entityone not driving force promoting formation the hexameric otherprotein otherprotein entitytwo complex
the hexameric entityone entitytwo otherprotein
the hexameric entityone otherprotein entitytwo complex
hexameric otherprotein entityone entitytwo complex
trimeric complex entityone entitytwo otherprotein
trimeric complex entityone otherprotein entitytwo forms
otherprotein entityone entitytwo forms
affinity the entityone its decreased ability couple otherprotein entitytwo suggest
affinity the entityone its decreased ability couple otherprotein otherprotein suggest a stable entitytwo dimer may
affinity the entityone its decreased ability couple otherprotein otherprotein suggest a stable il6 dimer may an efficient entitytwo antagonist
couple otherprotein entityone suggest a stable entitytwo dimer may
couple otherprotein entityone suggest a stable il6 dimer may an efficient entitytwo antagonist
a stable entityone dimer may an efficient entitytwo antagonist
interaction mammalian entityone otherprotein entitytwo
entityone originally identified a start gene budding yeast has shown be required association entitytwo otherprotein
entityone a entitytwo controls
specific association entityone otherprotein molecular chaperon entitytwo a
specific association entityone otherprotein molecular chaperon otherprotein a 44kda protein we identify mammalian entitytwo
molecular chaperon entityone a 44kda protein we identify mammalian entitytwo
physical interaction entityone entitytwo suggests
physical interaction entityone otherprotein suggests entitytwo may regulate
physical interaction entityone CDK4 suggests CD otherprotein may regulate mammalian cell cycle a direct effect entitytwo
otherprotein and entityone suggests entitytwo may regulate
otherprotein and entityone suggests CD otherprotein may regulate mammalian cell cycle a direct effect entitytwo
cdk4 suggests entityone may regulate mammalian cell cycle a direct effect entitytwo
association entityone otherprotein entitytwo otherprotein
association entityone otherprotein CD otherprotein and entitytwo may also
association entityone otherprotein CD otherprotein otherprotein may also imply mechanistic link the functions entitytwo and otherprotein
association entityone otherprotein CD otherprotein and hsp90 may also imply mechanistic link the functions CD otherprotein and entitytwo
otherprotein entityone entitytwo may also
otherprotein entityone otherprotein may also imply mechanistic link the functions entitytwo otherprotein
otherprotein entityone HSP90 may also imply mechanistic link the functions CD otherprotein and entitytwo
otherprotein entityone may also imply mechanistic link the functions entitytwo and HSP90
otherprotein and entityone may also imply mechanistic link the functions CD otherprotein and entitytwo
functions entityone entitytwo
interactions entityone mediator entitytwo assembly
interactions entityone mediator otherprotein assembly otherprotein heat shock proteins entitytwo otherprotein
interactions entityone mediator otherprotein assembly otherprotein heat shock proteins otherprotein entitytwo
mediator entityone assembly otherprotein heat shock proteins entitytwo otherprotein
mediator entityone assembly otherprotein heat shock proteins otherprotein entitytwo
heat shock proteins entityone entitytwo
assembly entityone entitytwo complexes
assembly entityone complexes vitro suggested entitytwo assembly
assembly otherprotein entityone complexes vitro suggested entitytwo assembly
these proteins entityone appears transiently assembly is a component functionally mature entitytwo complexes
antibody specific entityone on one hand inhibit formation mature entitytwo complexes containing
antibody specific entityone on one hand inhibit formation mature otherprotein complexes containing entitytwo otherprotein otherprotein
antibody specific entityone on one hand inhibit formation mature otherprotein complexes containing otherprotein entitytwo otherprotein
antibody specific entityone on one hand inhibit formation mature otherprotein complexes containing otherprotein otherprotein entitytwo immunophilins
antibody specific entityone on one hand inhibit formation mature complexes containing otherprotein otherprotein otherprotein immunophilins on other enhance recovery early entitytwo complexes containing
antibody specific entityone on one hand inhibit formation mature otherprotein complexes containing otherprotein otherprotein otherprotein immunophilins on other enhance recovery early otherprotein complexes containing entitytwo otherprotein
antibody specific entityone on one hand inhibit formation mature otherprotein complexes containing otherprotein otherprotein otherprotein immunophilins on other enhance recovery early otherprotein complexes containing otherprotein entitytwo otherprotein
antibody specific entityone on one hand inhibit formation mature otherprotein complexes containing otherprotein otherprotein otherprotein immunophilins on other enhance recovery early otherprotein complexes containing otherprotein otherprotein entitytwo
formation mature entityone complexes containing entitytwo otherprotein otherprotein
formation mature entityone complexes containing otherprotein entitytwo otherprotein
formation mature entityone complexes containing otherprotein otherprotein entitytwo immunophilins
formation mature entityone complexes containing otherprotein otherprotein otherprotein immunophilins on other enhance recovery early entitytwo complexes containing
formation mature entityone complexes containing otherprotein otherprotein otherprotein immunophilins on other enhance recovery early complexes containing entitytwo otherprotein
formation mature entityone complexes containing otherprotein otherprotein otherprotein immunophilins on other enhance recovery early complexes containing otherprotein entitytwo otherprotein
formation mature entityone complexes containing otherprotein otherprotein otherprotein immunophilins on other enhance recovery early complexes containing otherprotein otherprotein entitytwo
otherprotein complexes containing entityone entitytwo otherprotein
otherprotein complexes containing entityone otherprotein entitytwo immunophilins
complexes containing entityone otherprotein otherprotein immunophilins on other enhance recovery early entitytwo complexes containing
otherprotein complexes containing entityone otherprotein otherprotein immunophilins on other enhance recovery early otherprotein complexes containing entitytwo otherprotein
otherprotein complexes containing entityone otherprotein otherprotein immunophilins on other enhance recovery early otherprotein complexes containing otherprotein entitytwo otherprotein
otherprotein complexes containing entityone otherprotein otherprotein immunophilins on other enhance recovery early otherprotein complexes containing otherprotein otherprotein entitytwo
complexes containing otherprotein entityone entitytwo immunophilins
complexes containing otherprotein entityone otherprotein immunophilins on other enhance recovery early entitytwo complexes containing
complexes containing otherprotein entityone otherprotein immunophilins on other enhance recovery early otherprotein complexes containing entitytwo otherprotein
complexes containing otherprotein entityone otherprotein immunophilins on other enhance recovery early otherprotein complexes containing otherprotein entitytwo otherprotein
complexes containing otherprotein entityone otherprotein immunophilins on other enhance recovery early otherprotein complexes containing otherprotein otherprotein entitytwo
containing otherprotein otherprotein entityone immunophilins on other enhance recovery early entitytwo complexes containing
containing otherprotein otherprotein entityone immunophilins on other enhance recovery early otherprotein complexes containing entitytwo otherprotein
containing otherprotein otherprotein entityone immunophilins on other enhance recovery early otherprotein complexes containing otherprotein entitytwo otherprotein
containing otherprotein otherprotein entityone immunophilins on other enhance recovery early otherprotein complexes containing otherprotein otherprotein entitytwo
recovery early entityone complexes containing entitytwo otherprotein
recovery early entityone complexes containing otherprotein entitytwo otherprotein
recovery early entityone complexes containing otherprotein otherprotein entitytwo
otherprotein complexes containing entityone entitytwo otherprotein
otherprotein complexes containing entityone otherprotein entitytwo
containing otherprotein entityone entitytwo
model which entityone functions an intermediate stage entitytwo assembly
model which entityone functions an intermediate stage PR assembly facilitate formation subsequent entitytwo complexes lacking
model which entityone functions an intermediate stage otherprotein assembly facilitate formation subsequent otherprotein complexes lacking entitytwo
intermediate stage entityone assembly facilitate formation subsequent entitytwo complexes lacking
intermediate stage entityone assembly facilitate formation subsequent complexes lacking entitytwo
formation subsequent entityone complexes lacking entitytwo
since entityone typically found a complex otherprotein entitytwo otherprotein
since entityone typically found a complex otherprotein otherprotein entitytwo have
complex otherprotein entityone entitytwo have
entityone bind otherprotein entitytwo otherprotein
entityone bind otherprotein otherprotein entitytwo independently
otherprotein entityone entitytwo independently
since entityone entitytwo not
since entityone otherprotein not readily associate their it appears entitytwo the
since entityone otherprotein not readily associate their it appears otherprotein the central organizing component an entitytwo otherprotein otherprotein
since entityone otherprotein not readily associate their it appears p60 the central organizing component an otherprotein entitytwo otherprotein complex
since entityone hsp70 not readily associate their it appears otherprotein the central organizing component an otherprotein otherprotein entitytwo complex
since otherprotein entityone not readily associate their it appears entitytwo the
otherprotein entityone not readily associate their it appears otherprotein the central organizing component an entitytwo otherprotein hsp70
since otherprotein entityone not readily associate their it appears p60 the central organizing component an otherprotein entitytwo hsp70 complex
since otherprotein entityone not readily associate their it appears otherprotein the central organizing component an otherprotein otherprotein entitytwo complex
appears entityone the central organizing component an entitytwo p60 otherprotein
appears entityone the central organizing component an otherprotein entitytwo otherprotein complex
appears entityone the central organizing component an otherprotein p60 entitytwo complex
component an entityone entitytwo otherprotein complex
component an entityone otherprotein entitytwo complex
an otherprotein entityone entitytwo complex
mutational analysis entityone indicates the terminus required entitytwo binding
mutational analysis entityone indicates the terminus required otherprotein binding a central region containing tetratricopeptide repeat motifs necessary binding entitytwo otherprotein
mutational analysis entityone indicates the terminus required hsp70 binding a central region containing tetratricopeptide repeat motifs necessary binding otherprotein entitytwo
required entityone binding a central region containing tetratricopeptide repeat motifs necessary binding entitytwo hsp70
required entityone binding a central region containing tetratricopeptide repeat motifs necessary binding otherprotein entitytwo
necessary binding entityone entitytwo
entityone entitytwo otherprotein multichaperon
entityone otherprotein entitytwo multichaperon otherprotein
entityone otherprotein otherprotein multichaperon otherprotein is highly dynamic does appear be affected the entitytwo binding drug
otherprotein entityone entitytwo multichaperon otherprotein
hs otherprotein entityone otherprotein multichaperon otherprotein is highly dynamic does appear be affected the entitytwo binding drug
otherprotein otherprotein entityone multichaperon otherprotein is highly dynamic does appear be affected the entitytwo binding drug
interactions entityone entitytwo intermediate
interactions entityone otherprotein intermediate entitytwo complexes
interactions entityone otherprotein intermediate complexes shown be distinct their separate interactions early entitytwo complexes hsp70
interactions entityone otherprotein intermediate otherprotein complexes shown be distinct their separate interactions early otherprotein complexes entitytwo in
interactions entityone otherprotein intermediate complexes shown be distinct their separate interactions early complexes hsp70 in mature entitytwo complexes otherprotein
otherprotein entityone intermediate entitytwo complexes
otherprotein entityone intermediate complexes shown be distinct their separate interactions early entitytwo complexes otherprotein
hsp70 entityone intermediate otherprotein complexes shown be distinct their separate interactions early otherprotein complexes entitytwo in
otherprotein entityone intermediate complexes shown be distinct their separate interactions early complexes otherprotein in mature entitytwo complexes
otherprotein intermediate entityone complexes shown be distinct their separate interactions early entitytwo complexes otherprotein
otherprotein intermediate entityone complexes shown be distinct their separate interactions early complexes entitytwo in
otherprotein intermediate entityone complexes shown be distinct their separate interactions early complexes otherprotein in mature entitytwo complexes otherprotein
interactions early entityone complexes entitytwo in
interactions early entityone complexes otherprotein in mature entitytwo complexes otherprotein
early complexes entityone in mature entitytwo complexes otherprotein
appears entityone a key mediator the chaperoned assembly functional maturation entitytwo complexes
transcription factor entityone affect ability heterodimerize otherprotein entitytwo
nonproliferating cells entityone associates otherprotein inhibits cyclincycindependent kinase cdk holoenzymes containing otherprotein entitytwo otherprotein
nonproliferating cells entityone associates otherprotein inhibits cyclincycindependent kinase cdk holoenzymes containing otherprotein otherprotein entitytwo otherprotein
nonproliferating cells entityone associates otherprotein inhibits cyclincycindependent kinase cdk holoenzymes containing otherprotein otherprotein otherprotein entitytwo
otherprotein entityone entitytwo otherprotein
otherprotein entityone otherprotein entitytwo
otherprotein otherprotein entityone entitytwo
proliferating cells contain entityone protein otherprotein the interactions entitytwo otherprotein
addition entityone associates otherprotein three different cdks entitytwo otherprotein
addition entityone associates otherprotein three different cdks otherprotein entitytwo CD
addition entityone associates otherprotein three different cdks otherprotein otherprotein entitytwo
three different cdks entityone entitytwo CD
three different cdks entityone otherprotein entitytwo
different cdks otherprotein entityone entitytwo
amount entityone significantly lower the amount entitytwo these
amount entityone entitytwo associated
amount entityone CD otherprotein associated otherprotein entitytwo not
amount entityone CD otherprotein associated otherprotein otherprotein not change a cell cycledependent fashion cont otherprotein the amount entitytwo associated
amount entityone CD otherprotein associated otherprotein p27 not change a cell cycledependent fashion cont otherprotein the amount otherprotein associated otherprotein entitytwo lowest
otherprotein entityone associated otherprotein entitytwo not
otherprotein entityone associated otherprotein otherprotein not change a cell cycledependent fashion cont otherprotein the amount entitytwo associated
otherprotein entityone associated otherprotein p27 not change a cell cycledependent fashion cont otherprotein the amount otherprotein associated otherprotein entitytwo lowest
associated otherprotein entityone not change a cell cycledependent fashion cont otherprotein the amount entitytwo associated
associated otherprotein entityone not change a cell cycledependent fashion cont otherprotein the amount otherprotein associated otherprotein entitytwo lowest
amount entityone associated otherprotein entitytwo lowest
otherprotein entityone specific antibody suggest the entitytwo protein mediates
otherprotein entityone specific antibody suggest otherprotein protein mediates part the entitytwo associated otherprotein
otherprotein entityone specific antibody suggest otherprotein protein mediates part the otherprotein associated entitytwo kinase activity
suggest entityone protein mediates part the entitytwo associated otherprotein
suggest entityone protein mediates part the otherprotein associated entitytwo kinase activity
part entityone associated entitytwo kinase activity
cont otherprotein entityone complexes containing entitytwo incapable
cont otherprotein entityone complexes containing otherprotein incapable phosphorylating entitytwo
otherprotein complexes containing entityone incapable phosphorylating entitytwo
model wherein entityone cdk complexes sequester entitytwo dependent kinase
model wherein entityone cdk complexes sequester otherprotein dependent kinase inhibitory activity entitytwo
complexes sequester entityone dependent kinase inhibitory activity entitytwo
entityone stimulates tyrosine phosphorylation entitytwo receptor substrate
entityone stimulates tyrosine phosphorylation entitytwo substrate
entityone stimulates tyrosine phosphorylation entitytwo its
entityone stimulates tyrosine phosphorylation otherprotein substrate association otherprotein entitytwo and the
entityone stimulates tyrosine phosphorylation otherprotein substrate association otherprotein otherprotein and the entitytwo
tyrosine phosphorylation entityone entitytwo substrate
tyrosine phosphorylation entityone entitytwo its
tyrosine phosphorylation entityone receptor substrate association otherprotein entitytwo and the
tyrosine phosphorylation entityone receptor substrate association otherprotein otherprotein and the entitytwo
tyrosine phosphorylation entityone entitytwo its
tyrosine phosphorylation entityone substrate association otherprotein entitytwo and the
tyrosine phosphorylation entityone substrate association otherprotein otherprotein and the entitytwo
tyrosine phosphorylation entityone its association otherprotein entitytwo the
tyrosine phosphorylation entityone its association otherprotein otherprotein the entitytwo
association otherprotein entityone the entitytwo
growthpromoting effects entityone normal neoplastic gastrointestinal tissues been shown be mediated the entitytwo otherprotein
growthpromoting effects entityone normal neoplastic gastrointestinal tissues been shown be mediated the gastrin entitytwo belongs
mediated the entityone entitytwo belongs
demonstrate entityone stimulates tyrosine phosphorylation entitytwo receptor substrate
demonstrate entityone stimulates tyrosine phosphorylation entitytwo otherprotein
demonstrate entityone stimulates tyrosine phosphorylation otherprotein substrate entitytwo major
demonstrate entityone stimulates tyrosine phosphorylation otherprotein substrate otherprotein major cytoplasmic substrate the entitytwo receptor
demonstrate entityone stimulates tyrosine phosphorylation otherprotein receptor substrate otherprotein major cytoplasmic substrate the entitytwo
tyrosine phosphorylation entityone entitytwo otherprotein
tyrosine phosphorylation entityone receptor substrate entitytwo major
tyrosine phosphorylation entityone receptor substrate otherprotein major cytoplasmic substrate the entitytwo receptor
tyrosine phosphorylation entityone receptor substrate otherprotein major cytoplasmic substrate the entitytwo
tyrosine phosphorylation entityone entitytwo major
tyrosine phosphorylation entityone otherprotein major cytoplasmic substrate the entitytwo receptor
tyrosine phosphorylation entityone otherprotein major cytoplasmic substrate the entitytwo
otherprotein substrate entityone major cytoplasmic substrate the entitytwo receptor
receptor substrate entityone major cytoplasmic substrate the entitytwo
substrate the entityone entitytwo
entityone induced phosphorylation entitytwo rapid
following entityone stimulation observed time dosedependent association entitytwo otherprotein
following entityone stimulation observed time dosedependent association otherprotein otherprotein entitytwo regulatory subunit
following entityone stimulation observed time dosedependent association otherprotein otherprotein otherprotein regulatory subunit entitytwo otherprotein
following entityone stimulation observed time dosedependent association otherprotein otherprotein otherprotein regulatory subunit otherprotein entitytwo
dosedependent association entityone otherprotein entitytwo regulatory subunit
dosedependent association entityone otherprotein otherprotein regulatory subunit entitytwo otherprotein
dosedependent association entityone otherprotein otherprotein regulatory subunit otherprotein entitytwo
otherprotein entityone regulatory subunit entitytwo otherprotein
otherprotein entityone regulatory subunit otherprotein entitytwo
regulatory subunit entityone entitytwo
addition activation entityone detected anti entitytwo immunoprecipitates
addition activation entityone detected anti otherprotein immunoprecipitates entitytwo treated cells
addition activation entityone detected anti otherprotein immunoprecipitates otherprotein treated cells suggesting tyrosine phosphorylation entitytwo leads
addition activation entityone detected anti otherprotein immunoprecipitates otherprotein treated cells suggesting tyrosine phosphorylation otherprotein leads the rapid recruitment entitytwo might
addition activation entityone detected anti otherprotein immunoprecipitates gastrintreated cells suggesting tyrosine phosphorylation otherprotein leads the rapid recruitment otherprotein might one mechanism used entitytwo activate
addition activation entityone detected anti otherprotein immunoprecipitates otherprotein treated cells suggesting tyrosine phosphorylation otherprotein leads the rapid recruitment otherprotein might one mechanism used otherprotein activate entitytwo
detected anti entityone immunoprecipitates entitytwo treated cells
detected anti entityone immunoprecipitates otherprotein treated cells suggesting tyrosine phosphorylation entitytwo leads
detected anti entityone immunoprecipitates otherprotein treated cells suggesting tyrosine phosphorylation otherprotein which leads the rapid recruitment entitytwo might
detected anti entityone immunoprecipitates gastrintreated cells suggesting tyrosine phosphorylation otherprotein which leads the rapid recruitment otherprotein might one mechanism used entitytwo activate
detected anti entityone immunoprecipitates otherprotein treated cells suggesting tyrosine phosphorylation otherprotein which leads the rapid recruitment otherprotein might one mechanism used otherprotein activate entitytwo
immunoprecipitates entityone treated cells suggesting tyrosine phosphorylation entitytwo leads
otherprotein immunoprecipitates entityone treated cells suggesting tyrosine phosphorylation otherprotein leads the rapid recruitment entitytwo might
otherprotein immunoprecipitates entityone treated cells suggesting tyrosine phosphorylation otherprotein leads the rapid recruitment otherprotein might one mechanism used entitytwo activate
otherprotein immunoprecipitates entityone treated cells suggesting tyrosine phosphorylation otherprotein leads the rapid recruitment otherprotein might one mechanism used gastrin activate entitytwo
tyrosine phosphorylation entityone leads the rapid recruitment entitytwo might
tyrosine phosphorylation entityone leads the rapid recruitment otherprotein might one mechanism used entitytwo activate
tyrosine phosphorylation entityone leads the rapid recruitment otherprotein might one mechanism used otherprotein activate entitytwo
rapid recruitment entityone might one mechanism used entitytwo activate
rapid recruitment entityone might one mechanism used otherprotein activate entitytwo
mechanism used entityone activate entitytwo
tyrosine phosphorylation entityone its association otherprotein entitytwo otherprotein complex
tyrosine phosphorylation entityone its association otherprotein otherprotein entitytwo complex may
tyrosine phosphorylation entityone its association otherprotein otherprotein otherprotein complex may contribute the activation the entitytwo pathway
tyrosine phosphorylation entityone its association otherprotein otherprotein otherprotein complex may contribute the activation the otherprotein pathway entitytwo
otherprotein entityone entitytwo complex may
otherprotein entityone otherprotein complex may contribute the activation the entitytwo pathway
otherprotein entityone otherprotein complex may contribute the activation the otherprotein pathway entitytwo
otherprotein otherprotein entityone complex may contribute the activation the entitytwo pathway
otherprotein otherprotein entityone complex may contribute the activation the otherprotein pathway entitytwo
activation the entityone pathway entitytwo
report that entityone also interacts otherprotein tyrosinephosphorylated entitytwo response
report that entityone also interacts otherprotein tyrosinephosphorylated otherprotein response entitytwo
otherprotein tyrosinephosphorylated entityone response entitytwo
results suggest entityone may serve a converging target signaling pathways stimulated receptors belong different families as the entitytwo otherprotein
results suggest entityone may serve a converging target signaling pathways stimulated receptors belong different families as the otherprotein entitytwo proteincoupled
results suggest entityone may serve a converging target signaling pathways stimulated receptors belong different families as the otherprotein entitytwo the
results suggest entityone may serve a converging target signaling pathways stimulated receptors belong different families as the otherprotein otherprotein proteincoupled receptor the entitytwo receptor
results suggest entityone may serve a converging target signaling pathways stimulated receptors belong different families as the otherprotein otherprotein proteincoupled receptor the entitytwo
as entityone entitytwo proteincoupled
as entityone entitytwo the
as entityone otherprotein proteincoupled receptor the entitytwo receptor
as entityone otherprotein proteincoupled receptor the entitytwo
the otherprotein entityone entitytwo the
the otherprotein entityone proteincoupled receptor the entitytwo receptor
the otherprotein entityone proteincoupled receptor the entitytwo
the otherprotein entityone the entitytwo receptor
the otherprotein entityone the entitytwo
receptor the entityone entitytwo
entityone entitytwo otherprotein otherprotein
entityone otherprotein entitytwo otherprotein
entityone otherprotein otherprotein entitytwo otherprotein
entityone otherprotein otherprotein otherprotein entitytwo otherprotein substrate
entityone otherprotein otherprotein otherprotein otherprotein entitytwo substrate important
otherprotein entityone entitytwo otherprotein
otherprotein entityone otherprotein entitytwo otherprotein
otherprotein entityone otherprotein otherprotein entitytwo otherprotein substrate
otherprotein entityone otherprotein otherprotein otherprotein entitytwo substrate important
otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein entityone otherprotein entitytwo otherprotein substrate
otherprotein otherprotein entityone otherprotein otherprotein entitytwo substrate important
otherprotein otherprotein otherprotein entityone entitytwo otherprotein substrate
otherprotein otherprotein otherprotein entityone otherprotein entitytwo substrate important
otherprotein otherprotein entityone entitytwo substrate important
detected entityone the entitytwo otherprotein otherprotein
detected entityone the otherprotein entitytwo otherprotein
detected entityone the otherprotein otherprotein entitytwo
otherprotein the entityone entitytwo otherprotein
otherprotein the entityone otherprotein entitytwo
the otherprotein entityone entitytwo
entityone phosphorylates entitytwo serine
nterminal third entityone alone bound entitytwo strongly
nterminal third entityone alone bound otherprotein strongly did intact entitytwo suggesting
nterminal third entityone alone bound cam strongly did intact gap43 suggesting protein's cterminus may play role modulating the interaction otherprotein entitytwo
gap43 alone bound entityone strongly did intact entitytwo suggesting
otherprotein alone bound entityone strongly did intact otherprotein suggesting protein's cterminus may play role modulating the interaction otherprotein entitytwo
did intact entityone suggesting protein's cterminus may play role modulating the interaction otherprotein entitytwo
interaction entityone entitytwo
structure the entityone tumor suppressor bound the ankyrin SH3 domains entitytwo
in vitro entityone protein binding activity entitytwo
structure the entityone core domain bound the entitytwo protein
structure entityone core domain bound otherprotein protein contains SH3 src homology domain four ankyrin repeats revealed i the SH3 domain binds the L3 loop entitytwo a
structure entityone core domain bound otherprotein protein contains SH3 src homology domain four ankyrin repeats revealed i SH3 domain binds the L3 loop p53 a manner distinct that previously characterized sh3polyproline peptid otherprotein exes ii ankyrin repeat forms Lshaped structure consisting a beta hairpin two alpha helices binds the L2 loop entitytwo
bound entityone protein contains SH3 src homology domain four ankyrin repeats revealed i SH3 domain binds the L3 loop entitytwo a
bound entityone protein contains SH3 src homology domain four ankyrin repeats revealed i SH3 domain binds L3 loop p53 a manner distinct that previously characterized sh3polyproline peptid otherprotein exes ii ankyrin repeat forms Lshaped structure consisting a beta hairpin two alpha helices binds the L2 loop entitytwo
loop entityone a manner distinct that previously characterized sh3polyproline peptid otherprotein exes ii ankyrin repeat forms Lshaped structure consisting a beta hairpin two alpha helices binds L2 loop entitytwo
shows the entityone binding site the entitytwo core domain
frequently observed entityone mutations disrupt entitytwo binding
evidence the entityone entitytwo complex forms
evidence the entityone p53 complex forms vivo may a critical role the entitytwo pathway
the otherprotein entityone complex forms vivo may a critical role the entitytwo pathway
structure the entityone oncoprotein bound the entitytwo tumor suppressor
entityone oncoprotein a cellular inhibitor the entitytwo tumor suppressor
entityone oncoprotein a cellular inhibitor p53 tumor suppressor that can bind the transactivation domain entitytwo downregulate
inhibitor entityone tumor suppressor that can bind the transactivation domain entitytwo downregulate
certain cancers entityone amplification a common event contributes the inactivation entitytwo
aminoterminal domain entityone bound a 15residue transactivation domain peptide entitytwo revealed
aminoterminal domain entityone bound a 15residue transactivation domain peptide otherprotein revealed entitytwo a
aminoterminal domain entityone bound a 15residue transactivation domain peptide p53 revealed MDM2 a deep hydrophobic cleft which entitytwo peptide binds
domain peptide entityone revealed entitytwo a
domain peptide entityone revealed otherprotein a deep hydrophobic cleft which entitytwo peptide binds
p53 revealed entityone a deep hydrophobic cleft which entitytwo peptide binds
complementarity the entityone cleft the hydrophobic face the entitytwo alpha helix
complementarity the entityone cleft the hydrophobic face the p53 alpha helix in particular a triad entitytwo amino acidsphe19
complementarity the entityone cleft the hydrophobic face the otherprotein alpha helix in particular a triad otherprotein amino acidsphe19 otherprotein Leu26which insert deep the entitytwo cleft
face the entityone alpha helix in particular a triad entitytwo amino acidsphe19
face the entityone alpha helix in particular a triad p53 amino acidsphe19 otherprotein Leu26which insert deep the entitytwo cleft
triad entityone amino acidsphe19 otherprotein Leu26which insert deep the entitytwo cleft
same entityone residues also involved transactivation supporting hypothesis entitytwo inactivates p53
same entityone residues also involved transactivation supporting hypothesis otherprotein inactivates entitytwo concealing
hypothesis entityone inactivates entitytwo concealing
cytokineactivated tyrosine kinase entityone activates entitytwo a
cytokineactivated tyrosine kinase entityone activates otherprotein a entitytwo dependent manner
otherprotein activates entityone a entitytwo dependent manner
entityone member the janus kinase superfamily found interact functionally otherprotein entitytwo central
entityone member the janus kinase superfamily found interact functionally otherprotein otherprotein central component the entitytwo otherprotein signal
entityone member the janus kinase superfamily found interact functionally otherprotein otherprotein central component the otherprotein entitytwo signal transduction
functionally otherprotein entityone central component the entitytwo otherprotein signal
functionally otherprotein entityone central component the otherprotein entitytwo signal transduction
component the entityone entitytwo signal transduction
entityone several cytokines are known activate entitytwo kinase
entityone several cytokines are known activate entitytwo also
entityone several cytokines are known activate otherprotein kinase also found stimulate entitytwo kinase activity
entityone several cytokines are known activate otherprotein kinase also found stimulate entitytwo activity toward
entityone several cytokines are known activate otherprotein kinase also found stimulate otherprotein kinase activity toward entitytwo mammalian
known activate entityone entitytwo also
known activate entityone kinase also found stimulate entitytwo kinase activity
known activate entityone kinase also found stimulate entitytwo activity toward
known activate entityone kinase also found stimulate otherprotein kinase activity toward entitytwo mammalian
known activate entityone also found stimulate entitytwo kinase activity
known activate entityone also found stimulate entitytwo activity toward
known activate entityone also found stimulate otherprotein kinase activity toward entitytwo mammalian
found stimulate entityone entitytwo activity toward
found stimulate entityone kinase activity toward entitytwo mammalian
found stimulate entityone activity toward entitytwo mammalian
baculovirus coexpression system entityone activated entitytwo the
baculovirus coexpression system entityone activated JA otherprotein the presence entitytwo
activated entityone the presence entitytwo
ternary complex entityone entitytwo otherprotein
ternary complex entityone otherprotein entitytwo observed
otherprotein otherprotein entityone entitytwo observed
absence entityone coexpression entitytwo otherprotein
absence entityone coexpression JA otherprotein entitytwo resulted
absence entityone coexpression JA otherprotein otherprotein resulted an overall decrease the entitytwo kinase activity
otherprotein coexpression entityone entitytwo resulted
otherprotein coexpression entityone otherprotein resulted an overall decrease the entitytwo kinase activity
otherprotein entityone resulted an overall decrease the entitytwo kinase activity
addition entityone phosphorylated entitytwo sites
addition entityone phosphorylated otherprotein sites different those phosphorylated entitytwo
otherprotein phosphorylated entityone sites different those phosphorylated entitytwo
small fraction entityone coimmunoprecipitated otherprotein entitytwo lysates
small fraction entityone coimmunoprecipitated otherprotein otherprotein lysates cells which entitytwo activated
coimmunoprecipitated otherprotein entityone lysates cells which entitytwo activated
data suggest entityone entitytwo cooperate
data suggest entityone otherprotein otherprotein cooperate activate entitytwo
otherprotein entityone cooperate activate entitytwo
entityone induced interaction primary hiv1 entitytwo glycoproteins
entityone induced interaction primary hiv1 otherprotein glycoproteins otherprotein chemokine receptor entitytwo
primary hiv1 entityone glycoproteins otherprotein chemokine receptor entitytwo
particular chemokine receptors entityone entitytwo respectively
particular chemokine receptors entityone otherprotein respectively well the primary receptor entitytwo refs
receptors otherprotein entityone respectively well the primary receptor entitytwo refs
complex entityone exterior envelope glycoprotein macrophagetropic primary hiv1 soluble entitytwo interacts specifically
complex entityone exterior envelope glycoprotein macrophagetropic primary hiv1 soluble otherprotein interacts specifically otherprotein entitytwo inhibits
complex entityone exterior envelope glycoprotein macrophagetropic primary hiv1 soluble otherprotein interacts specifically otherprotein ccr5 inhibits binding the natural entitytwo ligands macrophage
complex entityone exterior envelope glycoprotein macrophagetropic primary hiv1 soluble otherprotein interacts specifically otherprotein otherprotein inhibits binding the natural otherprotein ligands entitytwo otherprotein
complex entityone exterior envelope glycoprotein macrophagetropic primary hiv1 soluble otherprotein interacts specifically otherprotein otherprotein inhibits binding the natural otherprotein ligands macrophage inflammatory protein otherprotein 1alpha entitytwo refs
hiv1 soluble entityone interacts specifically otherprotein entitytwo inhibits
hiv1 soluble entityone interacts specifically otherprotein ccr5 inhibits binding the natural entitytwo ligands macrophage
hiv1 soluble entityone interacts specifically otherprotein otherprotein inhibits binding the natural otherprotein ligands entitytwo otherprotein
hiv1 soluble entityone interacts specifically otherprotein otherprotein inhibits binding the natural otherprotein ligands macrophage inflammatory protein otherprotein 1alpha entitytwo refs
specifically otherprotein entityone inhibits binding the natural entitytwo ligands macrophage
specifically otherprotein entityone inhibits binding the natural ccr5 ligands entitytwo otherprotein
specifically otherprotein entityone inhibits binding the natural ccr5 ligands macrophage inflammatory protein otherprotein 1alpha entitytwo refs
the natural entityone ligands entitytwo otherprotein
the natural entityone ligands macrophage inflammatory protein otherprotein 1alpha entitytwo refs
natural otherprotein ligands entityone entitytwo refs
interaction entityone entitytwo dramatically
interaction entityone otherprotein dramatically lower the absence soluble entitytwo
otherprotein entityone dramatically lower the absence soluble entitytwo
absence entityone interaction a twodomain entitytwo fragment
absence entityone interaction a twodomain otherprotein fragment entitytwo observed
a twodomain entityone fragment entitytwo observed
entityone fragment retaining entitytwo binding site
entityone fragment retaining otherprotein binding site overlapping epitopes able interact otherprotein entitytwo if
fragment retaining entityone binding site overlapping epitopes able interact otherprotein entitytwo if
otherprotein entityone induced V3 epitopes entitytwo blocked
otherprotein entityone induced V3 epitopes otherprotein blocked interaction entitytwo cd4 complexes
otherprotein entityone induced V3 epitopes otherprotein blocked interaction otherprotein entitytwo complexes
otherprotein entityone induced V3 epitopes otherprotein blocked interaction otherprotein cd4 complexes otherprotein entitytwo
epitopes entityone blocked interaction entitytwo otherprotein complexes
epitopes entityone blocked interaction otherprotein entitytwo complexes
epitopes entityone blocked interaction otherprotein otherprotein complexes otherprotein entitytwo
interaction entityone entitytwo complexes
interaction entityone otherprotein complexes otherprotein entitytwo
interaction otherprotein entityone complexes otherprotein entitytwo
hiv1 attachment entityone creates highaffinity binding site entitytwo leading
entityone recruitment two distinct ligandinduced tyrosinephosphorylated docking sites the entitytwo receptor intracellular
entityone recruitment two distinct ligandinduced tyrosinephosphorylated docking sites the entitytwo intracellular domain
sites the entityone entitytwo intracellular domain
recruitment entityone entitytwo receptor the
recruitment entityone entitytwo the STAT
recruitment entityone otherprotein receptor the STAT proteins activated entitytwo different
otherprotein entityone entitytwo the STAT
otherprotein entityone receptor the STAT proteins activated entitytwo different
recruitment entityone the STAT proteins activated entitytwo different
cells tested entityone activated entitytwo otherprotein
cells tested entityone activated otherprotein entitytwo induced
tested otherprotein activated entityone entitytwo induced
entityone also activated entitytwo BaF3
entityone also activated otherprotein BaF3 cells stably expressed murine entitytwo receptor
entityone also activated otherprotein BaF3 cells stably expressed murine entitytwo
also activated entityone BaF3 cells stably expressed murine entitytwo receptor
otherprotein also activated entityone BaF3 cells stably expressed murine entitytwo
expressed murine entityone entitytwo
the murine entityone entitytwo found
the murine entityone receptor found be redundantly required receptor function for activation entitytwo not
the murine entityone receptor found be redundantly required receptor function activation otherprotein not for entitytwo otherprotein
the murine entityone found be redundantly required receptor function for activation entitytwo not
the murine entityone found be redundantly required receptor function activation otherprotein not for entitytwo otherprotein
activation entityone not entitytwo otherprotein
phosphorylated form coprecipitated entityone not entitytwo blocked
phosphorylated form coprecipitated entityone not otherprotein blocked entitytwo induced stat3
phosphorylated form coprecipitated entityone not otherprotein blocked otherprotein induced entitytwo phosphorylation
otherprotein not entityone blocked entitytwo induced otherprotein
stat3 not entityone blocked otherprotein induced entitytwo phosphorylation
otherprotein blocked entityone induced entitytwo phosphorylation
interact otherprotein entityone block entitytwo activation
data demonstrate entityone not entitytwo otherprotein
data demonstrate entityone not otherprotein entitytwo directly
data demonstrate entityone not otherprotein otherprotein directly recruited the ligandactivated entitytwo receptor
data demonstrate entityone not otherprotein otherprotein directly recruited the ligandactivated entitytwo binding
otherprotein not entityone entitytwo directly
otherprotein not entityone otherprotein directly recruited the ligandactivated entitytwo receptor
otherprotein not entityone otherprotein directly recruited the ligandactivated entitytwo binding
otherprotein entityone directly recruited the ligandactivated entitytwo receptor
otherprotein entityone directly recruited the ligandactivated entitytwo binding
the ligandactivated entityone entitytwo binding
the human entityone entitytwo alpha chain
the human entityone entitytwo
the human entityone entitytwo
the human entityone entitytwo alpha chain
the human entityone entitytwo otherprotein 3ralpha
the human entityone receptor alpha chain entitytwo
the human entityone entitytwo otherprotein 3ralpha
the human entityone alpha chain entitytwo
the human entityone entitytwo
weak entityone binding activity found cells transfected otherprotein entitytwo however
weak entityone binding activity found cells transfected otherprotein otherprotein 3ralpha however combination both entitytwo otherprotein
weak entityone binding activity found cells transfected otherprotein otherprotein 3ralpha however combination both otherprotein 3ralpha entitytwo resulted
weak entityone binding activity found cells transfected otherprotein otherprotein 3ralpha however combination both otherprotein 3ralpha otherprotein ralpha resulted substantial binding activity otherprotein Kd approximately pM indicating both chains essential components the entitytwo receptor
weak entityone binding activity found cells transfected otherprotein otherprotein 3ralpha however combination both otherprotein 3ralpha otherprotein ralpha resulted substantial binding activity otherprotein Kd approximately pM indicating both chains essential components the entitytwo
otherprotein entityone however combination both entitytwo otherprotein
otherprotein entityone however combination both otherprotein 3ralpha entitytwo resulted
otherprotein entityone however combination both otherprotein 3ralpha otherprotein ralpha resulted substantial binding activity otherprotein Kd approximately pM indicating both chains essential components the entitytwo receptor
otherprotein entityone however combination both otherprotein 3ralpha otherprotein ralpha resulted substantial binding activity otherprotein Kd approximately pM indicating both chains essential components the entitytwo
combination both entityone entitytwo resulted
combination both entityone otherprotein ralpha resulted substantial binding activity otherprotein Kd approximately pM indicating both chains essential components the entitytwo receptor
combination both entityone otherprotein ralpha resulted substantial binding activity otherprotein Kd approximately pM indicating both chains essential components the entitytwo
otherprotein 3ralpha entityone resulted substantial binding activity otherprotein Kd approximately pM indicating both chains essential components the entitytwo receptor
otherprotein 3ralpha entityone resulted substantial binding activity otherprotein Kd approximately pM indicating both chains essential components the entitytwo
components the entityone entitytwo
whereas entityone serves an alternative accessory protein the common entitytwo otherprotein
whereas entityone serves an alternative accessory protein the common otherprotein entitytwo otherprotein
whereas entityone serves an alternative accessory protein the common otherprotein otherprotein entitytwo signaling
whereas entityone serves an alternative accessory protein common otherprotein gammac otherprotein signaling could replace the function entitytwo allowing
whereas entityone serves an alternative accessory protein common otherprotein otherprotein otherprotein signaling could replace the function otherprotein allowing enhanced entitytwo binding activity
the common entityone entitytwo otherprotein
the common entityone otherprotein entitytwo signaling
common entityone gammac otherprotein signaling could replace the function entitytwo allowing
common entityone otherprotein otherprotein signaling could replace the function otherprotein allowing enhanced entitytwo binding activity
common otherprotein entityone entitytwo signaling
common otherprotein entityone otherprotein signaling could replace function entitytwo allowing
common otherprotein entityone otherprotein signaling could replace function gammac allowing enhanced entitytwo binding activity
otherprotein gammac entityone signaling could replace function entitytwo allowing
otherprotein otherprotein entityone signaling could replace function otherprotein allowing enhanced entitytwo binding activity
function entityone allowing enhanced entitytwo binding activity
cytoplasmic domain entityone entitytwo similar
cytoplasmic domain entityone gammac similar like entitytwo otherprotein 3ralpha
cytoplasmic domain entityone otherprotein similar like otherprotein entitytwo located
otherprotein 3ralpha entityone similar like entitytwo otherprotein 3ralpha
otherprotein 3ralpha entityone similar like gammac entitytwo located
similar like entityone entitytwo located
interaction entityone otherprotein entitytwo binding
aggregated entityone entitytwo a
complexes entityone otherprotein csf proteins a kbr gradient revealed association entitytwo w
entityone entitytwo second
entityone otherprotein second major csf protein formed sdsstabl otherprotein exes otherprotein entitytwo significantly
entityone otherprotein second major csf protein formed sdsstabl otherprotein exes otherprotein beta significantly decreased rate entitytwo fibril formation
otherprotein entityone second major csf protein formed sdsstabl otherprotein exes otherprotein entitytwo significantly
otherprotein entityone second major csf protein formed sdsstabl otherprotein exes otherprotein beta significantly decreased rate entitytwo fibril formation
exes otherprotein entityone significantly decreased rate entitytwo fibril formation
buffers CSF entityone exclusively decreased level entitytwo pentamers
endogenous entityone entitytwo complexes
surface the entityone monomer interact otherprotein entitytwo
propose entityone binding proteins play key role the modulation entitytwo aggregation
otherprotein entityone entitytwo
directly bound entityone entitytwo
265kd protein entityone entitytwo recently
domains recombinant entityone entitytwo CBPrelated
domains recombinant entityone otherprotein entitytwo related protein
recombinant cbp entityone entitytwo related protein
associations entityone otherprotein entitytwo otherprotein otherprotein
associations entityone otherprotein otherprotein entitytwo otherprotein
associations entityone otherprotein otherprotein otherprotein entitytwo otherprotein
associations entityone otherprotein otherprotein otherprotein otherprotein entitytwo proteins
otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein entityone otherprotein entitytwo otherprotein
otherprotein otherprotein entityone otherprotein otherprotein entitytwo proteins
otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein entityone otherprotein entitytwo proteins
otherprotein otherprotein otherprotein entityone entitytwo proteins
using human entityone protein the "bait" yeast twohybrid system have identified a human homolog yeast entitytwo designated otherprotein
using human entityone protein the "bait" yeast twohybrid system have identified a human homolog yeast otherprotein designated entitytwo interacts
using human entityone protein the "bait" yeast twohybrid system have identified a human homolog yeast otherprotein designated otherprotein interacts otherprotein entitytwo otherprotein otherprotein
using human entityone protein the "bait" yeast twohybrid system have identified a human homolog yeast otherprotein designated otherprotein interacts otherprotein rad52 entitytwo otherprotein
using human entityone protein the "bait" yeast twohybrid system have identified a human homolog yeast otherprotein designated otherprotein interacts otherprotein rad52 otherprotein entitytwo a
using human entityone protein the "bait" yeast twohybrid system have identified a human homolog yeast otherprotein designated otherprotein interacts otherprotein rad52 otherprotein otherprotein a ubiquitinlike protein entitytwo
homolog yeast entityone designated entitytwo interacts
homolog yeast entityone designated otherprotein interacts otherprotein entitytwo otherprotein otherprotein
homolog yeast entityone designated otherprotein interacts otherprotein otherprotein entitytwo otherprotein
homolog yeast entityone designated otherprotein interacts otherprotein otherprotein otherprotein entitytwo a
homolog yeast entityone designated otherprotein interacts otherprotein otherprotein otherprotein otherprotein a ubiquitinlike protein entitytwo
otherprotein designated entityone interacts otherprotein entitytwo otherprotein otherprotein
otherprotein designated entityone interacts otherprotein otherprotein entitytwo otherprotein
otherprotein designated entityone interacts otherprotein otherprotein otherprotein entitytwo a
otherprotein designated entityone interacts otherprotein otherprotein otherprotein otherprotein a ubiquitinlike protein entitytwo
interacts otherprotein entityone entitytwo otherprotein
interacts otherprotein entityone otherprotein entitytwo a
interacts otherprotein entityone otherprotein otherprotein a ubiquitinlike protein entitytwo
otherprotein otherprotein entityone entitytwo a
otherprotein otherprotein entityone otherprotein a ubiquitinlike protein entitytwo
otherprotein otherprotein otherprotein entityone a ubiquitinlike protein entitytwo
interactions entityone specific since another dna repairrelated ubiquitinconjugating enzyme entitytwo otherprotein
interactions entityone specific since another dna repairrelated ubiquitinconjugating enzyme otherprotein entitytwo not
repairrelated ubiquitinconjugating enzyme entityone entitytwo not
interaction entityone otherprotein entitytwo mediated
interaction entityone otherprotein rad52 mediated entitytwo selfassociation
otherprotein otherprotein entityone mediated entitytwo selfassociation
suggest the entityone dependent processes cell cycle control entitytwo mediated pathways
suggest the entityone dependent processes cell cycle control otherprotein mediated pathways ubiquitination interact human entitytwo
cell cycle control entityone mediated pathways ubiquitination interact human entitytwo
otherprotein entityone entitytwo complex
otherprotein entityone otherprotein complex entitytwo otherprotein
otherprotein entityone otherprotein complex otherprotein entitytwo mediated myeloid
otherprotein otherprotein entityone complex entitytwo otherprotein
otherprotein otherprotein entityone complex otherprotein entitytwo mediated myeloid
otherprotein complex entityone entitytwo mediated myeloid
molecules including entityone entitytwo
tyrosine phosphorylation entityone the interaction the entitytwo ccbl complex
tyrosine phosphorylation entityone the interaction the otherprotein entitytwo complex
tyrosine phosphorylation entityone the interaction the otherprotein ccbl complex otherprotein signaling proteins upon activation nontyrosine entitytwo tyrosine
tyrosine phosphorylation entityone the interaction the otherprotein ccbl complex otherprotein signaling proteins upon activation nontyrosine otherprotein tyrosine kinase entitytwo receptors leading
interaction the entityone entitytwo complex
interaction the entityone otherprotein complex otherprotein signaling proteins upon activation nontyrosine entitytwo tyrosine
interaction the entityone otherprotein complex otherprotein signaling proteins upon activation nontyrosine otherprotein tyrosine kinase entitytwo receptors leading
the otherprotein entityone complex otherprotein signaling proteins upon activation nontyrosine entitytwo tyrosine
the otherprotein entityone complex otherprotein signaling proteins upon activation nontyrosine otherprotein tyrosine kinase entitytwo receptors leading
activation nontyrosine entityone tyrosine kinase entitytwo receptors leading
found both entityone entitytwo ligands namely
found both entityone otherprotein ligands namely entitytwo otherprotein
found both entityone otherprotein ligands namely otherprotein entitytwo induce otherprotein
found both entityone otherprotein ligands namely otherprotein otherprotein induce entitytwo tyrosine phosphorylation
otherprotein entityone ligands namely entitytwo otherprotein
otherprotein entityone ligands namely otherprotein entitytwo induce otherprotein
otherprotein entityone ligands namely otherprotein otherprotein induce entitytwo tyrosine phosphorylation
otherprotein ligands namely entityone entitytwo induce otherprotein
otherprotein ligands namely entityone otherprotein induce entitytwo tyrosine phosphorylation
namely otherprotein entityone induce entitytwo tyrosine phosphorylation
adaptor protein entityone constitutively binds substantial fraction entitytwo the
the stable entityone entitytwo complex interacts
the stable entityone otherprotein complex interacts the entitytwo sh2 domain
stable entityone otherprotein complex interacts the grb2 sh2 domain otherprotein the entitytwo activated otherprotein
stable entityone otherprotein complex interacts the grb2 sh2 domain otherprotein the otherprotein activated entitytwo
stable grb2 entityone complex interacts the entitytwo sh2 domain
stable otherprotein entityone complex interacts otherprotein sh2 domain otherprotein the entitytwo activated otherprotein
stable otherprotein entityone complex interacts otherprotein sh2 domain otherprotein the otherprotein activated entitytwo
interacts entityone sh2 domain otherprotein the entitytwo activated otherprotein
interacts entityone sh2 domain otherprotein the otherprotein activated entitytwo
otherprotein entityone activated entitytwo
stimulation otherprotein entityone leads the formation a entitytwo complex containing
stimulation otherprotein entityone leads the formation a otherprotein complex containing entitytwo
formation a entityone complex containing entitytwo
hypothesis entityone mediates association entitytwo otherprotein
hypothesis entityone mediates association otherprotein otherprotein entitytwo
association entityone otherprotein entitytwo
found upon entityone stimulation entitytwo otherprotein complex
found upon entityone stimulation otherprotein entitytwo complex recruits
found upon entityone stimulation otherprotein otherprotein complex recruits entitytwo probably via
found upon entityone stimulation Grb2 otherprotein complex recruits otherprotein probably via entitytwo
otherprotein stimulation entityone entitytwo complex recruits
otherprotein stimulation entityone otherprotein complex recruits entitytwo probably via
otherprotein stimulation entityone otherprotein complex recruits otherprotein probably via entitytwo
stimulation otherprotein entityone complex recruits entitytwo probably via
stimulation Grb2 entityone complex recruits otherprotein probably via entitytwo
otherprotein complex recruits entityone probably via entitytwo
otherprotein the entityone exchanger factor entitytwo not
otherprotein the entityone exchanger factor otherprotein was detected anti entitytwo immunoprecipitates suggesting
otherprotein the entityone exchanger factor otherprotein was detected anti otherprotein immunoprecipitates suggesting entitytwo otherprotein
otherprotein the entityone exchanger factor otherprotein was detected anti otherprotein immunoprecipitates suggesting otherprotein entitytwo otherprotein
otherprotein the entityone exchanger factor otherprotein was detected anti otherprotein immunoprecipitates suggesting Grb2 otherprotein and entitytwo otherprotein
otherprotein the entityone exchanger factor otherprotein was detected anticCbl immunoprecipitates suggesting otherprotein otherprotein and otherprotein entitytwo present
otherprotein exchanger factor entityone not detected anti entitytwo immunoprecipitates suggesting
otherprotein exchanger factor entityone not detected anti otherprotein immunoprecipitates suggesting entitytwo otherprotein
otherprotein exchanger factor entityone not detected anti otherprotein immunoprecipitates suggesting otherprotein entitytwo otherprotein
otherprotein exchanger factor entityone not detected anti otherprotein immunoprecipitates suggesting Grb2 otherprotein and entitytwo otherprotein
otherprotein exchanger factor entityone not detected anticCbl immunoprecipitates suggesting otherprotein otherprotein and otherprotein entitytwo present
detected anti entityone immunoprecipitates suggesting entitytwo otherprotein
detected anti entityone immunoprecipitates suggesting otherprotein entitytwo otherprotein
detected anti entityone immunoprecipitates suggesting Grb2 otherprotein and entitytwo ccbl
detected anti entityone immunoprecipitates suggesting otherprotein otherprotein and otherprotein entitytwo present
immunoprecipitates suggesting entityone entitytwo Grb2
immunoprecipitates suggesting entityone otherprotein and entitytwo otherprotein
immunoprecipitates suggesting entityone otherprotein and grb2 entitytwo present
suggesting Grb2 entityone entitytwo otherprotein
suggesting otherprotein entityone otherprotein entitytwo present
otherprotein and entityone entitytwo present
results demonstrate entityone plays important role coupling tyrosine nontyrosine kinase receptors downstream effector molecules that different signaling molecules interact otherprotein entitytwo ccbl complex
results demonstrate entityone plays important role coupling tyrosine nontyrosine kinase receptors downstream effector molecules that different signaling molecules interact otherprotein otherprotein entitytwo complex
interact otherprotein entityone entitytwo complex
higher levels entityone entitytwo binding
entityone interacts otherprotein entitytwo otherprotein
entityone interacts otherprotein otherprotein entitytwo otherprotein
entityone interacts otherprotein otherprotein otherprotein otherprotein entitytwo receptors
interacts otherprotein entityone entitytwo otherprotein
interacts otherprotein entityone otherprotein otherprotein entitytwo receptors
otherprotein otherprotein entityone otherprotein entitytwo receptors
dcs express entityone entitytwo mrna
activation entityone entitytwo mediated
activation entityone inducing factor mediated entitytwo converting enzyme
activation entityone inducing factor mediated entitytwo
activation entityone mediated entitytwo converting enzyme
activation entityone mediated entitytwo
factor mediated entityone entitytwo
entityone entitytwo converting enzyme
entityone entitytwo otherprotein processes
entityone otherprotein converting enzyme entitytwo processes
entityone otherprotein beta converting enzyme otherprotein processes inactive entitytwo precursor
otherprotein beta entityone entitytwo otherprotein processes
otherprotein beta entityone converting enzyme entitytwo processes
otherprotein beta entityone converting enzyme otherprotein processes inactive entitytwo precursor
entityone entitytwo processes
entityone otherprotein processes inactive entitytwo precursor
beta converting enzyme entityone processes inactive entitytwo precursor
entityone also shown cleave precursor entitytwo inducing factor
entityone also shown cleave precursor entitytwo otherprotein
entityone also shown cleave precursor otherprotein inducing factor entitytwo the
entityone also shown cleave precursor otherprotein inducing factor igif the authentic processing site otherprotein high efficiency thereby activating entitytwo facilitating
precursor entityone entitytwo otherprotein
precursor entityone inducing factor entitytwo the
precursor entityone inducing factor igif the authentic processing site otherprotein high efficiency thereby activating entitytwo facilitating
precursor entityone entitytwo the
precursor entityone igif the authentic processing site otherprotein high efficiency thereby activating entitytwo facilitating
otherprotein inducing factor entityone the authentic processing site otherprotein high efficiency thereby activating entitytwo facilitating
lipopolysaccharideactivated entityone deficient ice kupffer cells synthesized entitytwo precursor
entityone entitytwo diminished
entityone otherprotein diminished the sera entitytwo mice exposed
otherprotein entityone diminished the sera entitytwo mice exposed
transcriptional inhibitors entityone entitytwo evidence toward
isoform the entityone transcription factor entitytwo interacts
isoform entityone transcription factor otherprotein interacts otherprotein the transcriptional inhibitor entitytwo otherprotein
isoform entityone transcription factor otherprotein interacts otherprotein the transcriptional inhibitor otherprotein entitytwo
otherprotein transcription factor entityone interacts otherprotein transcriptional inhibitor entitytwo otherprotein
otherprotein transcription factor entityone interacts otherprotein transcriptional inhibitor otherprotein entitytwo
transcriptional inhibitor entityone entitytwo
otherprotein entityone entitytwo otherprotein
otherprotein entityone otherprotein entitytwo effectively inhibited
otherprotein entityone otherprotein otherprotein effectively inhibited activation the musclespecific entitytwo promoter
otherprotein entityone otherprotein otherprotein effectively inhibited activation the musclespecific otherprotein promoter the myogenic transcription factor entitytwo
otherprotein otherprotein entityone entitytwo effectively inhibited
otherprotein otherprotein entityone otherprotein effectively inhibited activation the musclespecific entitytwo promoter
otherprotein otherprotein entityone otherprotein effectively inhibited activation the musclespecific otherprotein promoter the myogenic transcription factor entitytwo
otherprotein otherprotein entityone effectively inhibited activation the musclespecific entitytwo promoter
otherprotein otherprotein entityone effectively inhibited activation the musclespecific otherprotein promoter the myogenic transcription factor entitytwo
the musclespecific entityone promoter the myogenic transcription factor entitytwo
moreover entityone inhibited entitytwo promoter
indicated the entityone entitytwo heterodimer bound
indicated the entityone otherprotein heterodimer bound its specific dna binding site vitro the dna binding effectively blocked entitytwo otherprotein
indicated the entityone otherprotein heterodimer bound its specific dna binding site vitro the dna binding effectively blocked otherprotein entitytwo
the otherprotein entityone heterodimer bound its specific dna binding site vitro the dna binding effectively blocked entitytwo otherprotein
the otherprotein entityone heterodimer bound its specific dna binding site vitro the dna binding effectively blocked otherprotein entitytwo
effectively blocked entityone entitytwo
the activating entityone inhibitory entitytwo isoforms
competitive binding entityone entitytwo the
competitive binding entityone otherprotein the entitytwo
otherprotein entityone the entitytwo
integrity entityone suggesting functionally important interaction otherprotein and postsynaptic cytoskeleton entitytwo member
integrity entityone suggesting functionally important interaction otherprotein and postsynaptic cytoskeleton otherprotein member the spectrin entitytwo family
integrity entityone suggesting functionally important interaction otherprotein and postsynaptic cytoskeleton otherprotein member the spectrin otherprotein family entitytwo binding proteins
integrity entityone suggesting functionally important interaction otherprotein and postsynaptic cytoskeleton otherprotein member spectrin otherprotein family actinbinding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein and the putative otherprotein clustering molecule entitytwo otherprotein binds
integrity entityone suggesting functionally important interaction otherprotein and postsynaptic cytoskeleton alphaactinin2 member spectrin otherprotein family actinbinding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein and the putative otherprotein clustering molecule otherprotein entitytwo binds
integrity entityone suggesting functionally important interaction otherprotein postsynaptic cytoskeleton otherprotein member spectrin otherprotein family actinbinding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein and the putative otherprotein clustering molecule otherprotein otherprotein binds its central rod domain the cytoplasmic tail both entitytwo and otherprotein
integrity entityone suggesting functionally important interaction otherprotein postsynaptic cytoskeleton otherprotein member spectrin otherprotein family actinbinding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein and the putative otherprotein clustering molecule otherprotein otherprotein binds its central rod domain the cytoplasmic tail both otherprotein and entitytwo subunits
integrity entityone suggesting functionally important interaction nmda receptors the postsynaptic cytoskeleton otherprotein member the spectrin otherprotein family actinbinding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein nmda receptors the putative NMDA receptorclustering molecule otherprotein otherprotein binds its central rod domain the cytoplasmic tail both otherprotein otherprotein subunits the entitytwo can
integrity entityone suggesting functionally important interaction otherprotein postsynaptic cytoskeleton otherprotein member spectrin otherprotein family actinbinding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein the putative otherprotein clustering molecule psd95 otherprotein binds its central rod domain the cytoplasmic tail both otherprotein and otherprotein subunits the otherprotein and can immunoprecipitated otherprotein otherprotein and entitytwo rat
postsynaptic cytoskeleton entityone member the spectrin entitytwo family
postsynaptic cytoskeleton entityone member the spectrin otherprotein family entitytwo binding proteins
postsynaptic cytoskeleton entityone member spectrin otherprotein family otherprotein binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein and the putative otherprotein clustering molecule entitytwo alphaactinin2 binds
postsynaptic cytoskeleton entityone member spectrin otherprotein family otherprotein binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein and the putative otherprotein clustering molecule otherprotein entitytwo binds
postsynaptic cytoskeleton entityone member spectrin otherprotein family otherprotein binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein the putative otherprotein clustering molecule otherprotein alphaactinin2 binds its central rod domain the cytoplasmic tail both entitytwo and otherprotein
postsynaptic cytoskeleton entityone member spectrin otherprotein family otherprotein binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein the putative otherprotein clustering molecule otherprotein alphaactinin2 binds its central rod domain the cytoplasmic tail both otherprotein and entitytwo subunits
postsynaptic cytoskeleton entityone member the spectrin otherprotein family otherprotein binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein nmda receptors the putative nmda receptorclustering molecule otherprotein alphaactinin2 binds its central rod domain the cytoplasmic tail both otherprotein otherprotein subunits the entitytwo can
postsynaptic cytoskeleton entityone member spectrin otherprotein family otherprotein binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein the putative otherprotein clustering molecule psd95 alphaactinin2 binds its central rod domain the cytoplasmic tail both otherprotein otherprotein subunits the otherprotein and can immunoprecipitated otherprotein otherprotein and entitytwo rat
the spectrin entityone family entitytwo binding proteins
spectrin entityone family otherprotein binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein and the putative otherprotein clustering molecule entitytwo otherprotein binds
spectrin entityone family otherprotein binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein and the putative otherprotein clustering molecule otherprotein entitytwo binds
spectrin entityone family otherprotein binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein the putative otherprotein clustering molecule otherprotein otherprotein binds its central rod domain the cytoplasmic tail both entitytwo and otherprotein
spectrin entityone family otherprotein binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein the putative otherprotein clustering molecule otherprotein otherprotein binds its central rod domain the cytoplasmic tail both otherprotein and entitytwo subunits
the spectrin entityone family otherprotein binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein nmda receptors the putative nmda receptorclustering molecule otherprotein otherprotein binds its central rod domain the cytoplasmic tail both otherprotein otherprotein subunits the entitytwo can
spectrin entityone family otherprotein binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein the putative otherprotein clustering molecule psd95 otherprotein binds its central rod domain the cytoplasmic tail both otherprotein otherprotein subunits the otherprotein and can immunoprecipitated otherprotein otherprotein and entitytwo rat
otherprotein family entityone binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein and putative otherprotein clustering molecule entitytwo otherprotein binds
otherprotein family entityone binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein and putative otherprotein clustering molecule otherprotein entitytwo binds
otherprotein family entityone binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein putative otherprotein clustering molecule otherprotein otherprotein binds its central rod domain the cytoplasmic tail both entitytwo and otherprotein
otherprotein family entityone binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein putative otherprotein clustering molecule otherprotein otherprotein binds its central rod domain the cytoplasmic tail both otherprotein and entitytwo subunits
otherprotein family entityone binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein nmda receptors the putative nmda receptorclustering molecule otherprotein otherprotein binds its central rod domain the cytoplasmic tail both otherprotein otherprotein subunits the entitytwo can
otherprotein family entityone binding proteins identified as brain postsynaptic density protein colocalizes dendritic spines otherprotein otherprotein putative otherprotein clustering molecule psd95 otherprotein binds its central rod domain the cytoplasmic tail both otherprotein otherprotein subunits the otherprotein and can immunoprecipitated otherprotein otherprotein and entitytwo rat
otherprotein clustering molecule entityone entitytwo binds
otherprotein clustering molecule entityone otherprotein binds its central rod domain the cytoplasmic tail both entitytwo otherprotein
otherprotein clustering molecule entityone otherprotein binds its central rod domain the cytoplasmic tail both otherprotein entitytwo subunits
nmda receptorclustering molecule entityone otherprotein binds its central rod domain the cytoplasmic tail both otherprotein otherprotein subunits the entitytwo can
otherprotein clustering molecule entityone otherprotein binds its central rod domain the cytoplasmic tail both otherprotein otherprotein subunits the otherprotein can immunoprecipitated otherprotein otherprotein and entitytwo rat
clustering molecule otherprotein entityone binds its central rod domain the cytoplasmic tail both entitytwo otherprotein
clustering molecule otherprotein entityone binds its central rod domain the cytoplasmic tail both otherprotein entitytwo subunits
receptorclustering molecule otherprotein entityone binds its central rod domain the cytoplasmic tail both otherprotein otherprotein subunits the entitytwo can
clustering molecule psd95 entityone binds its central rod domain the cytoplasmic tail both otherprotein otherprotein subunits the otherprotein can immunoprecipitated otherprotein otherprotein and entitytwo rat
tail both entityone entitytwo subunits
tail both entityone otherprotein subunits the entitytwo can
tail both entityone otherprotein subunits the otherprotein can immunoprecipitated otherprotein otherprotein and entitytwo rat
otherprotein entityone subunits the entitytwo can
otherprotein entityone subunits the otherprotein can immunoprecipitated otherprotein otherprotein and entitytwo rat
subunits the entityone can immunoprecipitated otherprotein nmda receptors entitytwo rat
intriguingly entityone entitytwo binding
intriguingly entityone otherprotein binding directly antagonized Ca2+ entitytwo
intriguingly otherprotein entityone binding directly antagonized Ca2+ entitytwo
entityone interacts otherprotein protein phosphatases entitytwo otherprotein
entityone interacts otherprotein protein phosphatases otherprotein entitytwo disrupts
otherprotein protein phosphatases entityone entitytwo disrupts
the protein entityone interacted otherprotein protein entitytwo catalytic subunit
the protein entityone interacted otherprotein protein entitytwo otherprotein
the protein entityone interacted otherprotein protein otherprotein catalytic subunit entitytwo well
the protein entityone interacted otherprotein protein otherprotein catalytic subunit otherprotein well as entitytwo otherprotein
the protein entityone interacted otherprotein protein otherprotein catalytic subunit otherprotein well as otherprotein entitytwo mammalian
otherprotein protein entityone entitytwo otherprotein
otherprotein protein entityone catalytic subunit entitytwo well
otherprotein protein entityone catalytic subunit otherprotein well as entitytwo otherprotein
otherprotein protein entityone catalytic subunit otherprotein well as otherprotein entitytwo mammalian
otherprotein protein entityone entitytwo well
otherprotein protein entityone otherprotein well as entitytwo otherprotein
otherprotein protein entityone otherprotein well as otherprotein entitytwo mammalian
otherprotein catalytic subunit entityone well entitytwo otherprotein
otherprotein catalytic subunit entityone well otherprotein entitytwo mammalian
well entityone entitytwo mammalian
thus entityone a cellular oncogene targets entitytwo otherprotein
thus entityone a cellular oncogene targets otherprotein entitytwo of
oncogene targets entityone entitytwo of
the human entityone human entitytwo receptor binding
the human entityone human entitytwo binding interface
human interleukin6human entityone entitytwo binding interface
interaction entityone entitytwo otherprotein
interaction entityone il6 entitytwo receptor otherprotein
interaction entityone otherprotein entitytwo otherprotein
interaction entityone otherprotein otherprotein receptor entitytwo the
interaction entityone il6 otherprotein otherprotein the initial most specific step the entitytwo signaling pathway
interaction otherprotein entityone entitytwo receptor otherprotein
interaction otherprotein entityone entitytwo otherprotein
interaction otherprotein entityone otherprotein entitytwo the
interaction otherprotein entityone otherprotein otherprotein the initial most specific step the entitytwo signaling pathway
otherprotein il6 entityone entitytwo otherprotein
otherprotein il6 entityone receptor entitytwo the
otherprotein il6 entityone receptor otherprotein the initial most specific step the entitytwo signaling pathway
otherprotein otherprotein entityone entitytwo the
otherprotein il6 entityone otherprotein the initial most specific step the entitytwo signaling pathway
il6 otherprotein entityone the initial most specific step the entitytwo signaling pathway
studied human entityone entitytwo otherprotein
studied human entityone otherprotein entitytwo binding interface
human otherprotein entityone entitytwo binding interface
altered entityone entitytwo residues predicted
form entityone entitytwo complex
the human entityone entitytwo establishment
mutagenesis the entityone entitytwo otherprotein
mutagenesis the entityone receptor entitytwo permits analysis
mutagenesis the entityone receptor otherprotein permits analysis the contribution individual amino acid residues make entitytwo otherprotein binding
mutagenesis the entityone receptor otherprotein permits analysis the contribution individual amino acid residues make erythropoietin entitytwo binding
mutagenesis the entityone entitytwo permits analysis
mutagenesis the entityone otherprotein permits analysis the contribution individual amino acid residues make entitytwo otherprotein binding
mutagenesis the entityone otherprotein permits analysis the contribution individual amino acid residues make otherprotein entitytwo binding
the otherprotein entityone permits analysis the contribution individual amino acid residues make entitytwo otherprotein binding
otherprotein receptor entityone permits analysis the contribution individual amino acid residues make otherprotein entitytwo binding
residues make entityone entitytwo binding
referred as entityone entitytwo otherprotein
referred as entityone binding protein entitytwo the
referred as entityone binding protein otherprotein the entitytwo
referred as entityone entitytwo the
referred as entityone otherprotein the entitytwo
otherprotein binding protein entityone the entitytwo
coli soluble entityone analyzed entitytwo binding
expressed fulllength entityone the surface COS cells analyzed 125I entitytwo binding
involved entityone binding well other residues are conserved receptors the cytokine receptor family appear be necessary the proper folding andor stability of the entitytwo
stimulation entityone entitytwo results
pathway which entityone regulates cell growth cells lacking endogenous fgfr stably transfected otherprotein two different human isoforms entitytwo iiib
pathway which entityone regulates cell growth cells lacking endogenous fgfr stably transfected otherprotein two different human isoforms entitytwo otherprotein
pathway which entityone regulates cell growth cells lacking endogenous fgfr stably transfected otherprotein two different human isoforms otherprotein entitytwo iiic
pathway which entityone regulates cell growth cells lacking endogenous fgfr stably transfected otherprotein two different human isoforms otherprotein entitytwo result
pathway which entityone regulates cell growth cells lacking endogenous fgfr stably transfected otherprotein two different human isoforms otherprotein otherprotein result alternative splicing exon iii the entitytwo gene encoding
different human isoforms entityone entitytwo otherprotein
different human isoforms entityone iiib entitytwo iiic
different human isoforms entityone iiib entitytwo result
different human isoforms entityone iiib otherprotein result alternative splicing exon iii the entitytwo gene encoding
different human isoforms entityone entitytwo iiic
different human isoforms entityone entitytwo result
different human isoforms entityone otherprotein result alternative splicing exon iii the entitytwo gene encoding
isoforms otherprotein entityone entitytwo result
isoforms otherprotein entityone iiic result alternative splicing exon iii the entitytwo gene encoding
isoforms otherprotein entityone result alternative splicing exon iii the entitytwo gene encoding
expression entityone entitytwo stably
expression entityone iiic stably transfected cells conferred growth responses several members the fgf family including entitytwo 4
expression entityone iiic stably transfected cells conferred growth responses several members the fgf family including otherprotein 4 6 entitytwo iiibexpressing cells
expression entityone iiic stably transfected cells conferred growth responses several members the fgf family including otherprotein 4 6 entitytwo expressing cells
expression entityone iiic stably transfected cells conferred growth responses several members the fgf family including fgf1 4 6 otherprotein expressing cells responded to entitytwo
expression entityone stably transfected cells conferred growth responses several members the fgf family including entitytwo 4
expression entityone stably transfected cells conferred growth responses several members the fgf family including otherprotein 4 6 entitytwo iiibexpressing cells
expression entityone stably transfected cells conferred growth responses several members the fgf family including otherprotein 4 6 entitytwo expressing cells
expression entityone stably transfected cells conferred growth responses several members the fgf family including fgf1 4 6 otherprotein iiibexpressing cells responded to entitytwo
fgf family including entityone 4 6 entitytwo iiibexpressing cells
fgf family including entityone 4 6 entitytwo expressing cells
fgf family including entityone 4 6 otherprotein iiibexpressing cells responded to entitytwo
6 entityone entitytwo expressing cells
6 entityone iiibexpressing cells responded to entitytwo
6 entityone expressing cells responded to entitytwo
activation entityone upon ligand binding resulted activation entitytwo pathway
entityone utilizes two different pools adapter protein entitytwo link
entityone utilizes two different pools adapter protein otherprotein link entitytwo
adapter protein entityone link entitytwo
activated entityone predominantly interacts otherprotein entitytwo
entityone complex otherprotein previously identified 90kda protein designated protein entitytwo
ligand activation entityone suggesting the 66kda protein may play important role entitytwo specific signaling
unique pathway entityone also links entitytwo
entityone complex via adapter protein entitytwo
furthermore activated entityone not able induce dissociation entitytwo
entityone complex following entitytwo phosphorylation
summary entityone signaling pathway utilizes two entitytwo containing complexes
summary entityone signaling pathway utilizes two otherprotein containing complexes entitytwo
pathway utilizes two entityone containing complexes entitytwo
entityone entitytwo otherprotein
entityone otherprotein entitytwo
otherprotein entityone entitytwo
entityone these two complexes may alternatively link entitytwo otherprotein
entityone these two complexes may alternatively link otherprotein entitytwo
may alternatively link entityone entitytwo
finally activated entityone also found result phosphorylation entitytwo reduced
finally activated entityone also found result phosphorylation otherprotein reduced phosphorylation entitytwo
phosphorylation entityone reduced phosphorylation entitytwo
epitopetagging interaction entityone basichelixloophelix protein otherprotein entitytwo protein encoded
otherprotein human entityone mouse entitytwo confirmed
part entityone protein sequence interacted otherprotein the entitytwo basichelixloophelix
entityone a transcriptional modulator communicates otherprotein entitytwo the
entityone a transcriptional modulator communicates otherprotein otherprotein the entitytwo
communicates otherprotein entityone the entitytwo
entityone entitytwo transactivates viral
finding entityone directly interacts otherprotein entitytwo otherprotein
finding entityone directly interacts otherprotein rna polyme otherprotein II subunit entitytwo common
finding entityone directly interacts otherprotein rna polyme otherprotein II subunit otherprotein common subunit RNA polyme otherprotein implies entitytwo directly modulates
interacts otherprotein entityone entitytwo common
interacts otherprotein entityone otherprotein common subunit RNA polyme otherprotein implies entitytwo directly modulates
subunit entityone common subunit RNA polyme otherprotein implies entitytwo directly modulates
possibility entityone entitytwo interact
entityone entitytwo specifically bound
entityone otherprotein specifically bound entitytwo otherprotein
entityone otherprotein specifically bound otherprotein entitytwo vitro
otherprotein entityone specifically bound entitytwo otherprotein
otherprotein entityone specifically bound otherprotein entitytwo vitro
specifically bound entityone entitytwo vitro
proteins revealed entityone entitytwo otherprotein
proteins revealed entityone otherprotein entitytwo has
revealed otherprotein entityone entitytwo has
entityone substitution mutants had severely impaired trans otherprotein activity exhibited reduced binding affinity otherprotein otherprotein entitytwo otherprotein
entityone substitution mutants had severely impaired trans otherprotein activity exhibited reduced binding affinity otherprotein otherprotein otherprotein entitytwo a
entityone substitution mutants had severely impaired trans otherprotein activity exhibited reduced binding affinity otherprotein otherprotein otherprotein otherprotein a mutually exclusive manner suggesting entitytwo transactivation requires
entityone substitution mutants had severely impaired trans otherprotein activity exhibited reduced binding affinity otherprotein otherprotein otherprotein RPB5 a mutually exclusive manner suggesting HBx transactivation requires interactions both entitytwo otherprotein
entityone substitution mutants had severely impaired trans otherprotein activity exhibited reduced binding affinity otherprotein otherprotein TFIIB otherprotein a mutually exclusive manner suggesting HBx transactivation requires interactions both otherprotein entitytwo
otherprotein entityone entitytwo a
otherprotein entityone otherprotein a mutually exclusive manner suggesting entitytwo transactivation requires
otherprotein entityone RPB5 a mutually exclusive manner suggesting otherprotein transactivation requires interactions both entitytwo TFIIB
otherprotein entityone otherprotein a mutually exclusive manner suggesting otherprotein transactivation requires interactions both otherprotein entitytwo
otherprotein entityone a mutually exclusive manner suggesting entitytwo transactivation requires
otherprotein entityone a mutually exclusive manner suggesting otherprotein transactivation requires interactions both entitytwo otherprotein
TFIIB entityone a mutually exclusive manner suggesting otherprotein transactivation requires interactions both rpb5 entitytwo
manner suggesting entityone transactivation requires interactions both entitytwo otherprotein
manner suggesting entityone transactivation requires interactions both otherprotein entitytwo
interactions both entityone entitytwo
results indicated entityone a novel virus modulator facilitates transcriptional initiation stabilizing association RNA polyme otherprotein and entitytwo communication
results indicated entityone a novel virus modulator facilitates transcriptional initiation stabilizing association RNA polyme otherprotein otherprotein communication otherprotein entitytwo and otherprotein
results indicated entityone a novel virus modulator facilitates transcriptional initiation stabilizing association RNA polyme otherprotein tfiib communication otherprotein otherprotein and entitytwo
otherprotein entityone communication otherprotein entitytwo and TFIIB
otherprotein entityone communication otherprotein otherprotein and entitytwo
communication otherprotein entityone entitytwo
the typei entityone entitytwo complexed
the typei entityone receptor complexed otherprotein entitytwo
structure the entityone complexed otherprotein entitytwo
entityone entitytwo an
entityone family currently consists two agonists entitytwo otherprotein
entityone family currently consists two agonists otherprotein entitytwo one
entityone family currently consists two agonists otherprotein otherprotein one antagonist entitytwo
two agonists entityone entitytwo one
two agonists entityone otherprotein one antagonist entitytwo
agonists otherprotein entityone one antagonist entitytwo
type entityone entitytwo otherprotein
type entityone receptor entitytwo
binds the entityone entitytwo
binding entityone entitytwo otherprotein
binding entityone otherprotein entitytwo an
binding entityone otherprotein otherprotein an early step entitytwo signal transduction
otherprotein entityone entitytwo an
otherprotein entityone otherprotein an early step entitytwo signal transduction
otherprotein entityone an early step entitytwo signal transduction
threedimensional structure entityone bound the extracellular domain entitytwo otherprotein
threedimensional structure entityone bound the extracellular domain otherprotein entitytwo 25
extracellular domain entityone entitytwo 25
entityone binds entitytwo otherprotein
structure shows entityone consists three immunoglobulinlike domains wrap around entitytwo a
structure the entityone entitytwo otherprotein
producing cytokines entityone entitytwo otherprotein
producing cytokines entityone otherprotein entitytwo ref
cytokines otherprotein entityone entitytwo ref
ligands the entityone entitytwo otherprotein exist
ligands entityone receptor entitytwo exist the
ligands entityone receptor otherprotein exist the agonists entitytwo otherprotein
ligands entityone receptor otherprotein exist the agonists otherprotein entitytwo the
ligands entityone receptor otherprotein exist the agonists otherprotein otherprotein the entitytwo receptor antagonist
ligands entityone receptor otherprotein exist the agonists otherprotein otherprotein the entitytwo antagonist otherprotein
ligands entityone receptor otherprotein exist the agonists otherprotein otherprotein the entitytwo otherprotein
ligands entityone receptor otherprotein exist the agonists otherprotein otherprotein the otherprotein antagonist entitytwo ref
ligands entityone entitytwo exist the
ligands entityone otherprotein exist the agonists entitytwo otherprotein
ligands entityone otherprotein exist the agonists otherprotein entitytwo the
ligands entityone otherprotein exist the agonists otherprotein otherprotein the entitytwo receptor antagonist
ligands entityone otherprotein exist the agonists otherprotein otherprotein the entitytwo antagonist otherprotein
ligands entityone otherprotein exist the agonists otherprotein otherprotein the entitytwo otherprotein
ligands entityone otherprotein exist the agonists otherprotein otherprotein the otherprotein receptor antagonist entitytwo ref
otherprotein receptor entityone exist agonists entitytwo otherprotein
otherprotein receptor entityone exist agonists otherprotein entitytwo the
otherprotein entityone exist the agonists otherprotein otherprotein the entitytwo receptor antagonist
otherprotein receptor entityone exist agonists otherprotein otherprotein the entitytwo antagonist otherprotein
otherprotein receptor entityone exist agonists otherprotein otherprotein the entitytwo otherprotein ref
otherprotein receptor entityone exist agonists otherprotein otherprotein the otherprotein receptor antagonist entitytwo ref
exist agonists entityone entitytwo the
exist agonists entityone otherprotein the entitytwo receptor antagonist
exist agonists entityone otherprotein the entitytwo antagonist otherprotein
exist agonists entityone otherprotein the entitytwo otherprotein
exist agonists entityone otherprotein the otherprotein receptor antagonist entitytwo ref
agonists otherprotein entityone the entitytwo receptor antagonist
agonists otherprotein entityone the entitytwo antagonist otherprotein
agonists otherprotein entityone the entitytwo otherprotein
agonists otherprotein entityone the otherprotein receptor antagonist entitytwo ref
otherprotein the entityone entitytwo antagonist otherprotein
otherprotein the entityone entitytwo otherprotein
otherprotein the entityone receptor antagonist entitytwo ref
otherprotein the entityone entitytwo otherprotein
otherprotein the entityone antagonist entitytwo ref
otherprotein the entityone entitytwo ref
part typeI entityone entitytwo complexed
part typeI entityone complexed otherprotein entitytwo
extracellular part entityone complexed otherprotein entitytwo
biological function entityone 'receptor trigger site' not direct contact otherprotein receptor the entitytwo complex
domain activated entityone entitytwo absolutely
domain activated entityone otherprotein absolutely required interaction otherprotein specific inhibitor entitytwo otherprotein
domain activated entityone otherprotein absolutely required interaction otherprotein specific inhibitor otherprotein entitytwo
activated otherprotein entityone absolutely required interaction otherprotein specific inhibitor entitytwo otherprotein
activated otherprotein entityone absolutely required interaction otherprotein specific inhibitor otherprotein entitytwo
specific inhibitor entityone entitytwo
production entityone entitytwo wildtype
production entityone otherprotein wildtype mutant human entitytwo otherprotein
production entityone otherprotein wildtype mutant human otherprotein type entitytwo proteins
recombinant human otherprotein entityone wildtype mutant human entitytwo otherprotein
recombinant human otherprotein entityone wildtype mutant human otherprotein type entitytwo proteins
mutant human entityone entitytwo proteins
wildtype entityone well the entitytwo mutant lacking
wildtype entityone well mmp1 mutant lacking the Cterminal hemopexinlike domain des248450 entitytwo exhibit
wildtype entityone well mmp1 mutant lacking the Cterminal hemopexinlike domain des248450mmp1 exhibit enzymatic activity upon cleavage the prodomain treatment otherprotein entitytwo 4aminophenylmercuric
well entityone mutant lacking the Cterminal hemopexinlike domain des248450 entitytwo exhibit
well entityone mutant lacking the Cterminal hemopexinlike domain des248450mmp1 exhibit enzymatic activity upon cleavage the prodomain treatment otherprotein entitytwo 4aminophenylmercuric
hemopexinlike domain des248450 entityone exhibit enzymatic activity upon cleavage the prodomain treatment otherprotein entitytwo 4aminophenylmercuric
ete activesite des161228 entityone w otherprotein the catalytic domain mutation a single residue the zn2+ binding domain his199 generates stable forms entitytwo proteins
ete activesite des161228 entityone w otherprotein the catalytic domain mutation a single residue the zn2+ binding domain his199 generates stable forms MMP1 proteins are unable digest entitytwo otherprotein
ete activesite des161228 entityone w otherprotein the catalytic domain mutation a single residue the zn2+ binding domain his199 generates stable forms MMP1 proteins are unable digest otherprotein entitytwo
stable forms entityone proteins are unable digest entitytwo otherprotein
stable forms entityone proteins are unable digest otherprotein entitytwo
unable digest entityone entitytwo
assay using immobilized entityone determine structural requirements entitytwo form
cterminal mutant des248450 entityone proteins able form complexes otherprotein entitytwo
deletion mutants des161228 entityone des161228248450 entitytwo interact
deletion mutants des161228 entityone des161228248450MMP1 interact otherprotein entitytwo
des161228mmp1 des161228248450 entityone interact otherprotein entitytwo
hemopexin domain entityone cont otherprotein to corresponding regions entitytwo otherprotein
hemopexin domain entityone cont otherprotein to corresponding regions otherprotein entitytwo not
hemopexin domain entityone cont otherprotein to corresponding regions otherprotein otherprotein not interact otherprotein entitytwo
corresponding regions entityone entitytwo not
corresponding regions entityone otherprotein not interact otherprotein entitytwo
otherprotein entityone not interact otherprotein entitytwo
catalytic domain entityone its ability bind zn2+ absolutely required complex formation otherprotein entitytwo further
catalytic domain entityone its ability bind zn2+ absolutely required complex formation otherprotein otherprotein further underlines importance this region proper regulation enzymatic activity entitytwo
formation otherprotein entityone further underlines importance this region proper regulation enzymatic activity entitytwo
association entityone entitytwo otherprotein
association entityone otherprotein otherprotein entitytwo
otherprotein entityone otherprotein entitytwo
studies entityone knockout mice implicate entitytwo a
an imperfect entityone entitytwo like sequence
investigated whether entityone binds tyrosinephosphorylated entitytwo interacts
investigated whether entityone binds tyrosinephosphorylated otherprotein interacts otherprotein entitytwo following
binds tyrosinephosphorylated entityone interacts otherprotein entitytwo following
entityone activity the regulatory entitytwo subunit
entityone activity the regulatory otherprotein subunit entitytwo associated
entityone activity the regulatory otherprotein subunit PI 3kinase associated otherprotein entitytwo pervanadatestimulated
the regulatory entityone subunit entitytwo associated
the regulatory entityone subunit otherprotein associated otherprotein entitytwo pervanadatestimulated
otherprotein subunit entityone associated otherprotein entitytwo pervanadatestimulated
cellular entityone well the recombinant src homology SH2 domains entitytwo bound
entityone entitytwo associated
entityone otherprotein associated otherprotein entitytwo specifically
otherprotein entityone associated otherprotein entitytwo specifically
recruitment entityone entitytwo otherprotein
recruitment entityone otherprotein entitytwo
otherprotein entityone entitytwo
entityone forms complexes otherprotein beta integrins the integrins known regulate keratinocyte behaviour investigated entitytwo expression
extensive colocalisation entityone beta integrins microvilli at cellcell borders basal keratinocytes however cont otherprotein to integrins entitytwo not
entityone detected beta integrin immunoprecipitates also immunoprecipitates entitytwo otherprotein
entityone detected beta integrin immunoprecipitates also immunoprecipitates otherprotein and entitytwo not
immunoprecipitates entityone entitytwo not
entityone associated otherprotein alpha beta but alpha beta small amounts entitytwo also coimmunoprecipitated
antibodies entityone not affect proportion keratinocytes adhered entitytwo otherprotein
antibodies entityone not affect proportion keratinocytes adhered otherprotein entitytwo otherprotein
antibodies entityone not affect proportion keratinocytes adhered otherprotein otherprotein entitytwo did
adhered entityone entitytwo otherprotein
adhered entityone otherprotein entitytwo did
adhered otherprotein entityone entitytwo did
antibodies the entityone subunit anti entitytwo inhibited suspensioninduced
entityone prevents entitytwo otherprotein containing
entityone prevents otherprotein entitytwo containing otherprotein
entityone prevents otherprotein otherprotein containing entitytwo complexes formation
otherprotein prevents entityone entitytwo containing otherprotein
otherprotein prevents entityone otherprotein containing entitytwo complexes formation
otherprotein prevents otherprotein entityone containing entitytwo complexes formation
regulated the entityone entitytwo protein otherprotein
regulated the entityone otherprotein protein entitytwo the
regulated the entityone otherprotein protein otherprotein the pocket proteins entitytwo otherprotein
regulated the entityone otherprotein protein otherprotein the pocket proteins otherprotein entitytwo p
regulated the entityone otherprotein protein otherprotein the pocket proteins otherprotein otherprotein entitytwo otherprotein
regulated the entityone otherprotein protein otherprotein the pocket proteins otherprotein otherprotein p otherprotein entitytwo
the otherprotein entityone protein entitytwo the
the otherprotein entityone protein otherprotein the pocket proteins entitytwo otherprotein
the otherprotein entityone protein otherprotein the pocket proteins otherprotein entitytwo p
the otherprotein entityone protein otherprotein the pocket proteins otherprotein otherprotein entitytwo otherprotein
the otherprotein entityone protein otherprotein the pocket proteins otherprotein otherprotein p otherprotein entitytwo
otherprotein otherprotein protein entityone the pocket proteins entitytwo otherprotein
otherprotein otherprotein protein entityone the pocket proteins otherprotein entitytwo p
otherprotein otherprotein protein entityone the pocket proteins otherprotein otherprotein entitytwo otherprotein
otherprotein otherprotein protein entityone the pocket proteins otherprotein otherprotein p otherprotein entitytwo
pocket proteins entityone entitytwo p
pocket proteins entityone otherprotein entitytwo otherprotein
pocket proteins entityone otherprotein p otherprotein entitytwo
proteins otherprotein entityone entitytwo otherprotein
proteins otherprotein entityone p otherprotein entitytwo
otherprotein otherprotein entityone entitytwo
entityone complex containing mainly entitytwo p
entityone complex containing mainly otherprotein entitytwo otherprotein e2fg0g1
entityone complex containing mainly otherprotein p otherprotein entitytwo e2fg0g1 complex
entityone complex containing mainly otherprotein p otherprotein otherprotein entitytwo g0g1 complex
entityone complex containing mainly otherprotein p otherprotein otherprotein e2fg0g1 complex appears DNA synthesis arrests replacing entitytwo otherprotein containing
entityone complex containing mainly otherprotein p otherprotein otherprotein e2fg0g1 complex appears DNA synthesis arrests replacing otherprotein entitytwo containing e2f
entityone complex containing mainly otherprotein p otherprotein otherprotein e2fg0g1 complex appears DNA synthesis arrests replacing otherprotein otherprotein containing entitytwo complex
entityone complex containing mainly otherprotein p otherprotein otherprotein e2fg0g1 complex appears DNA synthesis arrests replacing otherprotein otherprotein containing e2f complex proliferating myoblasts entitytwo g1s complex
complex containing mainly entityone entitytwo otherprotein otherprotein
complex containing mainly entityone p otherprotein entitytwo otherprotein g0g1
complex containing mainly entityone p otherprotein otherprotein entitytwo g0g1 complex
complex containing mainly entityone p otherprotein otherprotein otherprotein g0g1 complex appears DNA synthesis arrests replacing entitytwo otherprotein containing
complex containing mainly entityone p otherprotein otherprotein otherprotein g0g1 complex appears DNA synthesis arrests replacing otherprotein entitytwo containing otherprotein
complex containing mainly entityone p otherprotein otherprotein e2fg0g1 complex appears DNA synthesis arrests replacing otherprotein otherprotein containing entitytwo complex
complex containing mainly entityone p otherprotein otherprotein e2fg0g1 complex appears DNA synthesis arrests replacing otherprotein otherprotein containing e2f complex proliferating myoblasts entitytwo g1s complex
otherprotein and entityone entitytwo otherprotein g0g1
mainly otherprotein entityone otherprotein entitytwo g0g1 complex
otherprotein and entityone otherprotein otherprotein g0g1 complex appears DNA synthesis arrests replacing entitytwo otherprotein containing
otherprotein and entityone otherprotein otherprotein g0g1 complex appears DNA synthesis arrests replacing otherprotein entitytwo containing otherprotein
mainly otherprotein entityone otherprotein e2fg0g1 complex appears DNA synthesis arrests replacing otherprotein otherprotein containing entitytwo complex
mainly otherprotein entityone otherprotein e2fg0g1 complex appears DNA synthesis arrests replacing otherprotein otherprotein containing e2f complex proliferating myoblasts entitytwo g1s complex
otherprotein entityone entitytwo g0g1 complex
otherprotein entityone otherprotein g0g1 complex appears DNA synthesis arrests replacing entitytwo otherprotein containing
otherprotein entityone otherprotein g0g1 complex appears DNA synthesis arrests replacing otherprotein entitytwo containing otherprotein
otherprotein entityone e2fg0g1 complex appears DNA synthesis arrests replacing otherprotein otherprotein containing entitytwo complex
otherprotein entityone e2fg0g1 complex appears DNA synthesis arrests replacing otherprotein otherprotein containing e2f complex proliferating myoblasts entitytwo g1s complex
otherprotein otherprotein entityone g0g1 complex appears DNA synthesis arrests replacing entitytwo otherprotein containing
otherprotein otherprotein entityone g0g1 complex appears DNA synthesis arrests replacing otherprotein entitytwo containing e2f
otherprotein otherprotein entityone g0g1 complex appears DNA synthesis arrests replacing otherprotein otherprotein containing entitytwo complex
otherprotein otherprotein entityone g0g1 complex appears DNA synthesis arrests replacing otherprotein otherprotein containing e2f complex proliferating myoblasts entitytwo g1s complex
arrests replacing entityone entitytwo containing otherprotein
arrests replacing entityone otherprotein containing entitytwo complex
arrests replacing entityone otherprotein containing e2f complex proliferating myoblasts entitytwo g1s complex
replacing otherprotein entityone containing entitytwo complex
replacing otherprotein entityone containing e2f complex proliferating myoblasts entitytwo g1s complex
otherprotein otherprotein containing entityone complex proliferating myoblasts entitytwo g1s complex
differentiating c2c12 cells entityone complexes switch dna synthesis response serum prevented entitytwo DNA binding
differentiating c2c12 cells entityone complexes switch dna synthesis response serum prevented MyoD DNA binding activity the cdks inhibitor entitytwo downstream effector
differentiating c2c12 cells entityone complexes switch dna synthesis response serum prevented otherprotein DNA binding activity the cdks inhibitor otherprotein downstream effector entitytwo induced
prevented entityone dna binding activity the cdks inhibitor entitytwo downstream effector
prevented entityone dna binding activity the cdks inhibitor myod downstream effector entitytwo induced
cdks inhibitor entityone downstream effector entitytwo induced
differentiation formation entityone entitytwo otherprotein containing
differentiation formation entityone p otherprotein entitytwo containing complexes
otherprotein and entityone entitytwo containing complexes
fibroblasts stably expressing entityone entitytwo otherprotein myod
fibroblasts stably expressing entityone otherprotein entitytwo otherprotein chimerae
fibroblasts stably expressing entityone myod otherprotein entitytwo chimerae
fibroblasts stably expressing entityone myod otherprotein myod chimerae found estrogen directed entitytwo activation prevents
fibroblasts stably expressing entityone otherprotein otherprotein otherprotein chimerae found estrogen directed otherprotein activation prevents reassociation entitytwo otherprotein
fibroblasts stably expressing entityone otherprotein otherprotein otherprotein chimerae found estrogen directed otherprotein activation prevents reassociation otherprotein entitytwo the
fibroblasts stably expressing entityone otherprotein otherprotein otherprotein chimerae found estrogen directed otherprotein activation prevents reassociation otherprotein otherprotein the entitytwo containing complex
fibroblasts stably expressing entityone otherprotein otherprotein otherprotein chimerae found estrogen directed otherprotein activation prevents reassociation otherprotein otherprotein the otherprotein containing complex following serum stimulation this correlates otherprotein suppression entitytwo activity
stably expressing otherprotein entityone entitytwo myod chimerae
stably expressing otherprotein entityone otherprotein entitytwo chimerae
stably expressing otherprotein entityone otherprotein myod chimerae found estrogen directed entitytwo activation prevents
stably expressing otherprotein entityone otherprotein myod chimerae found estrogen directed myod activation prevents reassociation entitytwo otherprotein
stably expressing otherprotein entityone otherprotein myod chimerae found estrogen directed myod activation prevents reassociation otherprotein entitytwo the
stably expressing otherprotein entityone otherprotein myod chimerae found estrogen directed myod activation prevents reassociation otherprotein otherprotein the entitytwo containing complex
stably expressing otherprotein entityone otherprotein myod chimerae found estrogen directed myod activation prevents reassociation otherprotein otherprotein the otherprotein containing complex following serum stimulation this correlates otherprotein suppression entitytwo activity
expressing otherprotein myod entityone entitytwo chimerae
expressing otherprotein myod entityone myod chimerae found estrogen directed entitytwo activation prevents
expressing otherprotein otherprotein entityone otherprotein chimerae found estrogen directed otherprotein activation prevents reassociation entitytwo otherprotein
expressing otherprotein otherprotein entityone otherprotein chimerae found estrogen directed otherprotein activation prevents reassociation otherprotein entitytwo the
expressing otherprotein otherprotein entityone otherprotein chimerae found estrogen directed otherprotein activation prevents reassociation otherprotein otherprotein the entitytwo containing complex
expressing otherprotein otherprotein entityone otherprotein chimerae found estrogen directed otherprotein activation prevents reassociation otherprotein otherprotein the otherprotein containing complex following serum stimulation this correlates otherprotein suppression entitytwo activity
otherprotein myod otherprotein entityone chimerae found estrogen directed entitytwo activation prevents
otherprotein myod otherprotein entityone chimerae found estrogen directed myod activation prevents reassociation entitytwo otherprotein
otherprotein myod otherprotein entityone chimerae found estrogen directed myod activation prevents reassociation otherprotein entitytwo the
otherprotein myod otherprotein entityone chimerae found estrogen directed myod activation prevents reassociation otherprotein otherprotein the entitytwo containing complex
otherprotein myod otherprotein entityone chimerae found estrogen directed myod activation prevents reassociation otherprotein otherprotein the otherprotein containing complex following serum stimulation this correlates otherprotein suppression entitytwo activity
estrogen directed entityone activation prevents reassociation entitytwo otherprotein
estrogen directed entityone activation prevents reassociation otherprotein entitytwo the
estrogen directed entityone activation prevents reassociation otherprotein otherprotein the entitytwo containing complex
estrogen directed entityone activation prevents reassociation otherprotein otherprotein the otherprotein containing complex following serum stimulation this correlates otherprotein suppression entitytwo activity
reassociation entityone entitytwo the
reassociation entityone otherprotein the entitytwo containing complex
reassociation entityone otherprotein the otherprotein containing complex following serum stimulation this correlates otherprotein suppression entitytwo activity
reassociation otherprotein entityone the entitytwo containing complex
reassociation otherprotein entityone the otherprotein containing complex following serum stimulation this correlates otherprotein suppression entitytwo activity
otherprotein the entityone containing complex following serum stimulation this correlates otherprotein suppression entitytwo activity
mechanism which entityone induces permanent cell cycle arrest involves entitytwo upregulation
mechanism which entityone induces permanent cell cycle arrest involves otherprotein upregulation suppression the proliferationassociated cdkscontaining entitytwo complexes formation
cycle arrest involves entityone upregulation suppression the proliferationassociated cdkscontaining entitytwo complexes formation
identity factors entityone entitytwo otherprotein otherprotein
identity factors entityone otherprotein entitytwo otherprotein
identity factors entityone otherprotein otherprotein entitytwo otherprotein
identity factors entityone otherprotein otherprotein otherprotein entitytwo otherprotein
identity factors entityone otherprotein otherprotein otherprotein otherprotein entitytwo TRAFs
identity factors entityone otherprotein otherprotein otherprotein otherprotein otherprotein TRAFs associated otherprotein of entitytwo otherprotein
identity factors entityone otherprotein otherprotein otherprotein otherprotein otherprotein TRAFs associated otherprotein otherprotein entitytwo forms of
factors otherprotein entityone entitytwo otherprotein
factors otherprotein entityone otherprotein entitytwo otherprotein
factors otherprotein entityone otherprotein otherprotein entitytwo otherprotein
factors otherprotein entityone otherprotein otherprotein otherprotein entitytwo TRAFs
factors otherprotein entityone otherprotein otherprotein otherprotein otherprotein TRAFs associated otherprotein of entitytwo otherprotein
factors otherprotein entityone otherprotein otherprotein otherprotein otherprotein TRAFs associated otherprotein otherprotein entitytwo forms of
factors otherprotein otherprotein entityone entitytwo otherprotein
factors otherprotein otherprotein entityone otherprotein entitytwo otherprotein
factors otherprotein otherprotein entityone otherprotein otherprotein entitytwo TRAFs
factors otherprotein otherprotein entityone otherprotein otherprotein otherprotein TRAFs associated otherprotein of entitytwo otherprotein
factors otherprotein otherprotein entityone otherprotein otherprotein otherprotein TRAFs associated otherprotein otherprotein entitytwo forms of
otherprotein otherprotein otherprotein entityone entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein entitytwo TRAFs
otherprotein otherprotein otherprotein entityone otherprotein otherprotein TRAFs associated otherprotein of entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein otherprotein TRAFs associated otherprotein otherprotein entitytwo forms of
otherprotein otherprotein otherprotein entityone entitytwo TRAFs
otherprotein otherprotein otherprotein entityone otherprotein TRAFs associated otherprotein of entitytwo otherprotein
otherprotein otherprotein otherprotein entityone otherprotein TRAFs associated otherprotein otherprotein entitytwo forms of
otherprotein otherprotein entityone TRAFs associated otherprotein of entitytwo otherprotein
otherprotein otherprotein entityone TRAFs associated otherprotein otherprotein entitytwo forms of
entityone entitytwo forms of
human entityone first characterized a entitytwo binding protein
human entityone first characterized a entitytwo based
characterized a entityone entitytwo based
show fulllength entityone interacts otherprotein activated entitytwo mammalian
show fulllength entityone interacts otherprotein activated ras mammalian cells defines minimum region 434 required efficient entitytwo binding
otherprotein activated entityone mammalian cells defines minimum region 434 required efficient entitytwo binding
entityone interacts otherprotein "effector domain" entitytwo employs
entityone interacts otherprotein "effector domain" RAS employs entitytwo determinants
entityone interacts otherprotein "effector domain" otherprotein employs otherprotein determinants are common and others are distinct those required the binding entitytwo known
entityone interacts otherprotein "effector domain" RAS employs RAS determinants are common and others are distinct those required the binding RA otherprotein known entitytwo effector
"effector domain" entityone employs entitytwo determinants
"effector domain" entityone employs RAS determinants are common and others are distinct those required the binding entitytwo known
"effector domain" entityone employs RAS determinants are common and others are distinct those required the binding RA otherprotein known entitytwo effector
employs entityone determinants are common and others are distinct those required the binding entitytwo known
employs entityone determinants are common and others are distinct those required the binding RA otherprotein known entitytwo effector
binding entityone known entitytwo effector
domain entityone binds entitytwo also interacts
domain entityone binds otherprotein also interacts otherprotein proteins extending similarity entitytwo other
domain entityone binds ras also interacts otherprotein proteins extending similarity RIN1 other entitytwo effectors
rin1 binds entityone also interacts otherprotein proteins extending similarity entitytwo other
otherprotein binds entityone also interacts otherprotein proteins extending similarity otherprotein other entitytwo effectors
similarity entityone other entitytwo effectors
mammalian cells entityone binding domain entitytwo act
entityone sequence shows preferential binding the entitytwo domain
aminoterminal domain entityone directly associates otherprotein is tyrosine phosphorylated entitytwo
otherprotein zip entityone bZip entitytwo proteins results
otherprotein zip entityone bZip otherprotein proteins results downregulation entitytwo activity
otherprotein bZip entityone proteins results downregulation entitytwo activity
otherprotein zip protein entityone screened cellular proteins could directly interact otherprotein entitytwo using
bZip protein entityone found efficiently interact otherprotein entitytwo
entityone specifically interacts otherprotein entitytwo not
entityone specifically interacts otherprotein otherprotein not otherprotein closely related family members entitytwo otherprotein otherprotein
entityone specifically interacts otherprotein otherprotein not otherprotein closely related family members otherprotein entitytwo otherprotein
entityone specifically interacts otherprotein otherprotein not otherprotein closely related family members otherprotein otherprotein entitytwo w
entityone specifically interacts otherprotein otherprotein not otherprotein closely related family members otherprotein otherprotein otherprotein or otherprotein entitytwo
interacts otherprotein entityone not otherprotein closely related family members entitytwo otherprotein otherprotein
interacts otherprotein entityone not otherprotein closely related family members otherprotein entitytwo otherprotein
interacts otherprotein entityone not otherprotein closely related family members otherprotein otherprotein entitytwo w
interacts otherprotein entityone not otherprotein closely related family members otherprotein otherprotein otherprotein or otherprotein entitytwo
related family members entityone entitytwo otherprotein
related family members entityone otherprotein entitytwo w
related family members entityone otherprotein otherprotein or otherprotein entitytwo
family members otherprotein entityone entitytwo w
family members otherprotein entityone otherprotein or otherprotein entitytwo
members otherprotein otherprotein entityone w otherprotein entitytwo
nterminal regions entityone required efficient interaction otherprotein entitytwo
vivo association entityone entitytwo been
expression exogenous entityone led a decrease entitytwo dependent transcription
coexpression exogenous entityone restored entitytwo activity
data show entityone entitytwo physically
family receptors entityone entitytwo otherprotein
family receptors entityone otherprotein entitytwo neuregulins help
receptors otherprotein entityone entitytwo neuregulins help
product the entityone gene a motif structure similar that neuregulins an alternative splicing site the entitytwo otherprotein like
product the entityone gene a motif structure similar that neuregulins an alternative splicing site the otherprotein entitytwo like domain
site the entityone entitytwo like domain
recombinant entityone induces tyrosinephosphorylation entitytwo otherprotein
recombinant entityone induces tyrosinephosphorylation otherprotein entitytwo otherprotein
recombinant entityone induces tyrosinephosphorylation otherprotein otherprotein entitytwo cell
tyrosinephosphorylation entityone entitytwo otherprotein
tyrosinephosphorylation entityone otherprotein entitytwo cell
tyrosinephosphorylation otherprotein entityone entitytwo cell
combinations ErbBs entityone activates w otherprotein entitytwo andor otherprotein
combinations ErbBs entityone activates w otherprotein otherprotein andor entitytwo suggesting
combinations ErbBs entityone activates w otherprotein otherprotein andor otherprotein suggesting signalling entitytwo mediated
combinations ErbBs entityone activates w otherprotein erbb3 andor otherprotein suggesting signalling otherprotein mediated entitytwo andor otherprotein
combinations ErbBs entityone activates w otherprotein otherprotein andor erbb4 suggesting signalling otherprotein mediated otherprotein andor entitytwo receptors
w otherprotein entityone andor entitytwo suggesting
w otherprotein entityone andor otherprotein suggesting signalling entitytwo mediated
w otherprotein entityone andor otherprotein suggesting signalling otherprotein mediated entitytwo andor otherprotein
w otherprotein entityone andor erbb4 suggesting signalling otherprotein mediated ErbB3 andor entitytwo receptors
otherprotein otherprotein andor entityone suggesting signalling entitytwo mediated
otherprotein erbb3 andor entityone suggesting signalling otherprotein mediated entitytwo andor erbb4
otherprotein otherprotein andor entityone suggesting signalling otherprotein mediated otherprotein andor entitytwo receptors
signalling entityone mediated entitytwo andor otherprotein
signalling entityone mediated otherprotein andor entitytwo receptors
mediated entityone andor entitytwo receptors
interaction entityone protein entitytwo response
telangiectasia designated entityone entitytwo ' is
protein tyrosine kinase entityone also defective radiationinduced arrest investigated possibility entitytwo might interact
protein tyrosine kinase entityone also defective radiationinduced arrest investigated possibility otherprotein might interact otherprotein entitytwo response
possibility entityone might interact otherprotein entitytwo response
show entityone binds entitytwo constitutively
sh3 domain entityone interacts otherprotein DPAPNPPHFP motif residues of entitytwo
findings indicate entityone involved the activation entitytwo DNA
work indicated entityone entitytwo might
work indicated entityone otherprotein might involved entitytwo mediated repression
otherprotein entityone might involved entitytwo mediated repression
physical interaction entityone entitytwo coactivator
physical interaction entityone otherprotein coactivator entitytwo not
physical interaction entityone otherprotein coactivator CREB not sufficient repression entitytwo mediated transcription
otherprotein entityone coactivator entitytwo not
otherprotein entityone coactivator CREB not sufficient repression entitytwo mediated transcription
coactivator entityone not sufficient repression entitytwo mediated transcription
repression entityone directed transcription may accomplished direct physical interaction entitytwo this
necessary entityone repress entitytwo otherprotein
necessary entityone repress otherprotein entitytwo mediated transcription
otherprotein repress entityone entitytwo mediated transcription
protooncoprotein entityone interacts otherprotein entitytwo activated
molecular adapter entityone rapidly tyrosine phosphorylated following stimulation the entitytwo associates
molecular adapter entityone rapidly tyrosine phosphorylated following stimulation the otherprotein associates otherprotein entitytwo homology domain2
molecular adapter entityone rapidly tyrosine phosphorylated following stimulation the otherprotein associates otherprotein otherprotein homology domain2 sh2sh3 domaincontaining adapters as entitytwo otherprotein
molecular adapter entityone rapidly tyrosine phosphorylated following stimulation the otherprotein associates otherprotein otherprotein homology domain2 sh2sh3 domaincontaining adapters as otherprotein entitytwo otherprotein
molecular adapter entityone rapidly tyrosine phosphorylated following stimulation the otherprotein associates otherprotein otherprotein homology domain2 sh2sh3 domaincontaining adapters as otherprotein otherprotein entitytwo interact
stimulation the entityone associates otherprotein entitytwo homology domain2
stimulation the entityone associates otherprotein otherprotein homology domain2 sh2sh3 domaincontaining adapters as entitytwo otherprotein
stimulation the entityone associates otherprotein otherprotein homology domain2 sh2sh3 domaincontaining adapters as otherprotein entitytwo otherprotein
stimulation the entityone associates otherprotein otherprotein homology domain2 sh2sh3 domaincontaining adapters as otherprotein otherprotein entitytwo interact
associates otherprotein entityone homology domain2 sh2sh3 domaincontaining adapters as entitytwo otherprotein
associates otherprotein entityone homology domain2 sh2sh3 domaincontaining adapters as otherprotein entitytwo otherprotein
associates otherprotein entityone homology domain2 sh2sh3 domaincontaining adapters as otherprotein otherprotein entitytwo interact
adapters as entityone entitytwo otherprotein
adapters as entityone otherprotein entitytwo interact
as otherprotein entityone entitytwo interact
suggests entityone may link entitytwo activation
SH2SH3containing protein entityone also contains guanine nucleotide exchange factor domain entitytwo a
SH2SH3containing protein entityone also contains guanine nucleotide exchange factor domain Vav a crucial role thymocyte development activation peripheral cells following stimulation the entitytwo
factor domain entityone a crucial role thymocyte development activation peripheral cells following stimulation the entitytwo
show entityone entitytwo form inducible
show entityone otherprotein form inducible molecular complexes entitytwo activated murine
otherprotein entityone form inducible molecular complexes entitytwo activated murine
entityone entitytwo interactions
entityone otherprotein interactions also detectable freshly isolated cells genetargeted mice lack T cellspecific inhibitory receptor entitytwo which
entityone ccbl interactions also detectable freshly isolated cells genetargeted mice lack T cellspecific inhibitory receptor otherprotein which entitytwo hyperphosphorylated
otherprotein entityone interactions also detectable freshly isolated cells genetargeted mice lack T cellspecific inhibitory receptor entitytwo which
otherprotein entityone interactions also detectable freshly isolated cells genetargeted mice lack T cellspecific inhibitory receptor otherprotein which entitytwo hyperphosphorylated
cellspecific inhibitory receptor entityone which entitytwo hyperphosphorylated
interaction entityone entitytwo directly
interaction entityone otherprotein directly mediated via SH2 domain entitytwo is
interaction entityone cCbl directly mediated via SH2 domain Vav is dependent tyrosine phosphorylation entitytwo
Vav entityone directly mediated via SH2 domain entitytwo is
otherprotein entityone directly mediated via SH2 domain otherprotein is dependent tyrosine phosphorylation entitytwo
sh2 domain entityone is dependent tyrosine phosphorylation entitytwo
mtp present entityone the binding site the entitytwo sh2 domain
data imply entityone a molecular adapter regulates function entitytwo thymocytes
cell migration entityone cleavage entitytwo
specific cleavage entityone entitytwo otherprotein
specific cleavage entityone otherprotein entitytwo otherprotein
specific cleavage entityone otherprotein otherprotein entitytwo shown
cleavage otherprotein entityone entitytwo otherprotein
cleavage otherprotein entityone otherprotein entitytwo shown
otherprotein otherprotein entityone entitytwo shown
entityone cleaved entitytwo gamma2 subunit
entityone cleaved entitytwo subunit
entityone cleaved otherprotein subunit residue exposing putative cryptic promigratory site entitytwo triggers
otherprotein cleaved entityone entitytwo subunit
otherprotein cleaved entityone gamma2 subunit residue exposing putative cryptic promigratory site entitytwo triggers
otherprotein cleaved entityone subunit residue exposing putative cryptic promigratory site entitytwo triggers
cleavage entityone entitytwo the
cleavage entityone otherprotein the resulting activation the entitytwo cryptic site
Ln5 entityone the resulting activation the entitytwo cryptic site
entityone entitytwo complex structural
entityone otherprotein complex structural basis GTPase activation its loss oncogenic entitytwo mutants
Ras entityone complex structural basis GTPase activation its loss oncogenic entitytwo mutants
between human entityone bound guanosine diphosphate the guanosine triphosphatase gtpaseactivating domain the human entitytwo otherprotein otherprotein
between human entityone bound guanosine diphosphate the guanosine triphosphatase gtpaseactivating domain the human otherprotein entitytwo otherprotein
between human entityone bound guanosine diphosphate the guanosine triphosphatase gtpaseactivating domain the human otherprotein otherprotein entitytwo the
the human entityone entitytwo otherprotein
the human entityone otherprotein entitytwo the
human otherprotein entityone entitytwo the
chain arginine789 entityone supplied the active site entitytwo neutralize
region entityone stabilized entitytwo thus allowing
region entityone stabilized otherprotein thus allowing glutamine61 entitytwo mutation
stabilized entityone thus allowing glutamine61 entitytwo mutation
arginine789 entityone glutamine61 entitytwo even
characterization entityone entitytwo otherprotein otherprotein
characterization entityone otherprotein entitytwo otherprotein interaction
characterization entityone otherprotein otherprotein entitytwo ligand interaction
characterization entityone otherprotein otherprotein entitytwo interaction
characterization otherprotein entityone entitytwo otherprotein ligand
characterization Fas entityone otherprotein entitytwo ligand interaction
characterization otherprotein entityone otherprotein entitytwo interaction
Fas otherprotein entityone entitytwo ligand interaction
otherprotein otherprotein entityone entitytwo interaction
fas otherprotein otherprotein entityone entitytwo interaction
deathinducing receptor entityone activated crosslinked the type membrane protein entitytwo ligand otherprotein
deathinducing receptor entityone activated crosslinked the type membrane protein entitytwo otherprotein
deathinducing receptor entityone activated crosslinked the type membrane protein otherprotein entitytwo
membrane protein entityone entitytwo otherprotein
membrane protein entityone ligand entitytwo
membrane protein entityone entitytwo
human soluble entityone otherprotein containing extracellular portion expressed human embryo kidney cells three nlinked glycans each entitytwo monomer
closely related entityone entitytwo complex
closely related entityone otherprotein complex molecular model the entitytwo homotrimer bound
closely related entityone otherprotein complex molecular model the otherprotein homotrimer bound three entitytwo molecules
related otherprotein alpha entityone complex molecular model the entitytwo homotrimer bound
related otherprotein alpha entityone complex molecular model the otherprotein homotrimer bound three entitytwo molecules
model the entityone homotrimer bound three entitytwo molecules
reduced cytotoxicity toward entityone positive cells otherprotein concomitant decrease the binding affinity the recombinant entitytwo immunoglobulin
Tyr218 entityone interacts otherprotein cluster three basic amino acid side chains entitytwo
entityone entitytwo a
characterize entityone binds activates receptor entitytwo
entityone like domain entitytwo tpo1153
entityone like domain otherprotein otherprotein has fused the entitytwo coat protein
like domain entityone tpo1153 been fused the entitytwo coat protein
both entityone receptor five anti entitytwo monoclonal
effective blocking entityone activity did block initial binding entitytwo its
results suggest entityone two distinct receptorbinding sites function dimerize entitytwo receptors
entityone negatively regulates entitytwo activity
entityone negatively regulates otherprotein activity interactions otherprotein entitytwo cysteinerich domain
otherprotein negatively regulates entityone activity interactions otherprotein entitytwo cysteinerich domain
although entityone a critical effector entitytwo signaling
although entityone a critical effector Ras signaling transformation mechanism which entitytwo promotes otherprotein
although entityone a critical effector otherprotein signaling transformation mechanism which otherprotein promotes entitytwo activation
critical effector entityone signaling transformation mechanism which entitytwo promotes otherprotein
critical effector entityone signaling transformation mechanism which ras promotes entitytwo activation
mechanism which entityone promotes entitytwo activation
recently reported entityone interaction otherprotein entitytwo cysteinerich domain
recently reported entityone interaction otherprotein entitytwo otherprotein crd
recently reported entityone interaction otherprotein otherprotein cysteinerich domain entitytwo residues
recently reported entityone interaction otherprotein otherprotein cysteinerich domain otherprotein crd residues may required entitytwo activation
otherprotein entityone entitytwo otherprotein crd
otherprotein entityone cysteinerich domain entitytwo residues
otherprotein entityone cysteinerich domain otherprotein crd residues may required entitytwo activation
otherprotein entityone entitytwo residues
otherprotein entityone otherprotein crd residues may required entitytwo activation
cysteinerich domain entityone residues may required entitytwo activation
entityone located the nh2terminal negative regulatory domain entitytwo is
integrity the entityone also critical entitytwo interaction
otherprotein entityone how interaction may mediate entitytwo function
demonstrate entityone binds directly the isolated entitytwo
moreover mutation entityone residues impairs binding 1433 not entitytwo the
moreover mutation entityone residues impairs binding 1433 not otherprotein the entitytwo
but entityone the entitytwo
otherprotein entityone may serve negative regulation entitytwo function
otherprotein entityone may serve negative regulation otherprotein function facilitating dissociation 1433 the nh2 terminus entitytwo promote
otherprotein entityone may serve negative regulation otherprotein function facilitating dissociation 1433 the nh2 terminus otherprotein to promote subsequent events necessary full activation entitytwo
negative regulation entityone function facilitating dissociation 1433 the nh2 terminus entitytwo promote
negative regulation entityone function facilitating dissociation 1433 the nh2 terminus otherprotein to promote subsequent events necessary full activation entitytwo
nh2 terminus entityone promote subsequent events necessary full activation entitytwo
interactions entityone the entitytwo receptor identification
interactions entityone the entitytwo identification
interactions entityone the otherprotein identification two ligand binding domains soluble entitytwo affinity
otherprotein the entityone entitytwo identification
otherprotein the entityone receptor identification two ligand binding domains soluble entitytwo affinity
otherprotein the entityone identification two ligand binding domains soluble entitytwo affinity
human neurotrophin entityone entitytwo expressed
human neurotrophin entityone receptor expressed Chinese hamster ovary cells a highly glycosylated protein possessing binding ability entitytwo otherprotein
human neurotrophin entityone receptor expressed Chinese hamster ovary cells a highly glycosylated protein possessing binding ability otherprotein entitytwo
the human entityone expressed Chinese hamster ovary cells a highly glycosylated protein possessing binding ability entitytwo otherprotein
the human entityone expressed Chinese hamster ovary cells a highly glycosylated protein possessing binding ability otherprotein entitytwo
binding ability entityone entitytwo
binding domains entityone isolated proteolytic digests the receptor affinity separation immobilized entitytwo
domain the entityone entitytwo binding
domain the entityone receptor binding entitytwo
domain the entityone binding entitytwo
subunit the entityone entitytwo different
subunit the entityone receptor different box interacts otherprotein entitytwo is
subunit entityone receptor different box interacts otherprotein otherprotein is sufficient activate the entitytwo stat pathway
subunit the entityone different box interacts otherprotein entitytwo is
subunit entityone different box interacts otherprotein otherprotein is sufficient activate the entitytwo stat pathway
interacts otherprotein entityone is sufficient activate entitytwo stat pathway
the human entityone entitytwo receptor
the human entityone entitytwo required
the human entityone ifnalpha receptor required the induction an antiviral state human entitytwo
human otherprotein entityone entitytwo required
human otherprotein entityone receptor required the induction an antiviral state human entitytwo
the human entityone required the induction an antiviral state human entitytwo
activate entityone stat pathway trigger antiviral state entitytwo binding
chain required entityone binding activation contains Box motif is important the interaction some cytokine receptors otherprotein entitytwo kinases
protein product entityone protooncogene known interact otherprotein several proteins including entitytwo otherprotein
protein product entityone protooncogene known interact otherprotein several proteins including otherprotein entitytwo otherprotein
protein product entityone protooncogene known interact otherprotein several proteins including otherprotein otherprotein entitytwo is
several proteins including entityone entitytwo otherprotein
several proteins including entityone otherprotein entitytwo is
proteins including otherprotein entityone entitytwo is
precise function entityone these pathways not clear although genetic analysis Caenorhabditis elegans suggests entitytwo a
precise function entityone these pathways not clear although genetic analysis Caenorhabditis elegans suggests cCbl a negative regulator the entitytwo receptor
precise function entityone these pathways not clear although genetic analysis Caenorhabditis elegans suggests cCbl a negative regulator the entitytwo
elegans suggests entityone a negative regulator the entitytwo receptor
elegans suggests entityone a negative regulator the entitytwo
regulator the entityone entitytwo
identified interactions involving entityone two isoforms entitytwo human unconventional
identified interactions involving entityone two isoforms otherprotein human unconventional myosin and recently identified sh3 domain containing protein entitytwo
two isoforms entityone human unconventional myosin and recently identified sh3 domain containing protein entitytwo
cell cycle regulator entityone entitytwo mediates repression
entityone entitytwo family
tumor suppressor protein entityone its partner entitytwo
demonstrate entityone may regulate activity the hiv1 long terminal repeat its ability bind sequences the entitytwo enhancer region
demonstrate entityone may regulate activity hiv1 long terminal repeat its ability bind sequences the nfkappab enhancer region to interact otherprotein the entitytwo subunit otherprotein
demonstrate entityone may regulate activity hiv1 long terminal repeat its ability bind sequences the otherprotein enhancer region to interact otherprotein the otherprotein subunit entitytwo
sequences entityone enhancer region to interact otherprotein the entitytwo subunit otherprotein
sequences entityone enhancer region to interact otherprotein the NFkappaB subunit entitytwo
otherprotein entityone subunit entitytwo
assays show entityone able bind specifically a site embedded otherprotein the two entitytwo elements
analysis using purified entityone entitytwo homodimers reveals
direct interaction entityone entitytwo the
assay demonstrates entityone represses entitytwo mediated transcription
both entityone entitytwo binding sites
both entityone otherprotein binding sites entitytwo mediated repression
otherprotein entityone binding sites entitytwo mediated repression
study suggest entityone activity may regulated its interaction otherprotein cell cycle regulatory protein entitytwo
entityone entitytwo dependent otherprotein
entityone otherprotein dependent entitytwo surface expression
otherprotein entityone dependent entitytwo surface expression
demonstrate entityone surface expression correlated otherprotein presence MHC class molecules provide suitable leader sequence peptides capable binding entitytwo
interaction entityone otherprotein molecules the endoplasmic reticulum revealed entitytwo associates
interaction entityone otherprotein molecules endoplasmic reticulum revealed HLAE associates otherprotein the entitytwo otherprotein
interaction entityone otherprotein molecules endoplasmic reticulum revealed HLAE associates otherprotein the transporter associated otherprotein antigen processing entitytwo otherprotein
interaction entityone otherprotein molecules endoplasmic reticulum revealed HLAE associates otherprotein the transporter associated otherprotein antigen processing otherprotein entitytwo that
interaction entityone otherprotein molecules endoplasmic reticulum revealed HLAE associates otherprotein the transporter associated otherprotein antigen processing otherprotein otherprotein that entitytwo expression
interaction entityone otherprotein molecules endoplasmic reticulum revealed hlae associates otherprotein the transporter associated otherprotein antigen processing tap otherprotein that HLAE expression entitytwo dependent
reticulum revealed entityone associates otherprotein entitytwo otherprotein
reticulum revealed entityone associates otherprotein transporter associated otherprotein antigen processing entitytwo otherprotein
reticulum revealed entityone associates otherprotein transporter associated otherprotein antigen processing otherprotein entitytwo that
reticulum revealed entityone associates otherprotein transporter associated otherprotein antigen processing otherprotein otherprotein that entitytwo expression
reticulum revealed entityone associates otherprotein transporter associated otherprotein antigen processing tap otherprotein that hlae expression entitytwo dependent
otherprotein entityone entitytwo otherprotein
otherprotein entityone otherprotein entitytwo that
otherprotein entityone otherprotein otherprotein that entitytwo expression
otherprotein entityone tap otherprotein that otherprotein expression entitytwo dependent
otherprotein antigen processing entityone entitytwo that
otherprotein antigen processing entityone otherprotein that entitytwo expression
otherprotein antigen processing entityone otherprotein that otherprotein expression entitytwo dependent
processing otherprotein entityone that entitytwo expression
processing tap entityone that otherprotein expression entitytwo dependent
otherprotein that entityone expression entitytwo dependent
addition entityone dissociates entitytwo upon binding
correlation entityone MHC class surface expression might relevant the function entitytwo
although entityone binding peptides derived signal sequences may released back the cytosol subsequently translocated the entitytwo complex
although entityone binding peptides derived signal sequences may released back the cytosol subsequently translocated the otherprotein complex loaded onto entitytwo molecules
translocated the entityone complex loaded onto entitytwo molecules